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Dear Fellow Natural Product Enthusiasts,
“Natural Products Rising to the Top,” was selected as the theme for the 2015 American Society of Pharmacognosy (ASP) 
Meeting. This topic symbolizes both the fact that this year’s meeting will take place at the highest altitude of any ASP meet-
ing held to date, as well as the profound rise in interests in natural products across many disciplines. The last half decade 
has witnessed a revolution in natural product research throughout the world and particularly in the United States. What 
makes these developments so exciting is the divergent evolution of how natural products are currently studied and used 
in research. This year’s meeting reflects these broadened and escalating interests in natural products by highlighting a rich 
variety of topics that will be presented by our symposium speakers, in parallel sessions, by award winners, throughout 
poster presentations, and within workshops. Scanning the enclosed abstracts reveals a breadth of topics including natural 
product drug discovery and development, medicinal and synthetic chemistry, genomics, ecology, botanicals, health and 
beauty, law, neuroscience, instrumentation, microbiome studies, and much more. These topics are sure to stimulate the 
hearts and minds of young and mature researchers alike as we join together to witness the wonderful science of our col-
leagues and friends.
A few additional special features are notable about this year’s meeting of the ASP. First, special efforts have been made to 
highlight the wide range of perspectives on natural products offered by colleagues from academic, government, and indus-
trial backgrounds. Second, this year’s lineup of parallel session speakers was selected solely by each session leader to best 
reflect the broadest possible spectrum of scientific interests and viewpoints. Notably, many of the parallel session leaders 
have been assembled from a growing number of ‘junior’ faculty (recently appointed assistant and research professors) 
whose voices are important to the growth of the ASP. And third, we are introducing a new session this year, ASP Younger 
Members Research Spotlight led by James Fuchs, which is devoted solely to the contributions of some of our most outstand-
ing graduate and postdoc researchers.
Such a wonderful meeting would not be possible without the help of many outstanding individuals and organizations. Spe-
cial thanks are given first and foremost to our terrific sponsors and vendors who have helped us achieve an all-time record 
for meeting support. Appreciation is also given to our presenters for sharing their original work and ideas about natural 
products. The great assistance of our scientific organizing committee is also acknowledged, especially my co-chair, Susan 
Mooberry who has helped recruit speakers and provide advice about session topics. It is important to note the enduring 
support and organizational acumen of Ms. Candace Coker who is the project manager for the Institute for Natural Prod-
ucts Applications & Research Technologies at the University of Oklahoma, which is the host of this year’s meeting. She has 
been at the heart of all matters related to the development, planning, and organization of the meeting and her dedication 
is greatly appreciated. Finally, it is vital that thanks and recognition be given to all of you who will be attending this year’s 
meeting. Without your comradery and willingness to share your time and thoughts concerning natural products, this 
meeting would not be possible. It is because of you that natural products are truly rising to the top and the view towards 
the future of the field looks spectacular.
Sincerely,
Robert H. Cichewicz, Ph.D. 
Chair of ASP 2015 
Regents’ Professor and Director  
Institute for Natural Products Applications & 
Research Technologies at the University of Oklahoma
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                                                               July 25 – 29, 2015
General Information
Oral Presentations
All oral presentations will be held in the Big Horn Room(s) and/or the Ptarmigan Room in the Copper Mountain Confer-
ence Center. Please make sure to check in with your session leader in the room of your talk 15 minutes prior to the session. 
Presentations will be loaded onto the PC in your session room provided by the ASP meeting. Please have your presentation 
ready on a USB flash drive. If you would prefer to use your own MAC or your own PC, you may do so, but please notify your 
session leader in advance. Please note: all data will be removed from the session computers at the conclusion of the meeting.
Poster Presentations
All posters sessions will take place in the Copper Pavilion. Poster Session 1: Posters should be set up for this session on Satur-
day, July 25 between the hours of 3:00 - 6:00 PM only. Posters should be removed on the same day between the hours of 10:00 
- 10:30 PM. Poster Sessions 2 & 3: Posters should be set up on the day of your session between the hours of 7:00 - 8:00 AM 
only. Posters should be removed on the same day between the hours of 5:30 - 6:00 PM. Posters not removed by the assigned 
time will be discarded.
Exhibitors
An exhibition of instrumentation, publications, and services will be located in the Copper Pavilion. We encourage everyone 
to visit these exhibits which will be open during every breakfast, coffee break, and poster session, Saturday, July 25 – Tuesday, 
July 28.
Registration
The 2015 ASP registration and information desk will be located in Kokopelli Trail, just outside of the Big Horn Room in the 
Copper Mountain Conference Center. 
Name Badges and Attire
Please wear your name badge for admission to the scientific program sessions and all social events. Casual attire is perfectly 
acceptable for all scientific program sessions and all social events. Average daytime temperature for Colorado in July is a mild 
88 degrees Fahrenheit with mornings and evenings being cooler. Rooms in the conference center may be cool as well, so we 
recommend that you bring a sweater or dress in layers. Copper Mountain is a very walkable community with many outdoor 
options to enjoy. You may consider wearing comfortable shoes. The Monday evening event and Tuesday afternoon Younger 
Member’s Event will both take place outside.
Extra Banquet Tickets
Extra banquet and event tickets must be purchased prior to 5:00 PM on Saturday, July 25. If you do not plan to attend the 
banquet, we would appreciate if you would return the ticket to the registration desk so that we may maintain an accurate 
count for the banquet.
Photography
No photos of presentations or posters will be permitted unless permission has been directly obtained from the presenter. 
Anyone in violation of this may be asked to leave. 
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Thank you to our 2015 Committee Members
Local Organizing Committee
Robert Cichewicz, University of Oklahoma (Meeting Chair) 
Anthony Burgett, University of Oklahoma 
Candace Coker, University of Oklahoma 
Adam Duerfeldt, University of Oklahoma 
Phil Proteau, Oregon State University (Ad Hoc) 
Indrajeet Sharma, University of Oklahoma 
Brad Stevenson, University of Oklahoma
Scientific Organizing Committee
Robert Cichewicz, University of Oklahoma (Chair) 
Susan Mooberry, UT Health Science Center, San Antonio (Co-Chair) 
Cindy Angerhofer, Aveda 
Emily Balskus, Harvard University 
Lou Barrows, University of Utah 
Sean Brady, Rockefeller University 
Anthony Burgett, University of Oklahoma 
John Cardellina, National Institutes of Health 
Jim Fuchs, Ohio State University 
Stefan Gafner, American Botanical Council 
Mark Hamann, University of Mississippi 
Liva Harinantenaina, Ohio State University 
Scott Lokey, University of California, Santa Cruz 
Nicholas Oberlies, University of North Carolina at Greensboro 
Melany Puglisi-Weening, Chicago State University 
Tom Prisinzano, University of Kansas 
April Risinger, UT Health Science Center, San Antonio 
Katherine Ryan, University of British Columbia 
Eric Schmidt, University of Utah 
Si Wu, University of Oklahoma 
Zhibo Yang, University of Oklahoma 
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Thank you to our 2015 Sponsors
Gold Premier Sponsors
                
          
Silver Premier Sponsors
                    
          
Bronze Premier Sponsors
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Thank you to our 2015 Exhibitors
Advion
AnalytiCon Discovery
Biotage
Buchi
Bruker Corporation
CAMAG Scientific, Inc.
CAS
Cerilliant Corporation
CRC Press/Taylor & Francis
Extrasynthese
Grace
Interchim, Inc.
Mestrelab Research
PhytoLab GmbH & Co. KG
Protea Biosciences, Inc.
Shimadzu Scientific Instruments
Sorbent Technologies, Inc.
Teledyne Iso
Thieme Publishers
Waters Corporation
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2015 Award Recipients
Norman R. Farnsworth Research Achievement Award 
Raymond Andersen, University of British Columbia
Varro Tyler Prize 
Cindy Angerhofer, Aveda
Matt Suffness Young Investigator Award 
John MacMillan, UT Southwestern Medical Center
2015 Waters Award for Excellence in Natural Products 
Paul Jensen, Scripps Institution of Oceanography
Research Starter Grant
Jason Kwan, University of Wisconsin-Madison
Student Research Award
Mayuramas Sang-Ngern, University of Hawaii
Undergraduate Research Awards
Nicole Nightingale, University of Pittsburgh 
Andrea Romanowski, Palm Beach Atlantic 
University
Paul Scesa, Florida Atlantic University 
ASP Student Travel Awards
Maryam Elfeki, University of Illinois at Chicago 
Krista Gill, University of Prince Edward Island, 
Canada Brittany Graf, Rutgers University 
Kyuho Moon, Seoul National University, Republic of 
Korea 
Jessica Ochoa, University of California, Santa Cruz 
Andrew Osborn, Oregon State University
Chris Thomas, University of Wisconsin-Madison
Active Member Travel Grant
Emily Mevers, Harvard University
Waquar H. Bhatti Student Travel Award
Ashley West, University of Connecticut
Lynn Brady Student Travel Award
Mary Choules, University of Illinois at Chicago
Ben Naman, Ohio State University
Yun Seo-Kil, Ewha Womans University, Seoul, 
Korea
David Carew Student Travel Award
Bailey Miller, University of California, San Diego
D. John Faulkner Travel Award
Sandra Loesgen, Oregon State University
Jerry McLaughlin Travel Award
Ian Miller, University of Wisconsin-Madison
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Program Schedule
Saturday, July 25, 2015
8:00 AM – 7:00 PM Registration Open (Kokopelli Trail)
Pre-Meeting Workshops | Registration required. Onsite registration available. 
9:00 AM – 12:00 PM Bioassays and Pharmacology of Natural Products  (Bighorn C2-3)
9:00 AM – 12:00 PM LC/MS: The Practical Aspects for Natural Product Analysis (Ptarmigan C)
9:00 AM – 12:00 PM Peer Review at NIH: Grantsmanship and the Peer Review Process at NIH; Strategic Funding 
Priorities for Basic and Mechanistic Research  (Ptarmigan B)
9:00 AM – 4:00 PM Advanced Analytical Technologies as Applied to Natural Products for Drug Discovery 
(Ptarmigan A)
1:00 PM – 4:00 PM Entrepreneurship and Natural Products; Early Stage Opportunities for Your Discoveries 
(Ptarmigan C)
1:00 PM – 4:00 PM The Nuts and Bolts of Contemporary NMR Spectroscopy (Ptarmigan B)
7:00 PM – 10:00 PM Opening Reception, Poster Session 1, Exhibits Open (Copper Pavilion)
 Hors d’oeuvres and cash bar. The Opening Reception is a ticketed event. One ticket is provided to 
all registrants, except One-Day registrants. Extra tickets can be purchased at the registration desk. 
Sunday, July 26, 2015
7:15 AM – 8:00 AM  Continental Breakfast, Exhibits Open (Copper Pavilion)
7:15 AM – 5:00 PM Registration Open (Kokopelli Trail) 
General Session (Bighorn)
Conference Welcome by Meeting Chair, Robert Cichewicz (University of Oklahoma)
8:00 AM – 8:50 AM Jonathan Baell (Monash University):  Your Natural Product Contains a Promiscuous 
 PAINS Motif: Is it Useful as a Biochemical Probe or in Drug Discovery?
8:50 AM – 9:40 AM Ben Shen (Scripps Florida): Microbial Genomics: New Opportunities for Natural Product
 Biosynthesis, Engineering, and Drug Discovery
9:40 AM – 10:15 AM Coffee Break, Exhibits Open (Copper Pavilion)
Sunday Morning Parallel Sessions
Session 1 - The Brave New World of Natural Product Total Synthesis (Bighorn B)
Chair: Anthony Burgett (University of Oklahoma)
10:18 AM Jason Chen (Iowa State University): Oxylipin Total Synthesis Uncovers Stereochemistry-dependent 
Conformations of Masked Diols
10:35 AM William Maio (New Mexico State University): The Taumycin a Macrocycle: Asymmetric Total Synthesis and 
Revision of Relative Stereochemistry
10:52 AM Jeremy May (University of Houston): Synthetic Discoveries from Polycyclic Natural Products
11:09 AM Joshua Pierce (North Carolina State University): Marine Natural Products Synthesis as a Driving Force for 
Chemical and Biological Discovery
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11:26 AM Thomas Poulsen (Aarhus University): Total Syntheses of Rakicidin A and BE-43547A1
11:43 AM Jennifer Stockdill (Wayne State University): Enabling Reactivity of Neutral Aminyl Radicals in Polycyclic 
Heterocycle Synthesis
Session 2 - Chemical Transformations in the Biosynthesis of Natural Products (Bighorn C)
Chair: Katherine Ryan (University of British Columbia)
10:15 AM Wilfred van der Donk (University of Illinois – Urbana/Champaign): Biosynthesis of Cyclic Peptide Antibiotics
10:45 AM Alessandra Eustaquio (University of Bergen): Spliceostatin Biosynthesis in Burkholderia spp.
11:10 AM David Zechel (Queen’s University): A Cure for Baldness and Cryptic Biosynthesis in Streptomyces Calvus
11:35 AM William Gerwick (Scripps Institute of Oceanography, University of California, San Diego): Discovery of 
Novel Cholorinated Acyl Amides from a Marine Cyanobacterium Using Inegrated Technologies
Session 3 - Natural Products and HIV, Progress and Directions (Ptarmigan) 
Chair: Lou Barrows (University of Utah)
10:15 AM   Kirk Gustafson (Center for Cancer Research, National Cancer Institute): Mining the Extensive Chemical 
Diversity of the NCI Natural Products Repository for New Agents that can Target HIV
10:40 AM Vicente Planelles (University of Utah School of Medicine): Ingenol 3,20 Dibenzoate Efficiently Reactivates 
Latent HIV
11:05 AM Prem Rai (University of Papua New Guinea School of Medicine and Health Sciences): Medicinal Plants Used 
by Traditional Medicine Practitioners for the Treatment of HIV/AIDS and Related conditions in Papua New 
Guinea
11:30 AM Sandra Loesgen (Oregon State University): News from Fungi – Targeting Viral Sweetspots
11:45 AM Mary Choules (University of Illinois at Chicago): A Rufomycin Analogue is an Anti-tuberculosis Drug Lead 
Targeting CLPC1 with No Cross Resistance to Eumicin
12:00 PM – 1:45 PM Boxed Lunches (Kokopelli Trail)
Sunday Afternoon Parallel Sessions
Session 4 - ASP Younger Members Research Spotlight (Bighorn B)
Chair: Jim Fuchs (Ohio State University)
1:50 PM Jessie Ochoa (University of California, Santa Cruz): Phylogenetic and Metabolomic Analysis of Marine 
Mammal Microbes Contributes to Emerging Spirotetronate Polyketides
2:00 PM Cong-Mei Cao (University of Kansas): Unusual Withanolides from Physalis Hispida (Waterf.) Cronquist
2:10 PM  Jie Li (Scripps Institution of Oceanography, University of California, San Diego): Discovery of Fatty Acid 
Synthase Inhibitors and their Biosynthetic Pathways by a Novel Target-directed Genome Mining Strategy
2:20 PM Weijing Cai (University of Florida): Discovery, Synthesis, and Biological Evaluation of Apratyramide, a 
Marine-derived Transcriptional Stimulator of Vegf-A
2:30 PM Joshua Kellogg (University of North Carolina at Greensboro): Chemometric-directed Bioexploration of 
Natural Products
2:40 PM Alyssa Sprouse (University of Illinois at Chicago): Pharmacokinetic Interactions Between Drugs and Botanical 
Dietary Supplements
2:50 PM Tyler Olsen (University of Oklahoma): Selectivity and Mechanistic Inquiries into the Reactivity of Pericosine A, 
an Electrophilic Chlorinated Shikimate Analogue
3:00 PM Susanna Chan (Molecular Targets Laboratory, Centre for Cancer Research, National Cancer Institute): 
Isolation and identification of Novel Natural Products that Inhibit P300/HIF-1α Interaction
3:10 PM Jaqueline von Salm (University of South Florida): Targeting Bioactive Chemical Space with a Small Natural 
Products Library: Expanding Diversity and Predicitability
3:20 PM Antonius Ola (University of Texas Health Science Center at San Antonio): Design, Synthesis and Biological 
Evaluation of New Bulky Acyloxy Taccalonolides as Potent Microtubule Stabilizers
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Session 5 - The Evolving Role of Natural Products in Neuroscience (Bighorn C)
Chair: Tom Prisinzano (University of Kansas)
1:50 PM Brian Blagg (University of Kansas): Natural Product Inspired Hsp90 Inhibitors
2:10 PM David Horgen (Hawaii Pacific University): Advances in the Validation of TRPM7 as a Drug Target Using 
Natural Products – Update on Waixenicin A
2:30 PM Scott Runyon (Research Triangle Institute): Development of Novel Neuroactive Steroids for the Potential 
Treatment of Neurological Disorders
2:50 PM Kevin Tidgewell (Duquense University): Panamanian Marine Cyanobacterial Extracts with In Vivo Activity 
in Models of Anxiety and Depression
3:10 PM Lyndon West (Florida Atlantic University): Discovery of Neuroprotective Marine Natural Products Using a 
Bioimaging/Optogenetics Approach and Drosophila Melanogaster
Session 6 - Recent Advances in Marine Chemical Ecology (Ptarmigan)
Chair: Melany Puglisi-Weening (Chicago State University)
1:50 PM Marcy Balunas (University of Connecticut): Functional and Biosynthetic Analyses of Secondary Metabolites in 
Host-Microbe Symbioses
2:10 PM Jason Kwan (University of Wisconsin at Madison): Integrated De Novo Metagenomics and 
Metatranscriptomics to Study Natural Products and Microbial Ecology In Situ
2:30 PM Amy Lane (University of North Florida): Biosynthesis and Ecological Functions of Diketopiperazine Natural 
Products from Marine Actinomycetes
2:50 PM David Rowley (University of Rhode Island): Mechanisms of Microbe-Microbe-Host Interactions in a Probiont-
Pathogen-Bivalve Model
3:10 PM Jennifer Sneed (Smithsonian Marine Station at Fort Pierce): Macroalgae May Interrupt Important Cues for 
Coral Larval Settlement
3:30 PM – 5:30 PM Poster Session 2, Coffee Break, Exhibits Open (Copper Pavilion)
General Session (Bighorn)
7:00 PM – 7:50 PM Amy Wright (Harbor Branch Oceanographic Institute of Florida Atlantic University): Discovery 
and Investigation of Therapeutically Important Marine Natural Products
7:50 PM – 8:40 PM Leslie Fischer (Novartis Pharmaceuticals): The Patent Eligibility of Natural Products in the United 
States: Understanding the Issues and Navigating the New Waters
 
MONDAY, JULY 27, 2015
7:15 AM – 8:00 AM  Continental Breakfast, Exhibits Open (Copper Pavilion)
7:15 AM – 5:00 PM  Registration Open (Kokopelli Trail)
General Session (Bighorn)
8:00 AM – 8:50 AM Paul Jensen (Center for Marine Biotechnology & Biomedicine, Scripps Institution of 
Oceanography): New Approaches to Microbial Natural Product Discovery. 2015 Waters Award for 
Excellence in Natural Products Innovation, Sponsored by Waters Corporation
8:50 AM – 9:40 AM  Carole Bewley (NIDDK, NIH Intramural Research): Beyond Structure – Diverse Mechanisms of 
Anti-infective Natural Products. Sponsored by Sequoia Sciences
9:40 AM – 10:15 AM Coffee Break, Exhibits Open (Copper Pavilion)
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Monday Morning Parallel Sessions
Session 7 - Natural Products and the Human Microbiota (Bighorn B) 
Chair: Emily Balskus (Harvard University)
Sponsored by Procter & Gamble & Takeda Pharmaceuticals International, Inc. 
10:30 AM Emily Balskus (Harvard University): Gut Reactions: Natural Products and the Human Microbiota
11:00 AM Peter Turnbaugh (University of California, San Francisco): Food, Drugs, and Bugs: A Metagenomic View of 
Pharamacology
11:30 AM Gerry Wright (McMaster University): Biotransformation of Anticancer Drugs by Human and Environmental 
Microbiomes
Session 8 - Natural Products Anticancer Drug Lead Discovery in Honor of Richard G. Powell (Bighorn C)
Chair: Susan Horwitz (Yeshiva University). Organizer: Douglas Kinghorn (Ohio State University)
Sponsored by the Journal of Natural Products
10:15 AM Richard Powell (National Center for Agricultural Utilization Research, USDA, Peoria, IL; Journal of 
Natural Products): Historical Aspects of Antitumor Compounds from Plants, including Homoharringtonine 
(Omacetaxine Mepesuccinate, Synribo TM)
10:30 AM David Kingston (Virginia Tech Center for Drug Discovery): Development of Taxol as an Anticancer Drug
11:00 AM Susan Moobery (University of Texas Health Science Center at San Antonio): North American Plants Remain 
an Excellent  Source for Compounds with Anticancer Potential
11:30 AM David Newman (National Cancer Institute): Are Natural Products Isolated from Plants, Products of EPI- and/
or Endo-phytic Microbial Interactions with/within the Host?
Session 9 - Bumpy Road to Beauty: Natural Products in the Cosmetic Industry (Ptarmigan)
Chair: Cindy Angerhofer (Aveda)
10:20 AM Jon Anderson (Actives International LLC): Paving the Way for Skincare
10:45 AM Chia Wen Chen (Estee Lauder): Ergothioneine, the Amazing Amino Acid
11:10 AM Vince Gruber (Sensient Color Technologies): From the Berry to the Barrier: Development of Natural Products 
for Skin and Hair Care
11:40 AM Artyom Duev (AkzoNobel Surface Chemistry): Selection of Prospective Ficus Species and Development of 
Novel Multifunctional Zeta Fractions for Personal Care
12:00 PM – 1:45 PM Lunch on your own
Monday Afternoon Parallel Sessions
Session 10 - Microbial Interactions in Humans and Other Animals (Bighorn B)
Chair: Eric Schmidt (University of Utah)
1:45 PM Jason Crawford (Yale University): Discovering and Deciphering the Pathogenic and Probiotic Activities form 
the Bacterial Colibactin Pathway
2:10 PM Nicole Lopanik (Georgia State University): Interactions Between the Marine Bryozoan Bugula Neritina, its 
Endosymbiont, and Symbiont-produced Bryostatins
2:35 PM Mohamed Donia (Princeton University): Small-molecule-mediated Interactions in Complex Microbial 
Communities
3:00 PM Margo Haygood (University of Utah): Versatile Bacterial Symbionts of Shipworms Contribute to Wood 
Digestion, Fix Nitrogen and Produce Secondary Metabolites
Session 11 - Novel Screening Strategies for the Identification of Therapeutic Lead Compounds (Bighorn C)
Chair: April Risinger (UT Health Science Center at San Antonio)
1:45 PM Daniel Hoeppner (Lieber Institute for Brain Development): Pluripotent Stem Cell Colonies Provide a 
Developmental Landscape for Pharmacogenomic Drug Development
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2:20 PM Babu Tekwani (University of Mississippi): Neurotrophic and Neuritogenic Drug Leads from Natural Products: 
A Combines In Vitro Assay for Evaluation of Cell Viability and NGF-Stimulated Neuritic outgrowth in 
Neuroscreen 1 Cells
2:37 PM April Risinger (University of Texas Health Science Center, San Antonio): Utilizing Differential Cytotoxicity 
Screening to Identify Lead Compounds for Rare Adult and Pediatric tumors
2:54 PM Danielle Demers (University of South Florida): New Antimicrobials from an Epigenetics Based Fungal 
Metabolite Screening Program
3:11 PM Daniel Todd (University of North Carolina at Greensboro): A Novel bioassay to Idenify Anti-Virulence Leads 
Against Gram-Positive Bacterial Pathogens
Session 12 - New Avenues in Botanical Research (Ptarmigan)
Chair: Stefan Gafner (American Botanical Council)
1:45 PM Muriel Cuendet (University of Geneva, Switzerland): HDAC Inhibitors for Cancer Chemoprevention
2:10 PM Vladimir Shulaev (University of North Texas): Global Lipidomics Profiling of Cotton Seed Oil Genotypes Using 
CO2-based Chromatography Coupled to Mass Spectrometry
2:35 PM Nanjoo Suh (Rutgers University): Natural Tocopherol Mixtures As Promising Cancer Preventive Agents
3:00 PM Birgit Dietz (University of Illinois at Chicago): Can Women’s Health Botanicals prevent Estrogen 
Carcinogenesis?
3:15 PM Clinton Dahlberg (Nature’s Sunshine): Clinical Evaluation of Formula F105, Designed and Developed to 
Address Elevated Oxidized LDL Cholesterol (oxLDL) Levels
3:30 PM – 5:30 PM Poster Session 3, Coffee Break, Exhibits Open (Copper Pavilion)
Off-Site Group Event
5:45 PM – 10:00 PM An Evening at Keystone Stables 
Join your colleagues for an evening of western-filled-fun at beautiful Soda Ridge Stables in 
Keystone, Colorado. Specially chartered buses will depart from Copper Circle at 6:00 PM. This is 
a ticketed event. One ticket is provided to all registrants, except One-Day registrants.
TUESDAY, JULY 28, 2015
7:15 AM – 8:00 AM Continental Breakfast, Exhibits Open (Copper Pavilion)
7:15 AM – 1:00 PM Registration Open (Kokopelli Trail)
General Session (Bighorn)
8:00 AM – 8:50 AM Derek Tan (Memorial Sloan-Kettering Cancer Center): Natural Product-based Strategies in 
Diversity-Oriented Synthesis
8:50 AM – 9:40 AM John Tallarico (Novartis Institute for BioMedical Research): Discoveries at the Interface of 
Pathways, Phenotypic Screening, and Chemical Biology
9:40 AM – 10:15 AM Coffee Break, Exhibits Open (Copper Pavilion)
Tuesday Morning Parallel Sessions
Session 13 - Applications of Mass Spectrometry to Natural Products Drug Studies (Bighorn B)
Chairs: Zhibo Yang (University of Oklahoma) and Si Wu (University of Oklahoma)
10:15 AM Neil Kelleher (Northwestern University): Metabologenomics: Discovery of New Natural Products and their 
Biosynthetic Gene Clusters by Genome-Informed Metabolomics
10:55 AM Markus Schirle (Novartis Institutes for BioMedical Research, Inc., Cambridge, MA): Mass Spectrometry-
based Chemoproteomics for Target Deconvolution of Bioactive Natural Products
11:15 AM Giorgis Isaac (Waters): State of Art Analytical Technologies to Solve Natural Products Challenges
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11:30 AM Zhibo Yang (University of Oklahoma): The Single-probe Mass Spectrometry for Single Cell Analysis and 
Biological Tissue Imaging
11:45 AM Laura Sanchez (University of California, San Diego): Visualizing Diverse Chemical Families with Molecular 
Networking
Session 14 - Enhancing Natural Product Leads via Synthetic Manipulation: In Celebration of Dr. Mansukh Wani’s 90th 
Birthday (Bighorn C)
Chairs: Nicholas Oberlies (University of North Carolina at Greensboro) and John Cardellina (National Institutes of Health)
10:15 AM James Fuchs (Ohio State University): Development and Optimization of the Phyllanthusmin
10:45 AM Thomas Prisinzano (University of Kansas): Synthesis of both Enantiomers of the Meta, Meta-bridged 
Diarylheptanoid Myricanol
11:15 AM Dale L. Boger (Scripps Research Institute): Vinblastine: Synthetic and Mechanistic Studies
Session 15 - Translational Studies of Natural Products (Ptarmigan)
Chair: Mark Hamann (University of Mississippi)
10:15 AM William Fenical (Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography): 
Challenges and Successes in the Development of Natural Product Drugs
10:45 AM Guy Carter (Biosortia): Measures of Success in Translational Research
11:05 AM Trevor Castor (Aphios): Development of Zindol® Through Multi-center Clinical Trial for Chemotherapy 
Induced Nausea and Vomiting
11:25 AM Bruce Littlefield (Eisai): Discovery and Development of Eribulin, a Macrocyclic Ketone Analog of Halichondrin 
B, for Treatment of Advanced Breast Cancer
11:45 AM Mark Butler (Institute of Molecular Bioscience, University of Queensland): Natural Products in Clinical 
Trials: Current State of Play and Future Directions
12:05 PM John Beutler (National Cancer Institute): Development of Englerins as Cancer Therapeutics
Younger Member’s Event 
12:30 PM Younger Member’s Event 
This is a ticketed event. One ticket is included with each students and postdoc registration. 
Junior faculty may attend by purchasing a ticket. Attendees will take the American Eagle Lift up 
the mountain to Solitude Station where they will enjoy lunch surrounded by the scenic views 
of Copper Mountain. Following lunch, attendees may choose to participate in a short guided 
hike on the Hallelujah Loop. Participants may then enjoy the American Eagle chair lift ride back 
down into Copper Village to enjoy discussion sessions tailored specifically to younger members.
4:00 PM Younger Member's Session (Ptarmigan)
WEDNESDAY, JULY 29, 2015
7:15 AM – 8:00 AM Continental Breakfast (Jack's)
7:15 AM – 5:00 PM Registration Open (Kokopelli Trail)
General Session (Bighorn)
8:00 AM – 8:50 AM Daniel Romo (Texas A&M University): Bioactivity-Guided Retrosynthesis: ‘Upping the Ante’ for 
Natural Product Total Synthesis
8:50 AM – 9:40 AM Peter Senter (Seattle Genetics): Potent Antibody-Based Conjugates for Cancer Therapy: From 
Early Stage Research to a Clinically Approved Drug
9:40 AM – 10:15 AM Coffee Break (Jack's)
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Wednesday Morning Parallel Sessions
Session 16 - Beyond The Rule of 5 in the Design of Next-Generation Therapeutics: What Can We Learn From 
Macrocyclic Natural Products? (Bighorn B)
Chair: Scott Lokey (University of California, Santa Cruz)
10:15 AM Roger Linington (Scripps Institution of Oceanography, University of California San Diego): Natural 
Products: Are We Close to the End?
10:40 AM Scott Lokey (University of California, Santa Cruz): Interrogating Cyclic Peptide Natural Products from an 
ADME Perspective: Beyond Cyclosporine A
11:05 AM David Craik (University of Queensland): Pharmaceutical Applications of Cyclotides
11:30 AM Andrei Yudin (University of Toronto): Peptide Macrocycles: From Structural Studies to Oral Bioavailability
Session 17 - Microbial Metabolites and Bioactive Compounds From Plant Microbial Associates (Epiphytes and 
Endophytes) (Bighorn C)
Chair: Liva Harinantenaina (Ohio State University)
10:15 AM Nicholas Oberlies (University of North Carolina at Greensboro): Endophytic Fungi of Medicinal Herbs: Basic 
Science and Source of New Drug Leads
10:45 AM Leslie Gunatilaka (University of Arizona): Exploring Plant and Lichen-Associated Microbial Diversity for 
Discovery of Small-Molecule Bioactive Agents
11:15 AM Marc Stadler (Helmholtz Centre for Infection Research): Biologically Active Secondary Metabolites from 
Epiphytic and Endophytic Fungi
11:45 AM Althar Ata (University of Winnipeg, Canada): Novel Bioactive Compounds from Endophytic Fungi and 
Aboriginal Medicinal Plants
Session 18 - Diverse Approaches for Finding and Making Natural Products (Ptarmigan)
Chair: Sean Brady (Rockefeller University)
10:15 AM Frank Schroeder (Cornell University): Comparative Metabolomics Reveals a Modular Library of Signaling 
Molecules in Nematodes
10:40 AM Jeremy Owens (Rockefeller University): Contemporary Strategies for Targeted Discovery and Transcriptional 
Activation of Natural Product Biosynthetic Gene Clusters
11:05 AM Gavin Williams (North Carolina State University): Harnessing the Promiscuity of Natural Product 
Biosynthesis: A Platform for Engineering Pathways with New Specificities
11:30 AM Greg Challis (University of Warwick): Manipulation of Actinobacterial Transcriptional Regulation to Discover 
New Specialized Metabolites
12:00 PM – 1:00 PM Lunch on your own
Award Symposium (Bighorn)
1:30 PM – 2:10: PM Norman R. Farnsworth Research Achievement Award: Raymond Andersen (University of 
British Columbia): Sponging Off Nature for New Drug Leads
2:10 PM – 2:50 PM Varro Tyler Prize: Cindy Angerhofer (Aveda): The Ins and Outs of Pharmacognosy: Plants for 
Health and Beauty
2:50 PM – 3:30 PM Matt Suffness Young Investigators Award: John MacMillian (UT Southwestern Medical 
Center): Use of High Content Screening for the Discovery and Biological Characterization of 
Natural Products
3:30 PM – 5:30 PM ASP Business Meeting (Ptarmigan)
6:00 PM – 7:00 PM Reception (Kokopelli Trail)
7:00 PM – 10:00 PM Annual Banquet (Copper Pavilion) 
 Ticketed Event.
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General Sessions
YOUR NATURAL PRODUCT CONTAINS A 
PROMISCUOUS PAINS MOTIF:  
IS IT USEFUL AS A BIOCHEMICAL PROBE OR IN DRUG 
DISCOVERY?
Jonathan Baell
Professor of Medicinal Chemistry, Monash Institute of Pharmaceutical 
Sciences (MIPS), Monash University
With increasing access to high throughput screening, academic drug 
discovery is being accompanied by a plethora of publications that report 
screening hits as good starting points for drug discovery or as useful tool 
compounds, whereas in many cases this is not so. These compounds may 
be protein-reactive but can also interfere in bioassays via a number of other 
means, many of which may remain unknown, and it can be very hard 
to prove early on that they represent false starts.1-5 We have termed such 
compounds Pan-Assay Interference Compounds, or PAINS. Examples of 
such compound cores are shown below. Some of these cores are prevalent in 
natural products. PAINS were defined from HTS libraries devoid of natural 
products. So how should one view PAINS-containing natural products in 
terms of useful biochemical probes or potential therapeutics? This presen-
tation will delve into such issues.
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1. Baell JB & Holloway GA. New substructure filters for removal of pan as-
say interference compounds [PAINS] from screening libraries and for their 
exclusion in bioassays. J. Med. Chem. 53, 2719-2740 (2010).
2. Baell JB. Observations on Screening-Based Research and Some Concern-
ing Trends in the Literature. Future Med. Chem. 2, 1529–1546 (2010).
3. Baell JB. Redox active nuisance screening compounds and their classifi-
cation. Drug Discov. Today 16, 840-841 (2011).
4.Baell JB, Ferrins L, Falk H, Nikolakopoulos G. PAINS: Relevance to Tool 
Compound Discovery and Fragment-Based Screening. Aust. J. Chem. 66 
(2013) 1483-1494.
5. Baell J & Walters MA. Chemical con artists foil drug discovery. Nature 
513 (2014) 481-483.
BEYOND STRUCTURE - DIVERSE MECHANISMS OF 
ANTI-INFECTIVE NATURAL PRODUCTS
SPONSORED BY SEQUOIA SCIENCES
Carole Bewley
Senior Investigator and Chief of the Natural Products Chemistry section in 
NIDDK, NIH.
During the past two decades Drs. Newman and Cragg have eloquently de-
scribed the indispensable role that natural products and their derivatives 
have played as sources of new drugs (J. Nat. Prod. 2007, ~3000 citations). 
This is especially true in the area of anti-infectives where synthetic librar-
ies have been less effective than natural products libraries in yielding new 
lead compounds and drugs. In addition to the discovery of new antibiotics 
and antivirals, we have been especially interested in identifying the targets 
of promising inhibitors and defining the chemical and structural basis for 
their activity. By taking a multidisciplinary approach that may involve mi-
croscopy, high-resolution structural and biophysical techniques, or com-
parative genomics we continue to be surprised at the diverse mechanisms 
that natural products use to exert their antimicrobial and antiviral effects. 
Recent progress in these areas including proteins and small molecules from 
Nature will be presented. 
THE PATENT ELIGIBILITY OF NATURAL PRODUCTS IN 
THE UNITED STATES: UNDERSTANDING THE ISSUES 
AND NAVIGATING THE NEW WATERS
Leslie Fischer
Senior Patent Attorney, Specialty Care Patent Group, Novartis 
Pharmaceuticals Corporation
United States (U.S.) patent law has historically held that purified and/or iso-
lated natural products are eligible for patenting. Subject matter as diverse as 
vitamins, proteins, DNA, yeast, bacteria, and antibiotics have all been the 
focus of valid U.S. patents. But, in June 2013, the U.S. Supreme Court intro-
duced uncertainty into the natural products’ patent arena, by holding that 
genomic DNA was not eligible for patenting “merely because” it is isolated. 
The U.S. Patent and Trademark Office and various U.S. federal courts have 
exacerbated this uncertainty with a series of official patent examination gui-
delines and decisions extending the Supreme Court’s limited genomic DNA 
holding to other types of natural products. In this lecture, we will explore 
the concept of what it means to be “patent eligible”, the historical analysis of 
patent eligibility in the natural products field, the new legal doctrines and 
how they are negatively impacting the patent eligibility of natural products, 
and how to best navigate this transitional legal period. 
NEW APPROACHES TO MICROBIAL NATURAL 
PRODUCT DISCOVERY
2015 WATERS AWARD FOR EXCELLENCE IN NATURAL PRODUCTS 
INNOVATION
Paul R. Jensen
Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California San Diego
Microbial natural products have provided some of today’s most important 
medicines. Despite an industrial downturn in natural product research, 
recent advances in the field have provided a new impetus to re-visit this 
resource for drug discovery. These advances have been driven in large part 
by ready access to genome sequence data, which has revealed that most 
bacteria maintain considerably more genetic potential than the compounds 
discovered to date would suggest. Coupled with advanced bioinformatic 
tools and analytical approaches, it has become possible to mine genome 
sequences and link pathways to products in unprecedented ways. The re-
sults have provided unprecedented insight into the evolutionary processes 
that generate structural diversity and rapid methods to detect known com-
pounds and target new molecules for characterization. Working with a mo-
del group of marine bacteria, it has been possible to apply these approaches 
to natural product discovery in ways that have provided insight into the 
relationships between secondary metabolism, biogeographic origin, and 
taxonomic diversity. The results are providing new opportunities to explore 
microbial diversity and capitalize on the wealth of biosynthetic potential 
that has yet to be exploited for natural product discovery.
BIOACTIVITY-GUIDED RETROSYNTHESIS: “UPPING 
THE ANTE” FOR NATURAL PRODUCT TOTAL 
SYNTHESIS
Daniel Romo
Texas A&M University
In recent years, synthetic chemists have made fantastic strides toward im-
proving the synthetic efficiency of complex bioactive natural product syn-
thesis through atom and step economy, avoidance of protecting groups, 
and the development of complexity-generating cascade processes that 
minimize step count and purifications. Our continued interest in under-
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standing the mechanism of action of bioactive natural products, including 
identification of their putative cellular receptors, has led us to consider add-
ing another requirement to our retrosynthetic strategies. Namely, we have 
sought to introduce the hypothesized pharmacophore of a natural product 
early in the synthetic sequence to enable SAR studies at an early stage of a 
total synthesis effort and continue these studies with increasingly complex 
intermediates as the natural product itself is approached. This strategy is 
most readily applicable to natural products that are readily hypothesized to 
covalently modify their putative cellular receptors (e.g. epoxide, β-lactone, 
exo-methylene carbonyl-containing natural products). Several cases stud-
ies implementing this retrosynthetic strategy will be presented along with 
biological studies that may substantiate this approach. 
POTENT ANTIBODY-BASED CONJUGATES FOR 
CANCER THERAPY: FROM EARLY STAGE RESEARCH TO 
A CLINICALLY APPROVED DRUG
Peter Senter
Seattle Genetics, 21823 30th Dr. SE, Bothell WA
Monoclonal antibodies (mAbs) have played a major role in cancer medi-
cine, with active drugs such as trastuzumab (Herceptin), cetuximab (Er-
bitux), bevacizumab (Avastin) and rituximab (Rituxan) in a wide range of 
therapeutic applications. The mechanism of activity of these agents once 
they bind to tumor associated antigens may involve direct signaling, inter-
actions with Fcg receptor positive cells on effector cells, and complement 
fixation. Several approaches have been explored to improve antibody-based 
therapies for cancer treatment by optimizing these activities and by using 
antibodies as delivery agents for highly potent cytotoxic drugs. These areas 
have advanced significantly in the past few years, leading to the approval 
of two antibody drug conjugates (ADCs) and a glyco-engineered antibo-
dy with enhanced binding to endogenous natural killer cells. New insights 
into how ADCs can be effectively developed have been gained through 
studies on cancer antigen targets and their expression on normal tissues, 
drug potency and mechanism, and linker stability and conditional drug 
release. Adcetris (brentuximab vedotin, SGN-35) is an example an ADC 
that has been designed with these parameters in mind. In August 2011, this 
drug was approved by the FDA for use in relapsed or refractory Hodgkin 
lymphoma and systemic anaplastic large cell lymphoma, two diseases with 
significant unmet medical needs. An overview of how Adcetris was deve-
loped and how the technology is being extended to include new antigen 
targets, new drugs, and new linker technologies will be provided.
MICROBIAL GENOMICS: NEW OPPORTUNITIES FOR 
NATURAL PRODUCT BIOSYNTHESIS, ENGINEERING, 
AND DRUG DISCOVERY
Ben Shen
Professor at the Departments of Chemistry and Molecular Therapeutics, 
Vice Chairman of the Department of Chemistry, and Director of Natural 
Products Library Initiative at The Scripps Research Institute (TSRI), TSRI, 
Jupiter, Florida.
Natural products are among the best sources of drugs and drug leads and 
serve as outstanding small molecule probes for dissecting fundamental 
biological processes. Natural product biosynthesis continues to push the 
frontier of modern chemistry, biochemistry, and molecular biology by re-
vealing novel chemical reactions, complex enzyme systems, and intricate 
regulatory mechanisms. The progress made in the last two decades in con-
necting natural products to the genes that encode their biosynthesis has 
fundamentally changed the landscape of natural products research and 
sparked the emergence of a suite of contemporary approaches to natural 
products discovery. Genetic manipulation of natural product biosynthe-
tic machineries offers a promising alternative to generate natural product 
structural diversity. Selected examples from our current research will be 
presented to highlight the opportunities for natural product biosynthesis, 
engineering, and drug discovery
DISCOVERIES AT THE INTERFACE OF PATHWAYS, 
PHENOTYPIC SCREENING, AND CHEMICAL BIOLOGY
John Tallarico
Executive Director, Novartis Institutes for Biomedical Research
In situations where the genetic bases of diseases are established and the 
biology is amenable to intervention, we can often develop a therapy. More 
frequently, understanding the genetics of disease does not yield a specific 
target and instead points us at specific signaling pathways and processes 
that are misregulated. For these situations, we have brought the expertise 
and technologies of several scientific disciplines to bear on the challenge of 
identifying new targets and mechanisms as potential therapies. A particular 
area of attention is small molecule phenotypic screening as an approach 
towards discovering new targets, new mechanisms, and new therapies. We 
will describe several of our technologies and how we applied them to parti-
cular aspects of disease biology. We will also share several examples where 
our research has uncovered new targets and new mechanisms that may be 
amenable for therapies.
NATURAL PRODUCT-BASED STRATEGIES IN 
DIVERSITY-ORIENTED SYNTHESIS
Derek S. Tan, Ph.D
Member and Tri-Institutional Professor, Molecular Pharmacology & 
Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York 
Ave., Box 422, New York, NY 10065
Genome sequencing and an increasingly molecular understanding of bio-
logy have revealed myriad new biological targets of both fundamental and 
potential therapeutic interest. However, the identification of highly specific 
small molecules to address these targets remains a significant challenge in 
chemical biology and drug discovery. To address this challenge, we are de-
veloping discovery libraries based on privileged structural motifs from na-
tural products. Such structures have a demonstrated ability to bind multiple 
classes of biological targets, but have distinct structural and physicochemi-
cal properties compared to existing drugs. Thus, these libraries are designed 
to access complementary regions of chemical structure space and spectra 
of biological targets. Notably, many of the existing approaches to synthesi-
zing these structures are unsuitable for use in diversity-oriented synthesis, 
due to its stringent requirements for reaction efficiency and flexibility. Thus, 
we are presented with numerous opportunities to develop new chemical 
methodologies with broader applications in organic synthesis. Our current 
synthetic targets include spiroketals and other oxygen heterocycles, macro-
cycles and medium rings, and polycyclic alkaloids. Our libraries are being 
screened against a wide range of targets through multidisciplinary colla-
borations with biologists, with the long-term goals of elucidating complex 
biological processes and exploring new therapeutic opportunities in cancer 
and infectious diseases.
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DISCOVERY AND INVESTIGATION OF 
THERAPEUTICALLY IMPORTANT MARINE NATURAL 
PRODUCTS
Amy E. Wright Ph.D.
Director for the Center of Excellence in Biomedical and Marine 
Biotechnology, Harbor Branch Oceanographic Institute of Florida Atlantic 
University
For many years Harbor Branch Oceanographic Institute operated the John-
son-Sea-Link human occupied submersible allowing for the collection of 
organisms from depths up to 3000 feet of seawater. Use of the submersible 
coupled to more standard collection methods such as scuba and snorkeling 
has led to a collection of over 18,000 marine macro organisms and 19,000 
microbial isolates that are used in our research. As part of an NIH funded 
National Cooperative Drug Discovery Group, we began creating an “en-
riched peak library” to overcome the issues related to screening crude ex-
tracts and the need for extensive bioassay-guided fractionation. With fun-
ding from NCCAM we greatly expanded our enriched fraction library. The 
library has been created using a Combiflash™ Companion™ Flash Chroma-
tography System which separates crude extracts into highly enriched frac-
tions, many of which can be up to 90% of a single component. Screening 
of the library has allowed us to find new modulators of gamma secretase; 
inhibitors of NFκB; compounds that modulate mast cell function related 
pancreatic cancer; antiplasmodial compounds and compounds selectively 
active against the intra-macrophage form of TB, to name a few activities. 
The presentation will highlight the use of the peak library in discovery of 
active natural products as well as some of our recent findings related to 
applications of natural products to cancer drug development. 
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SPONGING OFF NATURE FOR NEW DRUG LEADS
NORMAN R. FARNSWORTH RESEARCH ACHIEVEMENT AWARD
Raymond Andersen
Department of Chemistry and EOAS, University of British Columbia, 
Vancouver, B.C., Canada
The secondary metabolites found in marine organisms represent an ex-
tremely rich source of novel chemical diversity for academic drug disco-
very and chemical biology programs. Among the marine invertebrates, 
marine sponges have historically been one of the most prolific sources of 
new natural products. Our group at UBC has amassed a sizable library of 
crude extracts from marine sponges, other marine invertebrates, and cul-
tured marine microorganisms collected in many of the world’s oceans. In 
collaboration with biologists, this crude extract library has been screened 
for activity in cell-based and pure enzyme assays designed to identify pro-
mising marine natural product lead compounds for the development of 
drugs. Bioassay-guided fractionation of crude extracts and extensive spec-
troscopic analysis has been used to identify the structures of pure natu-
ral products active in the assays. Biology-oriented chemical synthesis has 
been undertaken to probe the SAR for new natural product pharmacopho-
res that we have discovered and to provide material for in vivo testing in 
animal models. Several new drug candidates for the treatment of cancer, 
inflammation, cystic fibrosis, and infectious diseases have emerged from 
this research program. Three of them have progressed to phase II clinical 
trials in humans and others are in preclinical evaluation/development. The 
lecture will present highlights from our academic ‘Drugs from the Sea’ and 
chemical biology research.
THE INS AND OUTS OF PHARMACOGNOSY: PLANTS 
FOR HEALTH AND BEAUTY
VARRO TYLER PRIZE
Cindy Angerhofer
Executive Director of Botanical Research, Aveda
Implicit in the word pharmacognosy is the concept that plants provided 
the first source and recognition of medicinal substances. For thousands of 
years, sages and healers, shamans, herbalists and clinicians have been ho-
ning the use of plants as medicines for internal and external applications. 
While modern medicine and even many dietary supplements often pursue 
highly purified single compounds, profound lessons are still to be discove-
red in crude plant materials. Relatively unrefined plant extracts like buriti 
oil and turmeric are complex in their chemistry and are used traditionally 
as foods and as effective topical treatments for the skin. Modern ingredients 
created from such plants for supplements or cosmetics range from pure 
compounds to minimally-refined botanicals, and cGMP requirements are 
vital to help guide production of quality products, but it is imperative to 
start the process with a sustainable, high quality plant. This presentation 
will emphasize the roles a pharmacognosist can play in the sourcing supply 
chain of botanicals as well as their effective application from the perspective 
of basic academic research as well as the cosmetic industry.
USE OF HIGH CONTENT SCREENING FOR THE 
DISCOVERY AND BIOLOGICAL CHARACTERIZATION 
OF NATURAL PRODUCTS
MATT SUFFNESS YOUNG INVESTIGATOR AWARD
John MacMillan
Department of Biochemistry, University of Texas Southwestern Medical 
Center
Over the past eight years our laboratory has focused on the use of high-con-
tent phenotypic screens for the discovery and biological characterization of 
natural products from a collection of marine-derived bacteria. Profound 
advances in the physical and functional annotation of the protein-coding 
elements of the human genome have had a transformative impact on dis-
covery science directed at the mechanistic basis of human disease. Taking 
advantage of this wealth of information, we have developed a technology 
platform to investigate the mechanism of action of entire natural product 
libraries and crude mixtures in the context of cancer cells. This strategy is 
based on perturbations of cells with miRNA, siRNA and natural products 
to produce a functional signature of ontology (FUSION) that link bioactive 
molecules to the proteins and biological processes that they engage in cells. 
We have used this platform to characterize compounds with functional ro-
les in autophagy, chemotaxis mediated by discoidin domain receptor 2, and 
activation of the kinase AKT.
In this presentation I will describe the FUSION platform and additional 
bioinformatics tools we have developed to characterize both known and 
new naturalproducts . This includes our efforts to elucidate the mechanism 
of action of didemnin B, the discovery of the discoipyrroles and the identi-
fication of selective toxins for non-small cell lung cancer.
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Parallel Sessions
Session 1 - The Brave New World of 
Natural Product Total Synthesis
OXYLIPIN TOTAL SYNTHESIS UNCOVERS 
STEREOCHEMISTRY-DEPENDENT CONFORMATIONS 
OF MASKED DIOLS
Shreyosree Chatterjee, Gayan A. Abeykoon, and Jason S. Chen
Department of Chemistry, Iowa State University, Ames, IA 50011, USA.
A two-step anti-1,2-diol synthesis was developed using aldehyde 
α-oxygenation followed by Grignard addition. This method was highligh-
ted in the synthesis and stereochemical assignment of two unnamed oxyli-
pins from Dracontium loretense. Unexpected NMR chemical shift signatu-
res in the differentially-masked 1,2-diols led to identification of unexpected 
stereochemistry-dependent conformational biases in 2,2,6,6-tetramethyl-
piperidinyl-masked 1,2-diols.
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THE TAUMYCIN A MACROCYCLE: ASYMMETRIC 
TOTAL SYNTHESIS AND REVISION OF RELATIVE 
STEREOCHEMISTRY
William A. Maio1
1Department of Chemistry and Biochemistry, New Mexico State University, 
Las Cruces, NM 88003, USA
The symbiotic association of marine microorganisms with their host spon-
ges continues to be an extraordinary source of hybrid polyketide / non-
ribosomal secondary metabolites that often possess unique structures in 
conjunction with interesting biological activity. Recently, taumycin A was 
isolated from a Madagascar sponge of genus Fascaplysinopsis. This work 
describes the first asymmetric total synthesis and revision of the relative 
configuration of the 12-membered macrocycle via the synthesis of taumy-
cin A aldehyde. Key to the success of this work is a novel alpha-keto ketene 
macrocyclization that provided an efficient means by which to access two 
diastereomers of the desired macrolide without the need to employ additio-
nal coupling agents or unnecessary oxidation state adjustments. 
SYNTHETIC DISCOVERIES FROM POLYCYCLIC 
NATURAL PRODUCTS
Jeremy May, Jiun-Le Shih, Thien S. Nguyen, Phong Le, Ravikrishna 
Vallakati, Chris Huynh, Tho Tran, Santa Jansone-Popova, Brian J. Lundy
Department of Chemistry, University of Houston, 112 Fleming Building, 
Houston, Texas 77204-5003, United States
Complex polycyclic natural products present daunting challenges to the 
synthetic organic chemist and thus drive innovation. We have been in-
spired by the challenges presented by chiral indole alkaloid and bridged 
polycyclic natural products. We present new experimental results for enan-
tioselective conjugate additions to generate alpha-chiral heterocycles and 
carbene cascade reactions to generate functionalized bridged bicycles. We 
also show the application of these methods to the total synthesis of these 
natural products.
MARINE NATURAL PRODUCTS SYNTHESIS AS A 
DRIVING FORCE FOR CHEMICAL AND BIOLOGICAL 
DISCOVERY
Joshua G. Pierce1*, Nataliia V. Shymanska1, and Grant A. Edwards1
1Department of Chemistry, North Carolina State University, Raleigh, NC 
27695, USA.
Natural products bearing complex structures and potent biological activi-
ties have long been the target of chemical synthesis and have served as suc-
cessful lead molecules for drug discovery. As part of our program centered 
on the synthesis and chemical biology of marine natural products we have 
achieved a rapid synthesis of synoxazolidinone A (1) and structural ana-
logs. Through these efforts we have revealed new chemical reactions and 
potent lead structures for infectious disease research. The synthesis and 
chemical biology of the synoxazolidinones will be presented. 
TOTAL SYNTHESES OF RAKICIDIN A AND BE-43547A1
Thomas B. Poulsen
Department of Chemistry, Aarhus University, Aarhus C, Denmark
Rakicidin A, a macrocyclic depsipeptide isolated from micromonospora 
sp., exhibits selective cytotoxicity towards hypoxic cancer cells and induces 
apoptosis in quiescent stem-like CML cells. Cancer stem cells are suspected 
to be a major driver of cancer progression and relapse. The hypoxia selecti-
vity of rakicidin A is independent of HIF-1 and the cellular target remains 
unknown. BE-43547A1 is a related natural product that also displays potent 
cytotoxicity. The macrocyclic systems of these molecules constitute signi-
ficant synthetic challenges due to the presence of both congested structural 
elements and a labile vinylogous dehydroalanine functionality. The latter is 
unique to this class of natural products. I will present our efforts aimed at 
the syntheses of both rakicidin A and BE-43547A1 with the further objecti-
ve to facilitate biological investigations.
Parallel Sessions - Sunday, July 26th
22Abstracts | 2015 Annual Meeting of the ASP | July 25th–29th, 2015 | Copper Mountain, CO, USA
ENABLING REACTIVITY OF NEUTRAL AMINYL 
RADICALS IN POLYCYCLIC HETEROCYCLE SYNTHESIS 
Ahmad A. Ibrahim, Alberto M. Lopez, Jennifer L. Stockdill
Wayne State University, 5101 Cass Avenue, Detroit, MI 48072, USA
Tertiary aliphatic amines are a privileged functional group in pharmaceu-
ticals. For example, 51% of FDA approved nervous system drugs possess a 
tertiary aliphatic amine. However, there is only one neurologic agent with 
this functionality disposed at a ring junction. This imbalanced representa-
tion of structural space likely points to a need for more efficient strategies 
for the synthesis of these compounds, rather than an inherent problem 
with these structures as drug agents. We have devised a general strategy to 
potentially access a variety of such compounds using radical cascade reac-
tions of N-centered radicals. In this seminar, a successful example of our 
approach that employs neutral dialkyl aminyl radicals will be discussed in 
the context of our efforts toward the total syntheses of the plant alkaloids 
daphniyunnine C and daphnicyclidin A.
Session 2 - Chemical Transformations 
in the Biosynthesis of Natural 
Products
BIOSYNTHESIS OF CYCLIC PEPTIDE ANTIBIOTICS
Wilfred van der Donk
Department of Chemistry, Howard Hughes Medical Institute and University 
of Illinois at Urbana-Champaign
Research in the 20th century identified several large families of natural pro-
ducts including terpenoids, alkaloids, polyketides, and non-ribosomal pep-
tides. The genome sequencing efforts of the first decade of the 21st century 
have revealed that another major class is formed by ribosomally synthe-
sized and post-translationally modified peptides (RiPPs). These molecules 
are produced in all three domains of life, their biosynthetic genes are ubi-
quitous in the currently sequenced genomes, and their structural diversity 
is vast. Lanthipeptides are examples of this growing class and many mem-
bers are highly effective peptide-derived antimicrobial agents that display 
nanomolar minimal inhibitory concentrations (MICs) against many patho-
genic bacteria. These peptides are post-translationally modified to install 
multiple thioether crosslinks. During their biosynthesis, a single enzyme 
typically breaks 8-16 chemical bonds and forms 6-10 new bonds with high 
control over regio- and chemoselectivity. This presentation will discuss in-
vestigations of the mechanisms of these remarkable catalysts as well as their 
use for the generation of non-natural cyclic peptides.
SPLICEOSTATIN BIOSYNTHESIS IN BURKHOLDERIA 
SPP.
Alessandra S. Eustáquio1,2, Jeffrey E. Janso1, Anokha S. Ratnayake1, Li-Ping 
Chang1, Christopher J. O’Donnell1, and Frank E. Koehn1
1Natural Products Laboratory, Worldwide Medicinal Chemistry, Pfizer 
Worldwide Research and Development, Groton, CT 06340, USA, 2Currently 
at: Department of Biology, University of Bergen, Norway. 
Spliceostatins are a suite of bacterial natural products that have been shown 
to target the spliceosome, an emerging mode of action in cancer therapy1. 
Spliceostatin biosynthesis in Burkholderia species is catalyzed by a hybrid 
nonribosomal peptide synthetase−polyketide synthase system of the trans-
acyl transferase type2, 3. In this presentation, genetic and biochemical evi-
dence for hemiketal biosynthesis via oxidative decarboxylation – rather 
than the previously hypothesized Baeyer-Villiger oxidation – will be de-
scribed4. In addition, roles for a cytochrome P450 and a flavin-dependent 
monooxygenase are proposed based on genetic studies. Understanding late 
steps in spliceostatin biosynthesis was instrumental to achieve gram-scale 
production and nearly single-component fermentation of a stable analog 
(thailanstatin A), which has enabled pre-clinical development of this class 
of natural products as chemotherapy5.
References
(1) Kaida, D. et al. (2007) Nat Chem Biol 3, 576-583.
(2) Zhang, F. et al. (2011) J Am Chem Soc 133, 2452-2462.
(3) Liu, X. et al. (2013) J Nat Prod 76, 685-693.
(4) Eustáquio, A. S. et al. (2014) Proc Natl Acad Sci U S A 111, E3376-E3385.
(5) Dirico, K. J. et al. (2014) Patent application WO 2014068443.
A CURE FOR BALDNESS AND CRYPTIC BIOSYNTHESIS 
IN STREPTOMYCES CALVUS
David L. Zechel
Department of Chemistry, Queen’s University, Chernoff Hall, 90 Bader Lane, 
Kingston, Ontario, K7L 3N6, Canada 
Streptomyces calvus was first isolated by American Cyanamid in 1956 based 
on its ability to produce nucleocidin, a mimic of adenosine that contains 
unusual fluorine and sulfamate substituents. S. calvus also differs from most 
Streptomyces in its inability to form spores on solid media, giving colonies 
a ‘bald’ appearance. The genome sequence of S. calvus revealed the pres-
ence of a point mutation in the bldA gene, which is predicted to encode a 
misfolded and nonfunctional Leu-tRNAUUA molecule. The bldA gene is well 
known to play a key role in sporulation and the expression of biosynthetic 
genes in Streptomyces. Upon complementation of S. calvus with a functio-
nal copy of the bldA gene, sporulation was restored and new secondary 
metabolites were observed in culture extracts. Recent work in identifying 
these new secondary metabolites and their cryptic biosynthetic genes will 
be presented.
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DISCOVERY OF NOVEL CHLORINATED ACYL AMIDES 
FROM A MARINE CYANOBACTERIUM USING 
INTEGRATED TECHNOLOGIES
Karin Kleigrewe1, Jehad Almaliti1, Isaac Yuheng Tian1,2, Robin B. Kinnel3, 
Anton Korobeynikov4,5,6, Emily A. Monroe1,7, Brendan M. Duggan10, 
Vincenzo Di Marzo8, David H. Sherman9, Pieter C. Dorrestein10, Lena 
Gerwick1 and William H. Gerwick1,10
1Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California San Diego, USA, 2University of 
California Berkeley, USA, 3Hamilton College, Clinton, NY, USA, 4Faculty 
of Mathematics and Mechanics, Saint Petersburg State University, Russia, 
5Center for Algorithmic Biotechnology, Saint Petersburg State University, 
Russia, 6Algorithmic Biology Laboratory, Saint Petersburg Academic 
University, Russia, 7Department of Biology, William Paterson University of 
New Jersey, USA, 8Institute of Biomolecular Chemistry, National Research 
Council, Pozzuoli, Italy, 9Life Sciences Institute, University of Michigan, Ann 
Arbor, Michigan, 10Skaggs School of Pharmacy and Pharmaceutical Sciences, 
University of California San Diego, USA
An innovative approach was developed for the discovery of new natural 
products by combining mass spectrometric metabolic profiling with geno-
mic analysis, and resulted in the discovery of the columbamides, a new class 
of di- and tri-chlorinated acyl amides with cannabinomimetic activity. By 
genome analysis, a presumed regulatory domain was identified upstream of 
several previously described biosynthetic gene clusters in two cyanobacte-
ria, and a similar regulatory domain was identified in the M. bouillonii PNG 
genome. A corresponding downstream biosynthetic gene cluster was loca-
ted and carefully analyzed. Subsequently, MS-based molecular networking 
identified a series of candidate products, and these were isolated and their 
structures rigorously established. 
Session 3 - Natural Products and HIV, 
Progress and Directions
MINING THE EXTENSIVE CHEMICAL DIVERSITY OF 
THE NCI NATURAL PRODUCTS REPOSITORY FOR NEW 
AGENTS THAT CAN TARGET HIV
Kirk R. Gustafson
Molecular Targets Laboratory, Center for Cancer Research, National Cancer 
Institute, Frederick, MD 21702
Extracts from a wide variety of terrestrial plants, marine organisms, and 
microbial isolates have been screened for anti-HIV properties using a cell-
based, infectious virus assay format. This type of phenotypic screening can 
identify inhibitory samples that target virtually any step in the virus infec-
tion or replication process. Assay-guided fractionation of active extracts 
has provided an array of novel, HIV inhibitory compounds that span many 
different structural classes. These discoveries include new small molecu-
le inhibitors such as alkaloids, terpenoids, quinones, and coumarins, as 
well as some larger anti-HIV peptides. Biological characterization of lead 
compounds revealed these metabolites can impact critical processes such 
as virus entry into host cells, membrane integrity, or reverse transcription 
of viral RNA. Several of these agents have undergone extensive preclinical 
evaluations and one has advanced to a Phase II clinical study. The com-
bination of a large, diverse library of natural product samples and a new 
antiviral screening platform, has provided a valuable resource for discovery 
of novel HIV inhibitors.
INGENOL 3,20 DIBENZOATE EFFICIENTLY 
REACTIVATES LATENT HIV
Adam M. Spivak1, Alberto Bosque2, Laura Martins2, and Vicente Planelles2
1Departments of Medicine and 2Pathology, University of Utah, Salt Lake 
City, UT 84108 
The HIV-1 latent reservoir represents a major barrier to viral eradication in 
aviremic HIV-1+ patients taking antiretroviral therapy (ART). Small com-
pounds and drugs capable of latency reversal that are active in vivo are scar-
ce. Here, we describe a careful characterization of the promising reactivation 
properties of an emerging candidate, ingenol 3,20 dibenzoate (IDB), in cells 
from aviremic patients, including the effects on cellular activation. Ingenol, is 
a protein kinase C (PKC) agonist found in Euphorbiacea, a family of succu-
lent plants from semi-desertic areas of Brazil. 
To be able to test candidate drugs in cells from HIV infected, aviremic pa-
tients, we formulated a rapid ex vivo assay as follows. After phlebotomy, re-
sting CD4+ T cells are isolated via negative magnetic bead purification and 
cultured in aliquots of 5x106 cells/mL RPMI-based culture medium. Cell 
aliquots are exposed to medium alone (negative control), candidate drug, 
or antibodies against CD3/CD28 to induce T cell receptor stimulation (po-
sitive control). After 48 hours in culture, quantitative rtPCR is performed 
using culture supernatant HIV-1 viral RNA. 
IDB, demonstrated viral reactivation comparable to CD3/28 antibody sti-
mulation (median reactivation = 49% of positive control). CD69, an early 
marker of T cell activation known to be up-regulated by ingenol, increased 
in all cell aliquots exposed to ingenol (median florescence intensity = 81% 
of positive control). 
Ingenol represents an exciting latency-reversing agent because it combines 
a potent reactivation ability with a very low toxicity profile, which sets it 
apart from other PKC agonists. 
MEDICINAL PLANTS USED BY TRADITIONAL 
MEDICINE PRACTITIONERS FOR THE TREATMENT OF 
HIV/AIDS AND RELATED CONDITIONS IN PAPUA NEW 
GUINEA
Prem P. Rai1, Teatulohi Matainaho1 and Louis R. Barrows2
1School of Medicine and Health Sciences, University of Papua New Guinea, 
PO Box 5623, Boroko, NCD, Papua New Guinea (raipp@yahoo.com); 
2Department of Pharmacology and Toxicology, University of Utah, 30 S. 
2000 E., Salt Lake City, UT, USA 84112
Papua New Guinea (PNG) has the highest burden of HIV/AIDS in the Pa-
cific region. An estimated 33,000 people in PNG are currently living with 
HIV and Aids. Since the beginning of the AIDS epidemic, patients have 
consulted both medical doctors and traditional medicine practitioners 
(TMPs) for all kinds of physical and emotional ills. Access to antiretroviral 
(ARV) drugs has been irregular, and is virtually non-existent in the rural 
areas of PNG. Moreover, resistance of opportunistic microbial pathogens to 
conventional medicines and the side effects associated with antiretroviral 
drugs are also a major drawback to the management of HIV/AIDS in the 
country. Due to these factors, many people opt to use of traditional medi-
cines. Traditional medicine practitioners (TMPs) use range of botanicals 
in the management of different opportunistic infections in people living 
with HIV/AIDS (PLHIV), namely antithrush, antifever, antidiarrhoea and 
antidysentery, anticough and anti-infective against various skin pathogens. 
In a pilot study conducted in the Oro and Milne Bay provinces of PNG it 
was established that traditional healers were indeed playing an important 
role in providing medical care and in alleviating suffering of PLHIV. Their 
main contribution was in improving quality of life by effectively treating 
many of the associated symptoms and helping patients regain energy and 
appetite. Conditions such as diarrhoea, skin infections, weight loss, sores 
and wounds were treated by selective administration of different herbal 
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preparations. In this study, an ethnobotanical survey was conducted to 
record the various plant families, species, and plant parts used to manage 
different HIV/AIDS-related opportunistic infections.This presentation ex-
amines and provides an account of most commonly used herbs by TMPs in 
management of HIV/AIDS in PNG. 
NEWS FROM FUNGI - TARGETING VIRAL SWEETSPOTS
Sandra Loesgen
Department of Chemistry, Oregon State University, Corvallis, OR 97331, 
USA.
As we enter the post-antibiotic era, there is an increasing demand for 
new anti-infective compounds. To address this need, we employed a two-
pronged drug discovery approach to identify anti-viral compounds from 
fungal extracts. To increase the probability of isolating unknown com-
pounds, we activated cryptic secondary gene clusters by environmen-
tal challenge, epigenetic modifiers, and gene manipulation. To increase 
throughput, we screened extracts for binding to the HIV viral envelope 
protein gp120 using a rapid protein-based biosensor assay supported by an 
in vitro cell assay. Here we present the fungal metabolites that were identi-
fied using this novel screening approach.
A RUFOMYCIN ANALOGUE IS AN ANTI-TUBERCULOSIS 
DRUG LEAD TARGETING CLPC1 WITH NO CROSS 
RESISTANCE TO ECUMICIN
Mary Choules1,2, Yang Yu2, Sang-Hyun Cho1, Jeff Anderson1, Wei Gao1,2, 
Larry Klein1, David C. Lankin2, Jin-Yong Kim4, Jinhua Cheng3, Seung Hwan 
Yang3, Hanki Lee3, Joo-Won Suh3,4, Scott G. Franzblau1, and Guido F. Pauli1,2
1Institute for Tuberculosis Research and 2Department of Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois 
at Chicago, Chicago, IL, 60612, USA; 3Center for Nutraceutical and 
Pharmaceutical Materials; 4Division of Bioscience and Bioinformatics, 
College of Natural Science, Myongji University, Cheoin-gu, Gyeonggi-Do 
449-728, Korea
Our recent efforts at finding new anti-tuberculosis drug leads from actino-
mycetes have led to the discovery of ecumicin (ECU, MW 1599.22, MIC 
0.16 uM) and; more recently, a rufomycin analogue (RUF-I, MW 1041.55, 
MIC 0.019 uM). Although both of these cyclic peptides target the cur-
rently unexploited chaperone protein ClpC1 ATPase complex, there is no 
observed cross resistance. In this study, the structures of RUF-I and other 
rufomycin analogues, heptapeptides, were elucidated by 1H, 13C, 2D NMR, 
MS and HiFSA. To understand the lack of cross resistance, clpC1 from 
spontaneously generated resistant clones from both leads were sequen-
ced. This revealed several distinct single point mutations, suggesting these 
compounds bind differently to ClpC1. Checkerboard assay indicated a lack 
of antagonism between ECU and RUF-I and potential synergistic effects. 
Preliminary data indicates that ClpC1 could be a multifaceted drug target 
for multidrug resistant M. tuberculosis. Research pertaining to the peptide 
drug leads, associated analogues, and their mechanism of action against 
ClpC1 will be presented.
Session 4 - ASP Younger Members 
Research Spotlight
PHYLOGENETIC AND METABOLOMIC ANALYSIS OF 
MARINE MAMMAL MICROBES CONTRIBUTES TO 
EMERGING SPIROTETRONATE POLYKETIDES 
Jessica Ochoa, Laura Sanchez, Roger Linington
University of California, Santa Cruz, Department of Chemistry and 
Biochemistry, 1156 High Street, Santa Cruz, CA, 95060
Constant exposure to varying environments along migrations routes sug-
gests that the marine mammal microbiome may be a unique environment 
for sample collections for natural product discovery. The organisms isolated 
in this study were prioritized through sequencing and metabolomics pro-
filing to create a highly bioactive screening plate that possesses new mole-
cules produced by marine microbiomes. Molecules elucidated in this study, 
both known and new provide detailed insight into the chemistry involved 
in signaling and/or defense within commensal bacteria as well as the capa-
bility of these molecules to be used to regulate pathogenesis for one of the 
worlds best sentinel organisms.
UNUSUAL WITHANOLIDES FROM PHYSALIS HISPIDA 
(WATERF.) CRONQUIST
Cong-Mei Cao1, Huaping Zhang1, Robert J. Gallagher1, and Barbara N. 
Timmermann*,1
1Department of Medicinal Chemistry, University of Kansas, Lawrence, KS 
66045, United States
Withanolides are a group of modified C28 ergostane-type steroids with a 
C-22, C-26 δ-lactone side chain. As part of our continuing search for unu-
sual withanolides for SAR studies, we isolated and characterized nine new 
withanolides (1−9), withahisolides A−I, as well as nine known compounds 
(10−18) from the aerial parts of Physalis hispida. The structures of 1−9 were 
elucidated through a variety of spectroscopic techniques, while those of 1 
and 2 were further confirmed by X-ray crystallographic analysis. Among 
the eight new withanolides (1-7, 9) with an unusual six-membered ring D, 
1−3 are the first withanolides possessing non-aromatic six-membered ring 
D moieties. In addition, withanolide 8 represents a novel withanolide ske-
leton due to the absence of a C-13−C-17 bond within its steroidal nucleus. 
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DISCOVERY OF FATTY ACID SYNTHASE INHIBITORS 
AND THEIR BIOSYNTHETIC PATHWAYS BY A NOVEL 
TARGET-DIRECTED GENOME MINING STRATEGY
Jie Li1 , Xiaoyu Tang1, Jia Jia Zhang1, Ellis C. O’Neill1, Simone M. 
Mantovani1 and Bradley S. Moore1,2
1Scripps Institution of Oceanography, University of California (UC), San 
Diego, La Jolla, CA 92093, 2Skaggs School of Pharmacy and Pharmaceutical 
Sciences, UC, San Diego, La Jolla, CA 92093
In order to avoid self-toxicity, many antibiotic-producing microbes have 
developed self-resistance mechanisms, with target modification being one 
frequent example. We propose that extra copies of an essential housekee-
ping gene found within or adjacent to a biosynthetic pathway may indicate 
that the compound(s) produced will target the protein encoded by the cor-
responding housekeeping gene. Thus, a novel and rational target-directed 
genome mining strategy was developed, by which potential self-resistance 
genes were analyzed bioinformatically, followed by a PCR-independent 
cloning and heterologous expression of the intact gene clusters for rapid 
production of compounds with desired bioactivities. As a proof-of-prin-
ciple study, two related orphan gene clusters with potential fabF resistance 
genes were identified and expressed, which led to the isolation of a group 
of unique thiotetronic acid natural products that inhibit bacterial fatty acid 
synthase (1–9). A notable advantage of this genome mining strategy is 
that specific molecular targets can be hypothesized in the absence of prio-
ri knowledge of the structures of the molecules biosynthesized, and may 
streamline mechanism of action studies for the products obtained.
DISCOVERY OF FATTY ACID SYNTHASE INHIBITORS AND THEIR BIOSYNTHETIC 
PATHWAYS BY A NOVEL TARGET-DIRECTED GENOME MINING STRATEGY 
 
Jie Li1 , Xiaoyu Tang1, Jia Jia Zhang1, Ellis C. O'Neill1, Simone M. Mantovani1 and Bradley S. Moore1,2 
1Scripps Institution of Oceanography, University of California (UC), San Diego, La Jolla, CA 92093, 
2Skaggs School of Pharmacy and Pharmaceutical Sciences, UC, San Die o, La Jo la, CA 92093 
 
In order to avoid self-toxicity, many antibiotic-producing microbes have developed self-resistance 
mechanisms, with target modification being one freq ent example. We propose that extra copies of an 
essential housekeeping gene found within or adjacent to a biosynthetic pathway may indicate that the 
compound(s) produced will target the protein encoded by the corresponding housekeeping gene. Thus, a 
novel and rational target-directed genome mining strategy was developed, by which potential self-
resistance genes were analyzed bioinformatically, followed by a PCR-independent cloning and 
heterologous expression of the intact gene clusters for rapid production of compounds with desired 
bioactivities. As a proof-of-principle study, two related orphan gene clusters with potential fabF 
resistance genes were identified and expressed, which led to the isolation of a group of unique 
thiotetronic acid natural products that inhibit bacterial fatty acid synthase (1–9). A notable advantage of 
this genome mining strategy is that specific molecular targets can be hypothesized in the absence of 
priori knowledge of the structures of the molecules biosynthesized, and may streamline mechanism of 
action studies for the products obtained. 
 
 
1 
SO
OH
SO
OH
Compounds 7–9 
are new with 
structures not 
shown here 2 3 4 5 6 
DISCOVERY, SYNTHESIS, AND BIOLOGICAL 
EVALUATION OF APRATYRAMIDE, A MARINE-DERIVED 
TRANSCRIPTIONAL STIMULATOR OF VEGF-A
Weijing Cai1,2, Lilibeth A. Salvador-Reyes1, Wei Zhang1, Susan Matthew1, 
Ranjala Ratnayake1,2, Valerie J. Paul3, Long H. Dang2,4, Hendrik Luesch1,2
1Department of Medicinal Chemistry, University of Florida, Gainesville, 
Florida 32610, USA, 2Center for Natural Products, Drug Discovery and 
Development (CNPD3), University of Florida, Gainesville, Florida 32610, 
USA, 3Smithsonian Marine Station, Fort Pierce, Florida 34949, USA, 
4Department of Medicine, University of Florida 32610, USA 
A collection of the marine cyanobacterium Moorea bouillonii from Apra 
Harbor in Guam afforded apratyramide, a linear depsipeptide consisting 
of four amino acid residues and one hydroxy acid moiety. The structure 
was elucidated by a combination 1D/2D NMR spectroscopic and mass 
spectrometric analysis. The absolute configuration of the stereocenters was 
determined by LC-MS analysis of the acid hydrolyzate. Apratyramide was 
then synthesized and tested for bioactivity. Apratyramide induced the tran-
scription and secretion of vascular endothelial growth factor A (VEGF-A) 
in multiple cell types. This activity is being explored for various applications 
where VEGF-A upregulation would be beneficial. 
CHEMOMETRIC-DIRECTED BIOEXPLORATION OF 
NATURAL PRODUCTS
Joshua Kellogg1, Daniel A. Todd1, Joseph M. Egan1, Huzefa A. Raja1, 
Nicholas H. Oberlies1, Olav M. Kvalheim2, and Nadja B. Cech1
1Department of Chemistry & Biochemistry, The University of North 
Carolina Greensboro, Greensboro, NC 27402, USA, 2Department of 
Chemistry, University of Bergen, Bergen, Norway
A workflow for the chemometric analysis of a chromatographic fractiona-
tion series was developed, integrating partial least-square (PLS) statistical 
modeling with high-resolution mass spectrometry to yield an associative 
model that correlated chemical composition and bioactivity. Goldenseal 
(Hydrastis canadensis) fungal endophytes were evaluated to determine their 
secondary metabolite profile and their influence on growth of Staphylococ-
cus aureus strain SA1199. Pyrenocheata sp. extract and fractions inhibited 
the growth of SA1199 as much as 95.8 ± 1.7%, and the resulting PLS model 
predicted a single active ion (m/z 343) as the purported bioactive compo-
nent. Follow-up analysis tentatively identified the m/z 343 ion as the known 
antimicrobial macrosphelide A.
PHARMACOKINETIC INTERACTIONS BETWEEN DRUGS 
AND BOTANICAL DIETARY SUPPLEMENTS
Alyssa A. Sprouse1,2 and Richard B. van Breemen1,2
1 Department of Medicinal Chemistry and Pharmacognosy, 2 UIC/NIH 
Center for Botanical Dietary Supplements Research University of Illinois at 
Chicago, Chicago, IL
The use of botanical dietary supplements has grown steadily over the last 20 
years despite incomplete information regarding active constituents, mecha-
nisms of action, efficacy, and safety. An important but under-investigated 
safety concern is the potential for popular botanical dietary supplements to 
interfere with the absorption, transport and/or metabolism of pharmaceuti-
cal agents. Clinical trials of drug-botanical interactions are the gold standard 
and are usually carried out only when indicated by unexpected consumer 
side effects or, preferably, by predictive in vitro studies. For example, Phase 
I clinical trials have confirmed clinical observations and in vitro studies that 
St. John’s wort (Hypericum perforatum) induces cytochrome P450 3A4/5, 
whereas Phase I studies did not substantiate in vitro predictions that milk 
thistle (Silybum marianum) would inhibit CYP1A2, CYP2C9, CYP2D6, 
CYP2E1, and CYP3A4. Here, we highlight discrepancies between in vitro 
and in vivo data concerning drug-botanical interactions and critically evalu-
ate why some in vitro models overestimate or sometimes underestimate the 
potential for drug-botanical interactions. Gaps in our knowledge are also 
highlighted for the potential of some popular botanical dietary supplements 
to interact with therapeutic agents with respect to absorption, transport and 
metabolism.
Supported by grant P50 AT000155 from the NIH ODS and NCCIH
SELECTIVITY AND MECHANISTIC INQUIRIES INTO THE 
REACTIVITY OF PERICOSINE A, AN ELECTROPHILIC 
CHLORINATED SHIKIMATE ANALOGUE
Tyler Olsen, Lin Du, Kenneth Nicholas, Robert Cichewicz
Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, University of Oklahoma, 
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman OK 73019
Microorganisms are constantly competing for limited resources in their 
environment as characterized by secondary metabolite production and 
enzymatic inactivation of toxins. Pericosine A, a shikimate analogue pro-
duced by a Tolypocladium sp., has been shown to directly differentiate and 
inactivate nucleophilic toxins in complex chemical environments. Herein 
we detail the selectivity of pericosine A towards a diverse set of nucleophi-
les, as well as the computational and structural studies of the mechanistic 
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pathways under which it operates. We also show reactivity of pericosine A 
adducts with monosaccharides to produce novel heterobicyclic scaffolds.
ISOLATION AND IDENTIFICATION OF NOVEL NATURAL 
PRODUCTS THAT INHIBIT P300/HIF-1α INTERACTION
Susanna T. S. Chan,1 Paresma R. Patel,2,3 Gary E. Martin,4 Robert T. 
Williamson,4 Josep Saurí,4 Alexei V. Buevich,4 Tanya R. Ransom,1 Curtis 
J. Henrich,1,5 Tawnya C. McKee,1 William D. Figg,6 James B. McMahon,1 
Martin J. Schnermann,2 and Kirk R. Gustafson1
1Molecular Targets Laboratory, Center for Cancer Research, National Cancer 
Institute, Frederick, MD 21702, 2Chemical Biology Laboratory, Center for 
Cancer Research, National Cancer Institute, Frederick, MD 21702, 3National 
Centre for Advancing Translational Sciences, National Institutes of Health, 
Bethesda, MD 20892, 1NMR Structure Elucidation, Process, and Analytical 
Chemistry, Merck & Co. Inc., Rahway, NJ, 07065 5Basic Science Program, 
Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer 
Research, Frederick, MD 21702, 6Medical Oncology Branch, Center for 
Cancer Research, National Cancer Institute, Bethesda, MD 20892.
Hypoxia-inducible factor-1 (HIF-1) is an important transcription factor 
for initiating a response against low oxygen environments in many solid 
tumors. Under hypoxic conditions, subunit HIF-1α dimerizes with subunit 
HIF-1β and binds to the multi-domain protein and transcriptional coacti-
vator, p300. Inhibition of the p300/HIF-1α interaction results in the sup-
pression of HIF-1 transcriptional activity during hypoxia. An extract of the 
marine ascidian Eudistoma sp. was identified as active in a high throughput 
screen for inhibitors of the p300/HIF-1α interaction. Three novel heterocy-
lic alkaloids were isolated from the extract and their structures elucidated 
using both spectroscopic analyses and synthesis. The core scaffold of the-
se alkaloids contains an unprecedented fused ring system with embedded 
guanidine and amidine functionalities. These compounds showed activity 
inhibiting the binding domains of p300 and HIF-1α.
TARGETING BIOACTIVE CHEMICAL SPACE WITH A 
SMALL NATURAL PRODUCTS LIBRARY: EXPANDING 
DIVERSITY AND PREDICTABILITY
Jacqueline L. von Salm1,2, Daniel Santiago1, Nerida G. Wilson3, Laurent 
Calcul1,2, Dennis E. Kyle4, Wayne C. Guida1,2,5, and Bill J. Baker1,2
1Department of Chemistry and 2Center for Drug Discovery & Innovation, 
University of South Florida, Tampa, FL 33620, USA, 3Western Australia 
Museum, Perth, Western Australia, Australia, 4Department of Global 
Health, University of South Florida, Tampa, FL 33620, USA, 5H. Lee Moffitt 
Cancer Center & Research Institute, Tampa, FL 33620, USA
Diverse compound libraries have become a necessity to drug discove-
ry efforts around the world. Target specific computational methods and 
high-throughput screening programs have aided the search for bioactive 
compounds, however, inefficiencies remain for neglected and tropical di-
seases. Detailed knowledge of mechanisms of action and target proteins 
is limited for parasitic diseases like malaria and leishmaniasis. In order to 
effectively lead research programs in these areas, our lab has developed a 
small compound library with diversity that mimics the NCI Diversity Set 
and the AntiMarin natural products database. Specific activity exhibited by 
each compound against Plasmodium falciparum and Leishmania donovani 
has been overlain to create activity “hotspots”, which we hope to improve 
activity prediction methods for unknown natural products isolated in the 
future. Limitations in diversity remain in all three libraries, and appear to 
have properties resembling small (MW < 400) hydrophobic molecules like 
terpenes. Here we use active antileishmanial terpenoids isolated from Ant-
arctic marine organisms as models to show expansion of overall diversity 
and future predictability of the library as a bioassay dereplication tool. 
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION 
OF NEW BULKY ACYLOXY TACCALONOLIDES AS 
POTENT MICROTUBULE STABILIZERS
Antonius R. B. Ola,1 April L. Risinger,1,2 Jiangnan Peng,1 Cynthia L 
Zamiello,1 and Susan L. Mooberry1,2
1Department of Pharmacology, 2Cancer Therapy & Research Center, 
University of Texas Health Science Center at San Antonio, Texas 78229, 
USA 
The taccalonolides are a new class of microtubule stabilizers isolated from 
plants of the genus Tacca. As part of our structure-activity relationship study 
(SAR) to identify taccalonolides with optimal microtubule stabilizing and 
antitumor actions, we conducted semi-synthetic reactions to modify C-15 
of taccalonolide B (1). In this study, five novel bulky acyloxy taccalonolides 
were synthesized via DMAP catalyzed esterification and DMDO epoxida-
tion. The new bulky acyloxy taccalonolide mono esters were further tested 
for their antiproliferative potency against HeLa cells. Remarkably, all bulky 
acyloxy taccalonolide esters demonstrated better potency than taccalono-
lide AF (12), including two with subnanomolar potencies (IC50 of 0.6 nM 
for 11 and 0.8 nM for 9). In vivo antitumor activities were also evaluated in 
a murine xenograft model.
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Session 5 - The Evolving Role of 
Natural Products in Neuroscience
NATURAL PRODUCT INSPIRED HSP90 INHIBITORS
Blagg, B.S.J.
Department of Medicinal Chemistry, The University of Kansas.
Natural products continue to play a key role in drug discovery, an example 
of which is highlighted by Hsp90 inhibitors. The 90 kDa heat shock pro-
teins (Hsp90) are responsible for the conformational maturation of nascent 
polypeptides, many of which are critical to the maintenance of cell signal-
ing networks that contribute to the six hallmarks of cancer. Thus, through 
Hsp90 inhibition, one can simultaneously derail multiple signaling net-
works through inhibition of a single biological target. The natural products, 
geldanamycin and radicicol, have served as lead compounds to develop 
multiple inhibitors that have entered clinical trials for the treatment of can-
cer that manifest their activity through inhibition of the Hsp90 N-terminal 
ATPase domain. In contrast, the natural products, novobiocin, EGCG, and 
silybin have served as lead compounds that regulate Hsp90 protein folding 
activity through allosteric modulation of the chaperone via the C-terminal 
dimerization domain. In addition, the natural products, cruentaren A, cel-
astrol and gedunin, have shown to provide a unique opportunity to mod-
ulate Hsp90 activity through disruption of co-chaperone interactions with 
Hsp90. In this presentation, the utilization of natural products to modulate 
the Hsp90 protein folding machinery will be discussed along with their po-
tential therapeutic applications.
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ADVANCES IN THE VALIDATION OF TRPM7 AS A DRUG 
TARGET USING NATURAL PRODUCTS – UPDATE ON 
WAIXENICIN A
F. David Horgen
Department of Natural Sciences, Hawaii Pacific University, Kaneohe, HI, 
96744
TRPM7 is a ubiquitously expressed divalent cation channel that plays an 
important role in cell adhesion and migration. TRPM7-dependence on the 
growth and metastasis of some cancers points to TRPM7 as a potential an-
ti-cancer target. Conversely, in brain ischemia models, dysfunctional activ-
ity and up regulation of TRPM7 sustains Ca2+ overload in neurons leading 
to cell death, which implicates TRPM7 inhibition as a potential target for 
stroke therapy. Motivated by the lack of selective inhibitors, we developed 
and optimization of a high throughput bioassay (J. Biomol. Screen. 2010, 15, 
498-507) that led to the isolation of waixenicin A, a diterpene from Sarco-
thelia edmondsoni, as a selective and potent inhibitor of TRPM7. In patch 
clamp experiments, waixenicin A demonstrated Mg2+-dependent inhibi-
tion of TRPM7 currents in native cells (J. Biol. Chem. 2011, 286, 39328), 
while further chemical investigation of the soft coral provided active and 
inactive analogues that revealed a pre-
liminary SAR. 
Since this recent work, waixenicin 
A has been employed in numerous 
on-going in vitro and in vivo studies 
aimed at better understanding the 
functions of TRPM7, particularly in 
the context of cancer. Most notably, 
collaborators at the Netherland Cancer 
Institute (Cell Calcium 2013, 54, 
404) demonstrated that inhibition of TRPM7 by waixenicin A disrupts 
invadosomes in neuroblastoma cells, a mechanism that appears consistent 
with the prognosis of TRPM7 expression for breast cancer metastasis and 
recurrence. Future investigations will seek to assess TRPM7 inhibition in 
animal tumor and ischemia models. The development of waixenicin A 
as a successful probe for studying TRPM7’s biological functions further 
demonstrates the value of natural product pharmacophores in advancing 
new targets for the treatment of disease.
DEVELOPMENT OF NOVEL NEUROACTIVE STEROIDS 
FOR THE POTENTIAL TREATMENT OF NEUROLOGICAL 
DISORDERS
Scott Runyon1, Michael Rogawski2, Kelvin Gee3, Nicholas Goeders4, and 
Christopher Schmoutz4
1Center for Drug Discovery RTI International, RTP, NC 27709. 2Dept. 
of Neurology, UC Davis, Sacramento, CA 95817. 3Department of 
Pharmacology, UC Irvine, Irvine, CA 92697. 4Department of Pharmacology, 
LSU Health Sciences Center. Shreveport, LA 71130 
NO2
HO
R
R6305-7 
R = H
Neuroactive steroids (NS) are defined 
as steroids active in the central ner-
vous system (CNS). NS were initially 
identified as metabolites of the hor-
mone progesterone (P) and have been 
subsequently shown to be potent po-
sitive allosteric modulators (PAMS) 
of extrasynaptic GABAA receptors. The most potent endogenous NS’s at 
GABAAR’s are allopregnanolone (AP) and 5α-THDOC; the principal meta-
bolites of the hormones progesterone and deoxycorticosterone respectively. 
Considering the physiological importance of AP and THDOC, our labora-
tory has begun to develop subtype selective and more drug-like analogs of 
endogenous steroids that have improved potency and reduced hormonal 
metabolism. Our studies have led to the development of a series of andro-
stane analogs that possess a nitro in the 17-position combined with a 
O
H
H
AcO
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3β-methyl group and a alternate substitutions at the 11β-position. The syn-
thesis of these analogs and potency at select GABAA subtypes along with 
the resulting pharmacokinetic properties will be discussed in addition to 
the in vivo data from anticonvulsant and substance abuse studies. 
PANAMANIAN MARINE CYANOBACTERIAL EXTRACTS 
WITH IN VIVO ACTIVITY IN MODELS OF ANXIETY AND 
DEPRESSION
Kevin Tidgewell1,3, Kh. Tanvir Ahmed1,3, Neil Lax2,3, and Benedict Kolber2,3
1Division of Medicinal Chemistry, Graduate School of Pharmaceutical 
Sciences, Mylan School of Pharmacy, 2Department of Biological Sciences, 
Bayer School of Natural and Environmental Sciences, 3Chronic Pain 
Research Consortium, Duquesne University, Pittsburgh, PA 15282
In the search for compounds with central nervous system (CNS) effects, 
the oceans are emerging as a largely unexplored source. A number of in-
teresting neurotoxins and ion channel modulators have been discovered 
from a variety of marine sources. The focus of this research was to screen 
and identify compounds which could modulate CNS diseases through acti-
vity at G-protein coupled receptors (GPCRs). As part of the Panama ICBG 
and in collaboration with the NIMH psychoactive drug screening program 
(PDSP) we have screened cyanobacterial fractions against a panel of ~48 
GPCRs and transporters involved in CNS disorders. From these initial 
screening efforts, a number of selective and potent hits are currently being 
explored to isolate and determine the active components. 2 fractions in par-
ticular have been explored because of their ability to bind to the 5-HT2c and 
5-HT7 receptors respectively. These fractions and some purified materials 
have been screened in vivo using behavioral models of depression and an-
xiety in C57Bl/6J mice via intra-cerebroventricular (ICV) injection. Both 
fractions have shown statistically significant alteration in behavior from 
single ICV injections. Results and progress to date will be presented. 
DISCOVERY OF NEUROPROTECTIVE MARINE 
NATURAL PRODUCTS USING A BIOIMAGING/
OPTOGENETICS APPROACH AND DROSOPHILA 
MELANOGASTER
Stacee Lee Caplan1, Ken Dawson-Scully1, and Lyndon M. West2
1Department of Biological Sciences, Florida Atlantic University, Boca Raton, 
FL 33431, USA, 2Department of Chemistry and Biochemistry, Florida 
Atlantic University, Boca Raton, FL 33431
Oxidative stress and cellular excitotoxicity is inherent in the pathophysiolo-
gy of an array of devastating human ailments. Natural products have played 
an important role in the treatment of a variety of human diseases and con-
tinue to drive the modern drug discovery and development process. The 
overall goal of this project is to design a novel neuroactivity assay to iden-
tify natural products capable of inducing neuroprotection against oxidative 
stress. This project will focus on a group of natural products, pseudoptero-
sins, known for their potent biological activities with a novel mechanism 
of action. We hypothesize that these compounds may be of potential the-
rapeutic benefit in protecting neurons and/or neural function both during 
and after episodes of excitotoxicity in disease states. 
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Session 6 - Recent Advances in 
Chemical Ecology
FUNCTIONAL AND BIOSYNTHETIC ANALYSES OF 
SECONDARY METABOLITES IN HOST-MICROBE 
SYMBIOSES
Marcy J. Balunas1
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, USA
Most if not all animals form benign and/or beneficial relationships with 
microorganisms. The importance of studying co-evolved beneficial relati-
onships in nature is now being realized (e.g., the recent large-scale effort 
to sequence the human microbiome). Our lab has been utilizing several 
well-studied host-microbe systems as unique sources of new biologically 
active drug leads. We have employed various analytical techniques to in-
terrogate these relationships including molecular networking, screening 
for biologically relevant activity (e.g., using antimicrobial, anti-cancer, and 
immunomodulatory assays), as well as isolating and identifying bioactive 
metabolites. In addition, we have begun characterization of the genomes, 
metagenomes, and transcriptomes from these host-microbe associations to 
better understand the biosynthetic capacity of these systems. Recent deve-
lopments from our chemical ecology investigations will be presented.
INTEGRATED DE NOVO METAGENOMICS AND 
METATRANSCRIPTOMICS TO STUDY NATURAL 
PRODUCTS AND MICROBIAL ECOLOGY IN SITU
Ian J. Miller1*, Theodore Weyna1*, Christine Mlot1, Stephen S. Fong2, Kerry 
McPhail3, Grace Lim-Fong4, Jason C. Kwan1
1Division of Pharmaceutical Sciences, University of Wisconsin-Madison, 
Madison, WI 53705, USA, 2Department of Chemical and Life Science 
Engineering, Virginia Commonwealth University, Richmond, VA 23284, 
USA, 3College of Pharmacy, Oregon State University, Corvalis, OR 97331, 
USA, 4Department of Biology, Randolph-Macon College, Ashland, VA 
23005, USA, *These authors contributed equally to this work.
Biosynthetic pathways that make secondary metabolites are widespread 
amongst bacteria, and the resulting small molecules presumably confer a 
selective advantage to producers. Because bacteria live in complex mixed 
communities in the environment and in association with higher host or-
ganisms, a variety of functions have been suggested for secondary metabo-
lites. These include the suppression of competitors, modulation of behavior 
or communication, as well as functions that align with the interests of a 
eukaryotic host. Discerning the roles of small molecules in the environ-
ment may uncover therapeutically relevant bioactivities, but natural bac-
terial communities are hard to study as most environmental bacteria are 
recalcitrant to culture. These uncultured communities can be accessed di-
rectly through sequencing of environmental DNA (metagenomics) or RNA 
(metatranscriptomics). Methods to deconvolute and assemble the genomes 
of multiple bacteria from metagenomes will be presented, with results from 
two model systems, the tunicate Lissoclinum sp. and the bryozoan Bugula 
neritina. In the latter system we have also integrated metatranscriptomics 
to give a snapshot of the global gene expression in a complex microbial 
assemblage.
BIOSYNTHESIS AND ECOLOGICAL FUNCTIONS OF 
DIKETOPIPERAZINE NATURAL PRODUCTS FROM 
MARINE ACTINOMYCETES
Amy L. Lane1, Elle James1
1Department of Chemistry, University of North Florida, Jacksonville, FL 
32224, USA
Molecules featuring 2,5-diketopiperazine (DKP) scaffolds are common in 
Nature and have been isolated from a variety of fungi and bacteria. These 
cyclodipeptides offer a range of medicinal activities, including antimicro-
bial, anticancer, and immunosuppressant effects. Cyclodipeptide synthas-
es (CDPSs) were recently revealed as a novel family of small (~30 kDa) 
enzymes that assemble DKPs from aminoacyl-tRNA substrates diverted 
from primary metabolic pathways. Although bioinformatics analyses of 
microbial genomes suggest that CDPSs are widespread amongst terrestrial 
and marine bacteria, fewer than a dozen CDPSs have been biochemical-
ly characterized. Here, we present the biochemical characterization of two 
CDPSs from a marine-derived Nocardiopsis sp. actinomycete. Our data re-
veal that both of these phylogenetically distinct CDPSs are highly selective 
for tryptophan-charged tRNA substrates to yield exclusively cyclo(L-Trp-L-
Trp). We also present results from field and laboratory experiments probing 
cyclo(L-Trp-L-Trp) and other microbial DKPs as mediators of interactions 
between marine microorganisms. Together, our data provide insights into 
the prevalent, yet understudied CDPS enzyme family and suggest import-
ant adaptive functions of corresponding DKP metabolites. 
MECHANISMS OF MICROBE-MICROBE-HOST 
INTERACTIONS IN A PROBIONT-PATHOGEN-BIVALVE 
MODEL
David Rowley1, Wenjing Zhao2, Tao Yuan1, Christine Dao1, Saebom Sohn3, 
Marta Gomez Chiarri3, Navindra Seeram1, and David R. Nelson2
1Biomedical and Pharmaceutical Sciences, 2Department of Cell and 
Molecular Biology, 3Fisheries, Animal and Veterinary Sciences, University of 
Rhode Island, Kingston, RI 02881
Marine mollusks are filter feeders and thus are continuously exposed to a 
myriad of microorganisms. While the majority of bacteria likely have no 
effect on the overall health of the animal, some microbes, including mem-
bers of the bacteria genus Vibrio, can cause infections that lead to rapid 
mortality, especially in larval and juvenile bivalves. For example, the oys-
ter pathogen Vibrio tubiashii causes sporadic crashes of larval oyster pro-
duction in commercial hatcheries. Alternatively, it is also clear that certain 
beneficial microorganisms can colonize mollusks and provide disease re-
sistance. Such microbes can potentially be developed as probiotic agents 
to combat disease outbreaks in bivalve hatcheries. To enable the rational 
development of such microbes as probiotics, a more comprehensive knowl-
edge of the mechanisms involved in microbe-microbe-host interactions 
is required. In this study, we investigated how the bacterium Phaeobacter 
gallaeciensis S4Sm reduces mortality of larval oysters when challenged with 
V. tubiashii. A combination of analytical chemistry, genetic mutation, and 
both in vitro and in vivo challenge assays were used to interrogate the roles 
of specific bacterial metabolites and also bacterial behaviors such as biofilm 
formation. Our results show that the probiotic activity of S4Sm is multi-
factorial, involving its ability to form extensive biofilms, production of the 
potent antibiotic tropodithietic acid, and quorum quenching of pathogen 
virulence genes. 
MACROALGAE MAY INTERRUPT IMPORTANT CUES 
FOR CORAL LARVAL SETTLEMENT
Jennifer M. Sneed, Sarah J. Harrison, Lawrence J. Houk, Valerie J. Paul
Smithsonian Marine Station at Fort Pierce, Florida, USA
Coral reefs are becoming increasingly dominated by fleshy macroalgae. 
Recovery of reefs is dependent on the recruitment of new corals and the 
presence of certain macroalgae impedes the settlement of coral larvae di-
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rectly through physical and chemical competition. However, there may be a 
third impediment to the successful recruitment of coral larvae on algal-do-
minated reefs, namely the interruption of bacterially produced settlement 
cues. For some corals, the settlement process appears to be dependent on 
the presence of chemical cues produced by biofilm bacteria. To determi-
ne if macroalgae impact bacterial communities on settlement substrata, 
we examined the effects of two species of macroalgae commonly found on 
Caribbean reefs (Halimeda opuntia and Dictyota sp.) on the bacterial com-
munities associated with the crustose coralline alga (CCA) Hydrolithon bo-
ergesenii. We attached either a live clump of algae or a fake aquarium plant 
to CCA pieces and placed them in individual flow-through chambers (n = 
5) on the reef. After 48 hours, we sampled the biofilm communities on the 
CCA and the algae and analyzed them using next-generation sequencing. 
Both algae caused a shift in the bacterial community found on the surface 
of the CCA; however H. opuntia had the greatest impact. Organic extracts 
of H. opuntia affected growth of bacterial strains isolated from the surface 
of H. boergesenii in laboratory assays and the compound halimedatetraace-
tate demonstrated antibiotic activity against several strains. This study de-
monstrates that macroalgae can alter biofilm bacterial communities, some 
of which may provide chemical cues necessary for coral larval settlement.
Session 7 - Natural Products and the 
Human Microbiota
Sponsored by Procter & Gamble, Co. & 
Takeda Pharmaceuticals International, Inc.
GUT REACTIONS: NATURAL PRODUCTS AND THE 
HUMAN MICROBIOTA 
Emily P. Balskus
Department of Chemistry and Chemical Biology, Harvard University, 
Cambridge, MA 02138
Humans are colonized by vast numbers of microorganisms whose metabo-
lisms are inextricably intertwined with our own. Advances in DNA sequen-
cing over the past twenty years have sparked a revolution in our understan-
ding of the human microbiota and its functional capabilities, causing us 
to rethink our very notion of our chemical selves. The chemical reactions 
performed by our microbial companions can be distinct from those of the 
human host, and there is growing evidence that the products of microbial 
metabolism may influence both human health and disease. My research 
seeks to discover and understand enzymes, metabolic pathways, and me-
tabolites from the human gut microbiota. We study reactions involved in 
transforming natural product-based drugs and dietary components, as 
well as the chemistry of secondary metabolite biosynthesis. This talk will 
highlight work from my lab and others that demonstrates how a molecular 
understanding of gut microbial metabolism can help to reveal the abun-
dance of important functions in these communities and guide strategies for 
manipulating these activities.
FOOD, DRUGS, AND BUGS: A METAGENOMIC VIEW OF 
PHARMACOLOGY
Peter J. Turnbaugh1
1Department of Microbiology and Immunology, G.W. Hooper Foundation, 
University of California, San Francisco, CA 94143.
Our gastrointestinal tracts harbor complex microbial communities (the gut 
microbiome) that are capable of a vast array of enzymatic activities, contri-
buting to the metabolism of our diet and the drugs we take. Yet the molecu-
lar mechanisms responsible often remain unknown, making it challenging 
to translate these findings to new therapies and diagnostics, or to appreciate 
their broader biological, ecological, and evolutionary implications. We are 
studying the interactions between gut microbes and xenobiotics, including 
host-targeted drugs (e.g., the cardiac drug digoxin) and diet-derived bioac-
tive compounds (e.g., polyphenols). I will discuss two ongoing projects in 
the lab. First, we have identified a cytochrome-encoding operon responsible 
for the bacterial inactivation of digoxin, inhibited by arginine in vitro and 
in vivo, absent in nonmetabolizing E. lenta strains, and predictive of di-
goxin inactivation by the human gut microbiome. Second, we have shown 
that food-derived compounds reshape the gut microbiota in a manner that 
may protect against metabolic syndrome. Ultimately, we aim to obtain a 
more comprehensive view of human metabolism, yielding fundamental 
insights into host-microbial interactions, and supporting translational ef-
forts to predict and manipulate the metabolic activities of our resident gut 
microbes. 
BIOTRANSFORMATION OF ANTICANCER DRUGS BY 
HUMAN AND ENVIRONMENTAL MICROBIOMES 
Gerry Wright
M.G.DeGroote Institute of Infectious Disease Research, McMaster 
University, 1280 Main St W, Hamilton, ON Canada L8S 4K1
Many anticancer drugs have toxic effects on microbes in addition to human 
cells. It is therefore not surprising that many microbes have intrinsic resi-
stance mechanisms that can be deployed to counteract anticancer drug to-
xicity. This is especially apparent for anticancer agents that are synthesized 
by soil microbes themselves. We have embarked on an effort to explore the 
resistomes of anticancer agents in the microbiomes of the human gut and 
in the environment. We have identified many microbes that can detoxify 
these anticancer drugs via degradation mechanisms. Understanding the 
molecular basis of these resistance mechanisms is of value in managing 
drug concentrations during therapy and possibly in avoiding toxicity and 
in bioremediation. 
Session 8 - Natural Product 
Anticancer Drug Lead Discovery in 
Honor of Richard G. Powell
Sponsored by the Journal of Natural Products
HISTORICAL ASPECTS OF ANTITUMOR COMPOUNDS 
FROM PLANTS, INCLUDING HOMOHARRINGTONINE 
(OMACETAXINE MEPESUCCINATE, SYNRIBOTM)
Richard Powell
National Center for Agricultural Utilization Research (retired), Peoria, 
Illinois. Current address: 4160 Caddie Dr. E., Bradenton, Florida 34203
Various preparations derived from vascular plants have been used utilized 
to treat tumors or cancerous conditions for centuries. The available litera-
ture was summarized by Jonathan Hartwell in a remarkable series of papers 
“Plants Used Against Cancer” published in Lloydia from 1967 to 1971. The 
U.S. National Cancer Institute (NCI) established the Cancer Chemotherapy 
National Service Center (CCNSC) in 1955. Hartwell transferred to CCNSC 
in 1957, and under his guidance a major program to discover plant anti-
cancer constituents was developed. Arrangements were made between the 
NCI and the U.S. Department of Agriculture (USDA) for extensive plant 
collections in 1960. Many of the collections were from countries that were 
involved in the Food for Peace Program, Public Law (PL) 480. The Wis-
consin Alumni Research Foundation (WARF) was awarded an extraction 
and screening contract, and research contracts were awarded to Drs. Mon-
roe Wall, Morris Kupchan, Norman Farnsworth, John Cassady and others. 
When plant seeds were obtained, they were sent to the Northern Regional 
Research Laboratory (NRRL) in Peoria, Illinois, where they were examined 
in a program to identify potential new crops. Extracts of many of the seeds 
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were prepared and screened for antitumor activity and the more significant 
results obtained from the seed extracts will be summarized.
DEVELOPMENT OF TAXOL® AS AN ANTICANCER DRUG
David G. I. Kingston
Department of Chemistry and Virginia Tech Center for Drug Discovery, 
Virginia Tech, Blacksburg, VA 24061 USA
The anticancer drug Taxol® (paclitaxel, 1) and its semisynthetic analogs 
docetaxel (2) and cabazitaxel (3) are some of the most effective weapons 
in the arsenal of drugs for the treatment of breast cancer, ovarian cancer, 
and various other cancers. The story of how the chemical compound taxol, 
discovered by Monroe Wall and Mansukh Wani as the major active com-
ponent of the bark of the Western Yew, Taxus brevifolia, became the major 
drug Taxol® is a fascinating one. It includes the discovery by Richard Powell 
and colleagues of the closely related compound cephalomannine (4), the 
discovery by Susan Horwitz of its unique mechanism of action, and a sum-
mary of the long and tortuous route to clinical approval. Some chemical 
and biological studies of paclitaxel from the author’s laboratory will also 
be included.
O
O
PhCOO
OR
HO
O
AcO
H
O
Ph
NH
O
OH
RO
2 Docetaxel R = H
3 Cabazitaxel R = Me
O
PhCOO
OH
HO
O
AcO
H
O
Ph
NH
O
OH
AcO
4 Cephalomannine
OO
Ph
O
PhCOO
OH
HO
O
AcO
H
O
Ph
NH
O
OH
AcO
1 Paclitaxel
O
NORTH AMERICAN PLANTS REMAIN AN EXCELLENT 
SOURCE FOR COMPOUNDS WITH ANTICANCER 
POTENTIAL 
Susan L. Mooberry
Department of Pharmacology and Cancer Therapy & Research Center, The 
University of Texas Health Science Center at San Antonio, 7703 Floyd Curl 
Drive, San Antonio, TX, 78229-3900. 
One of the most important chemotherapy drugs used clinically today, Tax-
ol®, was discovered from the bark of a North American tree, Taxus brevifo-
lia. Our efforts with plants of North America continue to yield new com-
pounds with significant biological activities against cancer cell lines. The 
use of bioassays as the sole criteria to guide fractionation, combined with 
modern chemical techniques, allows the rapid identification of these prom-
ising molecules. Approaches for discovery, isolation, synthesis as well as 
biological assay results of 8 new compounds from diverse North American 
plants including Amyris texana, Verbesina virginica, Dalea frutescens and 
Gochnatia hypoleuca will be discussed. New significant biological activities 
of known compounds can also be uncovered by these methodologies lead-
ing to the potential for discovery of targeted therapies from plants for the 
treatment of cancer. 
ARE NATURAL PRODUCTS ISOLATED FROM PLANTS, 
PRODUCTS OF EPI- AND/OR ENDO-PHYTIC MICROBIAL 
INTERACTIONS WITH / WITHIN THE HOST? 
David J. Newman1 and Gordon M. Cragg2
1Wayne, PA 19087, USA. 2Bethesda, MD 20814, USA.
Over the last 15 or so years, there have been multiple reports that “plant-de-
rived” molecules such as paclitaxel, camptothecin, vinca alkaloids, hyperi-
cin etc., have been purified from fermented microbes (usually fungal iso-
lates) that were endophytes of the “producing plant”. We will discuss these 
and other reports of the production of molecules as disparate as maytansine 
and kampferol by microbes isolated from the “producing-plant species”. It 
is tempting to suggest that at this time, we might be at a period in the study 
of plant metabolites comparable to the one that occurred in the late 1980s 
with marine invertebrates, when compounds isolated from marine sponges 
were shown to have structures very similar to those isolated from terrestrial 
microbes. This work led to the current recognition that a majority of ma-
rine invertebrate metabolites are in fact produced by associated microbes, 
even though in a number of cases, these microbes have not yet been cultiva-
ted. Is this now the case with “some” plant-derived compounds?
Session 9 - Bumpy Road to Beauty: 
Natural Products in the Cosmetic 
Industry
PAVING THE WAY WITH ACTIVES FOR SKINCARE
Jon Anderson, Young Anderson, and Thushara Diyabalanage
Actives International LLC, Allendale, NJ 07401.
Skin is our body’s largest organ and is responsible for many functions in-
cluding protection from environmental, mechanical, and pathogenic insult, 
regulation of moisture, sensation, and immune surveillance. The cosmetics 
and skincare industries focus on the care of healthy or healthy but damaged 
skin rather than solving disease states. However, contrary to popular opi-
nion, the industry is highly regulated and skincare companies often resort 
to soft claims to describe the benefits of their products. Nonetheless, exten-
sive research goes into the development of functional ingredients that can 
impart an observable benefit for the customer. An extensive knowledge of 
skin biology and a strong background in natural products chemistry are 
required when developing ingredients for modern skin care products.
During this presentation we will touch on various promising natural pro-
ducts showing unique activities on the skin that will serve by way of ex-
ample where the skincare industry is trending. Some of the areas of interest 
range from prevention and repair of photo and chronic aging, reduction of 
irritation and hyperpigmentation, and skin barrier maintenance.
ERGOTHIONEINE, THE AMAZING AMINO ACID
Chia Wen Chen1
1Estee Lauder Companies, 125 Pinelawn Road, Melville, NY 11747
Ergothioneine is a naturally occurring amino acid synthesized by microor-
ganism and fungi. Although Ergothioneine cannot be made in human cells, 
it is present in skin and some tissues at high level as it is absorbed from the 
diet. The amino acid has good antioxidant properties due to the presence of 
the thione (C=S) group which is different than other sulfur containing an-
tioxidants. Ergothioneine is called the new vitamin and ergothioneine rich 
food is often taken for liver and eye health with references for skin health 
for the reduction of sun damage.
In this presentation, I will share the journey of developing this novel ingre-
dient from concept to cosmetic friendly actives: from sourcing, through 
in-vitro substantiation, finding the relevance in skin with urban life style 
and global compliances.
FROM THE BERRY TO THE BARRIER: DEVELOPMENT 
OF NATURAL PRODUCTS FOR SKIN AND HAIR CARE
James V. Gruber1
1Sensient Cosmetic Technologies, 107 Wade Avenue, South Plainfield, NJ 
07080
The movement of the cosmetic industry away for harsh petroleum-based 
chemicals and more towards ingredients that originate from natural sour-
ces has been accelerating. While many consumers feel that “natural” ingre-
dients are safer and better for the environment, this is not always a truism. 
Reaching into plants or microorganisms to try and draw out unique ingre-
dients that might have benefits for skin care is not always easy. Often times, 
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extractions are done using solvents that might themselves not necessarily 
be considered all that friendly. This talk will examine Sensient Cosmetic 
Technologies’ capabilities in natural extraction technologies including su-
percritical, subcritical and standard solvent extractions that are employed 
to develop novel natural ingredients for food, pharmaceutical and cosmetic 
applications. From these technologies, various types of natural extracts in-
cluding essential oils, natural colors and antioxidants isolated from proan-
throcyanin-rich fruits, and protein hydrolysates from various crop sources 
are available. The company has begun exploring how these unique ingredi-
ents might be better employed in skin and hair care applications. The talk 
will address some of the pitfalls and difficulties that arise to bring a new 
ingredient into global compliance and looking at testing techniques that 
can pinpoint what the active might do when it is topically applied to the 
skin or scalp. 
SELECTION OF PROSPECTIVE FICUS SPECIES AND 
DEVELOPMENT OF NOVEL MULTIFUNCTIONAL ZETA 
FRACTIONS FOR PERSONAL CARE
Michael Koganov, Artyom Duev, Olga Dueva-Koganov, Li Zhang, Paul 
Recht, Xiaowen Hou, Steven Micceri, and Alfred Wong
BioMaterials, AkzoNobel Surface Chemistry LLC, 23 Snowden Avenue, 
Ossining, NY 10562
Underexplored potential of diverse Moraceae plant family was investigated 
by combination of phylogenetic relatedness analysis and novel Zeta Frac-
tion technology. F. benghalensis, F. elastica, F. microcarpa, F. carica, and 
F. trigonata were selected amongst over 800 species. Zeta Fraction tech-
nology was utilized to obtain multifunctional bioactive ingredients (Zeta 
Fractions) from living leaves of selected Ficus spp. as described in PCT 
WO2012033989, US 20140199419, US20130243710, and US20130323339. 
These fractions were analyzed by LC-UV, LC-MS, ToF/MS, and tested for 
in vitro activities related to skin aging, irritation, inflammation, and hyper-
pigmentation. Compared to respective conventional extracts, these frac-
tions contained a greater variety of compounds and demonstrated superior 
activities, safety, aesthetics and excellent sustainability. Zeta Fraction from 
F. benghalensis was free of proteins and pheophorbides, showed outstan-
ding activity in selected assays, and is currently used in numerous multi-
functional skin and hair care beauty products worldwide. Zeta Fractions 
from other Ficus spp. demonstrated specific activities particularly suited for 
mitigation of hyperpigmentation (F. carica) and inflammation (F. micro-
carpa). Development of these ingredients demonstrates how solvent-free 
Zeta Fraction technology, based on Density Functional Theory, isolates 
plant intracellular components in a reproducible and sustainable process. 
This technology protects integrity of molecular architecture in living cells, 
produces fractions capable of targeting multiple biological pathways with 
single ingredient, improves safety by removing the contaminants of con-
cern, and results in minimal environmental impact and no waste. In addi-
tion to providing opportunities for product differentiation and improved 
aesthetics, Zeta Fraction technology is a powerful tool for exploring and 
discovering new bioactive compounds from plants.
Session 10 - Microbial Interactions in 
Humans and Other Animals 
DISCOVERING AND DECIPHERING THE PATHOGENIC 
AND PROBIOTIC ACTIVITIES FROM THE BACTERIAL 
COLIBACTIN PATHWAY
Maria I. Vizcaino1,2, Eric Trautman1,2, Philipp Engel1,2,3, Emilee Shine4 and 
Jason M. Crawford1,2,4
1Department of Chemistry, Yale University, New Haven, CT 06520, 
2Chemical Biology Institute, Yale University, West Haven, CT 06516, 
3Department of Fundamental Microbiology, University of Lausanne, 
Lausanne, Switzerland, 4Department of Microbial Pathogenesis, Yale School 
of Medicine, New Haven, CT 06510 
Select strains of E. coli in our gut encode the “colibactin” pathway, a nonri-
bosomal peptide synthetase-polyketide synthase hybrid pathway phenoty-
pically linked to inflammatory bowel disease and colorectal cancer patients. 
A variety of cell biology and animal model studies have previously been 
reported for the pathway, but the responsible small molecules driving the 
phenotypes have remained enigmatic. Employing molecular networking 
tools, we developed a “pathway-targeted” molecular networking approach 
to map the colibactin pathway from both the meningitis pathogen E. coli 
IHE3034 and the probiotic E. coli Nissle 1917. A combination of bacteri-
al genetics, metabolomic network analyses, system-wide isotopic labeling 
studies, 1- and 2D-NMR, bioinformatics, and/or synthesis supported the 
structures and biosynthesis of at least 32 molecules from the colibactin pa-
thway. In vitro activity studies – 5-hydroxytryptamine-7 receptor antago-
nist, bacterial growth-inhibitory, and DNA interstrand crosslinking assays 
– for some of these molecules provide functional insights and pave the way 
for connecting bacterial small molecule chemistry to host physiology in 
animal model systems. 
INTERACTIONS BETWEEN THE MARINE BRYOZOAN 
BUGULA NERITINA, ITS ENDOSYMBIONT, AND 
SYMBIONT-PRODUCED BRYOSTATINS
Nicole B. Lopanik
Department of Biology, Georgia State University.
The invasive marine bryozoan, Bugula neritina, is distributed in temperate 
habitats worldwide. B. neritina possesses an uncultured bacterial symbi-
ont, “Candidatus Endobugula sertula” that is vertically transmitted from 
parent to offspring. It is also the source of the bryostatins, twenty bioactive 
polyketide metabolites with anticancer, anti-Alzheimer’s disease, and anti-
HIV activity. Antibiotic curing experiments showed that E. sertula is, in 
fact, the true source of the bryostatins, and in vitro biochemical assays with 
heterologously expressed portions of bry, the putative bryostatin polyketide 
synthase gene cluster, confirmed its role in bryostatin biosynthesis. Intere-
stingly, the bryostatins are ecologically relevant, as some of the bryostatins 
are distasteful and defend the host from predators such as fish, indicating 
that this symbiosis is a tritrophic interaction among the host, symbiont, 
and predator. Bryostatin levels are higher on larval B. neritina, which are 
exceptionally vulnerable to predators, compared to adult colonies which 
rely more on physical defense. Previous research showed that the host is 
a complex of three closely related sibling species that vary both in their 
symbiont and bryostatins, with one (Type N) lacking the symbiont and 
bryostatins. Our studies along the western Atlantic showed that, instead of 
being restricted to higher latitudes where predation pressure is presumed 
to be lower, Type N B. neritina can be found at lower latitudes, and Type S 
colonies at higher latitudes, indicating a more widespread host distribution 
than previously thought. Curiously, some of those host colonies varied in 
their symbiotic status, with Type N colonies at low latitudes possessing the 
symbiont whereas Type S colonies collected from high latitudes are apo-
symbiotic. Furthermore, the symbiont in Type N colonies at low latitudes 
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appears to be the same strain as that found in Type S. Together, these data 
indicate that the symbiont, but not the host, is restricted by biogeography, 
and that symbiont transmission is more flexible than previously thought. 
This system reflects the complexity and breadth of biological interactions 
resulting in symbiont-produced bioactive compounds. 
SMALL-MOLECULE-MEDIATED INTERACTIONS IN 
COMPLEX MICROBIAL COMMUNITIES
1Mohamed S. Donia 
1Department of Molecular Biology, Princeton University, Princeton, NJ, 
08540
In complex biological systems, small molecules often mediate microbe-
microbe and microbe-host interactions. Identifying these molecules, cha-
racterizing their biological activity, and explaining their relevance in a na-
tive context are challenging endeavors. Here, I will describe our ongoing 
efforts to develop computational and experimental tools for discovering 
small molecules encoded and produced in complex host-associated micro-
biomes. Examples from several systems will be discussed, including human 
and marine invertebrate microbiomes.
VERSATILE BACTERIAL SYMBIONTS OF SHIPWORMS 
CONTRIBUTE TO WOOD DIGESTION, FIX NITROGEN 
AND PRODUCE SECONDARY METABOLITES
Margo Haygood, Marvin Altamia, Sherif Elshahawi, Andrew Han, Zhenjian 
Lin, Meghan Betcher, Roberta O’Connor, Moriah Sandy, Amaro Trinidade-
Silva, Alison Butler, Eric Schmidt, Gisela Concepcion, Daniel Distel
Shipworms, bivalve mollusks that burrow into and consume wood, host in-
tracellular gamma proteobacterial symbionts in bacteriocytes located in the 
host gill. The bacteria produce cellulolytic enzymes and fix nitrogen, and 
were proposed to support the host’s ability to survive on a food source that 
is resistant to digestion and poor in nitrogen. Symbiont genomes reveal a 
surprising number of putative secondary metabolite biosynthesis pathways, 
leading us to propose that these symbionts may also contribute chemically 
to the symbiosis. We observed that the wood digestion organ portion of the 
gut is nearly devoid of microbes, allowing the host to consume the sugars 
resulting from wood digestion without competition. We demonstrated that 
cellulolytic enzymes produced by the symbionts in the gill are transported 
to the wood digestion organ, and we hypothesize that secondary metaboli-
tes also follow this route and suppress competing environmental microbes 
in the wood digestion organ. The candidate compounds found include a 
new family of catecholate siderophores, the turnerbactins, and tartrolon E, 
both of which are not only produced by the symbionts in culture, but can 
be detected by mass spectrometry in extracts of the intact association, sug-
gesting that they may play a vital role in the symbiosis.
Session 11 - Novel Screening 
Strategies for the Identification of 
Therapeutic Lead Compounds
PLURIPOTENT STEM CELL COLONIES PROVIDE 
A DEVELOPMENTAL LANDSCAPE FOR 
PHARMACOGENOMIC DRUG DISCOVERY
Daniel J Hoeppner1, Josh Chenoweth1, Suel-Kee Kim1, Amritha Jaishankar1, 
Yanhong Wang1, Nick Olivares1, Seungmae Seo1, Genevieve Stein-O’Brien1, 
Carlo Colantuoni1, and Ron McKay1
Lieber Institute for Brain Development, Baltimore, MD 21205
Human induced pluripotent stem cells (iPSCs) and their differentiated de-
rivatives are now widely used in disease modeling. However, the cellular 
heterogeneity and inter-line variability of these cultures has inhibited their 
wide application in drug discovery. To define the constant and variable fea-
tures of renewal and early differentiation we developed precise methods for 
cell culture and spatial analysis of unconstrained iPSC colony formation. 
Time-lapse recording and live-cell immunocytochemistry revealed that af-
ter passage, a reproducible set of developmental domains is spontaneously 
established in monolayer culture: (1) cellular aggregation establishes stable 
boundaries (2) an epithelial core then emerges on the internal surface with 
early neural properties of tight cell packing and expression of pro-neuro-
genic transcription factors. Using this developmental platform, we demon-
strate quantitative differences in the kinetics of domain production and 
associated signaling in iPS cells from multiple donors. Applying high-con-
tent analysis with targeted compound libraries, we can measure domain-
specific responsiveness revealing differential signaling between donors. We 
demonstrate a platform for successful drug discovery using human iPSCs 
if accounting for the critical domains of space, time, and donor genotype.
NEUROTROPHIC AND NEURITOGENIC DRUG LEADS 
FROM NATURAL PRODUCTS: A COMBINED IN 
VITRO ASSAY FOR EVALUATION OF CELL VIABILITY 
AND NGF-STIMULATED NEURITIC OUTGROWTH IN 
NEUROSCREEN 1 CELLS
Babu L. Tekwani1,2, Narayan D Chaurasiya1, Surabhi Shukla1,2, Ilias 
Muhammad1 and Larry A Walker1,2 
1National Center for Natural Products Research, Research Institute of 
Pharmaceutical Sciences and 2Department of BioMolecular Sciences, School 
of Pharmacy, University of Mississippi, University MS 38677 USA
Neuritogenesis or neuritic outgrowth is a fundamental cellular differentiati-
on process for formation of new neurons. Recent reports have indicated im-
portance of this process in neuroregeneration and repair of damaged neu-
rons. Neurotrophic and Neuritogenic substances, which repair damaged 
neurons through stimulation of neuritic outgrowth, may be important for 
restoration and readjustment of normal neuronal functions of the damaged 
neurons. Neurite outgrowth assays are important phenotypic methods to 
screen chemical effects on the neuronal cells, especially for discovery of low 
molecular weight neurotrophic agents. Bioactive small molecules with neu-
rotrophic and neuritogenic actions hold great promise as therapeutic agents 
for treatment of neurodegenerative diseases and neuronal injuries by virtue 
of their ability to stimulate neuritic outgrowth. A combined in vitro method 
that measures and quantifies neurite outgrowth along with the cell viability 
in a single assay has been described here. This assay is simple, less expensive 
and a useful tool for identification of new neurotrophic agents. The stimu-
lation of neurite outgrowth was measured by analysis of digital cell images 
by the NIS software in terms of multiple parameters namely, the effect of 
test compounds on mean neurite length, neurite length/cell, nodes/cell and 
number of neurites/cell. An important advantage of this method, which 
can be performed in a 96-well plate, is the determination of cytotoxicity 
and neurotrophic activity of the test compounds in a single assay. The assay 
has been successfully applied for screening natural as well as synthetic com-
pounds libraries. Focused screening of a library of harmala alkaloids and 
other natural products has identified new natural products leads, which 
produced significant activation of NGF-stimulated neuritic outgrowth. The 
lead natural products have been investigated further for interrogation of 
neurotrophin signaling pathways. Acknowledgement- Supported by NIH 
- National Institute of General Medical Sciences #P20GM104932 (COBRE-
In vitro Research Core) 
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UTILIZING DIFFERENTIAL CYTOTOXICITY SCREENING 
TO IDENTIFY LEAD COMPOUNDS FOR RARE ADULT 
AND PEDIATRIC TUMORS
April L. Risinger1,2, Lin Du3,4, Andrew Robles1, Pooja Sarkar1, Alejandro 
Perez1, Jarrod B. King3,4, Nicholas Dybdal-Hargreaves1, Wentao Dai3,4, Barry 
O’Keefe5,6, Robert H. Cichewicz3,4, Susan L. Mooberry1,2
1Department of Pharmacology and 2Cancer Therapy & Research Center, UT 
Health Science Center, San Antonio, TX 78229. 3Natural Products Discovery 
Group and 4Department of Chemistry and Biochemistry, University of 
Oklahoma, Norman, OK 73019. 5Natural Products Branch and 6Molecular 
Targets Laboratory, National Cancer Institute, Frederick, MD 21702.
Over the last several decades, natural products have become a mainstay in 
the treatment of cancers. However, it has become increasingly clear that 
even agents previously classified as general cytotoxins are only effective in 
subpopulations of patients, suggesting that these agents may be considered 
‘targeted therapies’. In addition to understanding the molecular markers 
that predict response to current therapies, there is a critical need to identify 
new compounds that specifically target rare, lethal malignancies with limi-
ted treatment options, including triple negative breast cancers and some 
classes of pediatric solid tumors. We have developed an effective method 
of screening extracts and fractions from fungi and plants that is yielding 
compounds with selective cytotoxic activities for these cancer subtypes.
                   
                     
NEW ANTIMICROBIALS FROM AN EPIGENETICS 
BASED FUNGAL METABOLITE SCREENING PROGRAM
Danielle Demers1, Renee Fleeman2, Brian Vesely3, Christopher Rice3, 
Beatrice Colon3, Ala Azhari3, Ashley Souza3, Dennis E. Kyle3, Lindsey N. 
Shaw2, Bill J. Baker1
1Department of Chemistry and Center for Drug Discovery and Innovation, 
University of South Florida, Tampa, FL 33620, 2Department of Cell Biology, 
Microbiology and Molecular Biology, University of South Florida, Tampa, 
FL 33620, 3Department of Global Health, University of South Florida, 
Tampa, FL 33613
Microbial natural products have historically played an important role in 
both antibacterial and antiparasitic drug discovery. However, with emer-
ging drug resistance as a global threat to nearly all current antimicrobial 
treatments on the market, new discovery efforts are needed with increasing 
urgency. Mangrove endophytic fungi, known as a source of great biological 
and chemical diversity, were investigated in a large epigenetics based scree-
ning program. Cultured under control and epigenetically modified condi-
tions, isolates were extracted and submitted for biological assay against the 
ESKAPE pathogens, the tropical disease causing parasite Leishmania dono-
vani, and the meningoencephalitis causing amoeba Naeglaria fowlerii. The 
chemical investigation of one active organism identified in this way yielded 
a suite of new antimicrobial compounds. Herein, the structure elucidation 
and biological profiles of these new compounds will be discussed. 
A NOVEL BIOASSAY TO IDENTIFY ANTI-VIRULENCE 
LEADS AGAINST GRAM-POSITIVE BACTERIAL 
PATHOGENS
Daniel A. Todd1, David B. Zich1, Alexander R. Horswill2, Nadja B. Cech1
1Department of Chemistry and Biochemistry, University of North Carolina 
Greensboro, NC 27412, USA, 2Department of Microbiology, University of 
Iowa, Iowa City, IA, USA
Infections from drug resistant bacteria result in millions of illnesses and 
thousands of deaths annually in the US each year, and cost an estimated 
$55 billion. The anti-virulence approach has emerged as a promising me-
thod for combating these infections. In theory, an anti-virulence therapeu-
tic would reduce bacterial pathogenesis, resulting in clearance by the host 
without promoting resistance. Our lab has developed a novel phenotypical 
bioassay to identify new broad spectrum anti-virulence therapeutic leads. 
Utilizing a uniquely engineered strain of Staphylococcus aureus coupled to 
a novel mass spectrometry detection method, we have screened for com-
pounds that interact with a very specific target within the quorum sensing 
system of Gram-positive bacteria, AgrB. This method has allowed us to ef-
ficiently screen over 500 natural product compounds, as well as numerous 
plant and fungal extracts. We have also employed the new assay to demon-
strate that the fungal metabolite ambuic acid targets AgrB, and has broad-
spectrum activity against multiple pathogenic bacteria. 
Session 12 - New Avenues in Botanical 
Research
HDAC INHIBITORS FOR CANCER CHEMOPREVENTION
Cuendet Muriel
School of Pharmaceutical Sciences, University of Geneva, University of 
Lausanne, 30 Quai Ernest-Ansermet, 1211 Geneva 4, Switzerland
The treatment of several diseases is highly dependent on natural products 
and this is especially true in the case of cancer. Most of human cancers 
seems to be potentially avoidable by controlling exogenous factors (prima-
ry prevention), but also by using agents interfering with carcinogenesis. 
These compounds can be divided into three categories: blocking agents 
(anti-initiation), agents against the promotion or the progression stages. 
Epigenetic changes, induced by compounds acting on the methylation or 
acetylation status of the histones, mostly act in the last stage. 
Histone deacetylases (HDACs) are enzymes that deacetylate lysine residues 
from histones, as well as several other nuclear, cytoplasmic or mitochon-
drial proteins. In mammals, there are 11 zinc-dependent HDACs classified 
in three classes: class I (HDACs 1-3 and HDAC8), class II which is subdi-
vided into classes IIa (HDAC4, 5, 7, and 9) and IIb (HDAC6 and 10), and 
class IV (HDAC11). During the past years, the number of enzyme subtypes 
has increased and offers the possibility to develop HDAC inhibitors with 
increased specificity. In the case of cancer, these specific inhibitors should 
have a better efficacy and decreased side effects. A method using mass spec-
trometry was developed to measure the inhibitory activity against classes I 
and II isoforms in a single sample. Various diterpenes and aurones showed 
promising results and will be discussed. The use of epigenetic modulators 
could be an optimal intervention to prevent early epigenetic changes and 
decrease the prevalence of age-related diseases such as cancer. 
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GLOBAL LIPIDOMICS PROFILING OF COTTON 
SEED OIL GENOTYPES USING CO2-BASED 
CHROMATOGRAPHY COUPLED TO MASS 
SPECTROMETRY 
Vladimir Shulaev1, Michael D. Jones2, Drew Sturtevant1, Kent D. Chapman1, 
and Giorgis Isaac2
1Department of Biological Sciences, College of Arts and Sciences, University 
of North Texas, Denton, TX 76203. 2Waters Corporations, 34 Maple Street, 
Milford, MA 01757
Refined cottonseed oil enjoys widespread applications in the food and che-
mical industries. Although the major lipids comprising cottonseed oil are 
well known, there are many diverse lipid species in cotton seeds that oc-
cur at much lower levels and have important nutritional or anti-nutritional 
properties. Lipidomics analysis of complex lipids in seed oil extracts using 
a single chromatographic technique is challenging due to the diversity of 
lipid polarity and the large range of concentrations of lipid species in biolo-
gical samples. Ultra Performance Convergence Chromatography (UPC2) is 
a chromatographic system that utilizes liquid CO2 as primary solvent and 
co-solvents such as methanol as a mobile phase to leverage the chromato-
graphic principles and selectivity of normal phase chromatography while 
providing the ease-of-use of reversed-phase LC. We have used UPC2 cou-
pled to mass spectrometry for the separation of free fatty acids, neutral and 
polar lipids in a single cotton seed lipid extract. Several seed oil genotypes, 
including high oleic acid line of Gossypium hirsutum cv. Coker 312 with a 
nonfunctional Brassica napus allele of delta-12 fatty acid desaturase (FAD2) 
and naturally occurring high oleic acid line of G. barbadense, were profiled 
to identify global consequences of modulating seed oil fatty acid composi-
tion. Potential markers that discriminate the different genotypes were iden-
tified and quantified.
NATURAL TOCOPHEROL MIXTURES AS PROMISING 
CANCER PREVENTIVE AGENTS
Nanjoo Suh
Department of Chemical Biology, Ernest Mario School of Pharmacy, 
Rutgers, The State University of New Jersey, Piscataway, NJ 08854 
Naturally occurring vitamin E, a family of fat-soluble antioxidants, exists 
in eight chemical forms of α-, β-, g-, or δ-tocopherols and α-, β-, g-, or 
δ-tocotrienols. Tocopherols are the major source of vitamin E in the U.S. 
diet. Tocopherols are widely occurring in corn, soybean, sesame and cot-
tonseed oils and nuts. Vitamin E is also often consumed as a dietary supple-
ment, with α-tocopherol as the most common form available. Numerous 
epidemiological studies suggest cancer preventive activity of vitamin E. 
However, recent large-scale randomized human trials with α-tocopherol 
did not demonstrate a cancer preventive effect. Importantly, each form of 
tocopherols has varying levels of biological activity. Our extensive studies in 
animal models of carcinogenesis have shown the cancer preventive activity 
of g-tocopherol and δ-tocopherol as well as a naturally occurring mixture 
of tocopherols, but the lack of cancer preventive activity by α-tocopherol. 
Here, we present the anti-cancer activity of natural dietary g-tocopherol 
rich tocopherol mixtures, g-TmT, in two different animal models of estro-
gen-mediated breast cancer. g-TmT inhibited estrogen-induced mamma-
ry tumorigenesis by lowering the levels of circulating estrogen, increasing 
estrogen metabolism via regulating metabolizing enzyme, CYP1A1, and 
facilitating the clearance of toxic metabolites and reactive oxygen species by 
stimulation of Nrf2-mediated antioxidant response. Activation of PPARg 
signaling and inhibition of cell proliferation could also contribute to the 
chemopreventive effects of g-TmT. Thus, dietary g-tocopherol rich mixtures 
could be safe and effective natural agents for the prevention and treatment 
of estrogen-induced breast cancer. 
CAN WOMEN’S HEALTH BOTANICALS PREVENT 
ESTROGEN CARCINOGENESIS?
Birgit M. Dietz, Tareisha L. Dunlap, Atieh Hajirahimkhan, Shuai Wang, 
Huali Dong, Charlotte Simmler, Rasika Phansalkar, René F. Ramos 
Alvarenga, Shao-Nong Chen, Dejan Nikolic, Richard B. van Breemen, Guido 
F. Pauli, and Judy L. Bolton
Department of Medicinal Chemistry and Pharmacognosy, UIC/NIH 
Center for Botanical Dietary Supplements Research, University of Illinois at 
Chicago, 833 South Wood Street, Chicago, Illinois 60612-7231, USA.
Breast cancer is the second most common malignancy among women be-
coming even more prevalent with age. Three major pathways are considered 
to be important in estrogen carcinogenesis: A) The hormonal ERα-mediat-
ed pathway leading to stimulation of tissue growth; B) chemical pathways 
involving estrogen metabolism to reactive intermediates which damage 
DNA; and C) the inflammatory pathway enhancing the formation of geno-
toxic estrogen metabolites. The botanicals, Glycyrrhiza species, Humulus lu-
pulus, and Angelica sinensis, are frequently used as alternatives to hormone 
therapy mainly due to their estrogenic activities. Recent evidence suggests 
that these botanicals have potential to prevent estrogen carcinogenesis 
through diverse pathways. In vitro and in vivo studies have shown that A. 
sinensis constituents can reduce the ERα–mediated effects of estrogens 
(pathway A). All three botanicals induce detoxification enzymes that can 
facilitate the removal of genotoxic estrogen metabolites (B). Interestingly, 
only one Glycyrrhiza species (G. inflata) reduces the formation of genotox-
ic estrogen metabolites (B). All three botanicals possess anti-inflammatory 
activities that might reduce inflammation in estrogen carcinogenesis (C). 
These findings highlight the importance of multi-factorial standardization 
to all bioactive markers including cytoprotective compounds, in order to 
achieve prevention of estrogen carcinogenesis. 
This research was supported by NIH Grants P50 AT000155 and T32 
AT007533. 
CLINICAL EVALUATION OF FORMULA F105, DESIGNED 
AND DEVELOPED TO ADDRESS ELEVATED OXIDIZED 
LDL CHOLESTEROL (oxLDL) LEVELS
Clinton J. Dahlberg1, Joseph Ou1, Wei Gao1, Mohan R. Kaadige1, Joseph 
Lamb1, William J. Keller1, John Babish1, Matthew L. Tripp1
1Nature’s Sunshine, Lehi, UT 84043, USA
In 2012, it is estimated that 17.5 million people died from cardiovascular 
disease (CVD) globally.1 Meta-analysis reveals that for every 1% reduction 
in cholesterol an estimated 2.5% reduction in coronary heart disease;2 in 
addition emerging science has shown oxLDL to be the most significant 
predictor of a future cardiac event.3 In a 12-week open-label clinical study 
of F105, 8 subjects saw the following changes to major cardiovascular risk 
factors without dietary intervention or weight loss:
Median 
Change
Median % 
Change P value* Hazard Ratio (95% CI)3
Total Cholesterol -23 -10 0.008 1.20 (0.93-1.56)
LDL -21 -10 0.031 1.90 (1.44-2.51)
Triglycerides -35 -27 0.039 2.34 (1.79-3.05)
Cholesterol/HDL -2.5 -45 0.016 6.12 (4.56-8.20)
oxLDL -14 -19 0.047 8.26 (6.15-11.11)
oxLDL/HDL -0.3 -25 0.039 13.92 (10.07-19.23)
* P-values were computed using the log-normal distribution of the ratio of change 
from baseline to 12 weeks using a Wilcoxon Signed Rank test of the median 
against the null hypothesis.
[1] WHO.int –Cardiovascular Diseases, Fact Sheet No 317.; [2] Holme I. 
Circulation 1990; 82:1916-1924.; [3] Johnston, N. et al. Am. J. Cardiol. 2006, 
97: 640–645.
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Session 13 - Applications of Mass 
Spectrometry to Natural Products 
Drug Studies
METABOLOGENOMICS: DISCOVERY OF NEW 
NATURAL PRODUCTS AND THEIR BIOSYNTHETIC 
GENE CLUSTERS BY GENOME-INFORMED 
METABOLOMICS 
Neil L. Kelleher1
1Departments of Chemistry and Molecular Bioscience, Northwestern 
University, Evanston, IL 60208, USA.
Over the past decade, the genomics revolution has provided a glimpse into 
the vast, untapped metabolic potential of microbial genomes. Simulta-
neously, the field of metabolomics, propelled by advances in LC-MS and 
informatics, now allows for high-throughput, semi-quantitative characte-
rization of metabolites. Focusing on actinomycetes we present a new ap-
proach, metabologenomics, marrying metabolomics and genomics to con-
nect exported metabolites to their biosynthetic gene clusters. With the high 
mass accuracy afforded by FT-Orbitrap instrumentation (<3 ppm), 2,521 
metabolite components were identified from the extracts of 178 actinobac-
terial growths. Of these, 110 were confidently identified as known natural 
products by searching an aggregated database of 9,817 actinomyctete na-
tural products. Detected metabolites and families of related gene clusters 
(GCFs) were used for a binary correlation scoring system, to evaluate the li-
kelihood that a cluster could be responsible for the production of a particu-
lar secondary metabolite. Output scores ranged from 0 to over 300. Known 
GCF-metabolite pairings were used to calibrate score interpretation, with 
27 known gene cluster families correctly paired with published biosynthetic 
clusters: these included oxyetracycline (score = 270), actinomycin D (score 
= 204) and rimocidin (score = 210). From the highest scoring pairs, we 
characterized a new metabolite and named it rimosamide (score = 264).
MASS SPECTROMETRY-BASED CHEMOPROTEOMICS 
FOR TARGET DECONVOLUTION OF BIOACTIVE 
NATURAL PRODUCTS
Markus Schirle
Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, 
Cambridge, MA 02139, USA
Natural products play an important role in phenotypic approaches to drug 
discovery. Recent years have seen the resurgence of these approaches, in 
particular due to their pre-selection for cell-active compounds and their 
ability to identify novel druggable nodes. Therefore, the identification of 
protein targets of natural products and the elucidation of their mechanism 
of action remain areas of high interest. Quantitative chemoproteomics 
has emerged for us as a principal strategy for generation of testable target 
hypotheses. It typically combines competition-based compound affinity 
chromatography from cell lysates with mass spectrometry-based protein 
identification and quantitation using e.g. isobaric labeling tags. These stu-
dies enable the identification of the full spectrum of cellular interactors of 
compounds under conditions approximating the disease-relevant in vivo 
situation, including the efficacy target(s) and also potential off-targets. Ho-
wever, for unbiased target deconvolution, the immobilization of compound 
on solid support is required at some stage during the workflow. While the 
introduction of a functionalized linker at a permissive site, as typically done 
for synthetic small molecules, is in principle also possible for natural pro-
ducts, it requires extensive knowledge of structure activity relationships 
which might not always be easily obtainable. Therefore, an extended tool-
box of approaches has proven to be valuable, including site-nonselective 
compound immobilization on photocrosslinker beads. Several variants of 
chemoproteomics as applied to natural products target deconvolution and 
validation will be presented.
STATE OF ART ANALYTICAL TECHNOLOGIES TO SOLVE 
NATURAL PRODUCTS CHALLENGES
Kate Yu1, Dhaval Patel2, Lirui Qiao3, Giorgis Isaac1, James Traub1, and 
Jimmy Yuk1 
1Waters Corporation, Milford, MA, USA; 2Waters Pacific Pte Ltd, Singapore; 
3Waters China, Shanghai, China
The study of natural products is a daunting task and sometimes intima-
ting for many scientists because of the complex nature of problems at 
hand. From analytical point of view, there are many analytical challenges 
to conduct natural product studies. For example: complex samples require 
comprehensive sample clean-up such as extraction, pre-fractionation, and 
purification; there is a need to have very high peak capacity and resolving 
power when it comes to separations; there are wide concentration range 
of analytes that require detectors with wide dynamic range; the chemical 
space within NP samples is so vast that an universal detector is strongly 
desired and yet, unavailable. As a result, having a good set of analytical tools 
that are fit for purpose and effective is vital for all natural products scien-
tists. As currently, there is not a single “one size fits all” analytical solution 
available to address the entire spectrum of the natural products challenges. 
In addition, with the advances in technology, and a variety of analytical 
solutions available to tackle different analytical problems, another challen-
ge for researchers is to be able to keep up with the pace of the technology 
advancement, and to understand how to use them effectively to answer the 
analytical questions at hand quickly and effectively.
The goal of this presentation is to provide updates for the natural products 
scientists with some example state of art analytical technologies, from 
sample preparation, to chromatographic separation to mass spectrometry 
detection to informatics platform through application examples. Examp-
les of technology updates that will be covered by this presentation include 
mentioned include: supercritical fluid technology (SFX), nano-fluidic chro-
matography, MS detector for routine analysis, Qtof mass spectrometry, as 
well as ion mobility (IMS) mass spectrometry. 
THE SINGLE-PROBE MASS SPECTROMETRY FOR 
SINGLE CELL ANALYSIS AND BIOLOGICAL TISSUE 
IMAGING 
Ning Pan, Wei Rao, Renmeng Liu, Naga R. Kothapalli, Anthony W. Burgett, 
Zhibo Yang
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman, OK 73019
Mass spectrometry (MS) is commonly used to analyze the molecular com-
position of prepared gas-phase or solution samples. With the recent deve-
lopment, MS has been used to obtain the cellular composition of single cell 
(i.e. single cell MS) and map the spatial distribution of species on biological 
tissues (i.e. MS imaging). We have developed a multifunctional device, na-
med as the Single-probe. This device can be coupled with MS for multiple 
applications, including single cell MS and MS imaging. 
To fabricate a Single-probe, a fused silica capillary and a nano-ESI emitter 
were glued into a dual-bore quartz needle (tip size <10 μm). The Single-
probe has been coupled with a X,Y,Z -stage system, digital microscopes, and 
a LTQ Orbitrap XL mass spectrometer. Single cell MS. We have cultured 
cancer cells were cultured and treated them with anticancer compounds. 
Cells were placed on a glass slide that is attached to the stage system. Using 
microscopes as the visual guide, the tip of the Single-probe was inserted 
into a cell by precisely lifting z-translation stage. The corresponding anti-
cancer compounds and cellular metabolites were observed. MS imaging. 
Mouse brain and kidney slices were prepared using a cryomicrotome, and 
placed on the stage system. We closely approached the Single-probe tip to 
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the tissue surface, and analytes on the corresponding spot were sampled by 
the Single-probe followed by MS analysis. We performed point-by-point 
analysis of the whole tissue slice to reconstruct the spatial distribution of 
compounds of interest using visualization software. We have obtained 
high-spatial resolution (8.5 μm) under ambient conditions without sample 
preparation.
VISUALIZING DIVERSE CHEMICAL FAMILIES WITH 
MOLECULAR NETWORKING
Laura M Sanchez1, Vanessa V Phelan1, Mingxun Wang2, Nuno Bandeira2, 
Pieter C Dorrestein1
1Collaborative Mass Spectrometry Innovation Center, Skaggs School of 
Pharmacy and Pharmaceutical Sciences, 2Center for Computational Mass 
Spectrometry and Department of Computer Science and Engineering, 
University of California San Diego, La Jolla, CA 92093, USA
Molecular networking (MN) is an ana-
lytical technique that relies on tandem 
mass spectrometry spectra to serve as a 
chemical finger print for molecular en-
tities. MN has been shown to improve 
many areas of natural product workflows 
including dereplication, discovery, and 
unveiling environmental niche che-
mistries. Recently, we have gathered MS/MS data on a thousands of pure 
compounds received from the NIH, user contributed data to the Global 
Social Natural Products (gnps.ucsd.edu) library, Massbank, and ReSpect. 
We have used these library spectra to mine for discernable patterns in the 
MS/MS data, analogous to structural class identification using 1H NMR. 
These patterns and other chemical trends have been explored to gather the 
maximum amount of information from a single MS/MS spectrum while 
simultaneously using various workflows on GNPS. 
Session 14 - Enhancing Natural 
Product Leads via Synthetic 
Manipulation: In Celebration of Dr. 
Mansukh Wani’s 90th Birthday
DEVELOPMENT AND OPTIMIZATION OF THE 
PHYLLANTHUSMIN CLASS OF ARYLNAPHTHALENE 
LIGNAN NATURAL PRODUCTS
James R. Fuchs
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210
A series of arylnaphthalene lignans, referred to collectively as the phyllan-
thusmins, was isolated from Phyllanthus poilanei by the Kinghorn lab as a 
part of a collaborative program project grant directed at the identificati-
on of novel anticancer agents (P01 CA125066). These compounds bear a 
strong structural resemblance to etoposide, a semi-synthetic DNA topoiso-
merase II (topo II) poison. Although the phyllanthusmins have been shown 
not to inhibit topo II activity, many of these compounds have demonstra-
ted potent in vitro antiproliferative activity against HT-29 and other cancer 
cells. In an effort to understand the structure-activity requirements and to 
remedy the limited aqueous solubility of this class of molecules for in vivo 
studies, a series of structural analogues has been synthesized and screened 
for biological activity, ultimately leading to compounds with improved pro-
perties. This iterative process of optimization in collaboration with other 
members of this program grant will be highlighted. 
Figure 1. 1H NMR (bottom) and MS/MS spec-
trum (top) for glycocholic acid, both indica-
tive of a steroid core. 
SYNTHESIS OF BOTH ENANTIOMERS OF THE 
META,META-BRIDGED DIARYLHEPTANOID 
MYRICANOL
Andrew P. Riley1 and Thomas E. Prisinzano1,2
1Department of Chemistry and 2Department of Medicinal Chemistry, 
University of Kansas, Lawrence, Kansas 66045
The meta,meta-bridged diarylheptanoid myricanol isolated from the stem 
bark of Myrica cerifera is able to lower the levels of tau protein – a protein 
involved in the progression of Alzheimer’s disease and several other neuro-
degenerative diseases. This biological activity, however, is highly dependent 
upon the stereochemistry of the sample. Here we report the synthesis of 
both enantiomers of myricanol. Pivotal to the success of this approach is the 
use of a remote stereocenter to influence the axial chirality of an aryl-aryl 
bond formed through an intramolecular Suzuki-Miyaura reaction.
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VINBLASTINE: SYNTHETIC AND MECHANISTIC 
STUDIES
Dale L. Boger
The Scripps Research Institute. 10550 N. Torrey Pines Road, La Jolla CA, 
92037
A brief summary of studies providing a first generation and second genera-
tion asymmetric total synthesis of vindoline based on the implementation 
of a powerful [4+2]/[3+2] cycloaddition cascade of 1,3,4-oxadiazoles will 
be presented along with its extension to the preparation of a series of key 
analogs. The development of a single-step biomimetic Fe(III)-promoted 
coupling of vindoline with catharanthine and subsequent in situ oxidation 
to provide vinblastine, its extension to the total synthesis of related natural 
products and key analogs, and new mechanistic insights into the reactions 
will be presented. Use of this work in key studies addressing the structural 
features of vinblastine contributing to its tubulin binding and antitumor 
properties, and the synthesis, evaluation, and discovery of potent analogs 
will be discussed. 
N
N OAc
CO2Me
Vinblastine
  
R
 = CH3
Vincristine
   
R
 = CHO
N
N
MeO2C
OH
MeO
R
OH
N
N OAc
Me CO2Me
Vindoline
MeON
CO2Me
N
H Et
Catharanthine
OH
H
Parallel Sessions - Tuesday, July 28th
37Abstracts | 2015 Annual Meeting of the ASP | July 25th–29th, 2015 | Copper Mountain, CO, USA
Session 15 - Translational Studies of 
Natural Products
CHALLENGES AND SUCCESSES IN THE DEVELOPMENT 
OF NATURAL PRODUCT DRUGS
William Fenical
Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California, San Diego.
One of the great challenges in academic drug discovery is finding a pathway 
for promising discoveries to provide entry into preclinical development. 
This is particularly challenging, as academics may not be fully aware of the 
complex characteristics a compound may need to be considered a truly 
promising lead. Complicating this picture is the perception that academics 
do not fully understand drug development and thus provide superficial evi-
dence of success at best. But, even with these difficulties, virtually all of the 
approved marine-derived drugs and most in clinical trials were discovered 
by academic laboratories. Some examples of success from personal experi-
ence, and suggestions on how to overcome these issues will be presented. 
MEASURES OF SUCCESS IN TRANSLATIONAL 
RESEARCH
Guy T. Carter, Ph.D.
Biosortia Pharmaceuticals, 565 Metro Place South, Suite 300 Dublin, Ohio 
43017
The ultimate measure of success in industrial natural products R&D is the 
launch of a new commercial product. In reality this is a rare event, parti-
cularly for those involved in the earliest stages of R&D (Discovery). Re-
gardless of the eventual commercial outcome, which may be governed by 
business considerations rather than science, there are many achievements 
in “translational research” that should be recognized as measures of success. 
Each time an issue that constitutes a roadblock to further product develop-
ment is overcome, there are valuable lessons learned that may be helpful 
in subsequent programs. In this presentation I will cover examples of such 
stepwise problem solving that helped advance natural product R&D pro-
jects originating from discoveries made at American Cyanamid Co. (Le-
derle Laboratories). 
	Dioxapyrrolomycin insecticide lead. Issue: preparation of ana-
logs for SAR
	 Ganefromycin animal health & growth promotion: stability & 
supply 
	Mannopeptimycin antibiotic lead: IP protection; stability & bio-
availability
During this time period the best known examples of translational success 
were the development of moxidectin (Cydectin) as an antiparasitic agent 
for animals, tigecycline antibiotic (Tygacil) to overcome resistance to the te-
tracyclines and the heroic crafting of calicheamicin (Mylotarg) as a payload 
for antibody-drug conjugate programs. 
DEVELOPMENT OF ZINDOL® THROUGH MULTI-CENTER 
CLINICAL TRIAL FOR CHEMOTHERAPY INDUCED 
NAUSEA AND VOMITING
Trevor P. Castor1
1Aphios Corporation, 3-E Gill Street, Woburn, MA 01801
Despite the widespread use of 5-HT3 receptor antagonist anti-emetics, 
chemotherapy induced nausea and vomiting (CINV) continues to be re-
ported by up to 70% of adult patients and up to 58% of children receiving 
highly emetogenic chemotherapy agents. Nausea and vomiting are among 
the most distressing side effects of chemotherapy. Zindol® is an enhanced 
ginger product that is standardized by the bioactive constituents, gingerols 
and shogaols, of ginger (Zingiber officinale Roscoe). We utilized polari-
ty-guided supercritical fluid fractionation SFS-CXF technology to establish 
conditions for the isolation of the active ingredients and then manufactured 
the API using SFS-CXP following cGMP. The API was then formulated to 
achieve a specific concentration of gingerols and shogaols with all-natu-
ral liquid excipients designed to maximize the stability and bioavailabil-
ity of the bioactive constituents and encapsulated into gel capsules with 
a nitrogen head following cGMP. Zindol® was successfully evaluated in a 
multi-center, 644-patient, dose-finding, placebo-controlled, randomized 
Phase II/III clinical trial as an adjunctive therapy to conventional 5-HT3 
anti-emetics for nausea in cancer patients undergoing chemotherapy (US 
Patent). We have since studied the MOA using a newly developed in vitro 
potency assay (US Patent Pending) and are planning to conduct a pivotal 
Phase III clinical trial for CINV and file an NDA with the FDA. A sister 
dietary supplement product, Zindol® DS, has been reported to be safe and 
effective in motion sickness, and nausea and vomiting related to pregnan-
cy, elective surgery and medications. We plan to conduct rigorous clinical 
trials for these indications after NDA approval of Zindol® for CINV in adult 
and pediatric populations.
DISCOVERY AND DEVELOPMENT OF ERIBULIN, A 
MACROCYCLIC KETONE ANALOG OF HALICHONDRIN 
B, FOR TREATMENT OF ADVANCED BREAST CANCER
Bruce A. Littlefield
Global Oncology Medical Affairs, Eisai Inc., 4 Corporate Drive, Andover, 
MA 01810, USA
Marine natural products represent rich sources of novel compounds for 
drug discovery. Owing to their roles in chemical defense, marine natural 
products are often remarkably potent in order to overcome highly diluting 
ocean environments. Halichondrin B (HB), originally isolated from the 
sponge Halichondria okadai, is one such compound. Early reports of HB’s 
remarkable antitumor activity led to significant interest in developing it as 
a new anticancer drug, but limited natural supplies ultimately foiled such 
efforts. Fortunately, the total synthesis of HB plus the discovery that its an-
ticancer activity resided in its macrolactone “right half ” moiety provided 
an opportunity to develop structurally simplified, fully synthetic analogs. 
Eribulin, a synthetic analog of HB’s right half, retains HB’s high potency 
with low/sub-nM activity against human cancer cells in vitro. Mechanisti-
cally, eribulin is a novel microtubule dynamics inhibitor that disrupts mi-
totic spindle formation, causing apoptosis after 10-12 hours of irreversible 
mitotic blockade. In vivo, eribulin induces tumor regression and long-term 
survival of nude mice bearing human tumor xenografts. Eribulin (as Hala-
ven®) is now approved for clinical use in the United States, European Uni-
on, Japan and many other countries for treatment of certain patients with 
advanced breast cancer.
NATURAL PRODUCTS IN CLINICAL TRIALS: CURRENT 
STATE OF PLAY AND FUTURE DIRECTIONS
Mark S. Butler
Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
Queensland 4072, Australia
The last 10 years have seen massive changes in the pharmaceutical industry 
with a narrowing of therapeutic focus, continued mergers, a large number 
of redundancies and a massive increase in outsourcing. During this period, 
the number of new small molecule drug approvals has been around 15-30 
NCE per year despite increased expenditure and more advanced technolo-
gies. Companies now predominantly rely upon of high throughput, frag-
ment and virtual screening to identifying new lead compounds with natu-
ral product (NP) screening being almost virtually ignored. This is counter 
initiative as NPs have always played an important role in drug development 
with a considerable number of marketed drugs being NP-derived. In addi-
tion, NPs often also occupy chemical space not usually found in synthetic 
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based screening libraries and are often excellent leads for drug development 
despite their often complex structures.
This talk will summarize the NPs, semi-synthetic (SS) NPs, NP-derived 
compounds and NP-containing antibody-drug conjugates (ADC) under-
going clinical evaluation or registration, and new NP drug pharmacophores 
will be analysed. In addition, an insight will be given on how NP-derived 
compounds move from the bench into clinical trials.
DEVELOPMENT OF ENGLERINS AS CANCER 
THERAPEUTICS
John A. Beutler
Molecular Targets Laboratory, Center for Cancer Research, National Cancer 
Institute, Frederick, MD 21702
The sesquiterpene englerin A, obtained from the Tanzanian plant Phyllan-
thus engleri (Euphorbiaceae), is a lead for drug development in kidney can-
cer and Ewing’s sarcoma. Englerin A is available in gm/kg quantities from 
the bark of the plant, and has been synthesized in excellent yields by several 
chemistry groups. It is active in xenograft models of kidney and prostate 
cancer. In kidney cancer cells, we have found englerin A to be selective ago-
nist for protein kinase C isoform θ, an effect which simultaneously induces 
glucose addiction and down-regulates the glucose transporter. We will re-
port on our recent efforts, which have focused on elucidating structure-
activity relationships, investigating pharmaceutical development questions 
such as formulation, route of administration, and ADME/PK, and conduc-
ting further in vivo studies. 
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Session 16 - Beyond the Rule of 5 
in the Design of Next-Generation 
Therapeutics: What Can We Learn 
from Macrocyclic Natural Products?
NATURAL PRODUCTS: ARE WE CLOSE TO THE END?
Cameron R. Pye1, Matthew J. Bertin2, R. Scott Lokey1, William H. Gerwick2, 
Roger G. Linington1
1Department of Chemistry and Biochemistry, University of California 
Santa Cruz, Santa Cruz, CA 95064, 2Center for Marine Biotechnology and 
Biomedicine, Scripps Institution of Oceanography, University of California 
San Diego, La Jolla, California 92037.
Natural products have historically played a central role in drug discove-
ry and development, but the re-isolation of known scaffolds is reported 
to increasingly hamper efforts to mine natural products chemical space 
for novel bioactive molecules. Despite the promise offered by orthogonal 
discovery strategies such as genome mining and the exploration of new 
taxonomic space, examination of the literature implies that most natural 
products being published today bear significant structural similarities to 
existing scaffolds.
This empirical observation inspired us to systematically explore the state of 
natural products discovery from the standpoint of both discovery rates and 
structural novelty. Using a database containing all microbial and marine-
derived natural products we determined the Tanimoto structure similari-
ty scores for all database members. We then used these data to examine a 
number of questions in this area, including: the rates of novel compound 
discovery over time, the effects of exploring novel source organisms on 
molecular diversity, and the projected rate of novel discovery for future na-
tural products efforts. Results from these analyses will be presented, along 
with a perspective on the implications of these findings for future natural 
products discovery strategies. 
INTERROGATING CYCLIC PEPTIDE NATURAL 
PRODUCTS FROM AN ADME PERSPECTIVE : BEYOND 
CYCLOSPORINE A. 
Cameron Pye and R. Scott Lokey
Department of Chemistry and Biochemistry, University of California Santa 
Cruz, Santa Cruz, CA 95064, 2
In terms of chemical diversity and complexity, the database of known natu-
ral products easily trumps the average diversity screening collection. Inde-
ed, most small molecule screening libraries are pre-filtered using classical 
metrics for drug likeness (e.g., Lipinski’s Rule of 5) that necessarily limit the 
size and complexity of their constituents. These metrics would categorize 
most natural products as non-druglike, despite numerous clinically prescri-
bed examples to the contrary. Many of these “beyond-Rule of 5” (b-Ro5) 
success stories include macrocyclic peptides like cyclosporine A (CSA), 
which has a molecular weight of 1200 and is both cell permeable and orally 
bioavailable. While CSA has been the poster child representing this new 
b-Ro5 modality, there are many other natural product cyclic peptides that 
have structural motifs (e.g., backbone N-methylation, mostly hydrophobic 
side chains, the presence of D-amino acids) that also suggest the potential 
for passive permeability. However, the rich chemical landscape of macrocy-
clic peptides has not been explored from a chemo-informatics perspective, 
and so we set out to analyze all known cyclic peptide natural products using 
various quantitative metrics relevant to ADME and pharmacokinetics. To 
do this we extracted structural information from a comprehensive data-
base of natural products and filtered it for cyclic peptide like species. I will 
present a survey of the resulting compounds with a focus in particular on 
structure/property relationships relevant to cell permeability and oral bio-
availability. 
PHARMACEUTICAL APPLICATIONS OF CYCLOTIDES
David J Craik, Conan Wang, Aaron Poth
Institute for Molecular Bioscience, The University of Queensland, Brisbane, 
Qld 4072, Australia
Cyclotides are macrocyclic peptides from plants that are notable for their 
exceptional stability and broad range of biological applications as well as 
their uses in indigenous medicines. They comprise a head-to-tail cyclic 
backbone of around 30 amino acids with a cystine knot arrangement of 
three disulfide bonds. Together these structural elements make cyclotides 
impervious to proteolytic breakdown and also exceptionally stable to high 
temperature and harsh solution conditions. These properties make cyclo-
tides valuable templates in drug design applications. So far, approximately 
a dozen examples have been reported in which foreign bioactive peptide 
sequences have been grafted into one of the loops of a cyclotide framework 
to enhance the stability of the peptide epitope while maintaining the biolo-
gical activity of that epitope. Applications have included cancer, cardiovas-
cular disease, wound healing, pain, infectious disease, and autoimmune di-
sease, amongst others1. This talk will describe the principles of the grafting 
of cyclotides as well as examining the biophysical2 and biopharmaceutical 
properties of cyclotides that underpin their applications as drugs.
1Poth A G, Chan L Y, Craik D J: Cyclotides as grafting frameworks for pro-
tein engineering and drug design applications. Biopolymers Peptide Science 
(2013) 100, 480-491.
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2Wang C K, Northfield S E, Swedberg J E, Harvey P J, Mathiowetz A M, Price 
D A, Liras S Craik D J: Translational diffusion of cyclic peptides measured 
using pulsed-field gradient NMR. J Phys Chem B (2014) 118, 11129-11136.
PEPTIDE MACROCYCLES: FROM STRUCTURAL 
STUDIES TO ORAL BIOAVAILABILITY
Andrei K. Yudin1
1Chemistry Department, University of Toronto, 80 St. George Street, Toronto, 
ON, M5S 3H6
Peptides represent a therapeutic modality that has received renewed inte-
rest over the past several years. While this surge of activity can be partially 
explained by the emergence of new technologies for targeted delivery of 
peptide drugs, there are also reasons to be optimistic about structure-based 
improvement of key properties of peptides that have traditionally been 
viewed as liabilities. Large polar surface area is one of these properties. Ma-
crocyclic topology allows one to minimize polar surface area of peptides 
by increasing the propensity to form intramolecular hydrogen bonds while 
shielding them from solvation. 
We have developed several enabling methods that allow for rapid synthesis 
of peptide macrocycles and their evaluation as potential therapeutic agents. 
I will present not only the foundational aspects of this technology, but also 
the progress we have made in the area of inflammatory bowel disease, 
wherein our lead molecule recently showed positive efficacy data in a 12-
day colitis study. We attribute this and other successes to our emerging un-
derstanding of the structure/activity relationship in macrocycles. I will also 
present our new data in the area of boron-containing peptides. This new 
class of molecules holds promise for the development of tool compounds to 
interrogate complex protease targets.
Session 17 - Microbial Metabolites 
and Bioactive Compounds from Plant 
Microbial Associates (Epiphytes and 
Endophytes)
ENDOPHYTIC FUNGI OF MEDICINAL HERBS: BASIC 
SCIENCE AND SOURCE OF NEW DRUG LEADS
Nicholas H. Oberlies
Department of Chemistry and Biochemistry, University of North Carolina at 
Greensboro, Greensboro, NC 27402,
Fungi are one of the most diverse organisms on the planet, second only 
to the insects. Estimates predict a range of 1.5 to 5.5 million fungi in the 
world, and yet, only about 100 thousand have been ascribed a name, and 
much fewer have been studied for drug leads. This is somewhat surprising 
given that the elixir of the 20th century, penicillin, was derived from a fungal 
Petri dish. Endophytes represent a unique niche of fungi, as they live at 
least some portion of their life within plants, but do so symbiotically and 
without imparting disease. Questions abound, such as: Do the endophytes 
stimulate the biosynthesis of defense compounds in the plant? Does the 
secondary metabolite profile of the endophytes help the plant? Can the en-
dophyte produce compounds similar to those found from the plant? Can 
the endophytes serve as a new source for drug leads? Can the endophytes 
be grown in culture, and if so, will they continue to biosynthesize a similar 
profile of secondary metabolites? Are the endophytes beneficial to the host, 
detrimental to the host, or simply saprobes in waiting? While we cannot 
provide definitive answers to any of these questions, we have amassed data 
that both probes some of the basic science questions, as well as, demonstra-
tes the generation of new drug leads. 
EXPLORING PLANT AND LICHEN-ASSOCIATED 
MICROBIAL DIVERSITY FOR DISCOVERY OF SMALL-
MOLECULE BIOACTIVE AGENTS
A. A. Leslie Gunatilaka1, E. M. Kithsiri Wijeratne1, Ya-ming Xu1, Bharat P. 
Bashyal1, Jianguang Luo1, Jair Mafezoli1,2, Maria C. F. Oliveira1,2, Angela M. 
Hoffman1,3, Patricia Espinosa-Artiles1, Manping X. Liu1, Scott G. Franzblau4, 
Luke Whitesell5
1Natural Products Center, School of Natural Resources & the Environment, 
University of Arizona, Tucson, AZ 85706, USA, 2Departamento de Química 
Orgânica e Inorgânica, Universidade Federal do Ceará, Campus do Pici, 
Fortaleza, Brazil, 3Department of Chemistry, University of Portland, 
Portland, OR 97203, USA, 4Institute for Tuberculosis Research, College 
of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA, 
5Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA
Plant and lichen-associated microorganisms represent a largely untapped 
resource of small-molecule natural products with chemical structures that 
have conceivably been optimized by evolution for biological and/or eco-
logical relevance. In our search for natural products with bioactivity and/
or novel structures, we have investigated numerous fungal strains living 
in association with plants and lichens. Extracts and/or pure compounds 
derived from cultures of these fungal strains have been screened in assays 
relevant for anticancer, anti-HIV and anti-TB drug discovery, and plant 
stress tolerance. Organisms producing extracts found to be active in the-
se assays were cultured on large-scale and the derived extracts have been 
subjected to bioactivity-guided fractionation to obtain a variety of natural 
products with bioactivity and/or novel structures suggesting the potenti-
al of this under-explored niche for small-molecule natural products with 
novel structural types and/or pharmaceutical and agricultural applications. 
Isolation, structure elucidation, bioactivity and possible biosynthetic origin 
of some selected small-molecule metabolites and the significance of their 
natural occurrence will be presented.
This work was supported by grants from NCI (USA), NIGMS (USA), 
CNPq (Brazil), and Arizona Biomedical Research Commission.
BIOLOGICALLY ACTIVE SECONDARY METABOLITES 
FROM EPIPHYTIC AND ENDOPHYTIC FUNGI
Marc Stadler
Dept. Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstr. 
7, 38124 Braunschweig, Germany.
Plant-associated fungi, and in particular fungal endophytes, are a prolific 
source for novel secondary metabolites. However, random isolation/scree-
ning approaches of these organisms may easily lead to disappointing results 
because many species have already been screened or just represent the ase-
xual states in the life cycle of well-known species. 
Our studies on the Xylariaceae have shown that there is an alternative: 
Using chemotaxonomic and ecologial data, as well as molecular phylogeny, 
as pre-selection criteria has resulted in a rather high discovery rate of novel 
metabolites. We found various strains that are extremely creative metaboli-
te producers. As exemplified by Hypoxylon rickii, extensive optimisation of 
culture conditions and subsequent scale up of production may even result 
in the discovery of several dozens of new compounds from a single strain. 
We are also investigating ecological interactions between fungal endophy-
tes, their host-specific insect vectors and their host plants, where certain se-
condary metabolites seem to play a pivotal role. Moreover, we are targeting 
poorly studied plant-associated fungal groups with peculiar ecology, such 
as the epiphytic capnodialean sooty blotch and flyspeck fungi, and even the 
Ash dieback pathogen Hymenoscyphus fraxineus. 
Numerous examples of our recent research will be shown to demonstrate 
that biodiversity can indeed be translated into chemical diversity if taxono-
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mists, ecologists and natural product chemists are working together more 
intensively than this used to be the case in the past. 
NOVEL BIOACTIVE COMPOUNDS FROM ENDOPHYTIC 
FUNGI OF ABORIGINAL MEDICINAL PLANTS
Athar Ata
Department of Chemistry, College for the Environmental and Science 
Complex, The University of Winnipeg, 599 Portage Ave. Winnipeg, MB, 
Canada R3B 2G3
Natural products exhibit interesting anti-microbial, anti-viral, and anti-
inflammatory activities. These bioactivities make them an important sour-
ce for the discovery of new pharmaceuticals. Currently, more than 60% of 
the drugs available on the market are of natural product origin. One of the 
aspects of drug discovery process is the identification of small molecules 
with enzyme-inhibiting activities. Enzymes are essential to human life, me-
diating biochemical processes including metabolism, cellular signal trans-
duction, cell cycling, and development. Malfunction in these biochemical 
systems often leads to disease that can be caused either by the dysfunction, 
overexpression, or hyper-activation of the enzymes involved. An under-
standing of diseases at the molecular level has provided several enzyme 
inhibitors in clinics. For instance, galanthamine, a potent acetylcholine-
sterase (AChE) inhibitor, is used to treat early symptoms of Alzheimer’s 
disease. α-Glucosidase (EC 3.2.1.20) is a membrane bound enzyme and 
lies at intestinal cells. This enzyme catalyzes the final step of carbohydrates 
digestion by hydrolyzing the glycosidic bonds in carbohydrates to libera-
te free glucose. The resulting glucose is a source of an exaggerated rise in 
blood sugar causing postprandial hyperglycemia. This causes type 2 dia-
betes mellitus and affects approximately 2.1 billion people worldwide. The 
potent α-glucosidase inhibitors prevent the breakdown of carbohydrates 
in small intestine and prolong the absorption of glucose or carbohydrates 
in blood. These compounds may be used as chemotherapeutic agents in 
clinics for the treatment of diabetes and obesity. Due to the catalytic role of 
α-glucosidase in carbohydrate digestion, these inhibitors may also be used 
as therapeutic target for other carbohydrate mediated diseases including 
viral infections, cancer, HIV and hepatitis. Our recent chemical investigati-
on of endophytes of Aboriginal medicinal plants of Canada resulted in the 
identification of natural products exhibiting potent bioactivities including 
anti-microbial, anti-α-glucosidase and anti-AChE activities. In this presen-
tation, isolation, structure elucidation of new bioactive natural products 
and their structure-activity relationships will be discussed. 
Session 18 - Diverse Approaches for 
Finding and Making Natural Products
COMPARATIVE METABOLOMICS REVEALS A NATURAL 
COMBINATORIAL LIBRARY AND A XYLOPYRANOSE-
BASED NUCLEOSIDE IN NEMATODES
Frank C. Schroeder
Boyce Thompson Inst./Dept. of Chem. & Chem. Biol., Cornell Univ., Ithaca, 
NY.
Worms are amazingly skilled chemists: using simple building blocks from 
conserved primary metabolism and a strategy of modular assembly, ne-
matodes such as the model organism C. elegans create complex molecu-
lar architectures to regulate almost every aspect of their life history. These 
compounds are based on the di-
deoxysugars ascarylose or pa-
ratose, which serve as scaffolds 
for attachment of moieties from 
amino acid, carbohydrate, neuro-
transmitter, lipid, and nucleoside 
metabolism, including an unusual xylopyranose-based adenosine deriva-
tive. The resulting signaling molecules can be active at femtomolar con-
centrations, i.e. encountering just a few molecules is sufficient for worms 
to respond.
Motivated by this unexpected structural and functional diversity, we are 
pursuing a systematic characterization of the C. elegans metabolome com-
bining mutant screens and 2D NMR/HPLC-MS-based comparative meta-
bolomics. Our screen has produced evidence for several thousand different 
metabolites of yet undetermined structures, ranging from simple lipids, 
amino acid derivatives, and nucleosides to complex modular assemblies. 
Their identification and subsequent quantification in genome-wide mutant 
screens will, akin to transcriptional profiling, provide a new basis for the 
study of metabolism and evolutionarily conserved signaling pathways in 
model organisms. 
CONTEMPORARY STRATEGIES FOR TARGETED 
DISCOVERY AND TRANSCRIPTIONAL ACTIVATION OF 
NATURAL PRODUCT BIOSYNTHETIC GENE CLUSTERS
Jeremy Owen
Rockefeller University
Soil samples represent some of the most complex microbial consortia 
known, with upward of 10,000 unique species per gram in some cases. Me-
tagenome libraries constructed from these consortia provide access to an 
enormous pool of biosynthetic gene clusters that have the potential to yield 
new, medicinally relevant natural products. This presentation will discuss 
two approaches aimed at generating an efficient, and broadly applicable 
metagenome based natural product discovery platform: First, biosynthetic 
profiling methodologies that use short DNA sequence tags to guide recove-
ry of gene cluster encoding specific compounds of interest will be discussed. 
Following this, generally applicable synthetic biological strategies for mo-
difying biosynthetic gene clusters to enable the production, isolation and 
characterization of new chemical entities will be presented.
HARNESSING THE PROMISCUITY OF NATURAL 
PRODUCT BIOSYNTHESIS: A PLATFORM FOR 
ENGINEERING PATHWAYS WITH NEW SPECIFICITIES
Gavin Williams
Department of Chemistry, NC State University, Raleigh, NC 27695
Many natural products are biosynthesized in a modular fashion by the 
selection and condensation of small molecule building blocks. Chimeric 
biosynthetic apparatus can be constructed in an attempt to produce ana-
logues for drug discovery. Yet, the scope and utility of such approaches is 
limited by the inherent substrate specificity and poor functional modularity 
of most biosynthetic components. Here, we show that several types of bio-
synthetic machinery are more tolerant towards non-natural building blocks 
than has been previously recognized. Such promiscuity forms a platform 
for constructing new biosynthetic parts with substrate specificities ortho-
gonal to those found in Nature. Accordingly, we describe a comprehensive 
program of enzyme engineering, directed evolution, and synthetic biology 
aimed at constructing artificial bacterial strains capable of producing com-
plex natural products that are regioselectively modified with non-natural 
chemical functionality. Our synthetic biology approach expands the syn-
thetic capabilities of natural product diversification strategies, and provides 
an improved understanding of the molecular basis for specificity in com-
plex molecular assemblies.
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MANIPULATION OF ACTINOBACTERIAL 
TRANSCRIPTIONAL REGULATION TO DISCOVER NEW 
SPECIALIZED METABOLITES
Gregory L. Challis
Department of Chemistry, University of Warwick, Coventry CV4 7AL, UK
A key challenge in genomics-driven natural product discovery is the de-
velopment of rational methods for inducing the expression of gene clusters 
that are expressed poorly, or not at all, in laboratory cultures. In 2008, we 
reported that 2-alkyl-4-hydroxymethylfuran-3-carboxylic acids (AHFCAs) 
induce the production of methylenomycin antibiotics in Streptomyces coeli-
color. Based on an understanding of the way in which AHFCAs are biosyn-
thesised in S. coelicolor and the role they play in regulating methylenomy-
cin biosynthesis, we have identified several putative specialised metabolite 
biosynthetic gene clusters in other actinobacterial genomes that also appear 
to be controlled by AHFCA-dependent regulatory networks. Deletion of a 
repressor gene within such networks upregulates AHFCA production and 
appears to prolong the expression of biosynthetic genes under their control. 
These findings have been applied to induction of the expression of putative 
AHFCA-regulated biosynthetic gene clusters in other actinobacteria that 
are silent under laboratory growth conditions, resulting in the discovery of 
novel specialised metabolites. 
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ANTIOXIDANT ACTIVITY AND ISOLATION STUDIES OF 
EXTRACTS OF SEEDS OF SYZYGIUM CUMINI L.
Khalid Hussain, Muhammad Islam, Naureen Shehzadi, Sohail Amjad, 
Nadeem I. Bukhari, Hamid Saeed 
University College of Pharmacy, University of the Punjab, Allama Iqbal 
Campus, Lahore-54000, Pakistan
The seeds of Syzygium cumini L. (Family: Myrtaceae), a well-known me-
dicinal and fruit plant, are used to treat a number of diseases involving 
free radicals, therefore the present study aims to investigate its extracts for 
antioxidant activity and isolation of active constituent(s). In 1,1-diphenyl-
2-picryl hydrazyl (DPPH) assay, methanol extract and its hexane fraction 
showed 68.54% and 58.42% free radical scavenging activity, respectively 
(Fig. 1). The extract and fraction also showed higher antioxidant activity 
in β-carotene-linoleate assay. From the hexane fraction, caffeic acid (I) was 
isolated and identified. Methanol extract and hexane fraction were found to 
contain 74.27 and 40.68 mg/g caffeic acid, respectively. The findings of the 
present study indicate that the methanol extract of seed of Syzygium cumini 
and its hexane fraction have good antioxidant activity, and contain caffeic 
acid, a known antioxidant. 
ANTIOXIDANT ACTIVITY AND ISOLATION STUDIES OF EXTRACTS OF SEEDS OF 
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Fig. 1. The antioxidant activity of extracts and 
fractions                          (I) 
of seed of Syzygium cumini, and standards using DDPH assay  
 
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
A
nt
io
xi
da
nt
 a
ct
iv
ity
 (%
)
Antioxidant activity [DPPH model]
 
Fig. 1. The antioxidant activity of extracts and fractions (I)
of seed of Syzygium cumini, and standards using DDPH assay 
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STEREOCHEMISTRY OF 2,2,5 TRISUBSTITUTED 
TETRAHYDROFURAN RING CONTAINING NATURAL 
PRODUCTS BASED ON 1H NMR SPECTROSCOPY: SOME 
OBSERVATIONS
Prabhakar S. Achanta, Raghuram Rao Akkinepally, Ravi Kumar Bobbala, 
Appa Rao V.N. Achanta
University College of Pharmaceutical Sciences, Kakatiya University, 
Warangal-506009, India.
A hydrogen in 2,2,5 trisubstituted tetrahydrofuran ring of some natural 
products appears as a triplet when the largest groups were cis oriented and 
as a doublet of doublet when they were trans oriented. In compounds con-
taining one THF ring, esterification/etherification of a hydroxyl group in 
the side chain carbon attached to position 2 of the THF ring was found to 
convert a triplet (in compounds not derivatized) into an atypical dd in the 
case of cis configured compounds and a typical dd into an atypical dd or a 
triplet in the case of trans configured compounds. Esterification/etherifica-
tion of the hydroxyl elsewhere in the molecules did not affect the splitting 
pattern.
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1003
PROSPECTING GREAT LAKES BACTERIA FOR DRUG-
LEAD DISCOVERY WITH HIGH-THROUGHPUT 
MICROBIOME SCREENING 
Maryam Elfeki1,2, Ankur Nakib4, Stefan J. Green4, Brian T. Murphy1-3*
1Department of Medicinal Chemistry and Pharmacognosy, 2Institute for 
Tuberculosis Research, 3Center for Pharmaceutical Biotechnology, College 
of Pharmacy, University of Illinois at Chicago, Chicago, IL 60607; 4DNA 
Services Facility, Research Resources Center, University of Illinois Chicago, 
Chicago, IL
Drug discovery ventures have focused on small molecule production from 
terrestrial actinomycete bacteria for nearly a century, and in the past few 
decades there has been a similar trend toward studies in the marine envi-
ronment. Conversely, small molecule production from freshwater-derived 
actinomycete populations is virtually unexplored. To address this know-
ledge gap, systematic studies of freshwater actinomycete communities are 
needed to identify the capacity of these systems to afford both novel taxa 
and novel small molecules. As part of the current study, we contrasted se-
diment microbial communities between two of the interconnected Great 
Lakes (Lakes Huron and Michigan) using high-throughput amplicon se-
quencing to determine how actinomycete communities were structured 
with respect to environmental gradients, and if these communities differed 
significantly as a function of increasing collection depth and geographic 
location. In both lakes, significant differences in total bacterial and actino-
bacterial community structure were observed between sediments sampled 
from shallow and deep locations. Furthermore, by growing bacteria using 
different media types, we assessed what portion of the in situ community 
was accessible through cultivation, and whether it was possible to retrieve 
the actinomycete diversity observed from amplicon sequencing. Details of 
these studies will be presented.
1004
RESVERATROL/GLUCAN/VITAMIN C COMBINATION 
OFFERS STRONG STIMULATION OF IMMUNITY
Vaclav Vetvicka, Jana Vetvickova
University of Louisville, Department of Pathology, 511 S. Floyd, Louisville, 
KY, 40292
Natural products, useful in preventing and/or treating various diseases, have 
been sought after throughout the history of mankind. The longest history 
as immunomodulators belongs to beta glucans. Despite the demonstrated 
activity of various glucans, the search for optimalization of their biological 
effects still continues. Recently, numerous substances have been shown to 
have synergistic effects with glucans. We decided to compare the biological 
activities of insoluble yeast-derived β1,3-D-glucan with a combination of 
glucan/resveratrol/vitamin C. Our data show that whereas resveratrol or 
vitamin C alone had only limited (if any) effects on immune reactions, the 
combination significantly increased the phagocytosis of peripheral blood 
leukocytes, specific antibody response, nitrite anion production and apo-
ptosis. This combination also showed strong effects on immunosuppres-
sion caused by various toxins. In addition, significant inhibition of cancer 
growth was found using two different experimental models. We can sum-
marize that whereas resveratrol or vitamin C alone had only limited effects 
on immune reactions, the combination significantly increased all tested 
immunological reactions. Our data represent further proof that combined 
preparations of glucan, resveratrol and vitamin C strongly stimulate the im-
mune reactions. We hypothesize that strong anti-cancer properties showed 
by the combination of these three compounds are manifested via stimula-
tion of immune reactions and apoptosis. A study attempting to reveal the 
exact mechanisms of these effects is currently under progress.
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SILVESTROL INDUCES AUTOPHAGY AND APOPTOSIS 
IN HUMAN MELANOMA CELLS 
Wei-Lun Chen1, Joanna E. Burdette1 and Steven M. Swanson1,2
1Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois at Chicago, Chicago, IL 60612, 2School of Pharmacy, University of 
Wisconsin-Madison, Madison, WI 53705
Silvestrol is a cyclopenta[b]benzofuran that was isolated from the fruits and 
twigs of Aglaia silvestris, which is indigenous to the island states of Sou-
theast Asia. Previous testing of silvestrol revealed that it is a potent inhibitor 
of protein synthesis and has cytotoxic activity similar to or more potent 
than many FDA approved anticancer agents. Silvestrol is currently under 
preclinical development at the National Institutes of Health Experimental 
Therapeutic (NExT) program. The purpose of the current study was to de-
termine if inhibition of protein synthesis caused by silvestrol triggers au-
tophagy and apoptosis in solid tumors. By 24h a clear decrease in cyclin 
B and cyclin D expression was observed in silvestrol-treated cells relative 
to control. In addition, silvestrol blocks progression through the cell cycle 
at the G2-phase. Silvestrol treatment also induced caspase-3 activation and 
apoptotic cell death in a time- and dose-dependent manner. Next, DAPI 
staining of nuclear chromatin showed nucleosomal fragments. Annexin V 
staining also showed an increase in apoptotic cells after silvestrol treatment. 
Furthermore, both silvestrol and SAHA enhanced autophagosome forma-
tion in MDA-MB-435 cells. Quantitation of the acidic vacuoles measured 
by flow cytometry further confirmed these results. MDA-MB-435 cells re-
sponded to silvestrol treatment with accumulation of LC3-II and dose-de-
pendent p62 degradation. However, bafilomycin A, an autophagy inhibitor, 
resulted in the accumulation of LC3 in cells treated with silvestrol. Silvestrol 
represents a natural product scaffold with the potential for the study of au-
tophagy and apoptosis mechanisms in cancer cells. It also highlights the 
direction of future drug development.
1006
SECONDARY METABOLITES FROM FUNGUS 
QUAMBALARIA CYANESCENS
Bishay DW1, Abdel-Baki AM1, Moharram AM2, Malak LG1 and Ross SA3*
1Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, 
Assiut 71526, Egypt, 2Mycological Center, Assiut University, Assiut 71515, 
Egypt, 3National Center for Natural Products Research, and Department of 
BioMolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS38677
In this study, phytochemical and biological investigations for the fungus 
Quambalaria cyanescens were proceeded. This fungus was provided by 
Assiut University Mycological Center (Accession No. 4123). It was grown 
on PDB media and provided the isolation of one new compound; 3-butyl 
phenol (1), along with four known compounds: glycerol-monooleate (2), 
pyrrolopiperazine-2,5-dione (3), 3-isobutyl-pyrrolopiperazine-2,5-dione 
(4) and 2-(4’-hydroxyphenyl) ethanol (5). The structures of the isolated me-
tabolites were elucidated based on spectroscopic and spectrometric tech-
niques. All the isolated compounds were evaluated for their antimicrobial, 
antimalarial and antileishmanial activities. 
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NEW ACIDIC TERPENOIDS FROM 
PSEUDOPTEROGORGIA ACEROSA
Paul D. Scesa, Lyndon M. West
Department of Chemistry and Biochemistry, Florida Atlantic University, 777 
Glades Rd, Boca Raton, FL, 33431
Abstract: One new cembranoid (1) and two new pseudopteranoids (2-3) 
were found in the Gorgonian coral Pseudopterogorgia acerosa collected 
in the Bahamas. These compounds demonstrate the rare carboxylic acid 
substitution pattern at C-18. Isolation of these compounds was performed 
using a combination of reversed phase column chromatography and prepa-
rative high pressure liquid chromatography. The structural elucidation was 
performed using extensive spectroscopic analysis, including mass spectro-
metry and 1D and 2D NMR spectroscopy. 
       
1        2                    3
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COMPARATIVE ANALYSIS OF THE ANTIOXIDANT 
PROPERTIES OF ICELANDIC AND HAWAIIAN LICHENS
Kehau Hagiwara,1 Patrick R. Wright,2 Nicole K. Tabandera,1 Dovi Kelman,1 
Sesselja Ómarsdóttir,3 and Anthony D. Wright.1
1DKI-College of Pharmacy, University of Hawaii at Hilo, 34 Rainbow Drive, 
Hilo, Hawaii 96720, 2Bioinformatics Group, Department of Computer 
Science, Albert-Ludwigs-University Freiburg, Georges-Köhler-Allee 106, 
D-79110 Freiburg, Germany, 3Faculty of Pharmaceutical Sciences, School 
of Health Sciences, University of Iceland, Hagi, Hofsvallagata 53, IS-107 
Reykjavik, Iceland
Antioxidant activity of symbiotic organisms known as lichens is an intri-
guing field of research because of its strong contribution to their ability to 
withstand extremes of physical and biological stress (e.g., desiccation, tem-
perature, UV radiation, and microbial infection). We present a comparative 
study on the antioxidant activities of 76 Icelandic and 41 Hawaiian lichen 
samples assessed employing the DPPH and FRAP based antioxidant assays. 
Utilizing this unprecedented sample size, we show that while highest indi-
vidual sample activity is present in the Icelandic dataset, the overall antioxi-
dant activity is higher for lichens found in Hawaii. Furthermore, we report 
that lichens from the genus Peltigera that have been described as strong 
antioxidant producers in studies on Chinese, Russian and Turkish lichens, 
also show high antioxidant activities in both Icelandic and Hawaiian lichen 
samples. Furthermore, we show that opportunistic sampling of lichens in 
both Iceland and Hawaii will yield high numbers of lichen species that ex-
clusively include green algae as photobiont.
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NATURAL PRODUCTS INVESTIGATION OF HAWAIIAN 
SAMPLES OF VERBASCUM THAPSUS – COMMON 
MULLEIN
Daniela Weingärtener Rosa,1 Kehau Hagiwara,2 and Anthony D. Wright.2
1Department of Pharmacy, Federal University of Santa Catarina, 
Florianópolis - Santa Catarina, Brazil, 2DKI-College of Pharmacy, 
University of Hawaii at Hilo, 34 Rainbow Drive, Hilo, Hawaii 96720
Verbascum thapsus or common mullein has a history of use in Europe that 
stretches back over 2000 years. It is commonly found in Asia, Africa and 
Europe and has found its way to Australia, North and South America and 
Hawaii, where it is classified as a weed. We became interested in this plant 
since it is only commonly found on the Big Island of Hawaii in areas where 
the ground has been recently disturbed at higher elevations, 1500 m, and 
because of its reported antimycobacterial (anti-TB) activity. Although the 
anti-TB activity of the methanol extract of the leaves proved to be negative 
we did find it to have some antimicrobial and antioxidant activty. On this 
basis we undertook fractionation of the extract and isolated and characte-
rized the main components; apigenin (1), luteolin (2), aucubin (3), 6-epi-
aucubin (4) and verbascocide (5). All of these isolates were determined to 
have antioxidant properties and apigenin (1), luteolin (2) and verbascoside 
(5) to have antimicrobial activity towards Staphylococcus aureus.
  
1010
MERGING GENOME MINING WITH ANCIENT THREE-
WAY SPECIES CO-EVOLUTION MAY OPEN A NOVEL 
GATE FOR INFORMATIVE NATURAL PRODUCTS 
DISCOVERY
Walaa Kamel Mousa1, Charles Shearer1, Cassandra Ettinger2, Jonathan 
Eisen2 and Manish Raizada1
1Department of Plant Agriculture, University of Guelph, Guelph, ON 
Canada N1G 2W1, 2University of California Davis, Genome Center, Davis, 
California, USA 95616
Finger millet is an ancient African cereal crop, resistant to many pathogens. 
It was domesticated 7000 years ago in Ethiopia, reaching India by 3000 
BC. Unlike other cereals, finger millet is resistant to the toxigenic fungal 
pathogen Fusarium graminearum. As this fungus is also ancient to Africa, 
we hypothesized that the crop may host microbes (endophytes) that co-
evolved to combat Fusarium. Here we describe the first ever discovery of 
endophytes from finger millet. We report a diverse array of anti-Fusarium 
secondary metabolites isolated from the fungal endophytes. A bacterial 
endophyte (strain M6) showed potent broad-spectrum antifungal activi-
ty including against F.graminearum, and was subsequently shown to be a 
novel Enterobacter species. Confocal microscopy showed that GFP-tagged 
M6 colonized different cereal tissues. Mechanistically, M6 caused cleavage 
of F.graminearum hyphae at septa. At the molecular level, Tn5 mutagene-
sis aided by whole genome sequencing and gene annotation uncovered 10 
operons responsible for the anti-fungal trait, including at least two phena-
zine biosynthetic ORFs. Real time PCR revealed that most of the candidate 
genes are inducible by F.graminearum. Knockouts of the genes caused loss 
of cereal resistance to F.graminearum. Biochemically, three new phenazi-
ne derivatives were discovered for the first time. We conclude, informative 
search for bioactive compounds opens a new revolutionary era for natural 
products discovery.
1011
METHOD TO HARNESS BIOACTIVE SECONDARY 
METABOLITES FROM INTACT QUINOA SEEDS WITH 
IMPLICATIONS FOR CHRONIC DISEASE PREVENTION
Brittany L. Graf1,3, Alexander Poulev1, Peter Kuhn1, Deborah Esposito2, 
Mary Ann Lila2, and Ilya Raskin1
1Department of Plant Biology and Pathology, Rutgers University, 59 Dudley 
Rd, New Brunswick, NJ 08901, USA 2Plants for Human Health Institute, 
North Carolina State University, 600 Laureate Way, Kannapolis, NC 28081, 
USA 3Centro de Investigación Traslacional, Universidad de Las Américas, 
Quito, Ecuador
Quinoa (Chenopodium quinoa Willd.) is an Andean seed crop rich in bio-
active phytochemicals, including phytoecdysteroids (PE) and flavonoid 
glycosides (FG). Innovations designed to harness the pharmacological 
value of quinoa through simple, food-grade technologies may facilitate the 
development of functional foods and nutraceuticals to combat global hu-
man health challenges. We optimized a method to leach and concentrate 
quinoa bioactives from intact (un-macerated) quinoa seeds into aqueous 
ethanol, yielding a complex phytochemical mixture termed quinoa leachate 
(QL). QL, comprised of 1.0% PE and 2.6% FG, contained essentially all PE 
and FG available in the initial seeds compared with traditional extraction 
of macerated seed powder (567.6 μg PE and 540.9 μg FG/g seed). QL sig-
nificantly lowered fasting blood glucose in obese, hyperglycemic C57Bl/6J 
mice and significantly attenuated lipopolysaccharide (LPS)-induced reac-
tive oxygen species (ROS) production in human dermal fibroblasts. Quinoa 
seed leaching provides an efficient means to produce a food-grade mix-
ture that may be applicable for the treatment and prevention of chronic, 
complex diseases, while rendering intact post-leached seeds available for 
additional uses in food.
1012
STRUCTURE ELUCIDATION AND BIOLOGICAL 
ACTIVITIES OF TWO CLASSES OF PEPTIDES 
PRODUCED BY THE ACTINOMYCETE, KITASATOSPORA 
CYSTARGINEA 
Krista Gill, Fabrice Berrue and Russell Kerr
Department of Chemistry, University of Prince Edward Island, 
Charlottetown, PE C1A 4P3, Canada. 
Kitasatospora is a rare genus of Actinobacteria that represents an underex-
plored resource for the discovery of structurally diverse natural products. 
To highlight the production of unique metabolites produced by twelve 
members of this genus, the chemical screening method that combines LC-
HRMS with Principal Component Analysis (PCA) was used. This approach 
identified the production of three novel compounds by K. cystarginea; 
which were determined to be a lipopeptide and two β-lactone contain-
ing peptide analogs, referred to as cystargamide and cystargolides A and 
B. Their structures were elucidated using NMR and MS/MS, and absolute 
configurations using advanced Marfey’s Method. The therapeutic potential 
of cystargamide and cystargolides A and B were evaluated in several bio-
assays. Most notably, cystargolides A and B displayed inhibition of human 
20S proteasome with IC50 values of 0.35 and 0.93 μM respectively.
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CONFORMATIONAL ANALYSIS OF SOME TYPE 
XII BISBENZYLTETRAHYDROISOQUINOLINE 
ALKALOIDS FROM THALICTRUM ALPINUM ASSISTED 
BY QUANTITATIVE NOE, J COUPLING CONSTANTS 
ANALYSIS AND ANISOTROPIC NMR PARAMETERS
C. Benjamin Naman1, Gaurav Gupta2, Sanjay Varikuti2, Heebyung Chai1, 
Raymond W. Doskotch1, Armando Navarro-Vázquez3, Abhay R. Satoskar2, 
A. Douglas Kinghorn1, and Roberto R. Gil4
1Division of Medicinal Chemistry and Pharmacognosy, and 2Department 
of Pathology, The Ohio State University, Columbus, Ohio 43210, USA, 
3 Departamento de Química Fundamental, Universidade Federal de 
Pernambuco, Cidade Universitária, CEP: 50.740-540 Recife, PE, Brazil, 
4Department of Chemistry, Carnegie Mellon University, Pittsburgh, PA 
15213, USA.
Northalrugosidine (1), a type XII bisbenzyltetrahydroisoquinoline alka-
loid, exhibits in vivo efficacy in a murine model of visceral leishmaniasis (J. 
Nat. Prod., 2015, 78, 552-556). The conformational space of the macrocy-
clic moiety in compounds within the same subgroups of this class should 
provide more clues on their structure-activity relationships, which will be 
very beneficial for the potential future medicinal chemistry optimization 
of 1. The solution-state conformation of this molecule was investigated by 
conducting NMR spectroscopic studies on two naturally occurring ana-
logues in the same subclass, thalrugosidine (2) and thalidasine (3). Residual 
dipolar couplings (RDCs), collected in compressed PMMA gel, were em-
ployed for the determination of relative spatial orientation of 1H-13C bonds, 
whereas 1H-1H inter-atomic distances were determined by measurement 
of quantitative nuclear Overhauser effects (qNOEs). The conformation of 
the studied molecules in solution was determined by simultaneous fitting 
of these NMR data and 3JH,H coupling constants with computed molecular 
models.
1014
MS, NMR, AND DNA BARCODING, COMPLEMENTARY 
METHODS FOR IDENTIFICATION AND 
AUTHENTICATION OF BLACK COHOSH (Actaea 
racemosa L.)
James Harnly, Pei Chen, Kimberly Colson, Joe-Ann McCoy, Danica 
Harbaugh Reynaud, Peter Harrington
Flow injection mass spectrometry (FIMS), proton nuclear magnetic re-
sonance spectrometry (1H-NMR) and DNA barcoding, two metabolic 
fingerprinting methods, and DNA barcoding were used to identify and 
authenticate Actaea species. Initially, vouchered Actaea racemosa samples 
from a single sources were distinguished from other Actaea species based 
on principal component analysis (PCA) and soft independent modeling of 
class analogies (SIMCA) of FIMS and 1H-NMR metabolic fingerprints. The 
chemometric results for FIMS and 1H-NMR agreed well and showed simi-
lar agreements with the identity of some of the non-vouchered samples. 
DNA barcoding confirmed misidentifications and led to discovery of mis-
labeling in the laboratory. Differences were observed between vouchered 
A. racemosa samples from four different sources although the within A. 
racemosa species variance was significantly less than the between species 
variance. A model based on the combined A. racemosa samples still per-
mitted distinction between species. Additionally, the combined A. racemo-
sa were distinguishable from commercial root samples and from commer-
cial supplements in tablet, capsule, or liquid form. DNA barcoding verified 
the lack of authenticity of the commercial roots and was unsuccessful in 
characterizing many of the supplements due to the lack of DNA.
1015
SYNTHESIS OF ACYLPHLOROGLUCINOLS AND THEIR 
ANTIBACTERIAL ACTIVITIES AGAINST CLINICAL 
ISOLATES OF MRSA STRAINS
M. Mukhlesur Rahman,1,2 Winnie Shiu,1 Simon Gibbons1 and John P. 
Malkinson1
1Department of Pharmaceutical and Biological Chemistry, UCL School 
of Pharmacy, London WC1N 1AX, UK, 2School of Health, Sport and 
Bioscience, University of East London, London E15 4LZ, UK
Bioassay-directed drug discovery efforts on various species of the genus 
Hypericum led to the discovery of a number of acylphloroglucinols inclu-
ding 4,6-dihydroxy-2-O-(3’’,7’’-dimethyl-2’’,6’’-octadienyl)-1-(2’-methyl-
butanoyl)benzene (6) from H. olympicum with MICs of 0.5-1 mg/L against 
a series of MRSA strains. Its potential activity prompted us to carry out 
the total synthesis of 6 and its related analogues in order to assess their 
structure-activity profile as a new group of antibacterial agents. Total syn-
thesis of 6 and a series of structurally related acylphloroglucinols (7-22) as 
well as their antibacterial activities against a panel of MRSA strains will be 
presented.
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PHYTOCHEMICALS AND THEIR ANTI-PROLIFERATIVE 
ACTIVITY OF ALOE PERRYI FLOWERS EXTRACT 
AGAINST VARIOUS HUMAN CANCER CELL LINES
Ebtesam S. Al-Sheddi1, Mai M. Al-Oqail1, Amina S. El-Shaibany1, Nida N. 
Farshori1
1Department of Pharmacognosy, College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia
In this study, phytochemical screening of petroleum ether, chloroform, ethyl 
acetate, n-butanol and methanolic extracts of Aloe perryi flowers and their 
antiproliferative activity against seven human cancerous cell lines (name-
ly liver (HepG2), colon (HCT-16), breast (MCF-7), lung adenocarcinoma 
(A549), prostate cancer (PC-3), human epidermoid cancer cells (HEp-2, 
and cervical cancer (HeLa)) were studied. The phytochemical screening 
was performed by Thin Layer chromatography (TLC) and antiproliferative 
activities by MTT assay. The quantitative tests of phytochemical screening 
revealed the presence of carbohydrates, glycosides, phytosterols, flavonoids, 
proteins and amino acids in the different extracts. The results also demon-
strated that almost all of the extracts more or less had the capacity to de-
crease the proliferation of cancer cells. The HCT-16 cells were found more 
sensitive against all the extracts studied. Among the extracts, the highest 
activity for petroleum ether extract was found against HCT-16 cell line 
(IC50=5.61 ug/ml) followed by HeLa (IC50=5.83), A-549 (IC50=7.54), MCF-
7 (IC50=7.88), HepG2 (IC50=8.2), PC-3 (IC50=9.51), HEp-2 (IC50=10.1). The 
results indicated that the extracts used in this study having phytochemicals 
and anticancer activity against all the cell lines. However, further studies are 
needed for evaluating their mechanism of action and to isolate the active 
anticancer compounds responsible for this activity.
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A GATEKEEPER ENZYME IN THE BIOSYNTHESIS OF 
INDOLMYCIN
Yi-Ling Du1, Lona M. Alkhalaf1, and Katherine S. Ryan1
1Department of Chemistry, University of British Columbia, Vancouver, 
British Columbia, V6T 1Z1, Canada.
Molecules discovered in the “golden age of antibiotics” are increasingly 
being revisited in an era where new antibiotics are desparately needed. One 
of these molecules, the bacterial tryptophanyl-tRNA synthetase inhibitor 
indolmycin, features a unique oxazolinone heterocycle whose biogenetic 
origins have remained obscure for over 50 years. We have identified and 
characterized the indolmycin biosynthetic pathway. Our work revealed the 
decades-long mystery of how the characteristic core oxazolinone ring is as-
sembled from tryptophan- and arginine-derived metabolites. Our efforts 
have furthermore shown the key role of a gatekeeper enzyme, which acts to 
re-route metabolites away from a unique shunt product. Our work establis-
hes the complete pathway for indolmycin formation and sets the stage for 
using genetic and chemo-enzymatic methods to generate new indolmycin 
derivatives as potential therapeutic agents.
1018
HONAUCIN A, MECHANISM OF ACTION AND ROLE AS 
A POTENTIAL CANCER PREVENTION AGENT. 
Lena Gerwick1, Samantha J. Mascuch1, Gabrial Navarro1, Paul Boudreau1, 
Tristan M. Carland1, Terry Gaasterland1, William H. Gerwick1. 
1Center for Marine Biotechnology and Biomedicine, Scripps Institution of 
Oceanography, University of California, San Diego, California 92093.
Three related natural products, the honaucins A-C, were isolated from a 
cyanobacterium overgrowing a coral reef in Hawaii. Subsequent biological 
investigations revealed that these molecules inhibit both prokaryotic quo-
rum sensing and eukaryotic inflammation. The honaucins were originally 
identified as molecules of interest in an in vitro assay that quantified their 
ability to attenuate nitric oxide production in LPS-stimulated macropha-
ges. Continued experiments using honaucin A displayed a transcriptional 
down-regulation of IL-6, TNFα, IL-1β, and iNOS in these cells, as well as 
in vivo anti-inflammatory activity in a murine model of ear edema. To un-
cover the mechanism of action of honaucin A, RNA deep sequencing was 
performed using total RNA from honaucin A-treated macrophages. Analy-
sis of differentially regulated transcripts strongly suggests that honaucin A 
is an activator of a pathway of cytoprotective genes. This signaling pathway 
has recently drawn interest for its potential application in the treatment of 
neurodegenerative and autoimmune diseases, as well as cancer. Experi-
ments involving reporter assays and protein pull down using a biotinylated 
probe to validate the proposed target will be discussed.
1019
STAT3 INHIBITORS FROM HAWAIIAN-PLANTS 
ASSOCIATED FUNGI
Chunshun Li1, Baojun Yang1, James Turkson1 and Shugeng Cao1,*
1Natural Products and Experimental Therapeutics, Cancer Center, 
University of Hawaii, 701 Ilalo Street, Honolulu, Hawaii 96813, USA
The STAT3 protein is a cytoplasmic transcription factor that is aberrant-
ly activated in many human cancers. Constitutive STAT3 activation is 
a molecular abnormality that is causally linked to cancer aggressiveness. 
The STAT3-dependent cell-based luciferase reporter assay captures STAT3 
transcriptional activity, based on the binding of active STAT3:STAT3 di-
mers to the STAT3-specific promoter sequence that drives the luciferase 
reporter. High Throughput Screening of our fungal natural product library 
against the STAT3-depedent NIH3T3vSrc cell line showed that some semi-
pure fractions were active against STAT3. Assay-guided separation of the 
active sample FT462 led to the identification of STAT3 inhibitors, which 
inhibited A2780 and MDA-MB-231. The isolation, structure elucidation, 
plausible biosynthesis and bioactivity of compounds 1-5 will be presented.
1020
CYTOTOXIC ACTIVITIES OF THAI LAXATIVE 
MEDICINAL PLANT RECIPE EXTRACT AGAINST COLON 
CANCER CELLS 
Bhanuz Dechayont1, Arunporn Itharat1
1Department of Applied Thai Traditional Medicine, Faculty of Medicine, 
Thammasat University, Pathumthani, Thailand
Trichintalamaga (TCG) recipe was discovered in Thai Phamacy scripture. 
This recipe has shown noteworthy lymphatic treat, which is closely related 
to its anticancer properties. The aim of the present study was to evaluate 
cytotoxic activities of TCG recipe and its fractions using the SRB assay. The 
assay was performed on human colon adenocarcinoma cell lines (LS 174T 
and SW 480). The ethanolic extract of TCG recipe was separated by using 
vacuum liquid chromatography (VLC). Different fractions were collected 
and tested for cytotoxic activity. The active fraction was identified for com-
pounds using liquid chromatography combined with electrospray ionizati-
on tandem mass spectrometry (LC-ESI-MS/MS). The ethanolic extract of 
TCG recipe showed the specific cytotoxicity against LS174T and SW 480 
cell lines with IC50 values of 0.51 ± 0.01 and 0.51 ± 0.02 µg/ml, respectively. 
After liquid–liquid partitioning sequence, the chloroform fraction showed 
the highest cytotoxicity against LS174T and SW 480 cells lines with IC50 
values of 0.45±0.04 and 0.51 ± 0.07 µg/ml, respectively. Fifteen compounds 
were isolated using LC-ESI-MS/MS guided isolation method. We conclu-
ded that major cytotoxic component should be isolated from the chloro-
form fraction. Therefore, these results support the use of Trichintalamaga 
recipe as an anticancer drug.
1021
BIOLOGICAL ACTIVITIES AND TOTAL PHENOLIC 
CONTENT OF TREGAYSORNMAS FORMULA 
Pathompong Phuaklee1, Arunporn Itharat1
1Department of Applied Thai Traditional Medicine, Faculty of Medicine, 
Thammasat University, Pathumthani, Thailand
Tregaysornmas formula was discovered in Thai Phamacy scripture inclu-
ding Jatropha multifida L., Nelumbo nucifera Gaertn. and Aegle marmelos L. 
In Thai traditional medicine, it used to treat fatigue and maintain body ba-
lance. The objective of this study was to investigate the anti-allergic, anti-in-
flammatory and antioxidant activities. The determination of total phenolic 
content of their extracts were also tested. The results showed that 95%EtOH 
and water extract of this formula showed the high antioxidant activity 
(3.861±0.109 µg/ml and 15.997±3.60 µg/ml, respecticely) and total pheno-
lic content (300.236±2.226 mg GAE/g and 184.915±4.328 mg GAE/g, res-
pecticely). Moreover, 95%EtOH extract exhibited a potent allergic activity 
(93.807±0.831 µg/ml). However, water extract had no anti-allergic activity. 
Both 95%EtOH and water extract did not show anti-inflammatory activity. 
We concluded that Tregaysornmas formula showed antioxidant and an-
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ti-allergic activities and it was related with the ethnomedical use as main-
taining body balance of patients in Thai traditional medicine.
1022
FLAVONOIDS MODULATING c-MET AND ALK ACTIVITY
Sun-Young Han1, Young Ok Choi2, Hyuk-Hwan Song2, Young-Mi Kim2, and 
Young-Won Chin2
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, 
Gyeongsang National University, Jinju, Gyeongnam 660-701, Republic 
of Korea, 2BK21PLUS R-FIND team and College of Pharmacy, Dongguk 
University-Seoul, Goyang, Gyeonggi-do 410-820, Republic of Korea,
Bioactivity-guided separation of the roots of Scutellaria baicalensis, using 
c-Met kinase assay, led to the isolation of 19 flavonoids. Of these isolates, 
norwogonin and baicalin were found to be active in the c-Met assay. Fur-
ther investigation for c-Met inhibitory compounds in the ALK assay re-
vealed that norwogonin and baicalin were active. Norwogonin and baicalin 
were found to inhibit both c-Met (IC50 6.24 and 13.4 μM, respectively) and 
ALK kinases (IC50 7.62 and 0.93 μM, respectively). Furthermore, the bind-
ing mode of norwogonin in the ATP binding site of c-Met was disclosed in 
docking study.
1023
STUDIES ON THE EXPLOITATION OF BROUSSONETIA 
PAPYRIFERA AND ITS ENDOPHYTIC FUNGI 
Baokang Huang, Chunyan Zhang
School of pharmacy, Second Military Medical University, Shanghai, 200433, 
China
Broussonetia papyrifera (L.) Vent.(Moraceae) is a deciduous tree which is 
native to Asia. Its fructus is the common TCM “Chushizi” with bioactivities. 
Its leaves and barks also have medicinal uses. The endophytic fungi from B. 
papyrifera provide new natural products with biological activities. A total of 
47 strains were isolated from the different parts of the tree. The leaves have 
high islation rates (average 0.91) with rich biodiversity. The anti-inflam-
matory activity of the fermentation products was investigated with 
mice macrophages RAW 264.7 in vitro. The results indicated that 14 
endophytes could fully inhibit the growth of inflammatory cell at the 
concentration of 100 µg/mL. The cytotoxic activity of fermentation pro-
ducts was evaluated by the MTT method, and five endophytic fungi possess 
significant anti-hepatoma activity in human SMMC-7721 and QJY7023 
cell lines. Thirty-six compounds were isolated from the ethyl acetate 
extract of the two strains Chaetomium globousm and Alternaria sp. Al-
tertoxin IV is a new compound. Altersolanol A showed significant inhibi-
tion to human MG-63 and SMMC-7721 cell lines with IC50 values of 0.53 
and 2.92 μg/mL. Endophytic fungi of Broussonetia papyrifera are promising 
sources of natural bioactive metabolites.
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SECONDARY METABOLITES FROM FUNGUS 
QUAMBALARIA CYANESCENS
Dawoud Bishay1, Afaf Abdel-Baki1, Ahmed Moharram2, Lourin Malak 1 and 
Samir Ross 3
1Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, 
Assiut 71526, Egypt, 2Mycological Center, Assiut University, Assiut 71515, 
Egypt, 3National Center for Natural Products Research, and Department of 
BioMolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS 38677
In this study, phytochemical and biological investigations for the fungus 
Quambalaria cyanescens were proceeded. This fungus was provided by 
Assiut University Mycological Center (Accession No. 4123). It was grown 
on PDB media and provided the isolation of one new compound; 3-butyl 
phenol (1), along with four known compounds: glycerol-monooleate (2), 
pyrrolopiperazine-2,5-dione (3), 3-isobutyl-pyrrolopiperazine-2,5-dione 
(4) and 2-(4’-hydroxyphenyl) ethanol (5). The structures of the isolated me-
tabolites were elucidated based on spectroscopic and spectrometric tech-
niques. All the isolated compounds were evaluated for their antimicrobial, 
antimalarial and antileishmanial activities. 
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BIPHASIC MODULATION OF HUMAN CATHEPSIN L BY 
A NOVEL CYANOBACTERIAL DEPSIPEPTIDE
Bailey Miller1, Matthew Bertin1, Vivian Hook2, and William H. Gerwick1,2
1Scripps Institution of Oceanography, University of California San Diego, La 
Jolla, CA, USA, 2Skaggs School of Pharmacy and Pharmaceutical Sciences, 
University of California, San Diego, La Jolla, CA, USA
Target-based screening of marine cyanobacterial extracts for small mole-
cule modulators of human cathepsin L, an intriguing target in both cancer 
and diseases related to the neurosciences, has led to the isolation of a no-
vel depsipeptide natural product. This compound displays an interesting 
biphasic dose-response against the purified enzyme, characterized by ac-
tivation at low doses and inhibition at high concentrations. Partial struc-
tural determination, based on NMR and MS2 spectroscopy, has identified 
multiple modified residues, including the hydroxy acid form of methionine 
sulfoxide, 3-methyl-2-aminopentanoic acid, and N-O-dimethyl tyrosine. 
A complete structure and kinetic analysis of enzyme modulation will be 
presented.
 
  
1026
ANTI-INFLAMMATORY EFFECTS OF COMPOUNDS 
DERIVED FROM BOTANICAL MEDICINAL PLANTS IN 
LPS-STIMULATED THP-1 CELL LINE
Hyo S. Park and Anthony L. Farone
Department of Biology, Middle Tennessee State University, Mufreesboro, TN 
13231
Despite of the importance of inflammation processes in protecting body 
from the pathogens, chronic inflammation is in the center of multiple im-
portant human diseases such as autoimmune and chronic inflammatory 
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diseases. In this study, we examined the anti-inflammatory effects of com-
pounds derived from botanical medicinal plants on LPS-stimulated mac-
rophages. Cytotoxicity assay, cytokine ELISA, immunofluorescence assay, 
and western blot analysis were performed to measure the proinflammatory 
cytokines response, p65 nuclear translocation, and expression of activat-
ed NF-κB mediators involved in NF-κB pathway. Out of our plant extract 
and compound library, we selected 3 best compounds for this presentation 
and they showed significant inhibition TNF-α, IL-1β, and IL-8 proinflam-
matory cytokines. Further investigation showed the inhibition of nuclear 
translocation of NF-κB transcription factor, p65, and significant reduction 
of inhibitor kappa B kinase, IKK-beta, phosphorylation which is an import-
ant regulatory component of NF-κB pathway.
1027
MASS SPECTROMETRY TOOLS FOR SCREENING OF 
MARINE CYANOBACTERIAL NATURAL PRODUCTS 
Tal Luzzatto Knaan1, Neha Garg1, Yao Peng1, Theodore Alexandrov1, 
Gabriel Navarro2, Evgenia Glukhov2, Lena Gerwick2, William H. Gerwick 1,2 
and Pieter C. Dorrestein1
1Skaggs School of Pharmacy and Pharmaceutical Sciences, CA, 2Scripps 
Institution of Oceanography, UCSD, La Jolla, CA 92093, USA
The marine environment is an 
extraordinarily rich source of 
natural products. Here we em-
ployed tandem mass spectrome-
try tools to screen a large-scale 
dataset from a worldwide coll-
ection of marine cyanobacteria, 
aiming to visualize and map the 
chemical universe of their me-
tabolites. Molecular networking 
was utilized to cluster molecules 
into families based on fragmen-
tation similarities that enabled 
the dereplication of known com-
pounds, the identification of new 
derivatives and targeting of novel natural products. Molecular features 
captured by mass spectrometry were subjected to geographical mapping, 
revealing the chemical distribution of these natural products and high-
lighting chemodiversity “hotspots” for potential new chemistries. 
1028
ACTIVITY COMPARISON OF CYCLIC 
LIPODEPSIPEPTIDES FROM MAMMALIAN 
MICROBIOME BACTERIAL SOURCES
Jeremy Lynn Motley, Carter A. Mitchell, Tiffany Culver, Jarrod King, Susan 
L. Nimmo, Douglas R. Powell, & Robert H. Cichewicz
Department of Chemistry and Biochemistry, University of Oklahoma, 101 
Stephenson Pkwy, Norman, OK 73019
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Cyclic lipodepsipeptides (CLDP) are produced by bacteria and have been 
studied extensively for their antimicrobial activities and wetting properties. 
Bacteria derived from opportunistically sampled mammals, including opos-
Fig 1: Mapping the distribution 
of Apratoxins molecular family 
[M+Na]+ using GNPS molecular 
networking and “LCMS 2D/3D 
toolbox”. 
sum, skunk, raccoon, boar, and deer, in Oklahoma were cultured and shown 
to produce CLDPs including viscosin, serratiamycin, and surfactin. Two di-
mensional NMR studies and MS analysis lead to 3 new serrawettin W2 ana-
logues. Their activities against several biological targets were assessed. 
1029
DISCOVERY OF NEUROPROTECTIVE MARINE 
NATURAL PRODUCTS USING DROSOPHILA 
MELANOGASTER
Stacee Lee Caplan1, Jennifer Krill1, Ken Dawson-Scully1, and Lyndon M. 
West2
1Department of Biological Sciences, Florida Atlantic University, Boca Raton, 
FL 33431, USA, 2Department of Chemistry and Biochemistry, Florida 
Atlantic University, Boca Raton, FL 33431
Oxidative stress and cellular excitotoxicity is inherent in the pathophysiolo-
gy of an array of devastating human ailments. Natural products have played 
an important role in the treatment of a variety of human diseases and con-
tinue to drive the modern drug discovery and development process. The 
overall goal of this project is to design a novel neuroactivity assay to iden-
tify natural products capable of inducing neuroprotection against oxidative 
stress. This project will focus on a group of natural products, pseudoptero-
sins, known for their potent biological activities with a novel mechanism 
of action. We hypothesize that these compounds may be of potential the-
rapeutic benefit in protecting neurons and/or neural function both during 
and after episodes of excitotoxicity in disease states. 
1030
INVESTIGATION OF NEIGHBORING HETEROATOMS 
AND COUPLING PATHWAY EFFECTS ON LONG-RANGE 
COUPLING CONSTANTS USING LR-HSQMBC
Ping Guo1, John D. Anderson2, Joseph J. Bozell2, Svetlana Zivanovic1
1Department of Food Science and Technology, 2510 River Drive, University 
of Tennessee, Knoxville, TN 37996, United States, 2Center for Renewable 
Carbon, 2506 Jacob Drive, University of Tennessee, Knoxville, TN 37996, 
United States TN 37996
LR-HSQMBC is one of the most recently developed NMR experiments for 
detection of long-range (nJCH, n>3) heteronulcear coupling, and for overco-
ming the challenges of structure elucidation of proton deficient molecules. 
To investigate the dependencies of long-range coupling constants on the 
neighboring heteroatoms and coupling pathway between proton and car-
bon nuclei, LR-HSQMBC was used to visualize 4-6JCH in molecules 1-4 be-
low. To aid in the investigation, density functional theory (DFT) was used, 
and a comparison of the calculated and experimental long-range coupling 
constant values will be presented.
            
         1. Phenoxazine                    2. Anthrone                3. 3,4,5-trimethoxy-         4. 3,4-dimethoxy-benzoic
                                                                                                    acid-NHS ester                 cinnamic acid-NHS ester
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1031
INVOLVEMENT OF CASPASE-DEPENDENT 
MITOCHONDRIAL PATYWAY IN CORM-2 INDUCED 
APOPTOSIS IN NEURONAL CELLS
Yilin Liu, Jing Wang *
Department of Pharmacology, School of Chinese Materia Medica, Beijing 
University of Chinese Medicine, Beijing 100102, China
The aim of this study is to investigate the effects of Tricarbonyldichlo-
roruthenium (II) dimer (CORM-2) induced apoptosis and its mechanism 
in neuronal cells of rats. Optical microscope was applied to observe the 
morphologic changes of neuronal cells. MTT assay was performed to as-
sess the survival rates of CORM-2 on neuronal cells. Apoptosis was exami-
ned by flow cytometric analysis and the expression of relative proteins was 
measured by Western Blotting analysis. The results suggested that CORM-
2 could influence survival rates in a time- and concentration-dependent 
manner. Survival rates decreased gradually after the cultures subjected 
to 24 h with 100 μmol·L-1, 200 μmol·L-1, 400 μmol·L-1 and 800 μmol·L-1 
CORM-2. After 24 h treatment, CORM-2 could induce neuronal apoptosis 
and activate Caspase-3, Caspase-9 and Cytochrome C, the main proteins in 
Caspase-dependent mitochondrial pathway in a concentration-dependent 
manner. To sum up, CORM-2 maybe induced neuronal apoptosis through 
Caspase-dependent mitochondrial pathway.
1032
EFFECTS OF ZXX FROM THE RHIZOME OF VALERIANA 
JATAMANSI ON THE RATS WITH IBS VIA THE 
REGULATION OF 5-HT PATHWAY 
Juan Wang1, Ruirui Shi1, Jing Wang1, Zengping Gao1, Jinghong Hu2, Xingli 
Yan2*
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, 
Beijing, 100102, China, 2School of Preclinical Medicine, Beijing University of 
Chinese Medicine, Beijing, 100029, China
The effects of 11-ethoxyviburtinal (ZXX) on the rat with irritable bowel 
syndrome via 7 chronic unpredictable mild stressors in 9 weeks were evalu-
ated. Results show that ZXX treatment for 9 weeks markedly decreased vis-
ceral hypersensitivity and prolonged the latency period of defecation in IBS 
rats. The anxiety- and depression-like behaviors were distinctly ameliorated 
by ZXX (0.6 and 1.2 mg/kg). Moreover, compared with the vehicle group, 
ZXX treatment at 0.6 and 1.2 mg/kg increased the contents of 5-HT in the 
hypothalamus and cortex. ZXX (0.3 and 0.6 mg/kg) elevated the activity of 
MAO-A in colon, but reduced MAO-A activity in the hippocampus. ZXX 
(0.3 mg/kg) inhibited the expression level of TPH||mRNA in the colon, 
ZXX (0.6 and 1.2 mg/kg) inhibited the expression level of TPH|mRNA in 
the brain stem. Therefore, ZXX could ameliorate the visceral hypersensiti-
vity, intestinal hyperactivity, and abnormal mental activity in IBS rats. The 
therapeutic mechanism maybe involved in the synthesis and metabolism of 
5-HT pathway in periphery intestinal system and central nervous system.
1033
INVESTIGATION OF IN VITRO BIOACTIVITY OF 
EXTRACTS AND SECONDARY METABOLITES OF 
CHUMASH NATIVE AMERICAN MEDICINAL PLANTS
Brittany Allison1, Victoria Hester1, Matthew Fleming1, Mark Allenby1, Shane 
Bryant1, and P. Matthew Joyner1.
1Department of Chemistry, Natural Science Division, Pepperdine University, 
24255 Pacific Coast Highway, Malibu, California, USA 90263
Medicinal plants have historically been a valuable source of new drugs. 
One reason for this is because many lifetimes of experience have already 
demonstrated the effectiveness of the chemical constituents of these species 
in treating human diseases. Unfortunately, there is a severe lack of knowl-
edge regarding the pharmacology and chemistry of many Native Ameri-
can traditional plant-derived medicines. We have investigated the in vitro 
bioactivity of extracts and chemical constituents of medicinal plants of the 
Chumash Native Americans of Southern California with the goal of estab-
lishing essential biological and chemical foundations for future studies of 
Chumash plant-derived medicines. Extracts of medicinal plants were as-
sayed for anti-inflammatory bioactivity by quantifying cytokine produc-
tion in murine macrophage cell cultures; extracts were also assayed for 
antibacterial bioactivity against a panel of representative bacterial species. 
Bioassay-guided fractionation was used to isolate three flavonoid com-
pounds from Artemisia californica with antibacterial activity. Our results 
indicate that some plants that have traditionally been used by the Chumash 
people for the treatment of cuts and infections demonstrate in vitro anti-
inflammatory and antibacterial bioactivity.
1034
VARIATION OF ACTIVE CONSTITUENTS OF AN 
IMPORTANT TIBETAN MEDICINAL PLANT SWERTIA 
MUSSOTII BETWEEN QINGHAI AND SICHUAN 
PROVINCE 
Yue Liu1, 2, Li Tang1, Chunbo Wang1, Yanxia Huang1, Tianjiao Wei1, Linxia 
Zhang1, Chuanchuan Chen1, Fengxian Guo
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2 National Resource Center for Chinese Materia 
Medica, China Academy of Traditional Chinese Medicine, Beijing 100700, 
China
Swertia mussotii Franch is an important Tibetan medicinal plant, which is 
called “Zangyinchen” in Tibetan region. Concetration of five phytochem-
ical constituents(swertianolin(S1), 3,7,8- trimethoxy-1-O-β-D- Glucoside 
(S2), 1-hydroxy-3,4,7,8-formethoxyxanthone(S3), 1,7-dihydroxy-3,8-dime-
thoxy- xanthone (S4), l,8-dihydroxy-3,7- dimethoxyxanthone(S5)) were de-
termined and compared in different parts of the title plant, Swertia mussotii, 
collected from Qinghai and Sichuan Province. The concentration of S1 was 
the most abundant in the buds of Swertia mussotii in Jinchuan county in 
Sichuan Province. While the concentration of S2, S3, S4 and S5 was the most 
abundant in the buds in the plants in Xiaojin county in Sichuan Province, 
the buds in Jinchuan county in Sichuan Province, the roots in Chengduo 
county in Qinghai Province, and the buds in Jinchuan county in Sichuan 
Province, respectively. The concentration of all of the constituents was 
highest in the buds, and successively reduced in buds, leaves, stems, and 
roots. Acknowledgment: financial support by project of NSFC-81274158, 
81373765, NCET-12-0578, 13-0624, “111”-B08044, URTP2014110018 and 
YLDX01013.
1035
A POLYPHENOL ENRICHED FRACTION OF ROSE OIL 
DISTILLATION WATER INHIBITS PROLIFERATION IN 
HACAT CELLS AND INDUCES APOPTOSIS
Jonas Wedler1, 2, Eliane Garo2, Krasimir Rusanov3, Matthias Hamburger2, 
Ivan Atanassov3, Veronika Butterweck1
1Institute of Pharma Technology, School of Life Sciences, University of 
Applied Sciences and Arts Northwestern Switzerland, Gründenstrasse 
40, 4132 Muttenz, Switzerland, 2Department of Pharmaceutical 
Sciences, University Basel, Klingelbergstr. 50, 4056 Basel, Switzerland, 
3AgroBioInstitute, 8 Dragan Tzankov Blvd., 1164 Sofia, Bulgaria
Water steam distillation of rose flowers (Rosa damascena) separates the es-
sential oil from the polyphenol containing rose oil distillation waste water 
(RODW). While the essential oil represents the desired liquid for the cos-
metic industry, the polyphenol containing RODW is in the center of our 
interest. Recently, a strategy was developed to separate RODW into a poly-
phenol depleted water fraction and a polyphenol enriched fraction [RF20-
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(SP-207)]. Polyphenols are known to have a wide spectrum of biochemical 
and pharmacological effects. In the present study, we investigated possible 
antiproliferative effects of RF20-(SP-207) and fractions thereof F(I)-(IV) in 
immortalized human keratinocytes (HaCaT). The BrdU cell proliferation 
assay was used to measure cell proliferation. Cell migration was elucidated 
by time lapse microscopy. The data demonstrated that from all tested frac-
tions only F(IV) revealed a concentration dependent antiproliferative effect 
which was comparable to RF20-(SP-207) (IC50 of approx. 10 µg/mL). This 
effect was similar to both positive controls LY294002 (PI3K-inhibitor, 30 
% inhibition) and NVP-BEZ235 (dual PI3K/mTOR-inhibitor, 30 % inhi-
bition) and clearly exceeded the anti-proliferative action of quercetin (ap-
prox. 20 % inhibition). Time lapse microscopy revealed that cell migration 
was dramatically decreased under influence of RF20-(SP-207) and F(IV). 
This effect was comparable to LY294002 and NVP-BEZ235. Fluorescence 
microscopy images confirmed the qualitative increase of apoptosis under 
influence of RF20-(SP-207) and (IV).
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NEW STRATEGY TO SEARCH LEAD COMPOUNDS WITH 
UNIQUE STRUCTURES FROM PLANTS
Tom Villani1,2, Kelsey Gustafson1,3, Jing Zhen1,2, James E. Simon1,2, Qingli 
Wu1,2,3
1 New Use Agriculture and Natural Plant Products Program, Department of 
Plant Biology, Rutgers University, New Brunswick, NJ 08901. 2 Department 
of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers 
University, Piscataway, NJ 08854. 3 Department of Food Science, Rutgers 
University, New Brunswick, NJ 08901 
For more than a century, natural products have been the most consistent 
source of lead compounds in drug discovery. Based on biosynthesis pa-
thway and basic structure, natural products found in seed plants (phytoche-
micals) could be categorized into three major groups including alkaloids, 
terpenoids and phenolics, and from the viewpoint of previous research and 
development on natural products chemistry, we now have sufficient data 
to suggest that most of the therapeutic agents derived from phytochemi-
cals are alkaloids or terpenoids. Whereas the natural phenolic compounds 
play a vital role in disease prevention. In recent decades, wide application 
of LC/MS technique enabled us to pre-screen the chemical profile of the 
matrices and identify the materials containing unique molecules with phar-
maceutical interest prior to the time-consuming process of isolation and 
elucidation. Using the novel strategy upon LC/MS pre-screening, dozens 
of medicinal plant samples collected from Africa on the basis of bioassay 
results and traditional application were subjected to in-depth chemical pro-
filing using LC/MS. Under LC/MS guided screening, most species failed to 
yield unique/new compounds, and only a few plant species were found to 
contain unique/novel structures. Under this model, we were able to suc-
cessfully narrow down the plant list to facilitate further natural products 
investigation, which is presently still very laborious work.
1037
GASTRIC ANTIULCER, ANTISECRETORY AND 
CYTOPROTECTIVE PROPERTIES OF CELERY (APIUM 
GRAVEOLENS) IN RATS
Tawfeq AlHowiriny ª*, Abdulmalik Alsheikh †, Mohammed Al-Yahya *, 
Kamal ElTahir * and Syed Rafatullahª*
*Departments of Pharmacognosy and Pharmacology, College of Pharmacy, 
King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, 
†Department of Pathology, P.O. Box 2925, King Khalid University Hospital, 
King Saud University, Riyadh 11461, Saudi Arabia, ªMedicinal, Aromatic 
and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, 
King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
Celery seed is generally regarded as safe for human consumption as a spice, 
natural seasoning and plant extract/essential oil. 500 grams of the shade 
dried aerial parts of celery was coarse powdered and macerated in 3 liters 
of 96% ethanol for 72 hours using percolation method. Wistar albino rats 
were used. Celery extract produced a dose-dependent significant protec-
tion against the ulcerogenic effect induced by indomethacin. In the ethanol 
and strong alkali-induced ulcer protocol, it was observed that the treatment 
with ethanolic extract of celery (250 and 500 mg/kg) significantly reduced 
the lesion index. A highly significant reduction of ulceration in rats’ stoma-
ch and intraluminal bleeding was recorded after celery extract pretreatment 
at the dose of 500 mg/kg orally. In the gastric secretion determination mo-
del, using ligated pylorus for 6 h, the treatment with celery extract (250 and 
500 mg/kg i.p.), reduced the volume of basal gastric secretion, titratable 
acidity and ulceration significantly in comparison with control group. The 
results show that ethanol extract of celery displays gastroprotective activi-
ty, as demonstrated by its significant inhibition of the formation of ulcers 
induced by different experimental models, and its ability to decrease basal 
gastric acid secretion. This gastric antiulcer capacity of celery extract could 
be related to its antioxidant properties, resulting in reduction of the lipid 
peroxidation and elevation of the NP-SH contents, besides, improving mu-
cus coat of the stomach. Therefore, we suggest that due to its antioxidative 
effects, it may be useful in the prevention of gastric disorders.
1038
ANTI-INFLAMMATORY ACTIVITY OF A NEW CYCLIC 
PEPTIDE, CITRUSIN XI, ISOLATED FROM THE FRUITS 
OF CITRUS UNSHIU
Hee Rae Kang1, Hee Jeong Eom1, Seulah Lee1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
In this study, we investigated the active constituents from the fruits of Citrus 
unshiu and evaluated the anti-inflammatory activity in order to support the 
traditional usage of C. unshiu. A new cyclic peptide, citrusinXI (1), was iso-
lated and identified from the fruits of C. unshiu. The structure of compound 
1 was elucidated by spectroscopic analysis, including 1D and 2D NMR, and 
HR-mass spectrometry, and its absolute configurations were further con-
firmed by the Marfey’s method. Compound 1 decreased NO production in 
LPS-stimulated RAW264.7cells in a dose-dependent manner with an IC50 
value of 70 μM. Compound 1 suppressed NO production by decreasing 
iNOS expression but COX-2 expression was slightly associated with the 
reduction by compound 1 in LPS-induced RAW264.7 cells. Furthermore, 
compound 1 inhibited NF-κB activation by blocking IκBα degradation and 
NF-κB phosphorylation in LPS-stimulated RAW264.7cells. This is the first 
study to clarify the underlying mechanism of the anti-inflammatory effect 
exerted by a pure isolated compound from C. unshiu in LPS-stimulated 
RAW264.7 macrophage cells.
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YUANHUADINE, A NATURAL DITERPENE, ENHANCES 
THE DEGRADATION OF AXL TO OVERCOME ACQUIRED 
GEFITINIB-RESISTANCE IN LUNG CANCER CELLS
Song Yi Bae, Ji-Young Hong, Hye-Jung Lee, Hyen Joo Park, Sang Kook Lee*
College of Pharmacy, Seoul National University, Seoul 151-742, Korea
Acquired resistance to epidermal growth factor receptor tyrosine kinase in-
hibitors (EGFR-TKIs), such as gefitinib, remains a major problem in non-
small cell lung cancer (NSCLC) treatment. Increased activation of AXL has 
been identified as a novel mechanism for acquired resistance to EGFR-TKIs 
in NSCLC treatment. However, the cause of uncontrolled AXL expression 
is not fully understood. Here, we first demonstrate that AXL is overex-
pressed in an acquired gefitinib-resistant cell line (H292-Gef) as a result of 
slow turnover and that AXL is degraded by presenilin-dependent regulated 
intramembrane proteolysis (PS-RIP). Based on the findings, we attempted 
to enhance AXL degradation to overcome acquired gefitinib-resistance by 
the treatment of gefitinib-resistant NSCLC cells with yuanhuadine (YD), 
a potent antitumor agent in NSCLC. Treatment with YD effectively sup-
pressed the cancer cell survival in vitro and in vivo. Mechanistically, YD 
accelerated the turnover of AXL by PS-RIP and resulted in the down-regu-
lation of the full-length AXL. Therefore, the modulation of the proteolytic 
process through degradation of overexpressed AXL may be an attractive 
therapeutic strategy for the treatment of NSCLC and EGFR-TKI-resistant 
NSCLC. [Acknowledgements: This work was supported by a National Re-
search Foundation of Korea (NRF) grant funded by the Korean Govern-
ment (MEST) (No. 2009-0083533 and No. 2010-0024361)]
1040
EVALUATING HEALTH CLAIMS ASSOCIATED WITH 
NATURAL PRODUCT CONTENT OF FOODS, SUCH AS 
EFFECTS OF SOY PROTEIN ON BLOOD CHOLESTEROL 
Robin J. Marles1, Karima Benkhedda1, Cynthia Boudrault1, Susan E. 
Sinclair2, Chaowu Xiao3, and Lynne Underhill1
1Nutrition Premarket Assessment Division, 2Nutrition Regulations and 
Standards Division, 3Nutrition Research Division, Bureau of Nutritional 
Sciences, Food Directorate, Health Products and Food Branch, Health 
Canada, 251 Sir Frederick Banting Driveway (Mail Stop 2203E), Ottawa, 
ON, Canada K1A 0K9
A health claim on the label or advertising of a food states, suggests or im-
plies that a relationship exists between consumption of the food and health. 
All food health claims are voluntary and must not be false, misleading or 
deceptive. Claims related to a list, set out in Canadian law, of serious di-
seases, disorders and abnormal states (e.g., diabetes) are prohibited unless 
an exemption has been granted based on a pre-market evaluation. While 
other health claims are subject to post-market federal compliance verifica-
tion, stakeholders can make a voluntary submission for pre-market evalua-
tion. Proposed health claims are evaluated in a systematic, comprehensive 
and transparent manner to ensure they are valid. For example, the Food 
Directorate recently completed evaluation of a voluntary submission for 
a food health claim regarding consumption of soy protein and choleste-
rol lowering. Systematic review and meta-analysis showed significant (P < 
0.00001) reductions in total cholesterol (-0.15 mmol/L, 95% C.I. -0.21 to 
-0.08) and LDL-cholesterol (-0.15 mmol/L, 95% C.I. -0.19 to -0.11) levels 
(approximately 2.6% and 4%, respectively) with consumption of soy prote-
in vs. non-soy controls. Epidemiological and intervention data suggest that 
for every 1% reduction in LDL-C there is a corresponding 1–2% reduction 
in cardiovascular events, making reduction of elevated LDL-cholesterol an 
important public health goal.
1041
PLANTAGO ASIATICA EXTRACTS PREVENT SKIN 
PHOTOAGING IN HAIRLESS MICE
Hee Rae Kang1, Hee Jeong Eom1, Seulah Lee1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
In this study, we examined the anti-wrinkle effects of Plantago asiatica seed 
(PAS) on UV-induced human dermal fibroblasts (HDFs) and hairless mice 
models to determine if an anti-inflammatory agent could also be develo-
ped as an anti-aging treatment. Acute UV irradiation induced matrix me-
tallproteinase (MMP)-1 protein expression levels, but this was suppressed 
by PAS in HDFs. Next, we investigated the effect of PAS on UV-induced 
skin changes in hairless mice. Chronic UV exposure of the dorsal skin in-
creased skin thickness and induced wrinkle formation. PAS significantly 
suppressed UV-induced morphologic skin changes. In addition, MMP-1 
expression was dramatically attenuated by treatment with plantainoside D 
which was purely isolated from PAS, indicating that this is the principle 
compound inhibiting MMP-1 expression in HDFs. Taken together, our 
data suggest that PAS can prevent the harmful effects of UV that lead to 
skin aging. 
1042
CREATION OF A HIGH-THROUGHPUT, HIGH-CONTENT, 
SCREENING ASSAY FOR THE HUMAN PARASITE 
TRICHOMONAS VAGINALIS.
Jarrod King, Robert Cichewicz
Institute for Natural Products Applications and Research Technologies, 
University of Oklahoma, Norman, Oklahoma 73019
The human sexually transmitted parasite Trichomonas vaginalis infects at 
least 170 million people worldwide and infections are treated with metro-
nidazole, a suspected human carcinogen. An assay was developed in order 
to quantify the growth, viability, and morphology of the organism, using 
the Perkin Elmer Operetta imaging platform. A counter-screen for toxicity 
was also developed using the normal human cervical cell line Ect1/E6E7 
and the Operetta. Initial screening was done on an internal library of pure 
compounds, followed by screening of our fungal extract library. Pure com-
pounds with up to twenty times the potency of metronidazole and extracts 
with favorable therapeutic indices up to 36 were found. Active compound 
isolation for the extracts is in progress.
CREATION OF A HIGH-THROUGHPUT, HIGH-CONTENT, SCREENING ASSAY FOR 
THE HUMAN PARASITE TRICHOMONAS VAGINALIS. 
Jarrod King, Robert Cichewicz. Institute for Natural Products Applications and R search Technologies, 
University of Oklahoma, Norman, Oklahoma 73019 
The human sexually transmitted parasite Trichomonas vaginalis infects at least 170 million people 
worldwide and infections are treated with metronidazole, a suspected human carcinogen. An assay was 
developed in order to quantify the growth, v ability, and morphology of the organism, using the Perkin 
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GENE SCREENING AND METABOLOMICS FOR 
IDENTIFICATION OF HALOGENATED NATURAL 
PRODUCTS FROM MARINE SPONGE-ASSOCIATED 
BACTERIA 
S. Goldberg1, B. Haltli1,2, F. Berrue2, R. Kerr1,2
1Department of Biomedical Sciences, Atlantic Veterinary College, PEI, 
2Department of Chemistry, University of Prince Edward Island, PEI
Marine sponges and their associated microbes are promising sources of ha-
logenated bioactive natural products. In many cases the halogen moiety is 
required for biological activity. Halogenation reactions are commonly cata-
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lyzed by flavin-dependent halogenases and vanadium-dependent haloper-
oxidases. This research addresses how to identify biosynthetically promi-
sing bacteria and how to access halogenated metabolites encoded in their 
genomes. A bacterial library consisting of 980 isolates was established from 
four Caribbean sponge species. A combinatorial approach utilizing gene-
tic screening and an HRMS-based metabolomics workflow was developed 
to identify strains capable of producing halogenated metabolites. Small-
subunit rDNA sequencing identified 25 OTUs using a similarity cutoff 
of 99%. Twelve strains represented putatively novel species based on 16S 
rDNA gene sequences exhibiting show ≤97% identity to known organisms. 
PCR screening identified 39 strains possessing the potential biosynthetic 
machinery necessary to produce halogenated metabolites. However, only 
a few putative halogenated metabolites were detected in a metabolomic 
analysis of 900 strains cultured under a single fermentation condition. This 
suggests that gene clusters encoding halogenated metabolites are cryptic in 
these strains. Investigation of enzyme diversity as well as induction efforts 
to elicit production of halogenated metabolites for strains positive in the 
PCR screen will be presented.
1044
ECOEFFICIENT PRODUCTION OF CORAL DERIVED 
PSEUDOPTEROSIN IN ENGINEERED E. COLI
Markus Reinbold1, Daniel Garbe1, and Thomas Brueck1.
1Division of Industrial Biocatalysis, Department of Chemistry, Technische 
Universitaet Muenchen, Lichtenbergstr. 4, D-85748 Garching, Germany
Pseudopterosins are diterpene glycosides, derived from the Caribbean soft 
coral Antillogorgia elisabethae. These anti-inflammatory compounds have 
a growing market in the cosmetics and pharmaceutical industry. Current 
production is derived from wild harvested coral, which poses environmen-
tal and supply issues for an expanding market. In this project we purify 
the key biosynthetic enzymes from coral and identify their sequence using 
proteomic methods. The sequence data will be used to construct a hetero-
logous pseudopterosin production system based on E. coli. To regulate me-
tabolic flux, the biosynthetic elements will be integrated into the genome.
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IN VITRO ANTITUMOR EFFECTS OF TWO NOVEL 
COMPOUNDS Y17 AND Y18, ISOLATED FROM A 
CHINESE MEDICINAL PLANT
Nadin Almosnid1, Ying Gao1, Elliott Altman1
1Tennessee Center for Botanical Medicine Research and the Department of 
Biology, Middle Tennessee State University, Murfreesboro, Tennessee, United 
States of America.
Naturally derived stilbenes have various biological properties, including 
cytotoxic, anti-ecdysteroidal, anti-mutagenic, anti-oxidative, anti-inflam-
matory, and anti-tumor activities. Previous phytochemical studies revealed 
that Chinese medicinal plants are rich in natural stilbenes. The purpose of 
the present study was to determine the anti-tumor effects and mechanism 
of action of the novel oligostilbene isomers, Y17 and Y18, isolated from a 
Chinese medicinal plant. Y17 and Y18 exhibited remarkable cytotoxicity 
against selected human cancer cell lines A549, BT20, MCF7, and U2OS, 
but showed much less toxicity to two normal human cell lines, HPL1A and 
HMEC. We also demonstrated that Y17 and Y18 exerted their anti-tumor 
effects by stimulating apoptosis, decreasing membrane mitochondrial po-
tential,  inhibiting cell motility, and  blocking the nuclear factor-kappa B 
(NF-κB) pathway  in human cancer cells.  In addition, we evaluated their 
respective bioefficacy and found that, interestingly,  Y17 is more potent 
than Y18. Collectively, we showed that both compounds Y17 and Y18 could 
be promising chemotherapeutic agents.
1046
FOUR NEW C
19
-NORDITERPENOID ALKALOIDS FROM 
DELPHINIUM ELATUM
Erika Asakawa, Yoshie Tosho, Ayako Nakata, Yuko Hasegawa, Hiroshi 
Yamashita, Koji Wada. 
Medicinal Chemistry, School of Pharmacy, Hokkaido Pharmaceutical 
University, 7-15-4-1, Maeda, Teine, Sapporo 006-8590, Japan
Four new C19-norditerpenoid alkaloids, melpheline (1), 19-oxoisodelphe-
line (2), N-deethyl-19-oxoisodelpheline (3), and N-deethyl-19-oxodel-
pheline (4), have been isolated from Delphinium elatum cv. Pacific Giant 
together with twelve known C19-norditerpenoid alkaloids, delpheline, pa-
cinine, pacidine, iminodelpheline, iminoisodelpheline, isodelpheline, yun-
nadelphinine, N-formyl-4,19-secopacinine, delcorine, 6-dehydrodelcorine, 
laxicyminine, and bonvalotidine C. The structures of these alkaloids were 
determined by their ms, 1D and 2D-nmr data. 6-Dehydrodelcorine, laxicy-
minine, and bonvalotidine C were isolated which have not previously been 
found in this plant.
1047
ISOLATION AND STRUCTURAL ELUCIDATION OF 
SIX TETRACYCLIC DITERPENOIDS FROM MARINE 
SOFT CORAL BRIAREUM ASBESTINUM
Long Zhang1 and Lyndon West1
1Department of Chemistry, Florida Atlantic University, Boca Raton, FL 
33431, USA 
Six new tetracyclic diterpenoids (1-6) of the class briarellin were isolated 
from the methanolic extract of the gorgonian octocoral Briareum asbesti-
num collected off the coast of South Florida. Compounds 1-5 are the first 
series of compounds possessing an unprecedented oxygenated functional 
group at C-15, and compounds 5 and 6 are briarellins with a longest fatty 
acid moiety so far, C9H19COO-. The structures of these secondary metabo-
lites were determined by spectral analysis including NMR and MS.
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FUNGAL ENDOPHYTES FROM TAXUS FAUNA AS A 
TREASURE OF BIOACTIVE COMPOUNDS
Hira Mehboob Mirza1, Ulyana Muñoz Acuña2, Safia Ahmed1, Karl A. 
Werbovetz2, Esperanza J. Carcache de Blanco2 , Masoom Yasinzai,1
1Department of Microbiology Quaid-i-Azam International University 
Islamabad, Pakistan, 45320, 2Divisions of Pharmacy Practice and Medicinal 
Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State 
University, Columbus, OH 43210
Throughout the ages humans have relied on nature to cater for their basic 
needs, not the least of which are medicines for the treatment of a wide spec-
trum of diseases. An increasing number of pathogenic microorganisms and 
the emergence of new diseases have created great demand for the search 
for novel chemical entities with improved antimicrobial properties. Among 
natural sources, recent discovery of microorganisms living asymptomati-
cally in the tissues of higher plants—endophytic microorganisms—are a 
promising source of pharmaceutically important metabolites. Northern 
areas of Pakistan have rich biodiversity of Taxus species. Crude extracts 
from endophytic fungi isolated from indigenous species of Taxus fauna 
have been screened in biological assays, as part of a bioassay-guided fractio-
nation scheme. Extracts of Taxus fauna have shown promising activities in 
antibacterial, NF-kB, K-ras and especially in antileishmanial assays. Cyto-
toxicity of the crude extracts has also been evaluated by the Sulforhodami-
ne B (SRB) assays. Further fractionation of the crude extracts have resulted 
in partially purified fractions which will be further studied to identify the 
bioactive metabolites. 
1049
MEDICINAL PLANT USE FOR MALARIA: TRENDS AND 
PROSPECTS
Woon-Chien Teng1, Ho Han Kiat1, Rossarin Suwanarusk2, Cheng-Shoong 
Chong1, Hwee-Ling Koh1
1Department of Pharmacy, National University of Singapore, Singapore 
117543. 2Singapore Immunology Network, Agency for Science Technology 
and Research, Biopolis, Singapore. 
Malaria is a potentially life-threatening disease that affects millions each 
year, with resistance to most anti-malarial agents documented. Given that 
two of the widely used agents for malaria today, quinine and artemisinin, 
are derived from plant sources, medicinal plants are a potentially viable 
source of novel anti-malarial agents. The objective of this work is to carry 
out a literature survey on medicinal plants documented for use in malaria. 
Keywords “ethnobotanical”, “survey”, “ethnopharmacological”, and “malar-
ia” were searched in Scopus, ScienceDirect, and PubMed. Other books and 
websites were also used. Plants that were reported to be used solely for fe-
ver (other than malarial fever), external application, or as insect repellents, 
were excluded. Data collected were analyzed according to family, genus, lo-
cation of use, method of preparation, part used, and indication (treatment 
and/or prevention). A comprehensive database documenting the usage and 
preparation of these medicinal plants for malaria has been compiled. A to-
tal of 1856 plants from 196 families and 1013 genera were reported to be 
used for malaria worldwide, with 66 plants reportedly used in three or more 
continents. Based on geographical extent of use, plant family, or genus, the 
plants for further research can be prioritized. There is evidence of sustained 
interest in anti-malarial medicinal plant research over the past decade. De-
tailed results of the survey will be presented, and trends and prospects of 
medicinal plants for use in malaria will be discussed.
1050
MYCOLIC ACID-CONTAINING BACTERIA INDUCE THE 
PRODUCTION OF NOVEL SECONDARY METABOLITES IN 
STREPTOMYCES STRAINS 
Shotaro Hoshino1, Lihan Zhang1, Takayoshi Awakawa1, Toshiyuki 
Wakimoto2, Hiroyasu Onaka3 and Ikuro Abe1
1Graduate School of Pharmaceutical Sciences, The University of Tokyo, 
Bunkyo-ku, Tokyo 113-0033, Japan, 2Graduate School of Pharmaceutical 
Sciences, Hokkaido University, Sapporo , Japan, 3Graduate School of 
Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 
113-8657, Japan
It was previously reported that several kinds of mycolic acid-containing 
bacteria interact with various kinds of Streptomyces strains and induce the 
secondary metabolites production (Onaka, H. et al. Appl. Environ. Mi-
crobiol. 2011, 77, 400−406). We applied this fermentation method to our 
collection of Streptomyces strains, employing Tsukamurella pulmonis as a 
mycolic acid-containing bacterium. As a result, novel cytotoxic alkaloid 
arcyriaflavin E (1) was isolated from Streptomyces cinnamoneus NBRC 13823 
and novel cytotoxic butanolides chojalactones A-C (2-4) were obtained 
from soil-derived Streptomyces CJ-5 respectively. The stereochemistries 
(including absolute configurations) of 2-4 were determined based on 
careful spectroscopic analysis and the total synthesis of 2 and 3, together 
with all of their stereoisomers.
1051
GENOTOXICITY EVALUATION IN VITRO BY COMET 
ASSAY OF COMPOUND AND CRUDE EXTRACT 
OBTAINED FROM P.Pubescens Benth.
Vanessa H.S.Souza1,3, Ana Paula O.Hohne2, Rogério Grando3, Nubia de 
Cassia de Almeida Queiroz3, Glaucia M.Pastore4, Ana L.T.Gois Ruiz2, João 
Ernesto de Carvalho, Humbert Moreiro Spindola1,2, Mary Ann Foglio1,3
1CPQBA/FOP-Unicamp, Brazil, 2DFT/CPQBA-Unicamp, Brazil, 3DQPN/
CPQBA-Unicamp, Brazil, 4FEA-Unicamp, Brazil.
Pterodon pubescens Benth, native of Brazilian Cerrado, is used in folk me-
dicine for pain treatment. Analgesic and anti-inflammatory efficacy was 
proven with further toxicity studies conducted to ensure safety issues. The 
genotoxic potential was assessed by Alckaline Comet in vitro Assay to de-
tect DNA single-strand damage at level of eukaryotic cell, where CHO-K1 
cells were exposed to the crude extract (EBD) and diterpene compound A 
(Dit-A) in 0.3, 3 e 30µg/ml concentrations for 4 hours. Cell suspensions, 
in agarose slides, were subjected to electrophoresis and then analyzed with 
ethidium bromide by fluorescence microscopy. The genotoxic potential was 
evaluated according to the percentage of DNA fragmentation and Tail Mo-
ment. The EBD 30µg/ml (13.11±13.20) and Dit-A 30µg/ml (17.73±9.95), 
when compared to control MMS 4,7µM (94.17±3.55), did not exhibit geno-
toxic potential (ANOVA, p<0,001).
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A PHENYLPROPANOID AND NEOLIGNANS FROM 
MYRISTICA FRAGRANS HOUTT WITH PARP-1 AND NF-
κB INHIBITORY ACTIVITY.
Ulyana Muñoz Acuña1,2, Peter J. Blanco Carcache1,2, Susan Matthew1,2, and 
Esperanza J. Carcache de Blanco1,2*. 
1Division of Pharmacy Practice and Administration and 2Division of 
Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio 
State University, 141N Parks Hall 500 W. 12th Avenue, Columbus, OH 
43210.
Bioassay guided fractionation of the aril of M. fragrans yielded five phenolic 
compounds, one new acyclic bis phenylpropanoid (1) and four previously 
known neolignans. Compound (1) (S) 1-(3, 4, 5-trimethoxyphenyl)-2-(3-
methoxy-5-(prop-1-yl) phenyl)- propan-1-ol, (2) benzenemethanol; α-[1-
[2,6-dimethoxy-4-(2-propen-1-yl)phenoxy]ethyl]-3,4-dimethoxy-1-ace-
tate, (3) odoratisol A, phenol, 4-[(2S, 3S)-2,3-dihydro-7-methoxy-3-meth-
yl-5-(1E)-1-propenyl-2-benzofuranyl]-2,6-dimethoxy, (4) 1,3-benzodiox-
ate-5-methanol,α-[1-[2,6-dimethoxy-4-(2-propenyl)phenoxy]ethyl]-ace-
tate, (5) licarin C; benzofuran, 2,3-dihydro-7-methoxy-3-methyl-5-(1E)-
1-yl-2-(3,4,5-trimethoxyphenyl). A NMR tube Mosher ester reaction was 
used to determine the absolute configuration of the new isolated chiral 
alcohol (1). PARP-1 inhibitory activity was evaluated for compound (1) 
(IC50 = 3.04 µM), compound (2) (IC50 = 0.001 µM), compound (4) (IC50 
= 22.07 µM) and compound (5) (IC50 = 3.11 µM). All isolated secondary 
metabolites were also tested for NF-κB (p65) and K-Ras inhibitory activity. 
Compounds (2) and (4) displayed potent NF-κB inhibition, IC50 = 1.5 nM 
and 3.4 nM, respectively.
1053
ANTITRYPANOSOMAL ACTIVITY OF AN IRIDAL FROM 
IRIS DOMESTICA AND INITIAL STRUCTURE-ACTIVITY 
RELATIONSHIPS 
Norma Dunlap1,3, Anuradha Liyana Pathiranage1, Jeannie Stubblefield2, and 
Anthony Newsome2,3
1Department of Chemistry, Middle Tennessee State University, Murfreesboro, 
TN  37132, USA, 2Department of Biology, Middle Tennessee State University, 
Murfreesboro, TN  37132, USA, 3Tennessee Center for Botanical Medicine 
Research, Middle Tennessee State University, Murfreesboro, TN  37132, 
USA.
The myristate eseter of iso-iridogermanal was identified as an antitrypa-
nosomal component of Iris domestica using bioassay-guided fractionation. 
This compound has previously been isolated from I. domestica, as well as 
other Iris species, and has been shown to be cytotoxic to tumor cells. Inve-
stigation of the antitrypanosomal activity of iso-iridogermanal, as well as 
semi-synthetic derivatives, will be presented. 
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PLANT-LIKE ALKALOID BIOSYNTHESIS IN FUNGI
Joshua A. Baccile1, Joseph E. Spraker2, Eileen Brandenburger3, Christian 
Gomez1, Jin-Woo Bok2, Dirk Hoffmeister3, Nancy P. Keller2, Frank C. 
Schroeder1
1Boyce Thompson Institute and Dept. of Chemistry & Chemical Biology, 
Cornell University, Ithaca, NY. 2Dept. of Medical Microbiology and 
Immunology, University of Wisconsin-Madison, WI. 3Hans-Knöll-Institute, 
Jena, Germany.
Traditional natural products discovery efforts have focused primarily on 
biosynthetic genes clusters (BGCs) containing large multi-modular NRPSs; 
however, sequencing of fungal genomes has revealed a vast reservoir of 
BGCs containing smaller NRPS-like genes whose biosynthetic functions 
have remained elusive. Using a comparative metabolomics approach, we 
show that a BGC in the human pathogen Aspergillus fumigatus named fsq, 
which contains an NRPS-like gene, produces a family of novel isoquino-
line alkaloids, the fumisoquins. Assembly of these compounds is based on 
an unprecedented carbon-carbon bond formation between L-serine- and 
L-tyrosine-derived building blocks, followed by formation of the isoquino-
line ring system via a sequence that is directly analogous to the biosynthe-
sis of an important family of isoquinoline alkaloids in plants. Fumisoquin 
biosynthesis requires the N-methylase FsqC and the FAD-dependent oxi-
dase FsqB, which represent functional orthologs of coclaurine N-methyl-
transferase and berberine bridge enzyme in 
plants. Analysis of fungal genomes revealed 
homologs of fsq genes in many species, sug-
gesting that plant-like isoquinoline biosynthe-
sis is widespread in fungi. We corroborated 
the biosynthetic role of these fungal genes by 
demonstrating isoquinoline biosynthesis by a 
different BGC in A. flavus. Our results provide 
a striking example for convergent evolution of 
a multistep biosynthetic mechanism and show 
that BGCs containing NRPS-like genes may 
reveal new biosynthetic paradigms.
1055
AN ETHNOBOTANICAL SURVEY ON THE USAGE OF 
FRESH HERBS 
Yin-Yin Siew1, Sogand Zareisedehizadeh1, Wei-Guang Seetoh1, Soek-Ying 
Neo1, Chay-Hoon Tan2, Hwee-Ling Koh1
1 Department of Pharmacy, Faculty of Science, National University of 
Singapore, Singapore, 2 Department of Pharmacology, Yong Loo Lin School 
of Medicine, National University of Singapore, Singapore
Medicinal plants are important sources of new therapeutics. The objective 
of this work is to interview users of fresh herbs regarding the usage and 
their perceptions. Information on demographic data, plant-use methods 
and perception of usage was collated. Chi-square or Fisher’s exact tests 
were used to study the association between sociodemographic variables 
and goals/motivations for plant usage. Two hundred users (age 18 to 97) 
reported the use of 104 species of herbs in the last 5 years. The five most 
commonly used plants were Clinacanthus nutans, Strobilanthes crispus, 
Pereskia bleo, Aloe vera and Zingiber officinale. The top 3 most commonly 
cited medical conditions were diseases of respiratory system, neoplasm and 
diseases of circulatory system. Recommendation by others (150, 75.0%), 
efficacy (137, 68.5%), and safety (117, 58.5%) were common reasons given 
for using fresh herbs. 173 users (86.5%) did not consult any healthcare pro-
fessional for advice about plant usage. Males were more likely to use herbs 
for treatment while females were more likely to use herbs for both general 
health and treatment (p = 0.020). Users with lower educational level were 
more likely than users with higher educational levels to use herbs because 
they perceived them to be safe and harmless given their natural origin (p 
= 0.016). Younger users were more likely to use herbs because of their af-
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fordability (p = 0.006). Mild, self-resolving symptoms were reported by 28 
(14.0%) participants using 16 plant species. Most users (170, 85.0%) were 
satisfied or highly satisfied with the outcome of plants used. Two hundred 
users of fresh herbs have been successfully interviewed and the informati-
on documented systematically in a database. The results suggest that fresh 
herbs have a role to play in healthcare in modern society. The information 
collated will serve as a useful resource for identifying promising plants for 
future drug discovery efforts.
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HERBAL PLANTS FOR ORAL DISORDERS IN CHINA
Chunlin Long1,2, Yilan Zhou1, Yuehu Wang2, Guihua Tang2
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2Kunming Institute of Botany, Chinese Academy of 
Sciences, Kunming 650201, China
Based on literature studies, ethnobotanical and ethnomedicinal surveys in 
China, we recorded 1524 taxa of plants used for oral diseases from 36 eth-
nic groups and Han Chinese. They belong to 164 families and 599 genera. 
An inventory had been finished with names (local name, Chinese name 
and scientific name), botanical description, habitat and distribution, taste 
or smell, functions, parts used, preparing method, other uses and ethno-
botanical information. Southwest China is the richest region with most 
species of medicinal plants, and with plentiful traditional knowledge to 
use herbal medicine to treat oral disorders. More species will be discove-
red in southwest China, particularly in Yunnan’s ethnic communities. A 
few species used by ethnic people for treating oral disorders were selected 
for phytochemical and pharmacological studies. For instance, the stems 
of Piper boehmeriaefolium (Piperaceae) have been used to treat toothache 
by the De’ang people in southwest Yunnan. We isolated 30 compounds 
from Piper boehmeriaefolium, in which 8 are new ones. Most of theses 
compounds are alkaloids of amides, which showed good biological acti-
vities. This study was supported by National Natural Science Foundation 
of China (31161140345), the Ministry of Science & Technology of China 
(2012FY110300), the Ministry of Education of China (B08044) and the 
Minzu University of China (YLDX01013).
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LANTIBIOTICS FROM THE ANAEROBE RUMINOCOCCUS 
FLAVEFACIENS FD-1
Xiling Zhao1 and Wilfred A. van der Donk1,2,3
1Department of Chemistry, 2Biochemistry, University of Illinois at Urbana-
Champaign, IL, USA, 3Howard Hughes Medical Institute, Chevy Chase, 
MD, USA
Lanthipeptides are a class of ribosomally synthesized and post-translatio-
nally modified natural products, a subset of which display antimicrobial 
activity and are called lantibiotics. Lanthipeptide biosynthetic machinery 
is conserved, which facilitates discovery efforts. Genome mining revealed 
a lanthipeptide gene cluster within the anaerobic organism Ruminococcus 
flavefaciens FD-1 that represents an example of lanthipeptide combinatorial 
biosynthesis in which a pair of enzymes could be responsible for the mo-
dification of twelve substrate peptides. In order to systematically assess the 
structures and bioactivities of the peptides encoded within the cluster, a he-
terologous host and in vitro production strategy was employed to access the 
modified peptides. The presence of characteristic post-translational modi-
fications in the processed peptides was confirmed by chiral gas-chromato-
graphy mass spectrometry and tandem mass spectrometry. Furthermore, a 
preliminary assessment revealed the FlvA peptides to be antibacterial and 
studies are underway to quantify their antimicrobial activity.
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DALEA EMORYI REVISITED: ANTHELMINTIC AND NEW 
COMPONENTS OF A PREVIOUSLY-STUDIED PLANT
Gil Belofsky1, Po Keang Kouch1, Jocelyn McCornack2, Kaitlin Koppinger2, 
and Blaise Dondji2
1Department of Chemistry, Central Washington University, Ellensburg, WA 
98926, USA, 2Department of Biological Sciences, Central Washington 
University, Ellensburg, WA 98926, USA.
Detailed chemical studies of Dalea emoryi A. Gray (syn: Psorothamnus 
emoryi (A. Gray) Rydb. (Fabaceae) were undertaken using taxonomic ra-
tionale. Other Dalea spp. have yielded anthelmintic components in our bio-
logical testing. D. emoryi was the subject of prior studies, and, interestingly, 
the crude extract was inactive in our bioassay. Nevertheless, new and active 
compounds 1 and 2, for example, were revealed upon further purification 
of the crude D. emoryi materials. These findings agree with prior obser-
vations regarding the importance of screening partially purified materials 
in addition to crude extracts. Anthelmintic activities were determined in 
an ex vivo assay with the hookworm Ancylostoma ceylanicum. Isolation of 
compounds was by classical open-column chromatographic methods, with 
characterization using extensi-
ve 1D and 2D NMR spectrosco-
pic methods and by HRESIMS. 
Details of the bioassay methods, 
results, and the isolation and 
characterization of D. emoryi compounds will be presented.
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BIOTRANSFORMATION OF BIOACTIVE MARINE 
NATURAL PRODUCTS BY THE MARINE-DERIVED 
MICROORGANISMS 
Keumja Yun and Byeng W. Son
Department of Chemistry, Pukyong National University, Busan 608-737, 
South Korea. 
As part of a program to explore the biological transformation of bioactive 
marine natural products produced by marine-derived actinomycete bac-
teria and ascomycete fungi isolated from marine habitats, we have studied 
biotransformation for some marine-derived fungal and bacterial metabo-
lites. The biotransformation was carried out by some modified Two-Stage 
Protocol.1,2 This presentation describes the production, isolation, and iden-
tification of new bioactive compounds by biotransformation. We will also 
show biological activity of the new biotransformed metabolites.
1. Smith, R. V. and Rosazza, J. P. J. Pharm. Sci. 1975, 64, 1737~1759.
2. Li, X.; Lee, S. M.; Choi, H. D. Kang, J. S.; Son, B. W. Chem. Pharm. Bull. 
2003, 51, 1458-1459.
TOPIC - Microbial Natural Products
KEYWORDS - biotransformation, marine-derived actinomycetes and as-
comycetes, 
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CHEMICAL MYCOLOGY OF FRESHWATER 
ASCOMYCETES FROM NORTH CAROLINA, USA 
Huzefa A. Raja1, Tamam El-Elimat1, Carol A. Shearer2, Andrew N. Miller3, 
Kazuaki Tanaka4, Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina, 
Greensboro, 2Department of Plant Biology, University of Illinois, Urbana, 
Illinois 61801, USA, 3Illinois Natural History Survey, University of Illinois, 
Champaign, Illinois 61820, USA, 4Faculty of Agriculture and Life Sciences, 
Hirosaki University, Aomori 036-8561, Japan
During our ongoing chemical mycological investigations of freshwater 
fungi in North Carolina, USA, we found two Dothideomycetes taxa from 
freshwater habitats in the Piedmont region that shared morphological si-
milarities with species of Minutisphaera. These new collections prompted a 
chemical study of the secondary metabolites produced by this genus as well 
as a molecular phylogenetic study of relationships of taxa within Minutis-
phaera. Based on maximum likelihood and Bayesian analyses of molecular 
data, as well as examination of morphology, we describe and illustrate two 
new species of Minutisphaera. Chemical analysis of the organic extract M. 
aspera sp. nov. resulted in the isolation and characterization of five known 
secondary metabolites, of which four were dipeptides (1-4) and one was an 
aromatic polyketide (5). On the other hand, two aromatic polyketides (5 
and 6) were isolated and identified from the organic extract of M. parafim-
briatispora sp. nov. The isolated compounds were tested for their antimi-
crobial activity against an array of bacteria and fungi. Compound 6 showed 
promising activity against Staphylococcus aureus and Mycobacterium smeg-
matis with MIC values of 30 and 60 µg/mL, respectively. The Minutisphae-
ra clade did not share phylogenetic affinities with any existing taxonomic 
group within the Dothideomycetes. We therefore establish a new order, Mi-
nutisphaerales, and new family, Minutisphaeraceae, for this monophyletic 
clade of freshwater ascomycetes. 
1061
REVERSED-PHASE HPLC ANALYSIS STUDIES OF THE 
SWEET DITERPENE GLYCOSIDES ISOLATED FROM 
STEVIA REBAUDIANA BERTONI
Venkata Sai Prakash Chaturvedula and Srinivasarao Meneni 
Natural Products Research Group, Wisdom Natural Brands, 1203 West San 
Pedro Street, Gilbert, AZ 85233, USA.
High Performance Liquid Chromatography (HPLC) studies were per-
formed on the nine sweet steviol glycosides reported in Joint Expert Com-
mittee on Food Additives (JECFA) namely rebaudioside A, steviolbioside, 
stevioside, rubusoside, rebaudioside B, rebaudioside C, rebaudioside D, 
rebaudioside F, and dulcoside A isolated from the leaves of Stevia rebaudi-
ana. Using Reversed-Phase (RP) HPLC method, individual retention times 
and area for nine naturally occurring ent-kaurane diterpene glycosides of 
S. rebaudiana have been determined at various temperatures from 20˚C to 
79˚C. HPLC results suggested that temperatures between 40˚C and 60˚C 
would be ideal conditions for better separation of steviol glycosides. Addi-
tional HPLC studies at five different temperatures 40˚C, 45˚C, 50˚C, 55˚C, 
and 60˚C under three different pH 2.4, 2.6, and 2.8 were performed and 
results suggested that temperatures 50˚C and 55˚C at pH 2.4 would be ideal 
condition for better separation of steviol glycosides.
1062
POST-TRANSLATIONAL ISOPRENYLATION OF 
TRYPTOPHAN
Masahiro Okada, Ikuro Abe
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan
A number of patterns of post-translational modification have been identi-
fied at various amino acid residues. One of them is isoprenylation, which 
generally refers to that of cysteine in eukaryotes. We first identified post-
translational isoprenylation in prokaryotes. ComX pheromone from Ba-
cillus subtilis had a post-translationally modified tryptophan residue with 
an isoprenoidal group, and ComX pheromone was biosynthesized by mo-
difying enzyme, ComQ, with either a geranyl pyrophosphate or a farnesyl 
diphosphate and precursor peptide, ComX.
Here, we report novel tryptophan farnesyltransferase from desulfitobac-
teria, which belongs to the class Clostridia. After homologues of ComQ 
and ComX were found in desulfitobacteria, the modifying enzyme candi-
date was overexpressed in Escherichia coli and the substrate candidate was 
chemically synthesized by solid-phase peptide synthesis. Using them, in 
vitro farnesylation was carried out in the presence of farnesyl diphosphate 
and magnesium ion. Consequently, it was confirmed that the tryptophan 
residue in the peptide was farnesylated by using LC-MS/MS. It was the first 
report of post-translational isoprenylation of tryptophan in out of bacilli.
1063
OLD TERPENES AS NEW ANTICANCER LEADS
Khaled Orabi1, Mohamed Abaza2, and Susan Kurien2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy and 
2Department of Biological Sciences, Faculty of Science, Kuwait University, 
Kuwait.
Plants were in the past and still are serving as a good source for providing 
lots of bioactive compounds including cytotoxic phytochemicals. Doxoru-
bicin, vinca alkaloids and paclitaxel are just few examples.
Three terpenes, saudinolide (1), plectranthone (2) and psiadin (3), were 
isolated from the dried aerial parts of Cluytia richardiana L., Plectranthus 
cylindraceus Hochst. ex Benth, and Psiadia arabica Jaub. et Spach, respec-
tively. The isolated pure compounds were evaluated for their potential anti-
proliferative activities. Plectranthone (2) and psiadin (3) exhibited marked 
growth inhibition on colorectal and hepatocellular cancer cell lines in time- 
and dose-dependent manner with minimal cytotoxicity against normal hu-
man breast cells. The anticancer effects of psiadin on both colorectal and 
hepatocellular cancer cells were higher than that produced by saudinolide 
and plectranthone. Comparison with standard antineoplastic drugs indica-
ted that the effects of 2 and 3 were comparable or even better than the tested 
cytotoxic drugs including 5FU, doxorubicin, camptothecin and ellipticine.
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SYNTHESIS OF MARINE NATURAL PRODUCTS THAT 
CONTAIN A CIS-ENAMIDE FRAGMENT.
Hugo K. H. Fong, David Barker and Brent R. Copp
School of Chemical Science, University of Auckland, 23 Symonds St, 
Auckland, New Zealand
Indolic enamides are a rare class of marine natural products that have de-
monstrated a broad range of biological activities, including cytotoxicity 
and antibacterial activities. Examples of this class of compounds include 
coscinamides A-C, isolated from the marine sponge Coscinoderma sp., and 
chondriamides A-C, isolated from the red alga Chondria sp. and Chondria 
atropurpurea. While a number of synthetic routes targeting the trans-enam-
ide moiety have been reported, little is known regarding the stereoselective 
synthesis of the indolic cis-enamide fragment. We have made use of a re-
cently reported alkyne hydroamidation methodology to develop a general 
strategy for the synthesis of cis-enamide containing natural products. This 
strategy, its strengths and weaknesses, as well as approaches to the synthesis 
of specific natural products will be presented. 
  
Coscinamide A R1=Br, R2=H  Chondriamide A R=H          Chondriamide C  
 Coscinamide B R1=R2=H  Chondriamide B R=OH    
 Coscinamide C R1=Br, R2=OH 
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SYNTHESIS AND CHEMICAL REACTIVITY OF α,β-
UNSATURATED CARBONYL FRAGMENTS RELATED TO 
THE MARINE NATURAL PRODUCT ONCHIDAL.
Melissa M. Cadelis, David Barker and Brent R.
Copp. School of Chemical Sciences, University of Auckland, Auckland, New 
Zealand. 
Resurgence of drugs that covalently modify their target has led to an ex-
pansion in this therapeutic class with 39 covalent drugs currently approved 
as treatments for a wide range of clinical applications. Many of these drugs 
contain electrophilic fragments (Michael acceptors) that are common 
among several natural products including curcumin, herbimycin A, butein, 
kaempferol and zampanolide. We have previously examined the electro-
philic properties of the dienone-containing alkaloids the discorabdins and 
the ketofuran containing halenaquinone. As part of our ongoing studies in 
this area, we recently initiated model studies on the covalent reactivity of 
the marine natural product onchidal. The reactivity of α,β-unsaturated al-
dehydes and masked 1,4-dialdehydes were examined utilising model thiol- 
and amine- based nucleophiles such as 1-pentanethiol and 1-pentylamine. 
To model potential reactions with cellular protein targets, the reactivity of 
these compounds towards lysozyme were studied. The synthetic strategy 
taken towards model compounds and biological studies undertaken on 
these compounds will be presented.
1066
THE SYNTHESIS OF DEHYDRODOPAMINE 
CONTAINING MARINE NATURAL PRODUCTS
Michael A. Pullar and Brent R.
Copp. School of Chemical Sciences, University of Auckland, NZ
The tunichromes are a family of modified peptide compounds, isolated 
from the blood cells of various ascidian species, all of which contain a de-
hydrodopamine moiety within their structure. The biological role of tuni-
chromes is uncertain, with vanadium uptake and protein crosslinking both 
being proposed. The low natural availability of these compounds, along 
with their instability, has meant a lack of biological analysis has been per-
formed. By using a copper catalysed coupling of a styryl iodide with an ami-
de, an enamide linkage can be formed to access these dehydrodopamine 
fragments. The mild reaction conditions have allowed for the synthesis of 
a library of dehydrodopamine enamides based upon the tunichromes, the 
synthesis and biological properties of which will be presented.
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NEOLIGNANS AND OTHER METABOLITES FROM 
OCOTEA CYMOSA FROM THE MAGADASCAR RAIN 
FOREST AND THEIR BIOLOGICAL ACTIVITIES 
Fotso S.,‡ Xiong Q.,‡ Graupner P. R.,‡ Rakotondraibe H. L.,†, Olson M.,‡ 
Wiley J. D.,§ Krai P.,§ Brodie P. J.,†. Callmander M. W., ┴Rakotobe E.,|| 
Ratovoson F., ┴Rasamison V. E,|| Cassera M. B.,§ Hahn D. R.,‡ and Kingston 
D. G. I. † 
†Department of Chemistry and Virginia Tech Center for Drug Discovery, 
‡Discovery Research, Dow AgroSciences, Zionsville Road, Indianapolis, 
§Department of Biochemistry and Virginia Tech Center for Drug Discovery, 
┴Missouri Botanical Garden, Madagascar, ||Centre National d’Application 
des Recherches Pharmaceutiques, Madagascar
In the course of investigations on plant derived extracts from Madagascar 
rain forest against agricultural relevant plants pathogens. The bio-guided 
isolation on Ocotea cymosa (Lauraceae) yielded ten new neolignans along 
with seven known compounds. Three compounds exhibited inhibitory ac-
tivity against Aedes aegypti, while ococymosin, ocobullenone derivative the 
known ocobullenone and virolongin B showed antiplasmodial activity. This 
poster highlights the isolation, structure elucidation and biological activi-
ties of these compounds.
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A NEW ANTI-VIRULENCE STRATEGY AGAINST 
PATHOGENIC BACTERIA: TARGETING SPREADING 
FACTORS
Emily R. Britton1, Carolyn B. Ibberson2, Martha Leyte-Lugo1, R. Owen 
Bussey III1, Huzefa A. Raja1, Nicholas H. Oberlies1, Alexander R. Horswill2, 
Nadja B. Cech1
1Department of Chemistry and Biochemistry, University of North Carolina 
Greensboro, Greensboro, NC 27412, USA, 2Department of Microbiology, 
University of Iowa, Iowa City, IA 52242, USA
The widespread use of antibiotics against bacterial pathogens has caused a 
surge in the emergence of drug resistant strains. Treating infections caused 
by drug resistant bacteria costs on average twice as much compared to their 
drug-susceptible counterparts, and is a burden on the economy and the 
healthcare system. A promising strategy is the anti-virulence approach, 
which targets bacterial pathogenicity, thereby facilitating clearance of the 
infection without pressuring the pathogen to become resistant. Here, we 
propose to target the enzyme hyaluronidase as an anti-virulence approach 
against bacterial pathogens such as Staphylococcus aureus and Streptococcus 
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agalactiae. Hyaluronidase is an enzyme responsible for degrading hyaluro-
nan in the body and contributes to bacterial growth and penetration. We 
have designed a mass spectrometry-based assay that can directly assess the 
anti-hyaluronidase activity of extracts and pure compounds. Additionally, 
we have identified several endophytic fungal species isolated from the roots 
of Anemopsis californica, a botanical used to treat skin infections, which 
produce compounds that inhibit hyaluronidase. This presentation will in-
clude the results of bioassay-guided fractionation experiments aimed at 
identifying hyaluronidase inhibitors from A. californica endophytes using 
the new assay. 
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NOVEL ANTICANCER AGENT, SQAP, BINDS TO FOCAL 
ADHESION KINASE AND MODULATE ITS ACTIVITY
Jesús Izaguirre-Carbonell, Hirofumi Kawakubo, Hiroshi Murata, Keisuke 
Ohta, Tomoe Kusayanagi, Senko Tsukuda, Takeshi Hirakawa, Kazuki 
Iwabata, Yoshihiro Kanai, Sachihiro Matsunaga, Shinji Kamisuki, Kengo 
Sakaguchi and Fumio Sugawara
Department of Applied Biological Science, Faculty of Science and 
Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-
8510, Japan.
Sulfoquynovosyl acylpropanediol (SQAP) is a novel and promising anti-
cancer agent that was obtained by structural modifications from a natural 
compound. SQAP has the ability to trigger antiangiogenesis in vivo with 
very few side effects. In this study, the mechanism by which SQAP modi-
fies the tumor microenvironment was revealed through the application of a 
T7 phage display screening. We could identify five SQAP-binding proteins 
including among them the FAT domain of focal adhesion kinase (FAK). 
Two independent experiments were used to verify the interactions. SQAP 
decreased FAK phosphorylation and cell migration in human umbilical 
vein endothelial cells and A549 cancer cells. The obtained data suggest that 
SQAP antiangiogenic activity may be due the modulation of FAK phos-
phorylation. Additionally, we hypothesized that SQAP radiosensitizing ac-
tivity might be at least partly due to ROS generation. Indeed, we observed 
that SQAP romotes ROS formation on HeLa cancer cells.
1070
BIOCONVERSION OF CURCUMIN AND ITS ANALOGS
Glenroy D. A. Martin, Cameron McKenzie and Monica Moore
Chemistry, Biochemistry and Physics Department, The University of Tampa, 
401 West Kennedy Blvd., Tampa, FL 33606 
Reduction of curcumin (1), a chemopreventive agent from Turmeric (Cur-
cuma longa L.), yielded five products. The three major compounds were 
identified as 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione (2), 
5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)heptan-3-one (3), and 
1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-diol (4). Incubation of 
compound (2) with Beauveria bassiana ATCC 7159 afforded the com-
pound (3) as the sole metabolite. Bioconversion of curcumin (1) with Rhi-
zopus oryzae ATCC 11145 yielded 1,7-bis(4-hydroxy-3-methoxyphenyl)
hept-1-en-3,5-dione (5) and metabolites 3 and 4. Metabolite 2 was not 
produced. No transformation of curcumin (1) was observed with Aspergil-
lus niger ATCC 16888. The bioactivities and structural elucidation of these 
metabolites are reported herein.
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PHARMACOPEIAL METHODS FOR POTENTIAL 
CONFOUNDING HERBAL MEDICINES 
Cuiying Ma, Nam-Cheol Kim, Gabriel I. Giancaspro
Department of Foods, Dietary Supplements, and Herbal Medicines, U.S. 
Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville MD, 
20852
In order to promote the quality of herbal medicines, USP launched Herbal 
Medicine Compendium (HMC) in May 2013. The monographs in HMC 
include selective analytical procedures to reduce the possibility of adultera-
tion by substitutes with potential confounders, mainly based on chromato-
graphic techniques, such as, HPLC, UPLC, HPTLC. We present examples 
in this work based on the monographs developed for Lonicera japonica 
Flower, Schisandra chinensis Fruit, Polygonum multiflorum Root, Antrodia 
camphorata Fruiting Body and Terminalia chebula Fruit. Orthogonality 
between HPLC and HPTLC procedures provide greater assurances in this 
matter. The HPLC and HPTLC identification sections of the monograph 
efficiently distinguish the potential confounding materials for each plant. 
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WITHANOLIDES FROM PHYSALIS COZTOMATL
Huaping Zhang1, Cong-Mei Cao1, Robert J. Gallagher1, Victor W. Day2, Kelly 
Kindscher3, and Barbara N. Timmermann1,*
1Department of Medicinal Chemistry, School of Pharmacy,2The Small-
Molecule X-ray Crystallography Laboratory, 3Kansas Biological Survey, 
University of Kansas, Lawrence, KS 66047
Six new withanolides (1-6), as well as the known physachenolide D (7) and 
withanoside VI (8), were isolated from the aerial parts of Physalis coztomatl 
(Mociño & Sessé) Ex Dunal (Solanaceae). Structural elucidations of 1-6 
were achieved through spectroscopic techniques including 2D NMR, while 
the structure of 1 was confirmed by X-ray crystallography. 13C NMR anal-
ysis revealed that coagulansin A in the literature contains a 17α-hydroxy 
rather than the reported 17β-hydroxy functionality.
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A NOVEL ISOFLAVONE FROM LEIOPHYLLUM 
BUXIFOLIUM (ERICACEAE) AND ITS 
ANTIPROLIFERATIVE EFFECT
Dan Tian1, John R. Porter1
1Program in Pharmacognosy, Department of Chemistry & Biochemistry, 
University of the Sciences, Philadelphia, PA 19104 USA
A new C-methyl-isoflavone, isosideroxylin 1, and a known C-methyl-fla-
vone, sideroxylin 2, were isolated from the EtOAc extract of the leaves of 
Leiophyllum buxifolium. HR-ASAP-MS and 1D and 2D NMR spectrosco-
pic data were used to determine the structure of 1. The two compounds 
were evaluated for their antiproliferative effects against ER-MDA-MB-231 
and ER+MCF-7 breast cancer cell lines and the NIH3T3 mouse fibroblast 
cell line with the sulforhodamine B assay. Compound 2 showed moderate 
antiproliferative activity on both cancer cell lines, while compound 1 dis-
played selective antiproliferative effect against MDA-MB-231 cells only, 
which supports the hypothesis of phytoestrogenic activity of 1. Neither 
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compound was inhibitory to the NIH3T3 mouse fibroblasts at the concen-
trations examined. Since 1 and 2 share the A ring substitution pattern, we 
concluded the 5-hydroxy-7-methoxy-6,8-dimethyl substitution pattern on 
the A ring is responsible for the antiproliferative activity. The presence of a 
C-methyl-isoflavone in the Ericaceae supports the presence of a isoflavone 
synthesis pathway in this family.
1 2
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HIT-TO-LEAD OPTIMIZATION OF SIPHOLANES 
FOR THE CONTROL OF INVASIVE BREAST CANCER 
THROUGH SUPPRESSION OF BRK AND FAK SIGNALING
Ahmed I. Foudah1, Mohamed R. Akl2, Asmaa A. Sallam2, and Khalid A. El 
Sayed2
1Department of Pharmacognosy, College of pharmacy, Sattam bin Abdulaziz 
University, Al-Kharj, KSA, 2College of Health and Pharmaceutical Sciences, 
The University of Louisiana at Monroe, Monroe, LA 71209
Sipholane triterpenes are natural products isolated from the Red Sea sponge 
Callyspongia siphonella. Semisynthetic modifications afforded sipholenol A 
4β-O-3`,4`-dichlorobenzoate (SPA) as a potent breast cancer migration in-
hibitor, with an IC50 of 1.3 µM in the wound-healing assay, without cytotox-
icity to the non-tumorigenic breast cells MCF10A. The effects of SPA on the 
growth, migration, and invasion of diverse human breast cancer cells were 
studied. Results showed that SPA inhibited the growth of the human breast 
cancer cells MDA-MB-231, MCF-7, BT-474, and T-47D in a dose-depen-
dent manner. SPA suppressed breast cancer cell migration, invasion, and 
decreased Brk and FAK activation in a dose-dependent manner. Molec-
ular docking study suggested a perfect fitting at the FAK’s FERM domain, 
inhibiting the main autophosphorylation site Y397, which was further 
confirmed by Western blot analysis. In vivo studies showed that SPA treat-
ment suppressed breast tumor growth, CD31, p-Brk and p-FAK expres-
sion in orthotopic breast cancer in nude mice. Pharmacophore modeling 
and 3D-QSAR studies highlighted the important pharmacophoric features 
responsible for the antimigratory activity and Brk phosphorylation inhibi-
tion, including rings A and B (perhydrobenzoxepine) together with substi-
tuted aromatic ester moiety, creating a simpler structure and eliminating 
rings C and D ([5,3,0]bicyclodecane system). This opens new horizons for 
future design of novel sipholane-inspired active leads with perhydroben-
zoxepine-aromatic cores, feasibly and cost-effectively.
1075
NEW TECHNIQUES IN EXTRACT COLUMN SCREENING II
Jack E. Silver
Teledyne ISCO, 4700 Superior Street, Lincoln, NE 68504
Column screening is an integral first step in purifying natural products. 
Efficient column screening allows facile and rapid purification of active 
components for further purification. The utilization of automated flash 
chromatography offers opportunities to streamline the column screenings 
of extracts. Combining pre-packed columns of a variety of chemistries 
with wide-polarity range chromatography is the first step in streamlining 
the process. Useful column chemistries include silica, ion-exchange, alu-
mina, C18, and diol. Coincident to streamlining column screening is the 
incorporation of simultaneous detection techniques such as UV-Vis, mass 
spectrometry, and ELSD. Utilizing this enhanced automated procedure not 
only allows rapid purification and early correlation with previously disco-
vered compounds, but also enables the researcher to focus on potentially 
novel active targets. The purification of extracts from the leaves of Camellia 
sinensis using ion exchange columns establishes a model protocol for other 
extracts. The screening of other column types was discussed previously.1 
Using this same example the advantages of simultaneous multiple detection 
techniques will be illustrated, as well as purification with a combined Flash/
Preparative HPLC system.
___________________________________
1Silver, J.E.; Bailey, C. New Techniques in Extract Column Screening. Pre-
sented at the American Society of Pharmacognosy meeting, August 2014; 
poster PM3
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FURTHER (9βH)-PIMARANES AND DERIVATIVES FROM 
ICACINA TRICHANTHA
Ming Zhao,1 Michael M. Onakpa,1,2 Wei-Lun Chen,1 Bernard D. 
Santarsiero,1 Steven M. Swanson,1,3 Joanna E. Burdette,1 and Chun-Tao Che.
1Department of Medicinal Chemistry and Pharmacognosy, and WHO 
Collaborating Center for Traditional Medicine, College of Pharmacy, 
University of Illinois at Chicago, Chicago, IL 60612, USA, 2Department of 
Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, 
University of Abuja, Abuja, Nigeria, 3School of Pharmacy, University of 
Wisconsin-Madison, Madison, WI 53705, USA
Further to our previous reports on 
the isolation of (9βH)-pimaranes, 
(9βH)-17-norpimaranes, and 
17-norpimaranes from the tubers 
of the African medicinal plant 
Icacina trichantha,1-2 eight addi-
tional diterpenoids (1-8) were 
identified. Noteworthily, 8 is a 17,19-dinorpimarane. We propose diter-
penoids in Icacina plants are biosynthesized from (9βH)-pimarane rath-
er than pimarane. All isolates were evaluated for cytotoxic activity against 
MDA-MB-435, MDA-MB-231, and OVCAR3 cell lines, with humirianthe-
nolide C being most active (IC50 of 0.7 μM).
1Chemistry & Biodiversity (2014), 11(12), 1914-1922.
2Journal of Natural Products (2015), DOI: 10.1021/np5010328
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METHOD DEVELOPMENT FOR ACCESSING NOVEL 
MYXOBACTERIAL CHEMOTYPES: ANALYSIS OF 
SEPARATE CULTURE CONDITIONS IN THE PURSUIT OF 
OPTIMIZING SECONDARY METABOLITE PRODUCTION
Laurence Niadj1,2, Alec Thompson1,2, Jarrod B. King1,2, Jianlan You1,2, Carter 
A. Mitchell1,2, Bradley S. Stevenson*,3, Robert H. Cichewicz*,1,2
1Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, University of Oklahoma, Norman, 
OK, 73019. 2Department of Chemistry and Biochemistry, University of 
Oklahoma, Norman, OK, 73019. 3Department of Microbiology and Plant 
Biology, University of Oklahoma, Norman, OK, 73019.
Myxobacteria are among the most metabolically talented Gram-negative 
δ-proteobacteria capable of producing a diverse array of secondary me-
tabolites. Nearly 40% of myxobacteria-derived metabolites possess novel 
chemical structures. They are among the more intensively studied bacte-
ria because of their unique “wolfpack” predatory lifestyle and cooperative 
cellular morphogenesis. From a chemical standpoint, the natural products 
secreted during their micropredatory activities represent an exciting op-
portunity to explore novel chemical mechanisms used by the myxobacteria 
to subdue microbial prey. However, pursuing these chemical-ecology-driv-
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en studies present one major challenge in that their secondary metabolite 
production often result in low yields. This project aims to overcome these 
issues by exploring new culture conditions in hopes to optimize secondary 
metabolite production.
1078
METABOLITE AND TRANSCRIPTOME ANALYSIS 
OF AN AUSTRALIAN EREMOHILA PLANT AND ITS 
CORRELATION TO ANTIBACTERIAL EFFECTS
Octavia N. Kracht1, Fabrice Berrué2, Ann-Christin Müller1, Joshua Kelly3, 
Markus Piotrowski1, Russell Kerr2, Daniel Wibberg4, Bradley Haltli2, Martin 
Lanteigne2, Jörn Kalinowski4, Thomas Brück5, Robert Kourist1
1Department of Biology and Biotechnology, Ruhr-University Bochum, 
Bochum, Germany, 2 Department of Chemistry and Biomedical Science, 
University of Prince Edward Island, Charlottetown, PEI, Canada, 3Nautilus 
Biosciences Canada, Charlottetown, PEI, Canada, 4Center for Biotechnology, 
University of Bielefeld, Bielefeld, Germany, 5 Department of Chemistry, 
Technical University Munich, Munich, Germany.
The Australian plant Eremophila belongs to the Myoporaceae tribe and in-
cludes over 200 different species. Some Eremophila species have been used 
in the Aboriginal medicine to alleviate symptoms like skin lesions and sore 
throat [1]. Various studies showed antibacterial effects of different Eremo-
phila species against a wide range of Gram positive bacteria. Interestingly, 
we also observed an antibacterial effect of semipurified Eremophila serru-
lata fractions against the Gram negative bacterium Proteus vulgaris. This 
study deals with the elucidation of terpene biosynthetic pathways in Ere-
mophila serrulata. Different terpene transcripts were identified by applying 
different bioinformatic approaches in a normalized transcriptome data set 
sequenced on the Illumina MiSeq system. The poster presents different ter-
penes identified from this plant and describes the results from sequence 
analysis of the transcriptome for metabolic reconstruction and of the ex-
pression and characterization of biosynthetic enzymes. 
[1] Ndi et al. (2007). Phytochemistry, 68. 
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CHEMICAL INVESTIGATION OF WINTER FIREFLIES 
(ELLYCHNIA CORRUSCA) REVEALS LUCIBUFAGINS
Connor F. Mosey1, Maha Gaber1, Zenab B. Ahmed1, Riley G. Risteen2, Scott 
R. Smedley2, Stephen T. Deyrup1
1Department of Chemistry and Biochemistry, Siena College, Loudonville, NY 
12211, USA, 2Department of Biology, Trinity College, Hartford, CT 06106, 
USA.
The behavior and coloration of the winter firefly, Ellychnia corrusca, are in-
dicative of the presence of chemical defenses. Also, E. corrusca is proposed 
to be phylogenetically related to other species of firefly that are known to 
exhibit chemical defenses. However, the identity of the defensive chemi-
stry of E. corrusca is unknown. Through extraction and partial purification, 
four compounds were identified by one-dimensional and two-dimensional 
NMR techniques, including COSY, HMBC and HSQC. The structures of 
these compounds were determined to be steroidal pyrones in the lucibufa-
gin family. Presence of this class of molecules in E. corrusca confirms that 
it has chemical defenses against predators and supports a recent molecular 
phylogenetic tree. 
1080
ANTI-INFLAMMATORY AND ANTIOXIDANT 
PROPERTIES OF ISOLATED COMPOUNDS FROM 
GARCINIA BRASILIENSIS 
Maria Luiza Zeraik1, Phanuel S. Arwa1, Valdecir F. Ximenes2, Dulce H. S. 
Silva1, Vanderlan S. Bolzani1
1NuBBE, Department of Organic Chemistry, Institute of Chemistry, São 
Paulo State University (UNESP), 14800-900, Araraquara, São Paulo, Brazil. 
2Department of Chemistry, Faculty of Sciences, São Paulo State University 
(UNESP), 17033-360, Bauru, São Paulo, Brazil.
Garcinia brasiliensis, a plant native to the Brazilian Amazon Rainforest, is 
used in traditional medicine to treat inflammation of the urinary tract, pep-
tic ulcers, arthritis and others. The purposes of this study were to analyze 
the chemical constituents of branches and leaves from G. brasiliensis and to 
evaluate the potential of isolated compounds to act as inhibitors of both the 
oxidative burst of stimulated neutrophils and oxidative damage in human 
erythrocyte membranes. The biflavonoids procianidine, fukugetine, amen-
toflavone and podocarpus flavone isolated from G. brasiliensis had potent 
inhibitory effect on the oxidative burst of neutrophils, reaching 50% inhi-
bition at 1 μmol L-1 on total reactive oxygen species (ROS) production and 
NADPH enzyme. These biflavonoids were also potent inhibitors of hemo-
lysis and lipid peroxidation of human erythrocytes, reaching the malondi-
aldehyde level (a biomarker of oxidative stress) of 8.5 ± 0.3 nmol/mg Hb at 
50 µmol L-1 for procianidine. These findings indicate that these biflavonoids 
modulate the oxidative stress, suggesting the use of G. brasiliensis extract 
as antioxidants and anti-inflammatory agents. Acknowledgements: FAPESP 
(grants #2010/52327-5, #2011/03017-6 and #2013/07600-3), CNPq and 
CAPES.
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TRIGGERING EPIPOLYTHIODIOXOPIPERAZINE 
ALKALOID BIOSYNTHESIS IN FUNGAL ENDOPHYTES 
OF GOLDENSEAL (HYDRASTIS CANADENSIS)
Diana Kao1, Huzefa A. Raja1, Noemi D. Paguigan1, Nadja B. Cech1, 
Nicholas H. Oberlies1. 
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC 27402,
Epipolythiodioxopiperazine (ETP) alkaloids are secondary metabolites that 
are biosynthesized in fungi and have been reported to have notable cyto-
toxic and antibacterial activities. ETPs are isolated from a wide variety of 
fungi, and their biosynthesis does not seem to be linked to certain genera. 
Preliminary LC-HRESIMS dereplication suggested the presence of ETPs 
in extracts of two fungal endophytes from goldenseal (Hydrastis canaden-
sis). However, these secondary metabolites were not encountered when re-
grown, which is a common challenge with fungal endophytes. Therefore, 
an evaluation of growth conditions to reactivate and maintain the ETP 
biosynthetic pathway was conducted by adopting the “One Strain-Many 
Compounds” (OSMAC) approach to culture-based methods. Both endo-
phytes were plated on solid media that varied in nutritional value and in the 
presence of autoclaved goldenseal and fungal material to trigger the target-
ed pathway. When these cultures reached full growth on Petri plates, they 
were subjected to extraction. Then dereplication and mass defect filtering 
was carried out to identify the presence of potential verticillin analogues 
under distinct conditions. 
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CONSTITUENTS FROM LITSEA JAPONICA LEAVES AND 
THEIR INHIBITORY EFFECTS ON AGES FORMATION 
AND ALDOSE REDUCTASE
Yu Jin Kim,1 Ik-Soo Lee,1 Yun Mi Lee,1 Joo-Hwan Kim,2 and Jin Sook Kim1
1KM Convergence Research Division, Korea Institute of Oriental Medicine, 
Daejeon 305-811, Korea, 2Department of Life Science, Gachon University, 
Seongnam, Gyeonggi-do 461-701, Korea
In our continuing efforts to identify effective naturally sourced agents for 
diabetic complications, two new (1 and 2) and 15 known compounds (3–
17) were isolated from the 80% EtOH extract of Litsea japonica leaves. The 
structures of the new compounds were established by spectroscopic and 
chemical studies. These isolates (1–17) were subjected to an in vitro bio-
assay evaluating their inhibitory activity on advanced glycation end-prod-
uct (AGE) formation and rat lens aldose reductase (RLAR) activity. Of 
the tested compounds, flavonoids (4, 6–8, 11, and 12) markedly inhibited 
AGE formation with IC50 values of 7.42–72.05 µM, compared with that of 
a positive control, aminoguanidine (IC50 = 975.9 µM). In the RLAR assay, 
consistent with the inhibition of AGE formation, flavonoids (4, 6–8, 11, and 
12) exhibited considerable inhibition of RLAR with IC50 values of 1.10–12.5 
µM. 
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LOCALIZATION OF KABIRAMIDES IN THE SPONGE 
PACHASTRISSA NUX AND SPONGE SURFACE-
ATTACHED BACTERIA
Oyenike O. Olatunji and Anuchit Plubrukarn
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of 
Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 
90112, Thailand.
The sponge Pachastrissa nux has been reported to be a rich source of cy-
totoxic macrolides. In our previous study, we found that the P. nux sponge 
has the ability to develop the capitum part, a gorgonian-like structure that 
sprouts from the substratum-attached base, and accumulate the macrolides 
predominantly in the protruding capitum. Using kabiramides B, C, and G 
as markers, here we demonstrate the impact of kabiramides allocation on 
the sponge surface-attached bacteria. The population density of bacteria 
that attach to the surface of the capitum part and also on the appendage 
extending from the core base part was significantly less than that on the 
surface of the base itself. Selected bacteria were identified, but no unusual 
bacterial species that may be specific to the sponge were detected. Although 
too premature to conclude whether the sponge intentionally produces such 
toxic metabolites as chemical defense against the microbial foulers, or oth-
erwise the settling microbes affect the chemical allocation, the correlation 
between the macrolide accumulation and the attachment of bacteria on the 
sponge’s surface clearly shows how the sponge has adapted to fit in its spe-
cific environment and how it interacts with the microbial cohabitants. 
1084
TWO NEW LACTAMS FROM THE HULLED SEEDS OF 
COIX LACHRYMA-JOBI VAR. MA-YUEN
Ah-Reum Han, Unwoo Kang, Yun-Seo Kil, and Eun-Kyoung Seo*
College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha 
Womans University, Seoul 120-750, Korea
Two new lactams, coixspirolactam F ((2R, 3R) - (+ ) -2-octanoate-spiro[furan- 
3(2H) , 3’- [3H] indole] - 2’, 5(1’H, 4H) - dione; 1) and coixspirolactam G ((2R, 
3R) - (+ ) -6’- hydroxy-2-octanoate-spiro[furan- 3(2H) , 3’- [3H] indole] - 2’, 
5(1’H, 4H) - dione; 2) were isolated from the hulled seeds of Coix lachryma-
jobi L. var. ma-yuen (ROM. CAILL.) STAPF (Gramineae). Their structures 
were elucidated by physical and spectroscopic data analysis, including 1D 
and 2D NMR, ESI-MS, and CD experiments. 
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CONSTITUENTS OF ANGELICA KEISKEI AND THEIR 
HEAT SHOCK PROTEIN INDUCING ACTIVITIES
Yun-Seo Kil, Seul-Ki Choi, Yun-Sil Lee, Eun-Kyoung Seo*
College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha 
Womans University, Seoul 120-750, Korea
Seven new compounds, 4,2’,4’-trihydroxy-3’-[(2E,5E)-7-methoxy-3,7-di-
methyl-2,5-octadienyl]chalcone (1), (±)-4,2’,4’-trihydroxy-3’-[(2E)-6-hy-
droxy-7-methoxy-3,7-dimethyl-2-octenyl]chalcone (2), 4,2’,4’-trihydroxy-
3’-[(2E)-3-methyl-5-(1,3-dioxolan-2-yl)-2-pentenyl]chalcone (3), 2’,3’-fu-
rano-4-hydroxy-4’-methoxychalcone (4), (±)-4-hydroxy-2’,3’-(2,3-di-
hydro-2-methoxyfurano)-4’-methoxychalcone (5), (±)-4,2’,4’-trihy-
droxy-3’-{2- hydroxy- 2- [tetrahydro- 2- methyl- 5- (1- methylethenyl) 
-2-furanyl]ethyl}chalcone (6), and (+)-(2’S,3’S)-2’,3’-dihydro-2’-hydroxy-
isopropyl-3’-methoxyangelicin (15), were isolated from the aerial parts of 
Angelica keiskei Koidzumi (Umbelliferae) together with eight known chal-
cones 7-14, which were identified as 4,2’,4’-trihydroxy-3’-[(6E)-2-hydroxy-
7-methyl-3-methylene-6-octenyl]chalcone, xanthoangelol, xanthoangelol 
F, xanthoangelol G, 4-hydroxyderricin, xanthoangelol D, xanthoangelol 
E, and xanthoangelol H, respectively. The isolates, 1-15 were evaluated for 
their promoter activity on heat shock protein 25 (hsp25, murine form of 
human hsp27). Among them, compounds 1 and 7 activated the hsp25 pro-
moter by 21.9- and 29.2-fold of untreated control at 10 μM, respectively. 
Further protein expression patterns of heat shock factor 1 (HSF1), HSP70, 
and HSP27 by 1 and 7 were examined. Compound 7 increased the expres-
sion of HSF1, HSP70, and HSP27 with 4.3-, 1.5-, and 4.6-fold of untreated 
control, respectively, without any significant cellular cytotoxicities, whereas 
compound 1 did not induce any expressions of these proteins. As a result, 
compound 7 seems to be a prospective HSP inducer.
1086
PROFILING FUNGAL CULTURES IN SITU VIA THE 
DROPLET-LMJ-SSP COUPLED WITH UPLC-PDA-HRMS-
MS/MS
Vincent P. Sica1, Huzefa A. Raja1, Tamam El-Elimat1, Vilmos Kertesz2, Gary 
J. Van Berkel2, Cedric J. Pearce3, and Nicholas H. Oberlies1.
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, P.O. Box 26170, Greensboro, North Carolina 27402, 
USA, 2Organic and Biological Mass Spectrometry Group, Chemical 
Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 
37831, USA, 3Mycosynthetix, Inc., 505 Meadowlands Drive, Suite 103, 
Hillsborough, North Carolina 27278, USA, 
Ambient ionization mass spectrometry techniques have recently become 
very prevalent in natural product research due to their ability to examine 
an organism in situ. Profiling a sample directly on an organism without 
the need for lengthy regrowth and extraction procedures is extremely at-
tractive. However, direct ambient ionization techniques, such as DESI and 
nanoDESI, lose the valuable capability of chromatographic separation, thus 
limiting the ability to differentiate isomers and confirm metabolite iden-
tities. To overcome this limitation, a droplet-liquid microjunction-surface 
sampling probe (droplet-LMJ-SSP) can be coupled with UPLC-PDA-
HRM-MS/MS, thus gaining the separation, retention times, and UV data. 
By capturing these mutually supportive data, the identity of secondary me-
tabolites can be assigned confidently and rapidly. Using the droplet-LMJ-
SSP, a protocol was constructed to dereplicate fungal cultures directly from 
the Petri dish. 
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THE COMBINATION OF DNA BARCODING AND 
METABOLOMICS FOR THE MULTI-CONSTITUENTS 
CHARACTERIZATION OF LICORICE BOTANICALS
Charlotte Simmler,1 Laura Gauthier,1 Jeffrey R. Anderson,2 Shao-Nong 
Chen,1 David C. Lankin,1 James B. McAlpine,1 Guido F. Pauli.1,2
1UIC/NIH Center for Botanical Dietary Supplements Research, Department 
of Medicinal Chemistry and Pharmacognosy, 2Institute for Tuberculosis 
Research, University of Illinois College of Pharmacy, 833 S. Wood Street, 
Chicago, Illinois 
Licorice sold as Botanical Dietary Supplements (BDSs) can be obtained 
from mainly three Glycyrrhiza species: G. glabra, G. uralensis, and G. in-
flata.1 Therefore, BDSs are composed of either single Glycyrrhiza species, 
mixtures of Glycyrrhiza species, or even hybrids. A DNA barcoding me-
thod2 was optimized and applied for the authentication of 51 licorice ac-
quisitions (capsules, bulk powders, sticks). Complementary chemometric 
models were developed with samples containing only single authenticated 
Glycyrrhiza species (37 among 51): PCA/SIMCA were performed on 1H 
NMR spectra, and CDA was carried out using UHPLC-UV data. These 
models enabled the chemical distinction of source Glycyrrhiza species, and 
the metabolomic characterization of licorice mixtures. Together with DNA 
barcoding, both models were utilized for the identification of Glycyrrhiza 
hybrids and species outliers. The study demonstrates that the composition 
in major flavanones and chalcones is specific to each Glycyrrhiza species, 
and can be used for the characterization of licorice sold as BDSs.3 Addi-
tionally, the present work addresses the congruence and complementarity 
between DNA analysis and metabolomics.
Abbreviations: PCA: Principal Component Analysis, CDA: Canonical 
Discriminant Analysis, SIMCA: Soft Independent Modeling of Class Anal-
ogy; 
Ref: (1) WHO monographs 1999, 1:183–194; (2) Kondo, K. et al. Biol. 
Pharm. Bull. 2007, 30:1497-1502; (3) Simmler, C. et al. J. Nat. Prod. 2015 
(submitted)
1088
STELLIOSPHAEROLS A AND B, SESQUITERPENE-
POLYOL CONJUGATES FROM AN ECUADORIAN 
FUNGAL ENDOPHYTE
Giovanni Forcina,1 Amaya Castro,2 Heidi R. Bokesch,2,3 Kaury Kucera,1 
James B. McMahon,2 Kirk R. Gustafson,2 and Scott Strobel3
1Department of Molecular Biophysics and Biochemistry, Yale University, 
New Haven, CT 06520-8114, USA, 2Molecular Targets Laboratory, Center 
for Cancer Research, National Cancer Institute, Frederick, MD 21702, 3Basic 
Science Program, Leidos Biomedical Research, Inc., Frederick National 
Laboratory, Frederick, MD 21702
Endophytic fungi are plant tissue-associated fungi that represent a rich 
resource of unexplored biological and chemical diversity with potential 
applications in the fields of medicine, bioremediation, and agriculture. As 
part of an ongoing effort to explore endophytes from the Amazon forest, 
numerous fungi were isolated and cultured using plants collected from the 
rainforest in Ecuador. From these samples, DNA sequencing and scanning 
electron microscopy (SEM) revealed a previously undescribed fungus in 
the order Pleosporales that was cultured from the tropical tree Duroia 
hirsuta. Extracts of this fungal isolate displayed modest activity against Sta-
phylococcus aureus, and were thus subjected to detailed chemical studies. 
Two compounds with very modest antibacterial activity were isolated and 
their structures were elucidated using a combination of NMR spectroscopic 
analysis, LC-MS studies, and chemical degradation. These efforts led to the 
identification of stelliosphaerol A (1) and B (2), new sesquiterpene-polyol 
conjugates that are responsible, at least in part, for the S. aureus inhibitory 
activity of the fungal extract.
Funded by FNLCR contract HHSN261200800001E
1089
ISOLATION AND STRUCTURE ELUCIDATION OF 
MEROCYCLOPHANE C FROM THE CULTURED 
CYANBACTERIUM NOSTOC SP. (UIC 10110)
Daniel May, Shangwen Luo, Aleksej Krunic, George Chlipala, Wei-Lun 
Chen, Joanna E. Burdette, Steven M. Swanson, and Jimmy Orjala
Department of Medicinal Chemistry and Pharmacognosy, College of 
Pharmacy, University of Illinois at Chicago, Chicago, IL 60612
Cyanobacteria are known to be prolific producers of biologically active nat-
ural products. Initial screening of the extract of UIC 10110, a Nostoc sp. 
based on 16S rRNA phylogenetic analysis, found it to be cytotoxic against 
MDA-MB-435 cells and HT-29 cells in an antiproliferation assay. Derep-
lication by mass spectrometry and NMR indicated the presence of a po-
tentially novel active constituent which was isolated using semipreparative 
C18 HPLC. Accurate mass spectrometry allowed for the determination of 
the molecular formula. This in combination with the proton NMR spec-
trum revealed the active compound to be a [7,7] paracyclophane. The com-
plete structure of Merocyclophane C was determined by a combination of 
1D and 2-D NMR experiments. The absolute stereoconfiguration of Mero-
cyclophane C was determined by CD spectroscopy.
1090
EXPLORING THE SPECTRUM OF ANTIMICROBIAL 
ACTIVITY FROM NATIVE NORTH AMERICAN PRAIRIE 
PLANTS
Kirk P. Manfredi1 and Michael Walter2 
1Department of Chemistry and Biochemistry, University of Northern Iowa, 
Cedar Falls, IA 50614; 2Department of Biology, University of Northern Iowa, 
Cedar Falls, IA 50614
For the past three years this lab has been investigating the use of North 
American prairie plants as sources of natural preservatives and antimicro-
bial compounds for use in personal care products. The experimental ap-
proach was to perform a simple agar-disk assay against a Gram positive 
bacteria from crude plant extracts. Compounds isolated from active frac-
tions were then quantitatively assayed against Gram positive bacteria to de-
termine their EC50 values. Commercial topical antibiotics (trioclosan) and 
preservatives (parabens) EC50 values were determined for the same assay 
and compared to the isolated plant compounds. To be effective antimicro-
bials and preservatives compounds must display an array of antimicrobial 
activity. We have expanded our antimicrobial assay to include organisms 
associated with non-sterile commercial personal care products (E.coli, 
C.albicans, A. niger, P. aeruginosa and S. aureus.). This presentation will 
discuss the spectrum of efficacy of compounds isolated from J. virginiana 
and P. argophylla against the aforementioned microorganisms. 
1091
A UPDATE OF BOTANICAL DRUG DEVELOPMENT IN 
THE UNITED STATES: STATUS OF APPLICATIONS 
Kuei-Meng Wu, Charles Wu, Jinhui Dou, Hanan Ghantous, Sau Lee, 
Lawrence Yu
We conducted a survey of botanical drug applications across the therapeu-
tic divisions within CDER, FDA since 1999. The objective is to evaluate 
the status and trend of botanical IND submissions under the current U.S. 
regulatory environment. The overall number of botanical submissions are 
as follows: 1999: 21(including Pre-IND: 0), 2000: 20(4), 2001: 24(3), 2002: 
21(5), 2003: 40(9), 2004: 33(11), 2005: 44(6), 2006: 33(11), 2007: 46(7), 
2008: 41(14), 2009: 37(10), 2010: 37(10), 2011: 41(8), 2012: 38(5), 2013: 
59(8), 2014: 46(11), 2015: 8 (3). The trend shows a surge in number of 
submissions after the publication of Agency’s Botanical Guidance in 2001, 
followed by steady submissions, ranging between 40-50 annually (except 
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in 2013 that peaked at 59). Among the 602 submissions totaled so far, 79% 
(476) are submitted in original IND and the rest 21% (126) in pre-IND 
format initially. From the therapeutic perspectives, more than 26% of the 
INDs have been focused on the unmet cancer-related therapy areas (161), 
followed by dermatology (71), GI (50), antiviral (43), endocrine/metabo-
lism (37), reproductive & urology (36), neuropharmacology (36), pulmo-
nary/allergy/rheumatology (30), cardiovascular (28), anti-infective (21) 
and ophthalmology (10), etc. In the last 5 years (2009-2014), 20 out of 217 
INDs were placed on clinical holds, indicating ≥90% of the original INDs 
were evaluated as safe to proceed for the initial human trials. This 10% rate 
of clinical holds is significantly less than those in the pre-botanical guidance 
era, during which 34% were placed on clinical hold, suggesting that the reg-
ulatory environment for botanical drug development has been becoming 
more transparent, consistent and harmonious. In summary, based on our 
analysis of the 602 INDs submitted, the Agency has undertaken a proactive 
role in this unique drug category in effectively coaching sponsors for botan-
ical drug development, and as a result, two products, namely kunecatechins 
(Veregen) and crofelemer (Fulyzaq), each achieved and met the human ef-
ficacy/safety standards for a new drug, and were approved for market uses 
in the United States.
1092
1,2-DEHYDROPYRROLIZIDINE ALKALOIDS IN 
THE TRADITIONAL ANDEAN HERBAL MEDICINE 
“ASMACHILCA”
Steven M. Colegate1,2, Michael Boppré3, Julio Monzón3, Joseph M. Betz4
1USDA, ARS, Poisonous Plant Research Laboratory, Logan, UT 84341, USA, 
2Department of Animal, Dairy & Veterinary Sciences, Utah State University, 
Logan, UT 84322, USA, 3Forstzoologie und Entomologie, Albert-Ludwigs-
Universität, D-79085 Freiburg, Germany, 4ODS, NIH, Bethesda, MD 20892, 
USA
Asmachilca is a Peruvian herb preparation ostensibly derived from Ariste-
guietia gayana (Wedd.) R.M. King & H. Rob. (Asteraceae). Decoctions are 
purported to be useful for bronchodilation. Its attractiveness to pyrrolizi-
dine alkaloid-pharmacophagous insects indicated a potential for human 
toxicity. “Asmachilca” materials were purchased in Lima, Peru and from 
internet-suppliers. LC-esi(+)MS and MS/MS screening of plant extracts 
found known and suspected 1,2-dehydropyrrolizidine alkaloids (dehydr-
oPA). Further structure elucidation of isolated alkaloids was based on 1D 
and 2D NMR spectroscopy. Five asmachilca samples contained rinderine 
and supinine and their N-oxides as the major dehydroPA. A 6th lacked su-
pinine or its N-oxide. Small quantities of other dehydroPA monoesters, in-
cluding echinatine and intermedine, were also detected. In addition, two 
previously undescribed major metabolites were isolated and identified as 
dehydroPA monoesters linked to viridifloric and/or trachelanthic acids. 
Total dehydroPA and N-oxide content in the asmachilca ingredients varied 
from 0.4 – 0.9% (w/dw). The mean dehydroPA content of a hot water in-
fusion of an asmachilca tea bag was 1.7 mg. Morphological and chemical 
evidence showed that asmachilca is prepared from several plant species. All 
asmachilca samples and infusions contained 1,2-dehydroPA at levels rele-
vant to human health. Many tasks for future research are obvious, including 
investigations of incidence of chronic disease associated with asmachilca 
use and the botany of asmachilca preparations.
1093
HONEY, BEES, AND A HEPATOTOXIC ALKALOID 
ECHIMIDINE
Jan A. Glinski1, Marta Dudek2, Peter Kinkade1, Vitold B. Glinski1, Sławomir 
Kaźmierski3, Joao Calixto3
1Planta Analytica LLC, 39 Rose St. Danbury, CT 06810, 2Dept. of Physical 
Chemistry, Medical University of Warsaw, 1 Banacha St, Warsaw Poland, 
3Centre of Molecular and Macromolecular Studies, PAN, Sienkiewicza 
112, Łódź, Poland, 4João B. Calixto, CIEnP, Av. Luiz Boiteux Piazza, 1302- 
Cachoeira do Bom Jesus, 88056-000- Florianópolis – S.C., Brazil.
Echimidine is the main pyrrolizidine alkaloid of Echium plantagineum 
L, (Jane’s Salvation, Patersons Curse), endemic to Australia. The plant is a 
great attractant for bees and as a result echimidine finds its way into honey. 
Because of its hepatotoxicity, echimidine became a target of new EU regula-
tion requiring testing of imported honey. Under normal RP HPLC conditi-
ons echimidine produces always a sharp peak. Only recently, we discovered 
that this single peak represents actually a mixture of three alkaloids. Using 
relatively new “core-shell” RP HPLC column (Kinetex EVO C18, Pheno-
menex) in a buffer system we resolved “echimidine” into two well separated 
peaks. An NMR analysis proved that later eluting peak belonged indeed to 
echimidine, while the earlier peak contained two, largely unresolved alkalo-
ids echihumiline (major) and hydroxymyoscorpine (minor). Each of them 
has been isolated before from other plants. All these alkaloids are isome-
ric C20H31NO7 and produce in MS a single MH+, signal at m/e 398, in and 
their NMR spectra are similar, which explains why they have not been de-
tected before. Examination of several of echimidine samples derived from 
different plant collections revealed that the contribution of the early peak 
varied from 13% to 43%. Considering that these alkaloids may contribute 
unequally to the hepatotoxicity, effects of both, purified echimidine and the 
mixture of echihumiline and hydroxymyoscorpine were compared in rat 
hepatocytes.
1094
SCREENING AND IDENTIFICATION OF UNDECLARED 
SYNTHETIC COMPOUNDS AS ADULTERANTS USING 
UPLC-QTOF-MS COUPLED TO A NOVEL INFORMATICS 
PLATFORM 
Dhavalkumar Narendrabhai Patel1, Lirui Qiao2, Jimmy Yuk3, Giorgis Isaac3, 
and Kate Yu3 
1Waters Pacific Private Ltd, Singapore, 2Waters Corporation, Shanghai, 
China, 3Waters Corporation, Milford, MA, USA
The wide spread use and increasing demand for herbal products as eco-
nomical and perceived safe alternatives to prescription drugs has led to 
the increase of such products being adulterated with undeclared synthetic 
compounds by unscrupulous manufacturers. LC–MS based methods are 
widely-used for the characterization of adulterants because of their high 
sensitivity and selectively for samples from complex matrices. However, 
from LC-MS sample acquisition to data processing/analysis, critical steps 
are required in order to effectively determine the answer. In this study, two 
commercial herbal product samples to relieve pain and inflammation were 
obtained from India and Taiwan and were analyzed using UPLC and QTof 
MS coupled to a novel informatics platform. A natural product analytical 
workflow was used to analyze the mass spectra of the herbal products which 
utilize tools such as an adulterant database library containing accurate mass 
fragment ions for confirmation of analytes of interest, structure elucidation 
module and automatic reports to effectively provide the visualization of the 
results. For the commercial sample obtained from India, phenylbutazone 
and oxyphenbutazone were identified as adulterants while, no adulterants 
were found from the sample purchased from Taiwan. Here, we present a 
comprehensive streamlined workflow to quickly screen and identify adul-
terants from a single LC/MS injection using a novel informatics platform. 
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LAESIMS STUDIES OF ECHINACEA PURPUREA, 
RUDBECKIA HIRTA, AND HELIANTHEMUM ANNUS
Tiffany Culver1,2, Allison Mattes1,2, Robert H. Cichewicz*,1,2
1Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, University of Oklahoma, Norman, 
OK, 73019. 2Department of Chemistry and Biochemistry, University of 
Oklahoma, Norman, OK, 73019. 
Laser ablation electrospray ionization mass spectrometry has provided a 
nearly sample-preparation-free imaging technique that is well suited to 
biological tissues. While a number of studies have focused on its applica-
tions to animal tissues, fewer have used LAESIMS with plants. We present 
here an investigation into a plant commonly used as an herbal supplement 
or tea, Echinacea purpurea, and two other plants of the Heliantheae tribe: 
Rudbeckia hirta and Helianthemum annus. Fresh and dried samples were 
subjected to LAESIMS and we present the results here. The LC-MS spectra 
are also presented.
1096
PHYTOTOXIC CONSTITUENTS FROM CURVULARIA 
INTERMEDIA INFECTING PANDANUS AMARYLLIFOLIUS 
Kumudini M. Meepagala, Robert D. Johnson and Stephen O. Duke
USDA-ARS, Natural Products Utilization Research Unit, P.O. Box 8048, 
University, MS 38677 USA. 
As part of an on-going effort in search for agrochemicals from natural 
sources, a fungus from an infeected leaf of Pandanus amaryllifolius show-
ing visible necrosis was isolated and identified as Curvularia intermedia. 
The fungus was cultured in potato dextrose agar (PDA) plates and then 
was grown in potato dextrose broth (PDB) culture medium at 24 0C for 14 
days. The liquid culture broth was extracted with ethyl acetate to afford a 
brownish solid that showed phytotoxicity on monocots and dicots. Silica 
gel biotage column chromatography fractionation followed by crystalliza-
tion afforded two phytotoxic compounds. The structures were determined 
as curvularin and dehydrocurvularin by spectroscopic techniques. Dehy-
drocurvularin inhibited seed germination and caused cellular leakage in 
cucumber cotyledons and the effects were less pronounced by curvularin 
at the same concentrations. Isolation and biological activity of these con-
stituents will discussed. 
1097
HIGH RESOLUTION MASS SPECTROMETRY BASED 
IDENTIFICATION AND QUANTIFICATION OF 
CHEMICAL MARKERS IN A TCM FORMULATION
Angela I. Calderón1, Ahmad J. Almalki1, Ahmed M. Zaher1, Johayra 
Simithy1, William J. Keller2, Matt Tripp2
1Department of Drug Discovery and Development, Harrison School of 
Pharmacy, Auburn University, 4306 Walker Building, Auburn, AL 36849, 
USA, 2Nature’s Sunshine Products, 2500 W. Executive Parkway, Lehi, Utah, 
84043, USA.
YANG XIN® is a traditional Chinese medicine (TCM) formulation used for 
nervous fatigue and consists of a proprietary blend of concentrated extracts 
from eighteen plants. In this study, liquid chromatography coupled with a 
quadruple time-of-flight mass spectrometer (LC-QTOF-MS) was used for 
identification of characteristic chemical markers from the eighteen plants 
present in the YANG XIN® formulation. LC-MS chromatograms of each 
plant were compared, the identities of the unique peaks were confirmed, 
and the structures elucidated by comparing the mass spectra and retention 
times with those of the reference compounds. The selected chemical mark-
ers were ophiopogonanone A, sibiricose A5, poricoic acid A, α-asarone, 
formononetin, ginsenoside Rf, swertisin, racemic mixture of 3-butylide-
nephthalide, schizandrol A, α-amyrin, 4,5-dicaffeoylquinic acid, cistano-
side D, polygonatine A, forsythoside A, neoxanthin, batatasin III, pinusol-
ide and armepavine. LC-QTOF-MS method was validated to quantify the 
chemical markers in the three samples of the formulation by constructing a 
calibration curve for each individual marker. The linear range was investi-
gated up to an analyte concentration of 62.5 µg/ml. The average amount of 
the eighteen chemical markers was found to be within the range of 0.02-933 
ug/g in the TCM formulation samples.
1098
PHENOLIC COMPOUNDS FROM THE LEAVES OF 
HOMONOIA RIPARIA AND THEIR INHIBITORY EFFECTS 
ON AGES FORMATION AND ALDOSE REDUCTASE
Song Yi Yu,1 Ik-Soo Lee,1 Yun Mi Lee,1 Joo-Hwan Kim,2 and Jin Sook Kim1
1KM Convergence Research Division, Korea Institute of Oriental Medicine, 
Daejeon 305-811, Korea, 2Department of Life Science, Gachon University, 
Seongnam, Gyeonggi-do 461-701, Korea
In searching for novel treatments for diabetic complications from natural 
resources, we found that the EtOAc-soluble fraction of the 80% EtOH ex-
tract of the leaves of Homonoia riparia has a considerable inhibitory effects 
on both AGEs (Advanced glycation end products) formation and rat lens 
aldose recuctase (RLAR). Further phytochemical study of this fraction re-
sulted in the isolation of 15 phenolic compounds (1–15). These compounds 
were evaluated in vitro for inhibitory activity against the formation of AGEs 
and RLAR. In the AGEs assay, compounds 3, 5–7, 10, 11, and 14 signif-
icantly inhibit the AGEs formation with IC50 values ranging from 2.23 to 
15.14 μM, compared to that of positive control, aminoguanidine (IC50, 962 
μM). In the RLAR assay, compound 4, quercitrin gallate, showed the most 
potent inhibitory activity with an IC50 value of 0.064 μM. 
1099
AUTHENTICATION IS FUNDAMENTAL FOR THE 
STANDARDIZATION AND GLOBALIZATION OF HERBAL 
MEDICINE
Zhongzhen Zhao1
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 
(China) 
Traditional Chinese medicine (TCM) has earned worldwide recognition 
for its efficacy. As TCM undergoes rapid globalization, the safety of Chine-
se medicinals is drawing international concern. Authentication is a key first 
step for standardizing Chinese medicinals for global markets and research. 
Authentication methods include origin identification, macroscopic iden-
tification, microscopic identification, physical/chemical identification, and 
molecular biological identification. Many issues related to authentication 
have remained unresolved since ancient times. Determining the authenti-
city and quality of Chinese medicinals remains as much a frontier as it is 
an essential science in guaranteeing the safety and efficacy of Chinese me-
dicinals in clinical use. Authentication is directly connected to the clinical 
efficacy of TCM. This can be a matter of life and death in clinical practice 
and will almost certainly influence the fate of Chinese medicinals. 
In the past 15 years, the School of Chinese Medicine (SCM) of Hong Kong 
Baptist University has laid a solid foundation in the field of Chinese medi-
cinal authentication and has made a major impact at home and abroad in 
this capacity. As a center of international trade, Hong Kong is the source of 
many Chinese medicinal materials reaching international markets, and the 
quality of Chinese medicinals in Hong Kong directly reflects the status of 
herbal markets overseas. SCM will continue to make great efforts to pro-
mote Chinese medicinal authentication and the development of medicinal 
resources, which will in turn further strengthen the competiveness and in-
fluence of Chinese medicinals in the international community.
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CYTOTOXIC SESQUITERPENOIDS FROM SIEGESBECKIA 
GLABRESCENS
Na Yeon Kim 1, Qian Wu 1, Hua Li 1, So Yoon Lee 1, Hwa Jin Lee 2 and Jae-
Ha Ryu 1
1Center for Cell Fate Control and College of Pharmacy, Sookmyung Women’s 
University, Seoul 140-742, Korea, 2Department of Natural Medicine 
Resources, Semyung University, Chungbuk 390-711, Korea
Two new sesquiterpenoids, siegenolides A (1) and B (2), and two known 
sesquiterpenes 3 and 4 were isolated from Siegesbeckia glabrescens. Their 
structures were elucidated by spectroscopic analyses, and they were further 
evaluated for their cytotoxic activities against human cancer cells (MCF-7, 
AsPC-1, SW480, HCT 116, HepG2, HeLa). Compounds 1–4 showed dif-
ferential cytotoxic effects on the target cancer cells with IC50 values in the 
range of 0.9–33.3 μM.
1101
DEHYDROCOSTUS LACTONE AND COSTUNOLIDE 
INHIBIT WNT/β-CATENIN PATHWAY IN COLON 
CANCER CELL
Ji Hye Jeong1, Guang-zhi Dong1, Ah-Ram Shim1, Hwa Jin Lee2, Jae-Ha Ryu1
1 Research Center for Cell Fate Control and College of Pharmacy, 
Sookmyung Women’s University, 52 Hyochangwon-Gil, Yongsan-Gu, Seoul 
140-742, Korea, 2 Department of Natural Medicine Resources, Semyung 
University, 65 Semyung-ro, Jecheon, Chungbuk 390-711, Korea
The suppression of abnormally activated β-catenin is one of good strategies 
for chemoprevention and treatment of colorectal cancer. In this study, we 
have isolated two main compounds from root of Saussurea lappa, dehydro-
costus lactone (DCL) and costunolide (CL), and investigated their anti-col-
orectal cancer activities. DCL and CL suppressed cylcin D1 and survivin 
through inhibiting nuclear translocation of β-catenin and galectin-3 that 
is one of coactivators of β-catenin. Furthermore, DCL and CL suppressed 
proliferation and survival of SW-480 colon cancer cells through inducing 
cell cycle arrest and cell death. Taken together, DCL and CL from root of 
Saussurea lappa have anti-colorectal cancer activities through inhibiting 
Wnt/β-catenin pathway. 
   
1102
PHENOLIC COMPOUNDS FROM THE WHITE FLOWERS 
OF IMPATIENS BALSAMINA
Chung Sub Kim1, Sun Yeou Kim2,3, Sang Zin Choi4, Mi Won Son4, Ki Hyun 
Kim1, and Kang Ro Lee1
1Natural Products Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea, 2Gachon Institute of Pharmaceutical 
Science, Gachon University, Incheon, 406-799, Korea, 3College of Pharmacy, 
Gachon University, Incheon 406-799, Korea, 4Dong-A Pharm Institute, 
Kiheung, Yongin 449-905, Korea
Impatiens balsamina L. is an annual herbaceous plant of Balsamineaceae 
family and the flowers of this plant have been used to treat lumbago, neur-
algia, burns and scalds. Previous phytochemical studies have led to reports 
of naphthalene derivatives, triterpene glycosides, and flavonoids asso-
ciated with anti-microbial, antitumor, anti-allergy, antioxidant, antifungal, 
and antinociceptive properties. In the course of our continuing search for 
biologically active compounds from Korean medicinal sources, we inve-
stigated the white flowers of I. balsamina. From their MeOH extract, two 
new phenolic compounds (1-2) containing nitrile group and eleven known 
phenolic compounds (3-13) were isolated. The chemical structures of new 
compounds (1-2) were determined through NMR, HRMS, and CD data. 
We tested the isolated compounds (1-13) for their neuroprotective activity 
by determining their effects on nerve growth factor (NGF) secretion in C6 
cells and anti-neuroinflammatory by measuring nitric oxide (NO) produc-
tion in a lipopolysaccharide (LPS)-stimulated BV-2 cells.
1103
NEW TRITERPENES FROM ABIES HOLOPHYLLA AND 
THEIR BIOLOGICAL ACTIVITES
Won Se Suh, Chung Sub Kim, Kyoung Jin Park, Oh Kil Kwon, Joon Min 
Cha, and Kang Ro Lee
Natural Products Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
Abies holophylla MAXIM. (Pinaceae), also known as Manchurian Fir or 
Needle Fir, is a evergreen and coniferous tree that is widely distributed in 
Korea, China, and Russia. Several species in Abies genus have been used as a 
Korean folk medicine for the treatment of colds, stomachache, indigestion, 
rheumatic diseases, and vascular and pulmonary diseases. Previous phyto-
chemical investigations on A. holophylla reported lignans, terpenoids, and 
phenolic compounds, and their cytotoxic and anti-inflammatory activities. 
However, few phytochemical and biological investigations on A. holophyl-
la have been performed. An extended phytochemical investigation of the 
trunk of A. holophylla afforded five new triterpenes (1-5) together with ele-
ven known ones (6-16). The structures of the new compounds (1-16) were 
characterized by extensive NMR methods (1H and 13C NMR, DEPT, 1H-
1H COSY, HMQC, HMBC, and NOESY). The isolated compounds (1-16) 
were tested for their anti-inflammatory activity measuring NO production 
in a LPS-activated murine microglial cells and their effects on NGF secre-
tion from C6 glioma cells. Also, we evaluated the cytotoxicity of isolates 
(1-16) against A549, SK-OV-3, SK-MEL-2, and HCT116 cell lines in vitro 
using the SRB bioassay.
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CHEMICAL NANO SHIFTS EXPLAIN THE NMR 
FINGERPRINTS OF DENTIN-ENHANCING OLIGOMERIC 
PROANTHOCYANIDINS
Joo-Won Nam1, Rasika S Phansalkar1, David C. Lankin1, Jonathan Bisson1, 
James B. McAlpine1, Ariene A. Leme2, Cristina M. Vidal2, Ana Karina 
Bedran-Russo2, Shao-Nong Chen1, and Guido F. Pauli1
1Department of Medicinal Chemistry and Pharmacognosy, College of 
Pharmacy, and 2Department of Restorative Dentistry, College of Dentistry, 
University of Illinois at Chicago, Chicago, IL 60612, USA
1D NMR spectra contain a wealth of vital structural information that can 
enhance the description of bioactive molecules. The present study demon-
strates how quantum-mechanics driven 1H iterative Full Spin Analysis 
(QM-HiFSA) is capable of distinguishing spectral detail that cannot be in-
terpreted manually or visually, but provides important information of the 
3D structure and bonding (re-)activity of the molecules. This approach is 
established by analyzing 1D NMR spectra of oligomeric proanthocyanidins 
(OPACs), which exhibit high dentin bioactivity, and were isolated from the 
inner bark of pine. The higher order coupling and proton-deuterium ex-
change effects observed in these complex molecules were fully explained 
and quantified by QM-HiFSA. Dimeric and trimer OPACs provide evi-
dence that high d precision is applicable to 13C, in addition to 1H 1D NMR 
spectra, requiring reporting to the ppb level and below. Both the nano 
chemical shifts (ppb) and the associated nano substituent chemical shifts 
(s.c.s.) are significant properties of the 1H and 13C NMR spectra and enable 
recognition of structural properties that are relevant to better understand-
ing of the intermolecular interactions between the OPAC pharmacophores 
and dentin micromolecules triggering enhanced tissue mechanics.
1105
GC/MS METHOD FOR CHARACTERIZATION 
AND QUANTITATIVE ANALYSIS OF GINKGOLIC 
ACIDS IN GINKGO BILOBA PLANTS AND DIETARY 
SUPPLEMENTS 
Mei Wang1, Jianping Zhao1, Bharathi Avula1, Yan-Hong Wang1, Cristina 
Avonto1, Amar G. Chittiboyina1, Philip L. Wylie3, Jon F. Parcher1 and Ikhlas 
A. Khan1,2
1National Center for Natural Products Research, and 2Division of 
Pharmacognosy, Department of BioMolecular Science, School of Pharamacy, 
University of Mississippi, University, MS 38677, 3Agilent Technologies, 2850 
Centerville Rd., Wilmington, DE 19808-1610, USA
A high resolution GC/MS with Selected Ion Monitor (SIM) method fo-
cusing on the characterization and quantitative analysis of ginkgolic acids 
(GAs) in Ginkgo biloba L. plants, extracts and commercial products was 
developed. The method involved sample extraction with (1:1) methanol 
and 10 % formic acid, liquid-liquid extraction with n-hexane, and derivati-
zation with trimethylsulfonium hydroxide (THSH). Separation of 2 satura-
ted (C13:0 and C15:0) and 6 unsaturated ginkgolic acid methyl esters with 
different positional double bonds (C15:1 ∆8 and ∆10, C17:1 ∆8, ∆10 and 
∆12, and C17:2) was achieved on a polar (88% cyanopropyl) aryl-polysilo-
xane HP-88 capillary GC column. The double bond positions in the GAs 
were determined by ozonolysis. The developed GC/MS method was fully 
validated according to ICH guidelines, and the quantitation results were 
verified by comparison with a standard HPLC method. Nineteen G. biloba 
authenticated and commercial plant samples and 21 dietary supplements 
purported to contain G. biloba leaf extracts were analyzed. Finally, the pres-
ence of the marker compounds, terpene trilactones and flavonol glycosides, 
for Ginkgo biloba in the dietary supplements was determined by UHPLC/
MS and used to confirm the presence of G. biloba leaf extracts in all of the 
botanical dietary supplements. 
1106
CYTOTOXIC ROTENOIDS AND ISOFLAVONOIDS FROM 
THE FRUITS OF MILLETTIA CAERULEA
Yulin Ren1, P. Annécie Benatrethina1, Ulyana Muñoz Acuña2, Chunhua 
Yuan3, Hee-Byung Chai1, Tran Ngoc Ninh4, Esperanza J. Carcache de 
Blanco1, Djaja D. Soejarto5,6, and A. Douglas Kinghorn1. 
1Division of Medicinal Chemistry and Pharmacognosy and 2Division of 
Pharmacy Practice and Administration, College of Pharmacy, 3Campus 
Chemical Instrument Center, The Ohio State University, Columbus, Ohio 
43210, United States, 4Institute of Ecology and Biological Resources, Vietnam 
Academy of Science and Technology, Hoang Quoc Viet, Cau Giay, Hanoi, 
Vietnam, 5Department of Medicinal Chemistry and Pharmacognosy, 
6Science and Technology, Field Museum of Natural History, Chicago, IL 
60605, United States
Three new and seven known rotenoids, along with two new isoflavonoids 
and a known analogue, were isolated from the n-hexane extract of the 
fruits of Millettia caerulea (Graham) Baker (Fabaceae) collected in Vietnam 
(sample A06946; voucher specimen DDS-14879). The structures of the new 
compounds were established by analysis of their ECD, IR, UV, NMR, and 
mass spectra, with those of the known compounds being determined by 
comparison of their spectroscopic data with literature values. Several of 
these compounds were found to be cytotoxic toward the HT-29 human co-
lon cancer cells, among which a known compound, 12β-hydroxyrotenone, 
was the most potently active, showing an IC50 value of 0.1 µM. This same 
compound was active (IC50 3.1 µM), when evaluated in a K-Ras inhibition 
assay using HT-29 cells. 
1107
HEMATOPOIETIC EFFECTS OF PAEONIFLORIN 
AND ALBIFLORIN ON RADIOTHERAPY 
AND CHEMOTHERAPY-INDUCED ANEMIA MICE
Yingli Zhu1, Jianyu Zhou1, Linyuan Wang1, Zhihui Yang2, Jianjun Zhang1*
1 Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Chaoyang 
Qu, Beijing 100029, China, 2 Department of Psychiatry & Neuroscience, 
University of Florida, Gainesville, FL 32608, USA.
Paeoniflorin (PF), a monoterpene glycoside isolated from P. lactiflora, 
possesses a variety of pharmacological activities. However, albiflorin (AF), 
another constituent regarded as a characteristic one, has not been well stud-
ied. This study aimed to investigate the hematopoietic effects of AF and PF 
on anemia mice induced by radiotherapy or chemotherapy and to explore 
the underlying mechanisms. The anemia mice were irradiated at a dose 
of 2.5 Gy using cobalt-60 gamma resources or  intraperitoneally injected 
with cyclophosphamide (160.0 mg/kg). The numbers of blood cells from 
peripheral blood were counted. The thymus index and spleen index were 
also measured. In addition, of the chemotherapy-induced mice, the levels 
of TNF-α, GM-CSF, IL-3 in serum were measured by RIA. AF and PF sig-
nificantly increased the numbers of peripheral blood cells and reversed the 
atrophy of thymus and spleen. Furthermore, AF and PF increased the levels 
of GM-CSF and IL-3 and reduce the level of TNF-αin serum.. Our results 
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suggest that AF and PF may promote the recovery of bone marrow hemo-
poietic function in a myelosuppressed mouse model.
1108
ANTIOXIDANT FLAVONOL GLYCOSIDES FROM HERBA 
EPIMEDII 
Fubo Han and Ik-Soo Lee
College of Pharmacy and Research Institute of Drug Development, 
Chonnam National University, Gwangju 500-757, Republic of Korea.
Herba Epimedii (Yinyanghuo in Chinese) is a traditional Chinese herbal 
medicine, which has been used as tonic, aphrodisiac and anti-rheumatic in 
China for thousands of years. It was proven to be an effective remedy for 
cardiovascular diseases, osteoporosis and for improving sexual and neuro-
logical functions. And it was verified that the effectiveness of Herba Epi-
medii is highly related to its antioxidant ingredients. Hence the antioxidant 
constituents from Herba Epimedii were investigated, and the ethyl acetate 
fraction of the methanolic extract of Herba Epimedii, which contains a ma-
jor bioactive component icariin, showed highest DPPH radical scavenging 
activity. Several known and novel flavonol glycosides were isolated by sili-
ca gel open column chromatography and HPLC. Structures of the isolated 
compounds were identified by analyses of spectroscopic data from 1D- and 
2D-NMR as well as UV, IR and MS. Details of isolation and structure elu-
cidation will be discussed.
1109
ANTI-CANCER ACTIVITY OF SOME SYNTHESIZED 
AROMATIC OXYBUTYNYL AMINE DERIVATIVES
Manas Omyrzakov1,2,3, Yerkebulan Orazbekov1,3,6, Guoyi Ma3, Ubaidilla 
Datkhayev1, Madi Omirzak2, Ahmad E. Mostafa3,5, Bauyrzhan Makhatov6, 
Kuandyk Orazbekuly7, Shokan Begaliyev1, Lyazzat Yeraliyeva1, Zuriyada 
Sakipova1, Kulpan Orynbasarova6, Samir A. Ross3,4*
1Department of Pharmacy, Kazakh National Medical University, Almaty, 
Kazakhstan,2Institute of Chemical Sciences, Almaty, Kazakhstan, 
3National Center for Natural Products Research, and 4Department of 
BioMolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS, USA. 5Department of Pharmacognosy, Faculty of 
Pharmacy, Univ. of Al-Azhar, Egypt, 6South Kazakhstan pharmaceutical 
academy, Shymkent,7International Kazakh-Turkish University, Turkestan, 
Kazakhstan.
Twelve aromatic oxybutynyl amine derivatives (1-12) were synthesized 
via Mannich reaction. All synthesized compounds were tested primarily 
for their anti-leukemic activity against leukemia K562 cells, in a conc. of 
10 µg/ml. Compound 9 showed the highest activity of 100% inhibition. 
Furthermore, compound 9 showed an IC50 value of 0.03 and 0.008 µg/ml 
against leukemia K562 and HL60 cells respectively, where IC50 value of Ta-
xol against both cells was 0.0023 µg/ml. 
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BIOACTIVE POLYKETIDES FROM A PENICILLIUM 
LANOSUM STRAIN DERIVED FROM A SWAB OF BAT’S 
WING
Guojian Zhang1,2, Jarrod King1,2, Andrew N. Miller3, and Robert H. 
Cichewicz1,2
1Institute for Natural Products Applications and Research Technologies, 
Natural Products Discovery Group, 2Department of Chemistry and 
Biochemistry, Stephenson Life Sciences Research Center, University 
of Oklahoma, 101 Stephenson Parkway, Norman, Oklahoma 73019-
5251, USA, 3University of Illinois, Illinois Natural History Survey, 1816 
South Oak Street, Champaign, Illinois 61820- 6970, USA 
Bacterial infection, particularly from multi-drug resistant strains, remains 
a serious threat to human lives. Thus, there is a clear and critical medical 
need for the discovery of novel antibacterial agents. Our recent work within 
the scope of an anti-multidrug-resistant Acinetobacter baumannii screen-
ing program led to the isolation of one fungal strain Penicillium lanosum 
1298-15 from a swab of bat’s wing. Bioassay guided fractionation of the 
secondary metabolites from the strain 1298-15 afforded 4 new polyketide 
lanoctones A-D (1-4), along with 3 known compounds: 3-chloro-2,5- dihy-
droxybenzyl alcohol (5), sohirnone A (6) and bislongiquinolide (7). Com-
pounds 5 and 6 exhibited strong activity with IC50 values of 5.7 nM and 45.4 
nM. However, compounds 1-4 and 7 showed weak or no activity.
1111
METABOLIC GIVE AND TAKE BETWEEN NEIGHBORING 
FUNGUS AND BACTERIUM
Jianlan You1,2, Bin Wang1,2, Jarrod B. King1,2, Sara K. Collins1,2, Robert H. 
Cichewicz1,2
1Department of Chemistry and Biochemistry, and 2Natural Products 
Discovery Group, Institute for Natural Products Applications and Research 
Technologies, Stephenson Life Sciences Research Center, University of 
Oklahoma, Norman, Oklahoma 73019
To understand the soil ecosystem, many studies focus on the secondary 
metabolites involved in the chemical interaction between microorganis-
ms. However, the interactions initiated by primary metabolites are often 
overlooked. When we were isolating fungi from soil on Czapek’s agar, we 
found a bacterium, Pseudomonas alcaligenes, inhibited the growth of a fun-
gus Curvularia inaequalis. This drew our attention, since the bacterium was 
unculturable when alone on Czapek’s agar. Using laser ablation electrospray 
ionization mass spectrum (LAESIMS), we observed the fungus helped the 
bacterium to grow on Czapek’s agar by digesting sucrose into glucose and 
fructose with only glucose being used directly by the bacterium as a car-
bon source. More interestingly, when it started to grow, the bacterium was 
able to inhibit the growth of the fungus. Bioassay guided purification yiel-
ded 2,4-diacetylphloroglucinol as fungal inhibitor. Further determination 
of sucrose uptake and digestion by LC-MS confirmed our observation on 
LAESIMS. It is the first report of the interaction of these two soil microbes. 
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TRANSFERRING FUNGI TO A DEUTERIUM-ENRICHED 
MEDIUM RESULTS IN ASSORTED, CONDITIONAL 
CHANGES IN SECONDARY METABOLITE PRODUCTION 
Bin Wang1,2, Elizabeth M. Park1,2, Jarrod B. King1,2, Allison O. Mattes1,2, 
Susan L. Nimmo2, Chaevien Clendinen3, Arthur S. Edison3, Clemens 
Anklin4, Robert H. Cichewicz1,2,*
1Institute for Natural Products Applications and Research Technologies, 
and 2Department of Chemistry & Biochemistry, University of Oklahoma, 
Norman, OK 73019, 3Department of Biochemistry & Molecular Biology, 
College of Medicine, University of Florida, Gainesville, FL 32610, 4NMR 
Applications Support, Bruker Biospin Corporation, Billerica, MA 01821
The incorporation of deuterium into organic substrates is known to alter 
the function of enzymes. Our study tested the extent to which deuterium 
enrichment would result in the modification of fungal secondary metabo-
lite production. Eight fungal cultures we tested were marked by changes 
in natural product production. Work-up of one Aspergillus sp. grown un-
der deuterium-enrichment conditions resulted in an active fungal extract 
against MRSA, which was not observed in the crude extract from the fun-
gus grown under non-deuterium enriched conditions. An assortment of 
NMR and mass spectrometry experiments enable us to identify isotope-
labelled brevianamide F (1), stephacidin A (2), notoamide D (3), notoami-
de L (4), notoamide C (5), and bacterial inhibitor pigmentosin A (6). 1 and 
3-6 have not been previously observed from this fungal isolate. Therefore, 
we propose that deuterium-enrichment might offer an effective method for 
further expanding a fungus’s chemical diversity potential.
1113
ANTIMALARIAL METABOLITES FROM BUXUS 
SEMPERVIRENS 
Shengxin Cai,1,2 April L. Risinger,3 Shalini Nair,4 Douglas R. Powell,2 Tim J. 
C. Anderson,4 Susan L. Mooberry,3 Robert H. Cichewicz1,2
1Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, and 2Department of Chemistry and 
Biochemistry, University of Oklahoma, Norman, OK 73019. 3Department 
of Pharmacology, The University of Texas Health Science Center at 
San Antonio, San Antonio, TX 78229. 4Department of Genetics, Texas 
Biomedical Research Institute, San Antonio, TX 78227.
Some malaria parasites (Plasmodium falciparum) have developed resistance 
to all currently available antimalarial drugs including artemisinin deriva-
tives, so there is an urgent need to discover new chemicals with antimalarial 
activity. Eight new lupinane derivatives (1-8) were isolated from the extract 
of the English boxwood (Buxus sempervirens) using bioassay guided frac-
tionation and examined for activity against malarial parasites Plasmodium 
falciparum. The lupinane derivatives range in potency from 0.49–3.36 μM 
against the drug sensitive HB3 parasite and retain efficacy in an artemisinin 
and multidrug resistant parasite recently isolated in Southeast Asia. Com-
pounds 2 and 3 in particular exhibited greater than 30-fold selectivity for 
malaria parasites as compared to human cancer cell lines. 
1114
QUANTITATIVE DETERMINATION OF FIVE 
TRITERPENOID GLYCOSIDS AND CHEMICAL 
PROFILING OF MOMORDICA CHARANTIA BY UHPLC-
ELSD/MS
Yan-Hong Wang1, Shuang Hu1,2, Bharathi Avula1, Mei Wang1, 
Satyanarayanaraju Sagi1, and Ikhlas A Khan1,3,4.
1National Center for Natural Products Research, Research Institute of 
Pharmaceutical Sciences, The University of Mississippi, University, MS 
38677, USA, 2School of Pharmacy, Shanxi Medical University, Taiyuan, 
030001, P.R.China, 3Department of BioMolecular Sciences, School of 
Pharmacy, The University of Mississippi, University, MS 38677, USA, 
4Department of Pharmacognosy, College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia
Bitter melon, Momordica charantia L. (Cucurbitaceae), is used in traditional 
medicine of the world and in dietary supplements of the United States. An 
UHPLC-UV-ELSD/MS method was developed to quantitative determina-
tion of five cucurbitane-type triterpenoids from M. charantia. The method 
was validated including extraction solvents, linearity, repeatability, limits 
of detection (LOD) and limits of quantification (LOQ). Cucurbitane-type 
triterpenoid saponins in M. charantia were classified into three sub-groups 
according to substitutions and oxidizations at C-3, C-7 and C-19. The key 
fragments of three sub-groups were characterized and further used for the 
identification of triterpenoids from M. charantia. This method was applied 
to the analysis and chemical profiling of plant samples of M. charantia and 
related products.
1115
SMALL SCALE PURIFICATION OF CONSTITUENTS 
FROM COMPLEX NATURAL PRODUCT EXTRACTS 
USING SUB-2-μM CHROMATOGRAPHY
Andrew J. Aubin, Giorgis Isaac, Jo-Ann M. Jablonski, and Wendy Harrop
Waters Corporation, Milford, MA, USA
Extracts from natural product samples can be complex often containing a 
large number of diverse compounds. Increased separation performance of 
sub-2-µm column technology along with low dispersion instrumentation 
provides a tool that produces sharp, narrow, and more concentrated peaks. 
When there is a need to collect narrow peaks from these complex mixtu-
res, traditional fraction collection instrumentation designed for preparative 
HPLC conditions does not provide an adequate solution. 
Extracts from several natural product samples were analyzed using sub-2-
ìm chromatography. Potential peaks of interest were identified and isolated 
using a fraction collector designed to overcome the limits of traditional 
fraction collectors. Collection of narrow peaks generated using modern 
sub-2 µm chromatography along with closely eluting compounds is de-
monstrated using a variety of collection modes including time based and 
peak detection techniques. Analysis of collected fractions to demonstrate 
purity is shown using UPLC.
Poster Session - Saturday, July 25th
69Abstracts | 2015 Annual Meeting of the ASP | July 25th–29th, 2015 | Copper Mountain, CO, USA
1116
DATA MINING OF SIMPLE SEQUENCE REPEATS 
IN TRANSCRIPTOME SEQUENCES OF MONGOLIA 
MEDICINAL PLANT ARTEMISIA FRIGIDA
Yue Liu1, 2, Xiaoqing Ma1, Yi Wang3, Hongbo Sun1, Huoli Yang1, Qin Li1, 
Fuxin Chen1, Linxia Zhang1, Chuanchuan Chen1, Hua Li1, Li Tang1
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2 National Resource Center for Chinese Materia 
Medica, China Academy of Traditional Chinese Medicine, Beijing 100700, 
China, 3 Department of Plant Sciences, University of California Davis, CA 
95616, USA
Artemisia frigida Willd. is a Mongolian traditional medicinal plant with 
pharmacological functions of stanch and detumescence. With the increas-
ing demand for commercial use, selection of germplasm with high pharma-
ceutical efficacy at molecular level is important and requires the availability 
of efficient genetic and molecular marker data. In this study, MicroSAtelite 
software was employed to screen SSRs in 143,700 contigs of Artemisia frigi-
da transcriptome sequences. There are 3,747 SSRs distributed in 3,614 con-
tigs which accounted for 2.51% of 143,700 contigs with 123 types of SSR 
motifs. The most abundant repeat type was tri-nucleotide (56.20%, 2,106), 
followed by the di-nucleotide (31.60%, 1,184). AAC/TTG and AC/TG 
were the main types of motif in tri-, di-nucleotide repeats. The most com-
mon number of tandem repeats was 5 (38.54%, 1,444). The primer pairs 
for 3,743 SSRs were designed for further investigation of the potential of 
these SSRs as genetic markers. These data could be further utilized in func-
tional genomics studies on Artemisia frigida. Acknowledgment: financial 
support by project of NSFC-81274158, 81373765, NCET-12-0578, 13-0624, 
GCCX2014110021, YLDX01013, and 111-B08044.
1117
A TCM HERBAL FORMULA INCREASES IGF-1 AND 
IGFBP-1 LEVELS IN THE SERA AND OVARIES IN AN 
AGED FEMALE RAT MODEL OF MENOPAUSE 
Min Wei1, Sheng Z. Zheng1, Ye Lu1, Daniel Liu2, Hong Ma3 and Gail B. 
Mahady4 
1 Jiangsu Institute of Botany, Chinese Academy of Science; Nanjing 210014, 
China; 2 Beijing Clinical Service Center, Beijing, China 100123 3 College 
of Basic Medicine, Nanjing University of Traditional Chinese Medicine; 
Nanjing, 210029, China; 4Department of Pharmacy Practice, College of 
Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA.
Menoprogen (MPG), a TCM herbal formula improves menopausal sym-
ptoms in clinical trials, however its mechanism has remained elusive. Pre-
vious studies show that MPG is not directly estrogenic, thus the goal of this 
study was to investigate the effects of MPG on IGF-1 and IGFBP-1 levels in 
an aged female rat model of menopause. In a six-armed study, 14-month-
old Sprague-Dawley (SD) female rats (n = 8 per arm) were randomly divi-
ded into an untreated aged group, an E2-treated aged group (17β-estradiol), 
and three arms with increasing doses of MPG groups (162, 324, or 648 mg/
kg/day). The sixth arm contained four-month-old SD female rats as a nor-
mal comparison group. Four weeks after MPG or E2 administration, the 
animals were sacrificed after blood draws, and then ovarian tissues were 
excised. The levels of E2 and progesterone (P4) were determined by radio-
immunoassay, and serum and ovarian tissue levels of IGF-1, IGFBP-1, and 
IGF-1 receptor (IGFR) were determined by ELISA. Compared with the 
normal group, the aged rats had significantly reduced serum levels of E2, 
P4, and IGF-1 and increased serum and ovarian tissue levels of IGFBP-1. 
MPG restored serum IGF-1 and IGFBP-1 levels and down-regulated the 
ovarian levels of IGFBP-1, which were closely related to increases of E2 and 
P4 levels in the aged rats. No significant differences were observed between 
the three doses of MPG for either IGF-1 or IGFBP-1. MPG has a direct in 
vivo effect in aged female rats by positively regulating serum and ovarian 
IGF-1 and IGFBP-1 levels. 
1118
NOVEL MECHANISM OF ACTION OF A TRADITIONAL 
CHINESE HERBAL FORMULA IN AN INTACT AGED 
FEMALE RAT MODEL OF MENOPAUSE 
Hong Ma1, Ye Lu2, Daniel Liu3, Sheila Wicks4 and Gail B. Mahady4
1Traditional Chinese Medicine Department of Nanjing University of Chinese 
Medicine, Nanjing, China; 2Institute of Botany, Chinese Academy of Science 
in Jiangsu Province, Nanjing, China; 3Beijing Clinical Service Center, Beijing, 
100007, PR China; 4College of Pharmacy, University of Illinois at Chicago, 
Chicago, IL, USA 60612.
The effects of Menoprogen (MPG), a traditional Chinese medicine formu-
lation for menopause, were determined on granulosa cell (GC) apoptosis 
in an aged rat model of menopause. Intragastric administration of MPG or 
estradiol valerate to 14-month-old female rats for 8 weeks increased plasma 
estrogen levels and the weight of both ovarian and uterine tissues. Flow 
cytometry (FCM) analysis of the GCs from treated animals showed reduc-
tions in both the G0/G1 ratio and apoptotic peaks. Electron microscopy of 
the GCs showed an increase in cell size, the numbers of cytoplastic organel-
les and intracellular gap junctions, reappearance of secretory granules and a 
lack of apoptotic bodies. Data from the TdT-mediated dUTP nick end-labe-
ling (TUNEL) assay revealed a reduction in GC apoptosis after treatment. 
Immunohistochemical analysis showed a down-regulation of Bax prote-
ins and an up-regulation of Bcl-2 proteins. In vitro, the addition of MPG 
medicated serum to the media of isolated GCs with cadmium chloride-
induced apoptosis reduced GC apoptosis as measured by FCM analysis in 
the TUNEL assay. A down-regulation of caspase-3 protein in GCs treated 
with MPG. This work demonstrates that both MPG and estradiol valerate 
inhibit GC apoptosis in aged female rats, and represents a novel mechanism 
of action for this herbal medicine for the treatment of menopause.
1119
ANTIMICROBIAL DEFENSES OF CAULERPA MEXICANA 
AND UDOTEA LOOENSIS AGAINST VIBRIO SPP. AND 
BACILLUS SP.
Bobby Owens1, Jordan Ekhoff1, Elizabeth Philip1, Jason Kwan2, Tomasz 
Jurga1, and Melany P. Puglisi1
1Chicago State University, College of Pharmacy, 9501 S. King Dr., Chicago, 
IL 60628, 2University of Wisconsin-Madison, 777 Highland Avenue, 
Madison, WI 53705
In a broad survey of extracts of common marine algae from the Florida 
Keys against an extensive panel of environmental bacteria, extracts from 
the green algae Caulerpa mexicana and Udotea looensis exhibited signifi-
cant activity against two conspecific strains of Vibrio sp. from Florida and 
one strain of Bacillus sp. from the Red Sea. To continue the investigation 
of antibacterial defenses of marine algae, crude extracts from C. mexicana 
and U. looensis were subjected to bioassay-guided fractionation. Extracts 
were partitioned between ethyl acetate and DI water. The non-polar frac-
tions were separated using Si gel medium pressure liquid chromatography 
followed by reverse phase high pressure liquid chromatography. Bacterial 
cultures were maintained on A1 media. Extracts were dissolved in DMSO 
(600 µg/ml ≤ natural volumetric concentration) and added to each well 
of a 96-well plate using DMSO (solvent), streptomycin and tetracycline 
(positive) as controls. Initial and final readings were obtained on a Biotech 
plate reader at 625nm. C. mexicana and U. looensis produce metabolites 
that selectively inhibit the growth of one strain of Vibrio sp. or Bacillus sp. 
and several others that show broad spectrum antimicrobial activity against 
potential pathogens in the marine environment. This study was conducted 
by PharmD candidates as part of a college wide research training program 
at Chicago State University. 
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CHANGE OF CHEMICAL COMPOSITION IN FLOS 
LONICERAE: AN INVESTIGATION OF HERBAL 
PROCESSING (PAO ZHI) USING NMR SPECTROSCOPY
Jianping Zhao1, Mei Wang1, Bharathi Avula1, Ikhlas A. Khan1,2,3
1National Center for Natural Products Research, 2Department of 
Pharmacognosy, School of Pharmacy, University of Mississippi, University, 
MS 38677, USA; 3Department of Pharmacognosy, College of Pharmacy, 
King Saud University, Riyadh, Saudi Arabia
Processing of herbal medicine, known as Pao Zhi in Traditional Chinese 
Medicine (TCM), is a unique part of TCM and has been widely used for the 
preparation of Chinese materia medica. It is believed that processing can 
alter the properties and functions of remedies, increase medical potency, 
and reduce toxicity and side effects. Both processed and unprocessed Flos 
Lonicerae (flowers of Lonicera japonica) are important drug ingredients in 
TCM. To gain insights on the effect of processing factors (heating tempera-
ture and duration) on the change of chemical composition, NMR combined 
with chemometric analysis was applied to investigate the processing of Flos 
Lonicerae. The results indicated that the composition changed significant-
ly, particularly when processing at the higher temperature. Five chemi-
cal components, viz. 3,4-dicaffeoylquinic acid, 4,5-dicaffeoylquinic acid, 
3,5-dicaffeoylquinic acid, chlorogenic acid and myo-inositol, whose con-
centration changed significantly during the processing, were isolated and 
identified. The changes of their concentrations were analyzed by UHPLC. 
The study demonstrated that an NMR-based chemometric approach could 
be a promising tool for investigation of the herbal processing in TCM.
1121
EXTRACTION AND GAS CHROMATOGRAPHY 
ANALYSIS OF ESSENTIAL OIL FROM GARLIC
Qing Zhao1, Xiu-Fen Pang1
1Department of Applied Chemistry, College of Science, Xi'an University of 
Technology, Xi'an 710054, China
Commercially available garlic (Allium sativum L.) has been widely used as 
spice and condiment for centuries. Extracts of the garlic have been used 
traditionally in Chinese herbal medicine against various human diseases 
and disorders. Previous phytochemical investigations have revealed that 
there are more than 200 compounds identified from garlic. Among them, 
the essential oil have raised interest because of their wide range of bioac-
tivities such as antioxidant, antifatigue, antiatherosclerotic, antidiabetic 
and immunomodulation effects. The present study was designed to obtain 
the optimum extraction condition for essential oil and analysis its major 
constituents by gas chromatography. An easy and convenient extraction 
process has been obtained with the 0.419% yield of essential oil by simple 
distillation, water as the solvent for 60 min at 50 oC. The GC analysis of the 
essential oil indicated that diallyl trisulfide, dimethyl sulfide, methyl prop-
1-enyl disulphide and diallyl thioether as the main constituents. 
1122
NEW CYCLIZED 9,11-SECOSTEROLS ENOL-ETHER FROM 
SOFT CORAL PSENDOPTEROGORGIA AMERICANA
Yang-Qing He1, Stacee Caplan2, Paul Scesa2, and Lyndon M. West2
1Department of Applied Chemistry, Xi’an University of Technology, Xi’an, 
Shaanxi 710054, P. R. China, 2Department of Chemistry and Biochemistry, 
Florida Atlantic University, Boca Raton, Florida 33431, USA
Chemical investigation of the MeOH extract from the gorgonian Pseu-
dopterogorgia americana afforded two rare sterols, ameristerenol A (1) and 
B (2), both 9,11-secosterols containing a seven-membered cyclic enol−
ether in ring C, and ameristerol A (3), the first 9,11-secosterol containing 
a gorgosterol side chain containing an exocyclic methylene group at C-24, 
along with three related known analogues. Ameristerenol A (1) was con-
verted to semi-synthetic sterols 4−6. The structures of compounds 1−6 
were determined on the basis of extensive spectroscopic analysis and by 
comparison with literature data.
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2001
THE FIRST NATURAL PRODUCTS INVESTIGATION 
OF THE HAWAIIAN ENDEMIC PLANT COPROSMA 
ERNODEOIDES OR NENE BUSH (‘AIAKANENE)
Myria Lang,1 Diana Zelta-Pinet,2 Kehau Hagiwara,2 and Anthony D. 
Wright2
1Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, 
Switzerland; 2DKI-College of Pharmacy, University of Hawaii at Hilo, 34 
Rainbow Drive, Hilo, Hawaii 96720
The Nene bush (Coprosma ernodeoides) or ‘Aiakanene in Hawaiian is a 
rambling perennial prostrate shrub endemic to Hawaii. Worldwide, mainly 
the Pacific Islands, there are around 110 species in the genus the majority of 
which (55) are to be found in New Zealand. The plant has very small leaves 
(2-3 mm) that grow densely along branches that can be up to three meters 
long. At various times of the year the bush produces shiny black edible ber-
ries (5-8 mm dia) that were and are used by native Hawaiians as laxatives. 
Our interest was drawn to this plant because of its distinctive berries, the 
fact that it is endemic to Hawaii and finally because there are no reported 
natural products investigation of any parts of the plant. The data presented 
on this poster result from investigations of methanol extracts made from 
the leaves and from the berries that both demonstrated antioxidant pro-
perties in DPPH and FRAP assays. From the berries the three known iri-
doid glycosides 1 - 3 were isolated and from the leaves the known iridoid 
glycoside 4.
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PHYLOGENETIC AND METABOLOMIC ANALYSIS OF 
MARINE MAMMAL MICROBES CONTRIBUTES TO 
EMERGING SPIROTETRONATE POLYKETIDES 
Jessica Ochoa, Laura Sanchez, Roger Linington
University of California, Santa Cruz, Department of Chemistry and 
Biochemistry, 1156 High Street, Santa Cruz, CA, 95060
Constant exposure to varying environments along migrations routes sug-
gests that the marine mammal microbiome may be a unique environment 
for sample collections for natural product discovery. The organisms isolated 
in this study were prioritized through sequencing and metabolomics pro-
filing to create a highly bioactive screening plate that possesses new mole-
cules produced by marine microbiomes. Molecules elucidated in this study, 
both known and new provide detailed insight into the chemistry involved 
in signaling and/or defense within commensal bacteria as well as the capa-
bility of these molecules to be used to regulate pathogenesis for one of the 
worlds best sentinel organisms.
2003
VIRIDICATUMTOXINS: EXPLORING STRUCTURAL 
DIVERSITY AND ANTIBIOTIC PROPERTIES
Zhuo Shang1, Angela A. Salim1, Zeinab G. Khalil1, Michelle Quezada1, Paul 
V. Bernhardt2 and Robert J. Capon1
1Institute for Molecular Bioscience, The University of Queensland, St Lucia, 
QLD 4072, Australia, 2 School of Chemistry and Molecular Biosciences, The 
University of Queensland, St Lucia, QLD 4072, Australia
Viridicatumtoxins are a rare class of antibiotics composed of a tetracycline 
scaffold and a geranyl-derived spirobicyclic ring. Chemical investigation of 
a fungus Paecilomyces sp. obtained from a marine mollusc Siphonaria sp. 
led to the isolation of three novel viridicatumtoxin lactones, named viri-
dicatumtoxins D–F (4–6), together with two known compounds, viridi-
catumtoxins A (1) and B (2). Re-cultivation of this fungus on rice solid 
media afforded one new compound viridicatumtoxin C (3), together with 
two known metabolites, spirohexaline (7) and previridicatumtoxin (8). 
Compounds 4 and 5 were proved to be natural products by the acid stabi-
lity study of 1. The antibacterial and cytotoxicity activities of 1–8 were also 
evaluated. 
2004
13C NMR SHIFTS IN 13α AND 13β MALABARICANES, 
THE EFFECT OF CYCLOBUTYL SIDE CHAIN: SOME 
INTERESTING OBSERVATIONS 
Prabhakar S. Achanta, Raghuram Rao Akkinepally, Ravi Kumar Bobbala, 
and Appa Rao V.N. Achanta
University College of Pharmaceutical Sciences, Kakatiya University, 
Warangal-506009, India.
13α-malabaricanes are fewer in number when compared with 13β-mala-
baricanes. In 13α-malabaricanes there is considerable upfield shift of C-30 
by about 10 ppm when compared with 13β-malabaricanes. However this 
observation which is valid in general, does not hold good in all cases. Ma-
labaricanes containing a cyclobutane ring in the side chain caused the same 
upfield shift despite the fact that H-13 was β oriented. Significant changes 
observed in 13C NMR shift values at other carbon atoms in epimeric and 
cyclobutane ring containing malabaricanes are discussed. 
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2005
ISOLATION AND IDENTIFICATION OF NOVEL NATURAL 
PRODUCTS THAT INHIBIT P300/HIF-1α INTERACTION
Susanna T. S. Chan,1 Paresma R. Patel,2,3 Gary E. Martin,4 Robert T. 
Williamson,4 Josep Saurí,4 Alexei V. Buevich,4 Tanya R. Ransom,1 Curtis 
J. Henrich,1,5 Tawnya C. McKee,1 William D. Figg,6 James B. McMahon,1 
Martin J. Schnermann,2 and Kirk R. Gustafson1
1Molecular Targets Laboratory, Center for Cancer Research, National Cancer 
Institute, Frederick, MD 21702, 2Chemical Biology Laboratory, Center for 
Cancer Research, National Cancer Institute, Frederick, MD 21702, 3National 
Centre for Advancing Translational Sciences, National Institutes of Health, 
Bethesda, MD 20892, 1NMR Structure Elucidation, Process, and Analytical 
Chemistry, Merck & Co. Inc., Rahway, NJ, 07065 5Basic Science Program, 
Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer 
Research, Frederick, MD 21702, 6Medical Oncology Branch, Center for 
Cancer Research, National Cancer Institute, Bethesda, MD 20892.
Hypoxia-inducible factor-1 (HIF-1) is an important transcription factor 
for initiating a response against low oxygen environments in many solid 
tumors. Under hypoxic conditions, subunit HIF-1α dimerizes with subunit 
HIF-1β and binds to the multi-domain protein and transcriptional coacti-
vator, p300. Inhibition of the p300/HIF-1α interaction results in the sup-
pression of HIF-1 transcriptional activity during hypoxia. An extract of the 
marine ascidian Eudistoma sp. was identified as active in a high throughput 
screen for inhibitors of the p300/HIF-1α interaction. Three novel heterocy-
lic alkaloids were isolated from the extract and their structures elucidated 
using both spectroscopic analyses and synthesis. The core scaffold of the-
se alkaloids contains an unprecedented fused ring system with embedded 
guanidine and amidine functionalities. These compounds showed activity 
inhibiting the binding domains of p300 and HIF-1α.
2006
IDENTIFICATION OF CYTOTOXIC AND ANTI-
INFLAMMATORY CONSTITUENTS FROM THE BARK 
OF TOXICODENDRON VERNICIFLUUM (STOKES) F.A. 
BARKLEY
Hee Rae Kang1, Hee Jeong Eom1, Seulah Lee1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
Toxicodendron vernicifluum (Stokes) F.A. Barkley (Anacardiaceae) has tra-
ditionally been used as a food supplement and in traditional herbal medi-
cine to treat inflammatory diseases and cancers for centuries in Korea. This 
study was designed to isolate the bioactive constituents from the ethanol 
extract of T. vernicifluum bark and evaluate their cytotoxic and anti-inflam-
matory activities. Bioassay-guided fractionation and chemical investigation 
of the ethanol extract of T. vernicifluum bark resulted in the isolation and 
identification of three new polyphenols (1–3) and six flavonoids (4–9). 
The structures of the isolated compounds were elucidated by spectroscop-
ic analysis, including 1D and 2D NMR, and HR-MS, and their absolute 
configurations were further confirmed by chemical methods and CD data 
analysis. Compounds 4–9 showed antiproliferative activity against the test-
ed cells, with IC50 values of 4.78–28.89 μM. Compounds 5 and 8 significant-
ly inhibited NO production in lipopolysaccharide (LPS)-stimulated BV-2 
cells with IC50 values of 23.37 and 11.68 μM, respectively.
2007
ALKALOIDS FROM ACORUS GRAMINEUS RHIZOMES 
AND THEIR BIOLOGICAL ACTIVITY
Hee Rae Kang1, Jae Sik Yu,1 Hee Jeong Eom1, Seulah Lee1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
As part of our ongoing search for bioactive constituents from natural Ko-
rean medicinal resources, a bioassay-guided fractionation and chemical 
investigation of the MeOH extract from the rhizomes of Acorus gramineus 
resulted in the isolation and identification of two alkaloids, including a new 
aporphine-type alkaloid (1), named gramichunosin, and a known pyrrole 
alkaloid (2). Their structures were determined by a combination of 1D and 
2D NMR spectroscopic analysis and HRMS. This is the first report of al-
kaloids from A. gramineus. Compounds 1 and 2 showed antiproliferative 
activities against A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines with 
IC50 values in the range of 7.46-45.23 μM. Moreover, the anti-neuroinflam-
matory activities of these compounds were determined by measuring the 
nitric oxide (NO) levels in the medium using murine microglia BV-2 cells. 
Compound 1 inhibited NO production in lipopolysaccharide-stimulated 
BV-2 with IC50 values of 7.83 μM.
2008
TARGETING BIOACTIVE CHEMICAL SPACE WITH A 
SMALL NATURAL PRODUCTS LIBRARY: EXPANDING 
DIVERSITY AND PREDICTABILITY
Jacqueline L. von Salm1,2, Daniel Santiago1, Nerida G. Wilson3, Laurent 
Calcul1,2, Dennis E. Kyle4, Wayne C. Guida1,2,5, and Bill J. Baker1,2
1Department of Chemistry and 2Center for Drug Discovery & Innovation, 
University of South Florida, Tampa, FL 33620, USA, 3Western Australia 
Museum, Perth, Western Australia, Australia, 4Department of Global 
Health, University of South Florida, Tampa, FL 33620, USA, 5H. Lee Moffitt 
Cancer Center & Research Institute, Tampa, FL 33620, USA
Diverse compound libraries have become a necessity to drug discove-
ry efforts around the world. Target specific computational methods and 
high-throughput screening programs have aided the search for bioactive 
compounds, however, inefficiencies remain for neglected and tropical di-
seases. Detailed knowledge of mechanisms of action and target proteins 
is limited for parasitic diseases like malaria and leishmaniasis. In order to 
effectively lead research programs in these areas, our lab has developed a 
small compound library with diversity that mimics the NCI Diversity Set 
and the AntiMarin natural products database. Specific activity exhibited by 
each compound against Plasmodium falciparum and Leishmania donovani 
has been overlain to create activity “hotspots”, which we hope to improve 
activity prediction methods for unknown natural products isolated in the 
future. Limitations in diversity remain in all three libraries, and appear to 
have properties resembling small (MW < 400) hydrophobic molecules like 
terpenes. Here we use active antileishmanial terpenoids isolated from Ant-
arctic marine organisms as models to show expansion of overall diversity 
and future predictability of the library as a bioassay dereplication tool. 
2009
MICROBIAL MANNOSIDATION OF CHLOROGENTISYL 
ALCOHOL BY THE MARINE-DERIVED FUNGUS 
CHRYSOSPORIUM SYNCHRONUM
Keumja Yun and Byeng W. Son
Department of Chemistry, Pukyong National University, Busan 608-737, 
Korea. 
The microbial transformation of the biologically active chlorogentisyl alco-
hol, isolated from the marine-derived fungus Aspergillus sp., was studied. 
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Preparative-scale fermentation of chlorogentisyl alcohol with marine-de-
rived fungus Chrysosporium synchronum resulted in the isolation of a new 
glycosidic metabolite, 1-O-(α-D-mannopyranosyl)chlorogentisyl alcohol. 
The stereostructure of the new metabolite obtained was assigned on the ba-
sis of detailed spectroscopic data analyses, chemical reaction, and chemical 
synthesis. Chlorogentisyl alcohol and its mannoside exhibited significant 
radical-scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) 
with IC50 values of 1.0 and 4.7 μM, respectively. Both compounds were 
more active than the positive control, L-ascorbic acid (IC50, 20.0 μM). 
TOPIC – Microbial Natural Products 
KEYWORDS - microbial mannosidation, 1-O-(α-D-mannopyranosyl)
chlorogentisyl alcohol, Chrysosporium synchronum
2010
UNUSUAL WITHANOLIDES FROM PHYSALIS HISPIDA 
(WATERF.) CRONQUIST
Cong-Mei Cao1, Huaping Zhang1, Robert J. Gallagher1, and Barbara N. 
Timmermann*,1
1Department of Medicinal Chemistry, University of Kansas, Lawrence, KS 
66045, United States
Withanolides are a group of modified C28 ergostane-type steroids with a 
C-22, C-26 δ-lactone side chain. As part of our continuing search for unu-
sual withanolides for SAR studies, we isolated and characterized nine new 
withanolides (1−9), withahisolides A−I, as well as nine known compounds 
(10−18) from the aerial parts of Physalis hispida. The structures of 1−9 were 
elucidated through a variety of spectroscopic techniques, while those of 1 
and 2 were further confirmed by X-ray crystallographic analysis. Among 
the eight new withanolides (1-7, 9) with an unusual six-membered ring D, 
1−3 are the first withanolides possessing non-aromatic six-membered ring 
D moieties. In addition, withanolide 8 represents a novel withanolide ske-
leton due to the absence of a C-13−C-17 bond within its steroidal nucleus.
2011
ECOLOGICAL AND ANTILEISHMANIAL ACTIVITY 
OF DITERPENES DERIVED FROM THE ANTARCTIC 
SPONGE DENDRILLA MEMBRANOSA
Christopher G. Witowski1,3, Jacqueline L. von Salm1, J. Alan Maschek1, 
Margaret O. Amsler4, Brian A. Vesely2, Dennis E. Kyle2, James B. 
McClintock4, Charles D. Amsler4, and Bill J. Baker1,3
Departments of 1Chemistry, 2Global Health, and 3Center for Drug 
Discovery and Innovation, University of South Florida, Tampa, FL 33612, 
and 4Department of Biology, University of Alabama at Birmingham, 
Birmingham, AL 35294
The cold waters of Antarctica harbor bountiful marine life and biodiversity 
that promotes competition and the biosynthesis of defensive secondary me-
tabolites. One inhabitant, the vibrant yellow sponge Dendrilla membrano-
sa, is known to inhibit feeding of Antarctic predators such as sea stars and 
amphipods. A metabolomics approach was undertaken to identify whether 
sponges within the amphipod-rich algal canopy adopt different chemical 
profiles to account for the increased predation pressure. In addition, our 
group has identified the membranolides from D. membranosa. This suite of 
methoxylated compounds possess potent and selective activity against the 
leishmaniasis-causing parasite Leishmania donovani. The origin of these 
compounds will be investigated as artifacts from methanolic degradation 
of aplysulphurin.
 
2012
NEW ANTI-PROLIFERATIVE PETASOL ANALOGS FROM 
FUNGUS FT087
Chunshun Li1, Baojun Yang1, James Turkson1 and Shugeng Cao1,*
1Natural Products and Experimental Therapeutics, Cancer Center, 
University of Hawaii, 701 Ilalo Street, Honolulu, Hawaii 96813, USA
In our search for anti-proliferative natural products from Hawaiian fungi as 
part of our Natural Product and Experimental Therapeutics Program, we 
screen our semi-pure natural product library against a panel of human can-
cer cell lines. One fraction generated from fungus FT087 was active against 
both A2780 (cisplatin-sensitive A2780) and A2780cisR (cisplatin-resistant 
A2780). Bioassay-guided fractionation led to the isolation of four new pe-
tasol analogs 1-4 together with a few known compounds. The structures 
of the new compounds were elucidated by spectroscopic methods. Some 
compounds showed strong antiproliferative activity against A2780S and 
A2780cisR.
2013
BIOACTIVE LIGNAN CONSTITUENTS FROM THE TWIGS 
OF LINDERA GLAUCA
Hee Rae Kang1, Hee Jeong Eom1, Seulah Lee1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
A bioassay-guided fractionation and chemical investigation of the MeOH 
extract from the twigs of Lindera glauca (SIEB. et ZUCC.) BLUME resulted in 
the isolation and identification of six lignans (1–6) including three new lig-
nan derivatives, named linderuca A (1), B (2), and C (3). The structures 
of the new compounds (1–3) were determined on the basis of spectro-
scopic analyses, including two dimensional NMR and circular dichroism 
(CD) spectroscopy studies. The cytotoxic activities of the isolates (1–6) 
were evaluated by determining their inhibitory effects on human tumor 
cell lines. Compounds 1–5 showed antiproliferative activities against A549, 
SK-OV-3, SK-MEL-2, and HCT-15 cell lines with IC50 values of 7.79–29.42 
μM. Based on the understanding that inflammation is a crucial cause of 
tumor progression, we also investigated the anti-inflammatory activities of 
the isolates (1–6) in the lipopolysaccharide-stimulated murine microglia 
BV-2 cell line by measuring nitric oxide (NO) levels. The new lignans (1–3) 
significantly inhibited NO production with IC50 values of 12.10, 9.48, and 
9.87 μM, respectively, without cytotoxicity.
2014
BACTERIAL SYMBIONTS ISOLATED FROM FUNGUS-
GROWING ANTS COLLECTED IN SÃO PAULO STATE, 
BRAZIL, AS SOURCES OF NATURAL PRODUCTS
Humberto E. Ortega1, Cameron R. Currie2, Jon Clardy3 and Mônica T. 
Pupo1
1School of Pharmaceutical Sciences of Ribeirão Preto, University of São 
Paulo, Ribeirão Preto-SP, Brazil, 2University of Wisconsin, Madison, USA, 
3Harvard Medical School, Boston, USA
As part of an ongoing ICBG (International Cooperative Biodiversity 
Groups) project we have focused collecting efforts on leaf-cutting ants from 
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different Brazilian biomes aiming the identification of new pharmacolo-
gically active natural products from insect bacterial symbionts. The initial 
collecting efforts have been centered on remaining areas of Atlantic Forest 
and Cerrado in São Paulo State. Seventy seven bacterial strains were isola-
ted from the bodies and fungal gardens of Acromyrmex ants. All bacterial 
strains were evaluated in antagonism bioassays against the specific patho-
genic fungus Escovopsis sp. Four of them showed good antagonist activity 
and presents morphology of actinobacteria. The four bioactive strains were 
cultured using ISP-2 agar and extracted with EtOAc. One extract has been 
fractionated by chromatographic methods and the antibiotics streptazolin 
(1) and its E-isomer (2) have been identified by NMR and HRESIMS; in ad-
dition to the diketopiperazines Cyclo(Leu-Pro) (3) and Cyclo(Ile-Pro) (4). 
Compound 1 has also been detected by HPLC-ELSD-PDA in the inhibition 
zone between the ant symbiont bacteria and Escovopsis sp.
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2015
STRUCTURE ELUCIDATION OF TWO NOVEL PEPTIDES 
FROM A MUSHROOM-DERIVED STREPTOMYCES SP.
Thomas P. Wyche1, Antonio C. Ruzzini1, Laura Schwab2, Cameron R. 
Currie2, and Jon Clardy1
1Department of Biological Chemistry and Molecular Pharmacology, 
Harvard Medical School, Boston, MA, 02115 USA, 2Department of 
Bacteriology, University of Wisconsin-Madison, Madison, WI 53706.
Bacterial-fungal interactions are present in numerous environments, inclu-
ding agriculture, food, and the human body, but in many cases, this rela-
tionship is not well understood. To investigate interactions between bacte-
ria and fungi, we examined the metabolites produced by several bacterial 
strains isolated from a collection of mushrooms. One strain (Streptomyces 
sp. HrubLS-53), isolated from the mushroom Hymenochaete rubiginosa, 
was found to produce enterobactin and paenibactin, as well as two novel 
peptides. The novel structures were determined by NMR and MS, inclu-
ding a 13C-13C COSY of isotopically enriched compounds. 
2016
PHYTOCHEMICAL AND ANTI-BACTERIAL STUDIES OF 
CISSUS IBUENSIS HOOK (VITACEAE)
Augustine A Ahmadu1, Adebola Onanuga2 and A. Agunu3
1Department of Pharmaceutical and Medicinal Chemistry, Niger 
Delta University, Wilberforce island,Bayelsa-Nigeria, 2 Department 
of Pharmaceutical Microbiology and Biotechnology, Niger Delta 
University,Wilberforce island,Bayelsa-Nigeria, 3 Department of 
Pharmacognosy and drug development,Ahmadu Bello University,  Zaria-
Nigeria
As part of our studies on Nigerian ethnomedicinal plants for bioactive 
plant metabolites,the leaves of Cissus ibuensis was examined. Cissus ibu-
ensis is a climber which belongs to the family Vitaceae and is widely dis-
tributed in tropical countries especially Nigeria,Niger,Togo and Ghana (1). 
Traditionally,the leaves of this plant is used in Northern Nigeria to treat 
gastrointestinal disturbance,as remedy for bacterial infections and to relie-
ve rheumatism and arthrithis (2). The acetone and ethanolic extracts of the 
leaves were screened for anti-bacterial activity against clinical isolates of 
S.aureus,B.subtilis,E.coli and Ps.aeruginosa using the method described by 
Mendoza (3). The ethanol extract showed significant activity against all the 
test bacteria isolates. The ethanol extract was then fractionated into ethyl 
acetate and n-butanol. The n-butanol soluble part of the ethanolic extract 
showed activity against all the test organisms with zones of inhibition ran-
ging from 16-20mm. The n-butanol extract was then subjected to column 
chromatography over silica gel and reverse phase HPLC to afford four fla-
vonoids namely: Rutin (15 mg),Kaempferol 3-O-α-rhamnopyranosyl 1-6) 
β-D-galactopyranoside (II),Kaempferol 3-O-rutinoside (III) and Kaempfe-
rol 3-O-dirhamnosyl galactoside (IV). The structures were elucidated using 
spectroscopic technique and compared with literature (4,5)
Reference
1.Irvine,F R (1961). Woody plants of Ghana. Oxford University Publication 
300-301
2.Dalziel,J M(1958). Flora of West Tropical Africa,PP 280-281
3. Mendoza,L;Wilkens M and Urzua A (1997) . Journ of Ethnopharmacol 
58(2):246-252
4.Mabry TJ et al (1970). The Systematic Identification of Flavonoids.
5.Markham KR et al (1978) 13C-NMR spectra of Flavonoids.
2017
ORTHOGONAL LC AND QNMR STANDARDIZATION 
CONFIRMS STABILITY OF RED CLOVER CLINICAL 
EXTRACT
Rasika S. Phansalkar, Shao-Nong Chen, Charlotte Simmler, David C. 
Lankin, James B. McAlpine, Guido F. Pauli
University of Illinois at Chicago, UIC/ NIH Center for Botanical Dietary 
Supplements Research, Department of Medicinal Chemistry and 
Pharmacognosy, 833 S. Wood Street, Chicago, Illinois.
Trifolium pretense L. (red clover) is well known for containing estrogenic 
isoflavones and is one of the commonly used herbs for the alleviation of 
post-menopausal symptoms. In this study, we have developed two ortho-
gonal methods, UHPLC-UV and qHNMR, for the quantitation of the two 
major isoflavones, biochanin A and formononetin, as well as several minor 
isoflavones including daidzein and genistein, in a 10-year old clinical trial 
extract. Quantitation by 1H-NMR has been performed using two approa-
ches. The first employs the traditional integral-based quantitation, internal 
calibration, and linear deconvolution of the signals to resolve the overlap. 
The second, more advanced approach uses the quantum-mechanical based 
deconvolution approach of the HiFSA-qHNMR method. Thus, quantita-
tion is performed based on the population ratios of different molecular 
species in the extract via QM-based spectral simulation. The quantitative 
results from the LC and the qHNMR methods are congruent, allow con-
clusions about precision and accuracy in botanical standardization, and 
demonstrate the chemical stability of the red clover extract over time.
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2018
OXYESTEROL-BINDING PROTEIN FAMILY (OSBP/ORP) 
LIGAND BINDING AND NATURAL PRODUCT DRUG 
DEVELOPMENT
Juan Nunez, Nicholas Wasinger, Anthony W.G. Burgett
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman, Ok 73109, USA
A structurally-diverse class of potent anti-cancer natural product com-
pounds – cephalostatin 1, OSW-1, ritterazine B and schweinfurthin A –
exert their anti-proliferative activity through binding to members of the 
oxysterol-binding protein (OSBP) and OSBP-related protein (ORP) family. 
Based on their shared OSBP/ORP cellular targets, these natural products 
are referred to as the ORPphilins. The ORPphilin compounds have been 
shown to bind with high affinity (Ki values = 20-70 nM) to two members 
of the OSBP/ORP family; namely OSBP and ORP4. This shared tight bind-
ing is remarkable due to the structurally-diversity of the ORPphilin natu-
ral product class of molecules, and the fact these compounds were isolated 
from very different biological sources. The cellular function(s) of the OSBP/
ORPs are yet to be fully determined, but some of the family members ap-
parently serve as sterol sensors and/or sterol transporting proteins. There 
are twelve different OSBP/ORPs in humans that show very different tissue 
distribution patterns. The expression levels and function of many differ-
ent OSBP/ORPs have been implicated in in many disease-states, including 
different cancers, diabetes and cardiovascular disease. Despite their con-
nections to disease, the OSBP/ORPs remain understudied with respect to 
their ligand binding and resulting biological function. The OSBP/ORP have 
been shown to experimentally bind oxysterols and phospholipids, but the 
physiological ligands for the OSBP/ORP members have not been identified. 
We have launched a systematic study of class-wide OSBP/ORP ligand bind-
ing, which includes understanding the binding interactions of the OSBP/
ORPs with the ORPphilin natural products. Our 96-well OSBP/ORP ligand 
binding assay allows screening of many ligands against the complete panel 
of OSBP/ORP proteins, and the screen will incorporate a diverse set of ox-
ysterols, phospholipids and ORPphilin-derived compounds. Through these 
comprehensive binding assays and subsequent biochemical studies, we will 
identify putative physiological ligands for individual OSBP/ORP family 
members. We will also begin to develop natural product-derived anti-can-
cer compounds, based on the ORPphilin compound OSW-1, that selective-
ly target the anti-cancer target protein ORP4 over the other members of the 
OSBP/ORPs family. 
2019
BIOACTIVE SALICIN DERIVATIVES FROM SALIX 
GLANDULOSA
Won Se Suh, Chung Sub Kim, Kyoung Jin Park, Oh Kil Kwon, Joon Min 
Cha, and Kang Ro Lee
Natural Products Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
The genus Salix (willow) includes about 400 species of deciduous trees, and 
extracts of their bark have been used in folk medicine for the treatment of 
fever, pain and inflammation. Salix glandulosa SEEMEN (= S. chaenomelo-
ides KIMURA, Salicaceae), also called “Korean King Willow”, is distributed 
in Korea, Japan and mainland China. In a continuing search for bioactive 
constituents from Korean medicinal plants, we found that the MeOH ex-
tract of S. glandulosa twigs showed anti-inflammatory effect. The CHCl3 
and EtOAc layers were subjected to repeated column chromatography and 
semi-preparative HPLC to give two new salicin derivatives (1-2), along 
with fourteen known analogues (3-16). The structures of 1-16 were cha-
racterized by the use of NMR methods (1H and 13C NMR, 1H-1H COSY, 
HMQC and HMBC), chemical hydrolysis, and GC/MS. All the isolates (1-
16) were evaluated for their inhibitory effects on nitric oxide (NO) produc-
tion in lipopolysaccharide (LPS)-activated BV-2 cells, a microglial cell line. 
2020
THREE NEW LIGNAN DERIVATIVES FROM THE TWIGS 
OF SAMBUCUS WILLIAMSII
Won Se Suh, Kyoung Jin Park, Joon Min Cha, Oh Kil Kwon, and Kang Ro 
Lee.
Natural Products Laboratory, School of Pharmacy, SungKyunKwan 
University, Suwon 440-749, Republic of Korea
As a part of our ongoing search for cytotoxic constituents from natural 
Korean medicinal sources, we investigated the constituents of the twigs of 
Sambucus williamsii var. coreana NAKAI (Caprifoliaceae). This plant is 
deciduous shrub, which is widely distributed throughout Korea, Japan and 
China. S. williamsii has been used as a Korean traditional medicine for the 
treatment of bone fracture and osteoporosis. Previous phytochemical in-
vestigation on S. williamsii reported triterpenes, phenolic compounds, and 
lignans. Especially, lignans were mainly isolated and some of them showed 
anti-proliferation activities on osteoblastic-like UMR106 cells. A bioassay-
guided fractionation and chemical investigation of the twigs of S. williamsii 
resulted in the isolation and characterization of three new lignan derivati-
ves (1-3) along with seven known lignans (4-10). The structures of these 
new compounds were determined on the basic of spectroscopic analyses 
including 2D NMR and CD spectroscopic data. The isolated compounds 
(1-10) were tested for their cytotoxic activity on the human tumor cell lines 
(A549, SK-OV-3, SK-MEL-2, and HCT-15) using a SRB assay.
2021
BIOACTIVITY-GUIDED ISOLATION AND 
QUANTIFICATION OF EPISILVESTROL AND 
SILVESTROL FROM AGLAIA PERVIRIDIS
Garima Agarwal,1 Li Pan,1 C. Benjamin Naman,1 Hee-Byung Chai,1 Tran 
Ngoc Ninh,2 Djaja Djendoel Soejarto,3,4 and A. Douglas Kinghorn.1
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, Ohio 43210; 2Institute of Ecology and 
Biological Resources, Vietnam Academy of Science and Technology, Hanoi, 
Vietnam; 3College of Pharmacy, University of Illinois at Chicago, Chicago, 
IL 60612; 4Science and Technology, Field Museum, 1400 S. Lakeshore Dr., 
Chicago, IL 60605
Bioactivity-guided isolation, fractionation and quantification from Aglaia 
perviridis Hiern (Meliaceae) (voucher specimen: Soejarto et al 14595) 
demonstrated it to be only the third plant of the genus Aglaia found to 
produce silvestrol and its epimer, 5´´´-episilvestrol (episilvestrol). Several 
fractions from the chloroform extract produced from the whole plant were 
found to be active against HT-29 human colorectal cancer cells in vitro. 
Further purification and chemical analysis of the active fractions interest-
ingly showed them to contain episilvestrol in a higher amount compared to 
silvestrol, contrary to the observation of silvestrol being the more abundant 
compound as in Aglaia foveolata.
2022
PHARMACOKINETIC INTERACTIONS BETWEEN DRUGS 
AND BOTANICAL DIETARY SUPPLEMENTS
Alyssa A. Sprouse1,2 and Richard B. van Breemen1,2.
1 Department of Medicinal Chemistry and Pharmacognosy, 2 UIC/NIH 
Center for Botanical Dietary Supplements Research University of Illinois at 
Chicago, Chicago, IL
The use of botanical dietary supplements has grown steadily over the last 20 
years despite incomplete information regarding active constituents, mecha-
nisms of action, efficacy, and safety. An important but under-investigated 
safety concern is the potential for popular botanical dietary supplements to 
interfere with the absorption, transport and/or metabolism of pharmaceuti-
cal agents. Clinical trials of drug-botanical interactions are the gold standard 
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and are usually carried out only when indicated by unexpected consumer 
side effects or, preferably, by predictive in vitro studies. For example, Phase 
I clinical trials have confirmed clinical observations and in vitro studies that 
St. John’s wort (Hypericum perforatum) induces cytochrome P450 3A4/5, 
whereas Phase I studies did not substantiate in vitro predictions that milk 
thistle (Silybum marianum) would inhibit CYP1A2, CYP2C9, CYP2D6, 
CYP2E1, and CYP3A4. Here, we highlight discrepancies between in vitro 
and in vivo data concerning drug-botanical interactions and critically evalu-
ate why some in vitro models overestimate or sometimes underestimate the 
potential for drug-botanical interactions. Gaps in our knowledge are also 
highlighted for the potential of some popular botanical dietary supplements 
to interact with therapeutic agents with respect to absorption, transport and 
metabolism.
Supported by grant P50 AT000155 from the NIH ODS and NCCIH
2023
FUNDING OPPORTUNITIES IN THE NCI’S CANCER 
DIAGNOSIS PROGRAM
Tawnya C. McKee
Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, 
DCTD, NCI, Bethesda, MD 20892-9704.
The Cancer Diagnosis Program is part of the NCI’s Division of Cancer 
Treatment and Diagnosis and supports a variety of funding opportuni-
ties related to cancer diagnosis and treatment. New funding opportuni-
ties include: NCI’s IMAT Program, Academic-Industrial Partnerships for 
Translation of Technologies for Cancer Diagnosis and Treatment, Assay 
Validation for High Quality Markers for NCI-Supported Clinical Trials, 
Opportunities in Bio-engineering Grants and Advancing Translational and 
Clinical Probiotic/Prebiotic and Human Microbiome Research. These and 
other related funding opportunities will be presented.
2024
BOTANICAL INITIATIVE FOR THE DIETARY 
SUPPLEMENT INGREDIENT DATABASE (DSID): 
PRELIMINARY DATA FOR GREEN TEA SUPPLEMENTS
Karen W Andrews1, Phuong-Tan Dang1, Sushma Savarala1, Pavel A Gusev1 
Fei Han1, Pamela R Pehrsson1, James M Harnly2, Pei Chen2, Johanna T 
Dwyer3, Joseph M Betz3, Leila G Saldanha3 and Rebecca B Costello3
1Nutrient Data Laboratory, US Department of Agriculture, Beltsville, MD 
20705, USA, 2Food Composition and Methods Development Laboratory, 
US Department of Agriculture, Beltsville, MD 20705, 3Office of Dietary 
Supplements, National Institutes of Health, Bethesda, MD 20892 
The Dietary Supplement Ingredient Database (DSID) provides analytical-
ly-derived estimates of the ingredient content in dietary supplements (DS). 
DSID 3.0 now includes 4 categories of DS: adult, children’s and non-pre-
scription prenatal multivitamin/mineral products (MVM), and omega-3 
fatty acid DS. Green tea was chosen for analysis in the pilot study for the bo-
tanical initiative due to high consumption and availability of certified refer-
ence materials and validated analytical methods. The goals of this study are 
to obtain estimates of content for catechins, caffeine and other ingredients 
in products with and without label information. Green tea DS (n=32) were 
purchased from multiple sales channels and analyzed by 3 laboratories. A 
third (33%) of the products had labeled amounts for caffeine (4–195 mg 
per day) or total catechins (19-700 mg per day). More products (75%) had 
labeled amounts for epigallocatechin gallate (EGCG) or total polyphenols 
ranging from 125-1050 mg per day and 28-1200 mg per day respectively. 
In initial tests, 44% of products failed disintegration testing. Preliminary 
evaluation of the quality control data showed agreement among the labs 
for caffeine and EGCG in certified reference materials. The final results will 
inform the plans for the next botanical study.
2025
THE DISCOIPYRROLES: A MULTIFACETED APPROACH 
TO UNDERSTAND A NOVEL FAMILY OF MARINE 
NATURAL PRODUCTS
Colosimo DA1, Cai F1, Hu Y1, Potts MB2, White MA2, Ready JM1, 
MacMillan JB1
1Department of Biochemistry, 2Department of Cell Biology, UT Southwestern 
Medical Center, Dallas, TX 75390
Around 4-8% of patients with squamous cell carcinoma, the most prevalent 
subtype of non-small cell lung cancer (NSCLC), carry genetic mutations in 
discoidin domain containing receptor 2, or DDR2 (Hammerman, PS, Can-
cer Discovery 2011). This unique receptor tyrosine kinase binds collagen in 
the extracellular matrix and initiates signaling for cellular processes such as 
migration and adhesion. We discovered a novel family of natural products, 
the discoipyrroles, produced by the marine bacteria Bacillus hunanensis 
that demonstrate potent cytotoxicty towards DDR2 mutated NSCLC cell 
lines, but not DDR2 wildtype NSCLC cell lines (Hu, Y, JACS 2013). Cur-
rently, we are investigating multiple aspects of the discoipyrroles including 
their optimization as potential therapeutics, the mechanism by which they 
elicit cell-specific cytotoxicity, and their intriguing biosynthesis which fea-
tures key non-enzymatic steps.
Cytotoxicity to lung cancer cell lines
 HCC366* H2286* A549† >40 cell lines†
DPA 0.12 0.256 10.2 >24 
DPB 0.19 0.276 8.8 -
DPC 0.712 0.796 19.6 -
DPD 0.275 0.412 13.4 -
Dasatanib 0.17 - 9.8 -
*DDR2 mutant cell lines (HCC366: L293R; H2286: I638F). 
†DDR2 wildtype cell lines. IC
50
 in μM.
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2026
IDENTIFICATION OF NEW THERAPEUTIC LEADS FOR 
TRIPLE NEGATIVE BREAST CANCER SUBTYPES
Andrew J. Robles1, Lin Du3, Shengxin Cai3, Robert H. Cichewicz3 and Susan 
L. Mooberry1,2.
1Department of Pharmacology and 2Cancer Therapy & Research Center, The 
University of Texas Health Science Center at San Antonio, 7703 Floyd Curl 
Drive, San Antonio, TX 78229. 3Natural Products Discovery Group, Institute 
for Natural Products Applications and Research Technologies, University of 
Oklahoma, 101 Stephenson Parkway, Norman, OK 73019. 
High-content screening of plant and fungal extracts in a panel of cell lines 
modeling triple negative breast cancer subtypes identified 11 extracts with 
selective activity against particular cell lines. Maximiscin, (P/M)-1, was 
identified as having selective cytotoxic efficacy against the basal-like MDA-
MB-468 cell line. Deguelin (2) was identified as having selective antiprolife-
rative activity against the MDA-MB-453 cell line, representing the luminal 
androgen receptor subtype of TNBC. Mechanistic studies showed that ma-
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ximiscin caused an accumulation of cells in G1. Immunoblotting of maxi-
miscin-treated whole cell lysates showed that maximiscin increases levels of 
P-p53, P-Chk1, P-Chk2, and γ-H2A.X. These results are consistent with the 
observed G1 accumulation and collectively suggest that maximiscin indu-
ces DNA damage. Preliminary experiments suggest deguelin modulates AR 
localization and inhibits phosphorylation of Akt, ribosomal protein S6 and 
4E-BP1 as soon as 2 h after treatment. These results demonstrate that new 
compounds with potential therapeutic value for the treatment of TNBC 
subtypes can be identified from nature. 
2027
CHEMICAL EXCHANGE IN ENDOPHYTIC 
ACTINOBACTERIA COMMUNITIES
Caraballo-Rodriguez, A. M.1, 2, Pupo, M. T.1, Dorrestein, P. C.2 
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, 
Avenida do Cafe s/n, 14040-903 Ribeirao Preto, SP, Brazil.1 Skaggs School of 
Pharmacy & Pharmaceutical Sciences, University of California-San Diego, 
9500 Gilman Drive, La Jolla, 92093-0751 San Diego, CA, United States.2 
Endophytic actinobacteria from Lychnophora ericoides -a Brazilian plant 
popularly used against wound, inflammation and pain- have not deeply 
studied yet, resulting in ignorance about the role this microorganisms play 
in this medicinal plant. Endophytic microorganisms are in a continuous 
endophyte-endophyte interaction inside plant tissues. For that reason, by 
simulating actinobacteria communities we were able to correlate phenoty-
pic differences in interacting actinobacteria as a consequence of metabolic 
exchange detected by recent mass spectrometry techniques. These intere-
sting results, as part of our efforts to understand the biological role of mi-
crobial molecules from endophytes and their impact into their hosts, will 
be presented.
Example of a MALDI-TOF image showing interaction of two endophytic 
actinobacteria resulting in elicitation of an unknown metabolite detected 
as the ion of m/z 311. Timecourse of coculture: a. 24, b. 48, c. 72 and d. 
96 hours. White colonies correspond to Streptomyces albospinus RLe7 and 
brown colonies correspond to Streptomyces mobaraensis RLe3.
2028
GARCINIA BENZOPHENONES PROMOTE HYPHAL 
APOPTOSIS AND POTENTIATE ACTIVITY OF 
FLUCONAZOLE IN CANDIDA ALBICANS BIOFILMS
Desmond N. Jackson1, Lin Yang1,2, Shi-Biao Wu3, Edward J. Kennelly2,3, and 
Peter N. Lipke1,2
1Biology Department, Brooklyn College of the City University of New York, 
Brooklyn, NY, 2The Graduate Center of the City University of New York, 
New York, NY, 3Department of Biological Sciences, Lehman College, The City 
University of New York, Bronx, NY, 10468
Xanthochymol and garcinol, isoprenylated benzophenones purified from 
Garcinia xanthochymus fruits, showed multiple activities against Candida 
albicans biofilms. Both compounds effectively prevented emergence of 
fungal germ tubes, although they did not affect fungal adhesion to sub-
strate. Xanthochymol indefinitely prevented hyphal emergence and thus 
prevented development of hyphae and subsequent biofilm maturation. 
Garcinol was a transient inhibitor. Xanthochymol (10-5 M) also induced 
hyphal-specific cell death in forming and mature biofilms. The death had 
characteristics of apoptosis, including externalization of phosphatydyl ser-
ine and DNA fragmentation, as evidenced by TUNEL fluorescence. This 
activity contributed to inhibition of biofilm maturation, and also led to hy-
phal death in mature biofilms. Further, xanthochymol was synergistic with 
fluconazole, reducing the EC50 value for the antifungal 80-fold from >1024 
µg/ml to 13 µg/ml. Therefore xanthochymol has potential both as a reagent 
for determining cellular mechanisms of morphogenesis and programmed 
death, and as an adjuvant for antifungal treatments.
2029
QUALITY EVALUATION OF TERPINEN-4-OL TYPE TEA 
TREE OILS AND COMMERCIAL PRODUCTS USING GC/
MS AND CHEMOMETRICS
Mei Wang1, Jianping Zhao1, Bharathi Avula1, Yan-Hong Wang1, Amar G. 
Chittiboyina1, Jon F. Parcher1 and Ikhlas A. Khan1,2
1National Center for Natural Products Research, and 2Division of 
Pharmacognosy, Department of BioMolecular Science, School of Pharamacy, 
University of Mississippi, University, MS 38677.
GC/MS, chiral GC/MS and chemometric techniques were used to evaluate 
a large set (n=104) of tea tree oils (TTO) and commercial products purpor-
ted to contain TTO. Twenty terpenoids were determined in each sample 
and compared with the standards specified by ISO-4730-2004. Several of 
the oil samples that were ISO compliant when distilled did not meet the 
ISO standards primarily due to the presence of excessive p-cymene and/or 
depletion of terpinenes. Forty-nine percent of the commercial products did 
not meet the ISO specifications. Four terpenes, viz., α-pinene, limonene, 
terpinen-4-ol and α-terpineol, present in TTOs with the (+) isomer pre-
dominant were measured by chiral GC/MS. The results clearly indicated 
that 28 commercial products contained excessive (+) isomer or contained 
the (+) isomer in concentrations below the norm. Of the 28 outliers, 7 met 
the ISO standards. There was a substantial subset of commercial products 
that met ISO standards but displayed unusual enantiomeric (+)/(-) ratios. 
A class predictive model based on the oils that met ISO standards was con-
structed. The outliers identified by the class predictive model coincided 
with the samples that displayed an abnormal chiral ratio. Thus, chiral and 
chemometric analyses could be used to confirm the identification of abnor-
mal commercial products including those that met all of the ISO standards. 
2030
STRUCTURES OF TWO OLEANANE-TYPE 
TRITERPENOIDS FROM AN EXTRACT OF CYRILLA 
RACEMIFLORA HOUSED IN A REPOSITORY
Yulin Ren1, Andrew VanSchoiack2, Hee-Byung Chai1, Michael Goetz3, and 
A. Douglas Kinghorn1.
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
and 2Mass Spectrometry and Proteomics Facility, Campus Chemical 
Instrument Center, The Ohio State University, Columbus, OH 43210, United 
States, 3Natural Products Discovery Institute (NPDI), Baruch S. Blumberg 
Institute (BSBI), Doylestown, PA 18902, United States
Two new oleanane-type triterpenoids were isolated from a small-scale sam-
ple of a dichloromethane partition of an ethanol-soluble extract of Cyrilla 
racemiflora L. (Cyrillaceae) collected in Dominica. This extract repository 
was donated to BSBI by Merck Research Laboratories, Rahway, NJ, USA. 
The structures of these compounds were elucidated by interpretation of 
their spectroscopic data, with an unusual compound containing a di-an-
gelated glucose residue being confirmed by its MS2 and MS3 mass spectra. 
The conformation of the pentacyclic ring system of these triterpenoids was 
characterized based on the published single-crystal structure of 3-O-acety-
loleanolic acid, and the absolute configuration of these two compounds 
was ascertained by analysis of their electronic circular dichroism (ECD) 
induced with [Mo2(OAc)4] and NOESY 2D NMR spectra.
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2031
NEW ANTIBACTERIAL COMPOUNDS INHIBITING 
STAPHYLOCOCCUS AUREUS ENOYL-ACP REDUCTASE 
FROM PENICILLIUM SP.
Nyung Kim1, Mi-Jin Shon1, Hiroyuki Koshino2, and Won-Gon Kim1
1Superbacteria Research Center, Korea Research Institute of Bioscience and 
Biotechnology, Yusong, Daejeon 305-806, Korea. 2Global Research Cluster, 
RIKEN, Hirosawa 2-1, Wako, Saitama 351-0198, Japan, and Division of 
Magnetic Resonance Research
Bacterial enoyl-ACP reductase (FabI) is an attractive antibacterial target 
which catalyzes the final and rate-limiting step in bacterial fatty acid syn-
thesis. Therefore, FabI inhibitors could be interesting lead compounds for 
treatment of multidrug-resistant bacteria. In the course of our screening 
for FabI inhibitors from microbial resources, a fungal strain Penicillium 
verruculosum producing FabI-inhibitory and antibacterial metabolites was 
selected. Five novel metabolites named verrulactones A-E with the known 
compound, altenuisol, were isolated from the fermentation broth of the 
fungal strain. Their chemical structures were elucidated by 2D NMR and 
MS analysis. Verrulactones A and B were dimeric compounds of alternari-
ol. Verrulactones C was a dispiro compound. Verrulactones D and E were 
highly quaternary and unique compounds. Verrulactones A and B stron-
gly inhibited Staphylococcus aureus enoyl-ACP reductase with an IC50 of 1 
µM. Verrulactones C-E also showed FabI-inhibition even though weaker 
than Verrulactones A and B. They, however, didn’t inhibit S. aureus FabG, 
another reductase of bacterial FAS, even at 300 µM. It indicated selective 
inhibition for FabI. Consistent with their FabI inhibitory activity, they also 
showed inhibition on intracellular fatty acid biosynthesis in S. aureus as 
well as antibacterial activity against S. aureus and MRSA. 
2032
RAPID IDENTIFICATION OF MINOR ACTIVE 
METABOLITES IN EXTRACTS OF MARINE ORGANISMS: 
A PLATFORM FOR EFFICIENT DRUG DISCOVERY
Oliver B. Vining, Lisa Vuong, Tina Cheng, Tamara Mayer, Venkat Macherla, 
Jacob Beverage, Eduardo Esquenazi.
Sirenas Marine Discovery, 3550 General Atomics Court, Bldg 02/211, San 
Diego, CA, 92121.
Efficient identification of biologically active metabolites present in complex 
crude extracts continues to be a significant challenge in natural products 
discovery. To overcome this obstacle, contemporary drug discovery pro-
grams have placed an emphasis on the development of multifaceted ap-
proaches to capture comprehensive biological and chemical data early in 
the isolation workflow. This information can be used to quickly characterize 
active metabolites and direct research efforts to those with the highest po-
tential for development as drug leads. Here we outline a discovery platform 
used to rapidly generate and screen a large fraction library from extracts of 
marine organisms. Fractions are concurrently analyzed by high-resolution 
LC-MS/MS and assayed against a panel of human cancer cell lines. Analy-
sis of aggregate biological and mass spectrometric data is combined with 
molecular networking to evaluate the structural diversity of active metabo-
lites and direct future isolation efforts. To highlight the effectiveness of this 
platform, we describe the identification of dolastatin 10 and symplostatin 
1, potent cytotoxic linear peptides, in multiple extracts of phylogenetically 
diverse organisms collected from a single geographic area. Production of 
these compounds is attributed to a cyanobacterial strain co-occurring in 
low abundance with the field collected organisms. Subsequent purification 
of both compounds, guided by the chemical information collected during 
library generation, allowed structural verification by NMR.
2033
EFFECT OF PAEONIFLORIN ON NERVOUS SYSTEM: A 
SYSTEMATIC REVIEW
Jianjun Zhang1*, Zhihui Yang2, Yingli Zhu1, Linyuan Wang1, Jingxia Wang1, 
Kevin K.W.2*
1Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Chaoyang 
Qu, Beijing 100029, China, 2Department of Psychiatry&Neuroscience, 
University of Florida, Gainesville, FL 32608, USA.
Radix Paeoniae Alba, a well-known Chinese herbal, has been widely used 
in Chinese Medicine for thousands of years. Paeoniflorin (PF) has been 
extensively studied in the last 5 years and shows multiple pharmacological 
actions. In this paper, we review the relevant literature to know the effect 
of PF on nervous system (NS). Data sources of PUBMED from January 
2012 to April 2015 were searched. Inclusion criteria clearly described the 
effect of PF on NS. Among 280 articles identified in the literature search, 
22 studies met the review inclusion criteria. According to current findings, 
PF was found to ameliorate the decline of memory and learning capacities 
among NS-related pharmacological models. In addition, PF shows protec-
tive effects on depression, cerebral ischemia injury as well as Parkinson’s 
disease by reliving the pain and improving neural synapse plasticity. The 
pharmacological targets involve multiple pathways including adenosine A1 
receptor, M cholinergic receptor, opiate receptor calcium ion channel, NF-
κB, Akt and NGF. 
2034
DISCOVERY OF FATTY ACID SYNTHASE INHIBITORS 
AND THEIR BIOSYNTHETIC PATHWAYS BY A NOVEL 
TARGET-DIRECTED GENOME MINING STRATEGY
Jie Li1 , Xiaoyu Tang1, Jia Jia Zhang1, Ellis C. O’Neill1, Simone M. 
Mantovani1 and Bradley S. Moore1,2
1Scripps Institution of Oceanography, University of California (UC), San 
Diego, La Jolla, CA 92093, 2Skaggs School of Pharmacy and Pharmaceutical 
Sciences, UC, San Diego, La Jolla, CA 92093
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In order to avoid self-toxicity, many antibiotic-producing microbes have 
developed self-resistance mechanisms, with target modification being one 
frequent example. We propose that extra copies of an essential housekee-
ping gene found within or adjacent to a biosynthetic pathway may indicate 
that the compound(s) produced will target the protein encoded by the cor-
responding housekeeping gene. Thus, a novel and rational target-directed 
genome mining strategy was developed, by which potential self-resistance 
genes were analyzed bioinformatically, followed by a PCR-independent 
cloning and heterologous expression of the intact gene clusters for rapid 
production of compounds with desired bioactivities. As a proof-of-prin-
ciple study, two related orphan gene clusters with potential fabF resistance 
genes were identified and expressed, which led to the isolation of a group 
of unique thiotetronic acid natural products that inhibit bacterial fatty acid 
synthase (1–9). A notable advantage of this genome mining strategy is 
that specific molecular targets can be hypothesized in the absence of prio-
ri knowledge of the structures of the molecules biosynthesized, and may 
streamline mechanism of action studies for the products obtained.
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2035
HEMATOPOIETIC EFFECTS OF PAEONIFLORIN 
AND ALBIFLORIN ON RADIOTHERAPY AND 
CHEMOTHERAPY-INDUCED ANEMIA MICE
Yingli Zhu1, Jianyu Zhou1, Linyuan Wang1, Zhihui Yang2, Jianjun Zhang1*
1 Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Chaoyang 
Qu, Beijing 100029, China, 2 Department of Psychiatry & Neuroscience, 
University of Florida, Gainesville, FL 32608, USA.
Paeoniflorin (PF), a monoterpene glycoside isolated from P. lactiflora, 
possesses a variety of pharmacological activities. However, albiflorin (AF), 
another constituent regarded as a characteristic one, has not been well stud-
ied. This study aimed to investigate the hematopoietic effects of AF and PF 
on anemia mice induced by radiotherapy or chemotherapy and to explore 
the underlying mechanisms. The anemia mice were irradiated at a dose 
of 2.5 Gy using cobalt-60 gamma resources or  intraperitoneally injected 
with cyclophosphamide (160.0 mg/kg). The numbers of blood cells from 
peripheral blood were counted. The thymus index and spleen index were 
also measured. In addition, of the chemotherapy-induced mice, the levels 
of TNF-α, GM-CSF, IL-3 in serum were measured by RIA. AF and PF sig-
nificantly increased the numbers of peripheral blood cells and reversed the 
atrophy of thymus and spleen. Furthermore, AF and PF increased the levels 
of GM-CSF and IL-3 and reduce the level of TNF-αin serum.. Our results 
suggest that AF and PF may promote the recovery of bone marrow hemo-
poietic function in a myelosuppressed mouse model.
2036
IRISH OSMUNDEA spp.: FOOD OR SHELTER FOR 
APLYSIA sp.?
Sylvia Soldatou1, Ryan M. Young1,2, Candice L. Bromley1, Svenja Heesch3, 
and Bill J. Baker1,2
1School of Chemistry, National University of Ireland, Galway, Ireland 
2Department of Chemistry and Center for Drug Discovery and Innovation, 
University of South Florida, Tampa, FL 33620, 3 Irish Seaweed Research 
Group, Ryan Institute for Environmental, Marine and Energy Research, 
National University of Ireland, Galway, Ireland.
The Irish coastline is approximately 7500 Km long representing one of the 
most biodiverse and rich-species habitats in Europe. With only few studies 
conducted in the North East Atlantic region, Irish waters can be a great 
source of new and unexplored chemical diversity. Four different Osmun-
dea sp., commonly found in intertidal zone, have been described from Irish 
waters. Aplysia sp., is a sea hare which has been found to be associated with 
Osmundea algae. This project is focusing on the isolation and characterisa-
tion of secondary metabolites from Osmundea spp. and Aplysia sp. samples 
collected from the shore of Western Ireland in county Galway. The ultimate 
aim is to compare the chemistry produced by these two marine organisms 
and determine whether the sea hares are sequestering the compounds from 
the algae or they are using the Osmundea spp. as a shelter from predators 
and strong water currents. Thus half the Aplysia sp. collected were allowed 
to fast prior to analysis affording an opportunity to sample the chemistry 
contained within the sea hares rather than that contained within the diges-
tive tract. The algal and animal samples were extracted separately in organ-
ic solvents followed by purification and isolation of secondary metabolites 
by means of Medium Pressure Liquid Chromatography (MPLC) and High 
Performance Liquid Chromatography (HPLC). Comparisons between the 
algal and sea hare extracts were carried out through metabolomics anal-
ysis using Liquid Chromatography-Mass Spectrometry (LC-MS) and Gas 
Chromatography-Mass Spectroscopy (GC-MS). Moreover, the structures 
of pure metabolites were elucidated by means of 1D and 2D Nuclear Mag-
netic Resonance (NMR) spectroscopy. 
2037
ACAI (EUTERPE OLERACEA MART.) ATTENUATES 
ALCOHLO-INDUCED LIVER DISEASE IN RATS 
Jianyu Zhou1,2, Jianjun Zhang1, Chun Wang1, Shengsheng Qu1, Yingli Zhu1, 
Zhihui Yang3, and Linyuan Wang1*
1Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Chaoyang 
Qu, Beijing 100029, China, 2Chengde Medical University, Hebei province 
Chengde 067000, China, 3Department of Psychiatry & Neuroscience, 
University of Florida, Gainesville, FL 32608, USA.
Alcohol-induced oxidative stress plays a crucial role in the pathological 
development of alcoholic liver disease. Açaí has been shown with high 
levels of phytochemicals that exhibit anti-oxidant and anti-inflammatory 
activities in many studies. However whether these features of açaí make 
it a good candidate for treating ALD is unknown. The aim of this study is 
to investigate the effects of açaí on hepatic oxidative stress and consequent 
liver disfunction in rats. Açaí puree (1mL /100g body weight) was adminis-
tered to alcohol-induced liver disease rats for 8 weeks. Various biochemical 
parameters related to oxidative stress and inflammatory factors along with 
histology of liver were evaluated to assess the effect of açaí against ALD. 
Our present study has shown that the administration of açaí puree attenu-
ated liver injury caused by alcohol consumption. The production of inflam-
mation mediators, such as TNF-α, TGF-β and IL-8 were elevated in alcohol 
treated rats but decreased upon the administration of açaí puree. With the 
administration of açaí, the levels of NF-κB and CD68 were lowered. The 
results obtained here strongly suggested the protective role of açaí against 
ALD and these effects are via its effects on oxidant stress and inflammation. 
2038
MICROBIAL METABOLISM OF PRENYLATED APIGENIN 
DERIVATIVES 
Yina Xiao and Ik-Soo Lee
College of Pharmacy and Research Institute of Drug Development, 
Chonnam National University, Gwangju 500-757, Republic of Korea
Prenylated flavonoids are rich in structural variety and pharmacological ac-
tivity. It has been reported that the introduction of a prenyl group into the 
flavonoids could improve their biochemical and pharmacological proper-
ties. Many prenylated apigenins have been shown to exhibit significant an-
titumor, anticonvulsant, anti-inflammatory and vascular protective prop-
erties, but their biological activities are often limited by their poor water 
solubility. Microbial transformation is a useful method to modify chemical 
structures of natural products to derivatives which are difficult to produce 
synthetically, as well as to improve the solubility and biological activities. 
The aim of our study is to identify more polar metabolites of the bioac-
tive prenylated apigenin derivatives through microbial metabolism. The 
detailed procedure of fermentation, isolation and structure elucidation of 
these metabolites will be presented.
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THE PROCESS OF DESIGNING AND DEVELOPING 
SPLICEOSTATIN CLASS OF SPLICING INHIBITORS AS 
PAYLOADS FOR ANTIBODY DRUG CONJUGATES 
Anokha S. Ratnayake1, Edmund Graziani1, Jesse Teske1, Kenneth Dirico1, 
Haiyin He1, Alessandra Eustaquio2, Sujiet Puthenveetil1, Nathan Tumey1, 
Li-Ping Chang1, Jeffrey E. Janso1, Christopher J. O’Donnell1, Chakrapani 
Subramanyam1, Frank E. Koehn1 and Frank Loganzo3
1Natural Products Laboratory, Worldwide Medicinal Chemistry, Pfizer 
Worldwide Research and Development, 558 Eastern Point Road, Groton, 
Connecticut 06340. 2University of Bergen, Thormohlens gate 53 A, Bergen, 
Norway 5008. 3Pfizer Oncology, 401 N. Middletown Road, Pearl River, New 
York 10965.
The natural product FR901464 (1), spliceostatin C (2) and thailanstatin (3), 
are ultrapotent inhibitors of eukaryotic RNA splicing, via binding to the 
SF3b subunit of the U2 snRNA subcomplex, an essential component of the 
spliceosome. Manipulation of the biosynthetic genes that control produc-
tion of these analogs in the bacteria have allowed us to generate sufficient 
material for a medicinal chemistry approach to evaluating this mechanistic 
class as potential payloads for antibody drug conjugates (ADCs). This oral 
presentation will detail some successful ways to leverage spliceostatin ana-
logs to generate potent and efficacious ADCs for the treatment of cancer.
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2040
SMALL MOLECULE SCREENING LINKS METABOLIC 
PLASTICITY WITH THE TARGET ORGAN SELECTIVITY 
OF TRIPLE-NEGATIVE BREAST TUMOR METASTASES 
Yu-Dong Zhou1, Fakhri Mahdi1, Kun-Ping Li1,2, Sandra Milasta3, Mika B. 
Jekabsons4, Yan-Hong Wang5, Ikhlas A. Khan1,5, Jieying Gao1,6, Jing Wu7, 
Taosheng Chen7, Yannan Ouyang8, Douglas R. Green3, Kounosuke Watabe9, 
Dale G. Nagle1,6
1Department of Biomolecular Sciences and RIPS, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA, 2Department of 
Pharmacy, Guangdong Pharmaceutical University, Guangzhou, Guangdong 
Province 510006, China, 3Department of Immunology, St. Jude Children’s 
Research Hospital, Memphis, TN 38105, USA, 4Department of Biology, 
University of Mississippi, University, MS 38677, 5National Center for Natural 
Products Research, University of Mississippi, University, MS 38677, 6School 
of Pharmacy, Hunan University of Chinese Medicine, Changsha, Hunan 
Province 410208, China, 7Department of Chemical Biology & Therapeutics, 
St. Jude Children’s Research Hospital, Memphis, TN 38105, 8Cell and Tissue 
Imaging Center, St. Jude Children’s Research Hospital, Memphis, TN 38105, 
9Department of Cancer Biology, Wake Forest University Baptist Medical 
Center, Winston-Salem, NC 27157
Metastatic disease is responsible for over 90% of cancer mortality. In breast 
cancer, the major secondary lesion sites are the lungs, bones, brain, and liver. 
Small molecule screening and comparative flux studies revealed metabolic 
heterogeneity in human triple-negative breast cancer MDA-MB-231-derived 
metastatic subclones that were isolated from the lungs (LM), bones (BoM), 
and brain (BrM). Oxygen consumption was significantly reduced in LM 
and BoM, relative to MDA-231 and BrM cells. The extracellular acidificati-
on/glycolytic rates were comparable among the cell lines. The mitochondria 
electron transport chain retained functionality in LM cells, but appeared dys-
functional in BoM and BrM cells. Incorporation of oxidative phosphorylati-
on into its cellular metabolic portfolio afforded LM cells an apparent growth 
advantage and immunity from glucose depletion, but made LM cells more 
susceptible to mitochondria-targeted metabolic disruptors. The observed 
metabolic diversity suggests that organ-dependent metabolic plasticity may 
serve as a new means to selectively target metastases.
2041
GLUCURONIDE METABOLITES OF FLAVONOLIGNANS 
FROM MILK THISTLE (SILYBUM MARIANUM): 
ENZYMATIC SYNTHESIS
Tyler N. Graf1, Noemi D. Paguigan1, Brandon T. Gufford2, Mary F. Paine2, 
and Nicholas H. Oberlies1.
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, North Carolina, USA; 2Experimental and 
Systems Pharmacology, College of Pharmacy, Washington State University, 
Spokane, Washington, USA
Milk thistle (Silybum marianum), an herbal product used therapeutically 
for nearly 2000 years, has been studied extensively as treatment for hepatic 
disorders and as a perpetrator of herb-drug interactions. Relative to drugs, 
rigorous pharmacokinetic knowledge of herbal product constituents is limi-
ted at best and is virtually nonexistent when considering quantification of 
herbal constituent metabolites. Generation and characterization of authentic 
metabolite standards are essential to understanding the chemical fate and dis-
position of natural products both in vitro and in vivo. Regulatory guidelines 
highlight the importance of identifying metabolites to demonstrate safety and 
determine if metabolites contribute to the overall pharmacology of the drug.
A preliminary study to address this need for authentic flavonolignan glucu-
ronide standards was conducted to determine the most cost-effective method 
for generating individual glucuronides of the major flavonolignans (silybin 
A, silybin B, isosilybin A, and isosilybin B). The following biosynthetic condi-
tions were examined: concentrations of key reagents, enzyme concentration, 
enzyme source, and time course for each reaction condition. A large scale 
enzymatic synthesis was carried out under the optimized conditions, obtain-
ing glucuronides in good yield (>52%) and at a substantially reduced cost of 
synthesis.
2042
ANTIFUNGAL PRENYLATED ISOFLAVONOIDS FROM 
MACLURA AURANTIACA 
Yerkebulan Orazbekov1,2,3, Ubaidilla Datkhayev2, Manas Omyrzakov1,2, 
Ahmed M. Metwaly5, Bauyrzhan Makhatov3, Melissa R. Jacob1, Bakhyt 
Ramazanova2, Zuriyada Sakipova2, Amir Azembayev6, Kuandyk 
Orazbekuly7, Kulpan Orynbasarova3, Samir A.Ross 1,4*
1National Center for Natural Products Research,USA, 2Department of 
Pharmacy, Kazakh National Medical University, Almaty, Kazakhstan, 
3South Kazakhstan pharmaceutical academy, Shymkent, Kazakhstan, 
4Department of BioMolecular Sciences, School of Pharmacy, The University 
of Mississippi, University, MS 38677, USA. 5Department of Pharmacognosy, 
Faculty of Pharmacy, The University of Al-Azhar, Cairo 11371, Egypt,6 
Scientific Centre for Anti-infectious Drugs, Kazakhstan, 7International 
Kazakh-Turkish University named after Ahmet Yesevi, Kazakhstan.
Three prenylated isoflavonoids (1-3) have been isolated from the 
ethanolic extract of Maclura aurantiaca fruits. The isolated compounds 
were chemically identified as 3’-hydroxyeuchrenone (1), euchrenone (2), 
5,3’,4’-trihydroxy-6-(3-methylbut-2-en-1-yl) isoflavone (3). Compounds 1 
and 2 showed antifungal activities against Candida glabrata with IC50 values 
of 5.7 µg/ml and 1.0 µg/ml, respectively. Compound 3 showed antifungal 
activities against Cryptococcus neofomans and Candida glabrata with IC50 
values of 5.0 μg/ml and 4.9 µg/ml, respectively.
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GLUCURONIDE METABOLITES OF FLAVONOLIGNANS 
FROM MILK THISTLE (SILYBUM MARIANUM): 
STRUCTURAL CHARACTERIZATION
Noemi D. Paguigan1, Tyler N. Graf1, Brandon T. Gufford2, Mary F. Paine2, 
and Nicholas H. Oberlies1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro North Carolina, USA; 2Experimental and 
Systems Pharmacology, College of Pharmacy, Washington State University, 
Spokane, Washington, USA
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Milk thistle (Silybum marianum) is a commonly used herbal product, of 
which the crude extract, termed silymarin, is a well-known hepatoprotec-
tant. Relative to conventional drugs, rigorous pharmacokinetic knowledge 
of herbal constituents is limited, largely due to the scarcity of reference stan-
dards. Glucuronidation is a conjugation reaction that plays a key detoxi-
fying role in xenobiotic metabolism. Glucuronide metabolites are needed 
as reference standards to advance the understanding of silymarin metabo-
lism, particularly with respect to situations when silymarin is taken in com-
bination with drugs. The aim of this study was to identify the structures and 
the glucuronidation sites of chemoenzymatically synthesized glucuronides 
of one constituent, silybin A, by HRMS and NMR. Glucuronide biosyn-
thesis resulted in three O-glucuronide regioisomers (1-3), with the highest 
yield from glucuronidation at the 7 position.
2044
NOVEL 22-MER PEPTAIBOLS ISOLATED FROM 
TOLYPOCLADIUM SP. WITH POTENT ANTITUMOR 
ACTIVITIES
Lin Du1,2, April L. Risinger4,5, Carter A. Mitchell1,2, Blake W. Stamps3, Ning 
Pan2, Jarrod B. King1,2, Zhibo Yang2, Bradley S. Stevenson3, Robert H. 
Cichewicz1,2
1Natural Products Discovery Group, Institute for Natural 
Products Applications and Research Technologies, University of 
Oklahoma.2Department of Chemistry and Biochemistry, University of 
Oklahoma. 3Department of Microbiology and Plant Biology, University of 
Oklahoma, Norman, OK 73019. 4Department of Pharmacology, University 
of Texas Health Science Center. 5Cancer Therapy & Research Center, 
University of Texas Health Science Center, San Antonio, TX 78229.
Genome mining of a Tolypocladium sp. isolate led to the purification and 
identification of gichigamin A (1), the first 22-mer and longest peptaibol 
from a natural source. The β-alanine rich sequence of 1 results in the as-
sembly of an unprecedented 310-like helical structure, which was revealed 
by single-crystal X-ray diffraction analysis. The unique structural character 
of 1 was determined to be essential for its unexpected high penetrability 
through cell membranes. As a result, gichigamin A (1) exhibited potent in 
vitro cytotoxicity by direct disruption of mitochondrial function and the 
capability to inhibit MIA PaCa-2 xenograft tumor growth in nude mice. 
2045
QUANTITATION OF MAJOR INDOLE AND OXINDOLE 
ALKALOIDS FROM DIFFERENT KRATOM (MITRIGYNA 
SPECIOSA) STRAIN EXTRACTS USING UHPLC-MS/MS
Zane Hauck, Daniel G. Nosal, Richard B. van Breemen.
Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois College of Pharmacy, 833 S. Wood St., Chicago, IL 60612
Kratom (Mitragyna speciosa) is a common plant found in Southeast Asia, 
particularly Indonesia, Malaysia and Thailand. Kratom is high in the al-
kaloid mitragynine, as well as other minor constituents of the indole and 
oxindole classes. Mitragynine is an indole alkaloid that acts on opioid 
receptors and might be a viable alternative to morphine. When taken in 
conjunction with morphine, mitragynine has been shown to improve an-
algesia and delay tolerance significantly. This combination would offer an-
algesic synergism to allow a reduction of the required dosage. When taken 
alone, mitragynine has similar analgesic activity as codeine. Kratom has a 
complex extract profile. Published work has analyzed organic extracts but 
not aqueous extracts, which are the forms of routine human use (such as 
steeping kratom leaves in water). There are also variations in the chemical 
profiles between different strains of kratom. However, the only published 
quantitation of kratom constituents concerned plant material purchased 
via the internet that was not characterized by strain. In this study, UHPLC-
MS/MS was used to quantify and compare 4 major constituents of 5 diffe-
rent strains of kratom. 
2046
NEAR REAL TIME IN SITU ANALYSIS OF FUNGAL 
NATURAL PRODUCTS USING LAESIMS
Allison Mattes, Carter Mitchell, Jeremy Motley, Robert Cichewicz
Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, University of Oklahoma, 
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman, OK 73019.
Laser ablation electron spray ionization mass spectrometry (LAESIMS) can 
be used to rapidly detect compounds in situ with minimal sample prepara-
tion at ambient conditions. LAESIMS was explored for use as a dereplicati-
on method in a natural products discovery pipeline with a natural product 
pure compound library. This resource helped test the limits of LAESIMS 
detection. The resulting data were analyzed for correlations between detec-
tion and physical properties (functional groups and ACD calculated variab-
les). Selected fungal compounds were analyzed in situ by LAESIMSMS to 
assess the prospects of using this method for metabolite dereplication from 
microbial colonies on Petri plates.
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2047
COMPARATIVE STUDIES IN THE PHYTOCHEMICAL 
PROFILE OF CICHORIUM INTYBUS 
Chelsea R. Harmon1,3,4, Matthew E. Wright1,3,4, Stephen M. Wright2,3, Norma 
Dunlap1,3
1Department of Chemistry, Middle Tennessee State University, Murfreesboro, 
TN 37132, USA, 2Department of Biology, Middle Tennessee State University, 
Murfreesboro, TN 37132, USA, 3Tennessee Center for Botanical Medicine 
Research, Middle Tennessee State University, Murfreesboro, TN 37132, USA, 
4Salomon’s House, LLC, Murfreesboro, TN 37130, USA.
Bioassay guided fractionation of Cichorium intybus collected in East 
Tennessee yielded two active metabolites in minute quantities. Attempts 
have been made to optimize active metabolite production from liquid cell 
culture and hairy root transformation. Quantification of active metabolite 
profiles from various methods will be presented here.
2048
METABOLOMIC APPROACH TOWARDS STABILITY OF 
HERBA ANDROGRAPHIDIS
Abdulaziz Wadeng and Anuchit Plubrukarn
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of 
Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 
90112, Thailand
Herba Andrographidis is the aerial part of Andrographis paniculata (Burm. 
F.) Nees (Acanthaceae). The herb is widely used in traditional medidine 
throughout several Asian countries. In WHO Monographs on Selected Me-
dicinal Plants (vol. 2), Herba Andrographidis has been listed as a prophy-
laxis and for the treatment of common cold and upper respiratory infection, 
as well as for lower urinary tract infection and diarrhea. The herb has a very 
disadvantageously short shelf life of six months. Here we traced stability of 
Herba Andrographidis using an NMR-based metabolomics approach. The 
herb was stored over a period of six months. The 1H NMR spectra of the 
crude CHCl3 extracts (CDCl3, 500 MHz) showed only two major diterpene 
lactones, andrographolide and deoxyandrographolide, predominated the 
NMR spectra. After four months, PCA began to show a cluster due to the 
decomposition of the chemical constituents in the herb. The NMR spectra 
agreed with the loading plots and showed that whereas the contents of de-
oxyandrographolide varied very little, andrographolide, which is also the 
most active components, have started to disappear. The results were in line 
with the recommended short shelf life (<6 months); however, we were still 
unable to trace dideoxy-anhydrodehydroandrographolide, reported previ-
ously as the degraded products from the heat-accelerated experiments, nor 
were other derivatives that might be possible decomposition products of 
the disappearing andrographolide. 
2049
DIGGING DEEP FOR NEW COMPOUNDS FROM 
SILPHIUM LACINIATUM
Russell B. Williams,1 Vanessa L. Norman,1 Mark O’Neil-Johnson,1 Scott 
Woodbury,2 Gary R. Eldridge,1 and Courtney M. Starks1
1Lead Discovery and Rapid Structure Elucidation Group, Sequoia Sciences, 
Inc., 1912 Innerbelt Business Center Drive, St. Louis, MO 63114, USA, 
2Whitmire Wildflower Garden, Shaw Nature Reserve, Missouri Botanical 
Garden, P.O. Box 38, Gray Summit, MO 63039, USA
The compass plant, Silphium laciniatum, is an iconic perennial plant of the 
North American tallgrass prairie. The plants of the tallgrass prairie have 
historically been subjected to a number of biological and environmental 
stresses. Among the adaptations developed by S. laciniatum is a large deep 
taproot. This study of the chemical constituents of the root of S. laciniatum 
was undertaken in two phases. The first was an examination of the variation 
in constituents based on depth of the root material. The second was the iso-
lation of compounds with activity against the NCI-H460 human large-cell 
lung carcinoma cell line. This investigation has led to the identification of 
fifteen new terpenoids and two new semisynthetic terpenoids. 
2050
LICOCHALCONE A AND ISOLIQUIRITIGENIN FROM 
LICORICE SPECIES DIFFERENTIALLY MODULATE P450 
1B1-MEDIATED ESTROGEN METABOLISM
Tareisha L. Dunlap, Shuai Wang, Charlotte Simmler, Shao-Nong Chen, 
Guido F. Pauli, Birgit M. Dietz, and Judy L. Bolton
Department of Medicinal Chemistry and Pharmacognosy, UIC/NIH 
Center for Botanical Dietary Supplements Research, University of Illinois at 
Chicago, 833 South Wood Street, Chicago, Illinois 60612
The risk of breast cancer increases with cumulative exposure to estrogens. 
Estrogens are metabolized to genotoxic metabolites by P450 1B1, which is 
up-regulated through inflammation and activation of the aryl hydrocarbon 
receptor (AhR). Accordingly, cytokine-induced P450 1B1 mRNA levels 
were inhibited by either a nuclear factor-kappaB (NF-κB) inhibitor or an 
AhR antagonist in breast cells. Extracts of three pharmacopoeial licorice 
species, Glycyrrhiza glabra (GG), G. inflata (GI), and G. uralensis (GU), and 
their constituents were tested to determine their effects on inflammation 
and P450 1B1-mediated estrogen metabolism. GI, which specifically con-
tains Licochalcone A (LicA) and has the highest levels of isoliquiritigenin 
(LigC) equivalents, inhibited iNOS activity more strongly compared to the 
other species. GI and LicA reduced P450 1B1 mRNA levels with and with-
out cytokines, yet GG, GU, and LigC with cytokines additively increased 
its expression. Similarly, in a sensitive LC-MS/MS assay, GG, GU, and LigC 
increased genotoxic estrogen metabolites, yet GI and LicA reduced their 
production. LicA inhibited whereas LigC increased P450 1A/1B activity. 
LicA also inhibited TCDD-induced XRE-luciferase reporter activity, indi-
cating AhR antagonism. Thus, GI and LicA may protect women against es-
trogen carcinogenesis by inhibiting inflammation and P450 1B1-mediated 
estrogen oxidative metabolism. Supported by NIH Grants P50 AT000155 
and T32 AT007533
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2051
A MODERN APPROACH TO TRADITIONAL MEDICINE: 
SCREENING, BIOFILMS, AND MECHANISM OF ACTION 
IN CANDIDA ALBICANS
Caleb L. Sutton1 and Mary B. Farone1
1Department of Molecular Biosciences, Middle Tennessee State University, 
Murfreesboro, TN, 37132; USA.
The Chinese, along with other cultures, have been using plants medicinally 
to treat infections, inflammation, and cancer for thousands of years. Until 
recently, modern approaches have not been used to understand the effec-
tiveness of traditional Chinese medicine (TCM). Along with TCM, aurones 
are naturally occurring heterocyclic compounds in plants such as snapdrag-
ons that lend the flowers a yellow pigment. Due to the antifungal activities 
of a group of related biosynthetic precursor compounds, it is reasonable to 
believe that aurones may also possess antifungal activity. Candida albicans 
is a polyphenic fungus that is known to cause opportunistic infections of 
the oral cavity and genitalia in humans in a variety of diseases under the 
collective term candidiasis, where this particular species is the most prev-
alent cause. We use standardized screening methods to test extracts and 
aurones against various infectious organism. The focus of this study is to 
evaluate the efficacy of these TCM extracts and aurones on C. albicans. Of 
156 TCM extracts and 26 aurone compounds, 19 exhibited greater than 
80% inhibition of C. albicans growth. IC50 doses fall below common anti-
fungal treatment concentrations. Preliminary results from treatment with 
aurones also suggest biofilm degradation and prevention. It is imperative to 
discover and develop new treatments for fungal infections due to the dele-
terious effects that current treatments such as amphotericin B have on the 
body and growing resistance to antifungals. We have already identified sev-
eral compounds that can be used as alternative treatments and are currently 
working to understand their mechanisms of action against C. albicans.
2052
DEREPLICATION OF NATURAL PRODUCTS BASED ON 
RATIO ANALYSIS 1H NMR SPECTROSCOPY AND HPLC-
DAD-ESI-QToF-MS/MS
Fausto Carnevale Neto1, Alan Cesar Pilon1, Haiwei Gu2, Rafael Teixeira 
Freire1, Patrícia Cardoso1, Daniel Raftery2, Vanderlan da S. Bolzani1 and Ian 
Castro-Gamboa1
1Nucleus of Bioassays, Biosynthesis and Ecophysiology of Natural Products, 
NuBBE, Department of Organic Chemistry, Institute of Chemistry, Sao 
Paulo State University, Rua Francisco Degni 55, Araraquara, São Paulo 
14800-900, Brazil, 2 Northwest Metabolomics Research Center, Department 
of Anesthesiology and Pain Medicine, University of Washington, 850 
Republican St., Seattle, WA 98109.
A new strategy for dereplication of natural products directly from plant 
crude extracts was performed by ratio analysis 1H NMR spectroscopy 
(RANSY) in association with HPLC-DAD-ESI-QToF-MS/MS. 1H RANSY 
metabolite identification was applied using the ratio between 1H NMR peak 
heights of multiple spectra and their coefficient of variation values. In this 
work, fourteen leaves extracts from Jatropha multifida (Euphorbiaceae), 
were analyzed. A selective extraction, using solvents of different polarity, 
produced a variation of the metabolite concentrations between samples, 
mandatory for RANSY application. The relationship of spin-correlated 
peaks, obtained after RANSY, was integrated with the UV and MS data and 
led to selective dereplication of C-glucosylflavonoids, already reported for 
Jatropha. This is the first attempt to integrate NMR, MS and UV data for the 
in situ detection of bioactive natural compounds.
2053
HIGH THROUGHPUT SCREENING OF NATURAL 
PRODUCTS UTILIZING PULSED ULTRAFILTRATION OR 
MAGNETIC MICROBEAD AFFINITY SELECTION WITH 
UHPLC-MS/MS
Michael Rush, Elisabeth Walker, Richard B. van Breemen
Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois College of Pharmacy, 833 S Wood Street, Chicago, IL
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As natural products remain an important resource in the discovery of new 
potential drugs, it is imperative to develop efficient and sensitive high-
throughput screening techniques to find ligands for macromolecular recep-
tors and enzymes. Two techniques developed by our research group, Pulsed 
Ultra Filtration (PUF) and the higher-throughput Magnetic Microbead 
Affinity Selection Screening (MMASS), are target-based screening techni-
ques that can be used to identify potential ligands within complex mixtu-
res such as natural product extracts. Based on PUF and MMASS screening 
of 14 traditional Native American medicinal botanicals for ligands to the 
anti-inflammation target 15-lipoxygenase (15-LOX), Proserpinaca palustris 
L – Mermaid Weed – showed a hit with an accurate mass of 449.108(+) 
and 447.095(-). However, this compound could be one of a variety of con-
stitutional isomers of this mass known in this and related species. Given 
that these constitutional isomers showed similar retention times, MS/MS 
fragmentation patterns were used to distinguish them. UHPLC was used 
with a Shimadzu IT-TOF high resolution hybrid mass spectrometer and 
LCMS-8040 triple quadrupole mass spectrometer to compare the hit with 
standards. This natural product hit was identified as quercitrin (3-quercetin 
rhamnose) which is a known inhibitor of 15-LOX.
Supported by grant R01 AT007659 from the NIH NCCIH
2054
FOUR ANTIMALARIAL LIMONOIDS ISOLATED FROM 
CARAPA GUIANENSIS AND TWO ANTIPROLIFERATIVE 
DITERPENES ISOLATED FROM HYPOESTES SP. 
Ming Wang1, Priscilla Krai2, Seema Dala2, Maria Cassera2, Michael Goetz3, 
Stéphan Rakotonandrasana4, Vincent E. Rasamison4, and David G. I. 
Kingston1
1Department of Chemistry and Virginia Tech Center for Drug Discovery, 
Virginia Tech, Blacksburg, VA 24061 USA, 2Department of Biochemistry, 
Virginia Tech, Blacksburg, VA 24061 USA, 3Natural Products Discovery 
Institute, 3805 Old Easton Road, Doylestown, PA, 18902, USA, 4Centre 
National d’Application de Recherches Pharmaceutiques, Antananarivo, 
Madagascar.
In a search for antimalarial natural products from plants in collaboration 
with the Natural Products Discovery Institute we investigated an antiplas-
modial extract from Carapa guianensis (Meliaceae). This extract gave a 
DCM fraction with activity against the chloroquine-resistant Dd2 strain of 
P. falciparum with an IC50 value about 4 μg/mL. The four active limonoids 
(1-4) were isolated from this fraction and their structures were elucidated 
by 1D and 2D NMR spectroscopic and MS data. This is the first report of 
the antimalarial activity of 6α,11β-diacetoxygedunin (1). In a separate stu-
dy as part of our work in the Madagascar International Cooperative Biodi-
versity Group program, two diterpenes with good antiproliferative activity 
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against the A2780 human ovarian cancer cell line as well as antimalarial 
activity were found in the hexanes fraction from the extract of Hypoestes 
sp. (Acanthaceae). This is the first report of the activity of crotonolide G (5) 
towards A2780 cell lines and of its antiplasmodial activity.
2055
ANTIPROLIFERATIVE COMPOUNDS FROM 
PENICILLIUM CHRYSOGENUM, A FUNGAL ASSOCIATE 
OF THE LIVERWORT TRICHOCOLEA TOMENTELLA
L. Harinantenaina Rakotondraibe,1 Keith Nichols,1 Hyun-Young Park,1 
Tehane Ali,1 Hee-Byung Chai,1 Chad Rappleye2
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, 2Department of Microbiology, Center for 
Microbial Interface biology, The Ohio State University, Columbus, OH 
43210, USA
Our ongoing systematic work on developing new sources of antiproliferative 
compounds led to the isolation of the bioactive fungus Penicillium chrysoge-
num from the liverwort Trichoclea tomentella collected in Newport, Virginia. 
Bioassay guided fractionation of an Ethyl Acetate extract of a fermentation 
of this strain using potato dextrose agar led to the isolation of 2,5-dihydro-
xybenzyl alcohol (1) and epiepoxydon (2) as the active compounds with 
IC50 values of 6.4 and 24.3 µM, respectively. Fermentation of the same strain 
in rice medium afforded a bioactive fraction with IC50 value of 2.5 mg/mL 
against the HT-29 colon cancer cell line. New and known methylxanthones 
together with compounds 1 and 2 and their derivatives have been isolated 
from this active fraction. The structure determination of the new and bioacti-
ve compounds using spectroscopic methods, the bioassay, and the structure-
antiproliferative (against HT-29 colon and MCF-7 human breast carcinoma) 
activity relationship study of the isolated compounds will be presented. 
2056
SCREENING BIOACTIVE SECONDARY METABOLITES 
FROM COSTA RICAN ENVIROMENTAL MICROBIAL 
COMMUNITIES 
Juan J. Araya1-2, Max Chavarría, Adrián Pinto-Tomás3, Catalina Murillo3, 
Lidieth Uribe4, Leida Castro4, Lorena Uribe5
1 Centro de Investigación en Productos Naturales (CIPRONA) y Escuela 
de Química, Universidad de Costa Rica, 2060 Costa Rica, 2 Instituto 
de Investigaciones Farmacéuticas (INIFAR) y Facultad de Farmacia, 
Universidad de Costa Rica, 2060 Costa Rica, 3 Centro de Investigación en 
Estructuras Microscópicas (CIEMIC), Universidad de Costa Rica, 2060 
Costa Rica, 4 Centro de Investigaciones Agronómicas (CIA), Universidad 
de Costa Rica, 2060 Costa Rica, 5 Centro de Biología Celular y Molecular 
(CIBCM), Universidad de Costa Rica, 2060 Costa Rica.
Our group at the University of Costa Rica has started an initiative to explo-
re the microbial diversity of our country making a screening campaign to-
wards biological evaluation of organic extracts from different environmental 
microbial communities. Our collection of microbial isolates currently has 
more than 300 microorganisms, including bacteria, actinomycetes and 
fungi. Those microbes have been isolated from diverse sources like insects, 
insect’s nests, soil, frog skins and extreme environments. We have started 
the process of small-scale fermentation, extraction and biological evaluati-
on. Preliminary results, including entomopathogenic bacteria Photorabdus 
temperata and Xenorhabdus sp, will be presented. Future plans include ex-
pansion of our microbial and organic extract collection as well as testing 
using new biological assays.
2057
ISOLATION OF SESQUITERPENE LACTONES FROM 
TRICHOSPIRAS VERTICILLATA
Yongle Du1, Yumin Dai1, Priscilla Krai2, Michael Goetz3, Maria B. Cassera2, 
and David G. I. Kingston1. 
1Department of Chemistry and the Virginia Tech Center for Drug 
Discovery, Virginia Tech, Blacksburg, Virginia 24061, USA. 2Department 
of Biochemistry and the Virginia Tech Center for Drug Discovery, Virginia 
Tech, Blacksburg, Virginia 24061, USA. 3Natural Products Discovery 
Institute, 3805 Old Easton Road, Doylestown, Pennsylvania 18902, USA.
A CH2Cl2 extract of Trichospiras verticillata from the Natural Products Dis-
covery Institute was found to have good antimalarial activity, with an IC50 
value of 5 μg/mL. After purification by liquid-liquid partition, chromato-
graphy on Sephadex LH-20, and C-18 reverse phase HPLC, the four new 
sesquiterpenes 1-4 were isolated. The structures of the new compounds 
were determined by using NMR spectroscopy, MS and CD. Among these 
four compounds, the conjugated dienone 4 had the most potent antimala-
rial activity.
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2058
SIMULTANEOUS DETERMINATION OF TEN HIGH-
INTENSITY SWEETENERS OF REGULATORY INTEREST 
USING UHPLC-UV-ELSD/MS
Yan-Hong Wang1, Shuang Hu1,2, Bharathi Avula1, Mei Wang1, 
Satyanarayanaraju Sagi1, and Ikhlas A Khan1,3
1National Center for Natural Products Research, Research Institute of 
Pharmaceutical Sciences, The University of Mississippi, University, MS 
38677, USA, 2School of Pharmacy, Shanxi Medical University, Taiyuan, 
030001, P.R.China, 3Department of BioMolecular Sciences, School of 
Pharmacy, The University of Mississippi, University, MS 38677, USA
High-intensity sweeteners have been widely used in food, beverage and 
drugs. With the purpose of quality assurance and adulterant assessment, 
an efficient and sensitive method was developed for the quantitative de-
termination of ten high-intensity sweeteners using UHPLC-UV-ELSD/
MS. These sweeteners including saccharin, aspartame, acesulfame potassi-
um, sucralose, neotame, advantame, rebaudioside A, stevioside, dulcoside 
A and neohesperidin dihydrochalcon were baseline separated in a 13 min 
run. The method was validated according to the validation of analytical 
procedures of ICH guidelines and applied to quantitation of these analytes 
and identification of adulterants form various food, beverage and other 
products.
2059
SESTERTERPENES AND A NORTRITERPENE SAPONIN 
FROM THE SPONGE CLATHRIA GOMBAWUIENSIS
Jung-Kyun Woo1, Chang-Kwon Kim1, Seong-Hwan Kim1, Heegyu Kim2, 
Chan-Hong Ahn2, Dong-Chan Oh1, Ki-Bong Oh2, and Jongheon Shin1
1Natural Products Research Institute, College of Pharmacy, Seoul National 
University, Gwanak, Seoul 151-742, Korea, 2Department of Agricultural 
Biotechnology, College of Agriculture and Life Science, Seoul National 
University, Gwanak, Seoul 151-921, Korea
Six new sesterterpene metabolites (1-6) were isolated from the Korean ma-
rine sponge Clathria gombawuiensis. On the basis of the results of com-
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bined spectroscopic analyses, gombaspiroketals A−C (1-3), tetracyclic se-
sterterpenes of a novel skeletal class, the structures of phorone B (4) and 
ansellone C (5) were determined to be the phorone and ansellone classes, 
respectively, whereas the saponin gombaside A (6) was a nortriterpene so-
dium O-sulfonato-glucuronide of the rare 4,4,14-trimethylpregnane class. 
Six compounds exhibited moderate cytotoxicity and antibacterial activity. 
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2060
ISOLATION OF STRONGYLOPHORINES FROM 
THE MARINE SPONGE PETROSIA CORTICATA, AS 
PROTEASOME INHIBITORS
Sachiko Tsukamoto, Ai Noda, Eriko Sakai, and Hikaru Kato
Graduate School of Pharmaceutical Sciences, Kumamoto University, 
Kumamoto 862-0973, Japan
The proteasome is a new oncology target after the approval of Velcade® and 
we have been searching for new inhibitors from natural sources. Recently, 
we isolated two new strongylophorines (1 and 2) along with six known 
congeners (3-8) from the marine sponge Petrosia corticata and measured 
their inhibitory activities against the chymotrypsin-like activity of the pro-
teasome. 
2061
MANGROVE ENDOPHYTE METABOLITES AND 
HERBIVORY- ECOLOGY OF THE BIOACTIVE NICHE
Elizabeth A Yancey1, Keith Stokes2, Bill J Baker1, and Peter Stiling2.
1Department of Chemistry and Center for Drug Discovery and Innovation, 
and 2Department of Integrative Biology, University of South Florida, 4202 E 
Fowler Ave, Tampa, FL 33620
With such great species diversity, it is unsurprising that the mangrove eco-
system harbors many complex ecological interactions. Even within each 
mangrove we observe a world teeming with biodiversity- we enter the 
realm of endophytes. The diverse and innumerable fungal and bacterial 
species create a unique chemical environment, affecting not only the trees 
themselves, but also the other residents of the mangrove community. Iso-
lated endophytes produce many bioactive metabolites, with pathogens one 
would associate with the tropical mangrove environment. We have begun 
to observe the ecological interactions these endophytes and their secondary 
metabolites have on the invertebrate herbivores that predate the three spe-
cies of mangroves found in costal Florida, white (Laguncularia racemosa), 
red (Rhizophora mangle), and black (Avicenna germinans). Identification 
and quantification of leaf tissue damage alongside a metabolomic study of 
the fungal metabolites, allows us to outline the ecological significance for 
the endophytes. 
2062
ADVANCES IN PROFILING OF NATURAL PRODUCTS BY 
TRIPLE DETECTION TECHNIQUES COMBINED WITH 
SUPER CRITICAL CO2 MOBILE PHASES AND SUB-2μM 
STATIONARY PHASES
Paula Hong1, Giorgis Isaac1, Helene Boiteux2, and Patricia R. McConville1
1Waters Corporation, Milford, MA; 2Waters S.A.S., En Yvelines Cedex, 
France
Convergence chromatography (CC) is a separation technique that utilizes 
both super and sub-critical carbon dioxide (CO2) and sub-2 µm stationary 
phases to achieve unique selectivity, low solvent usage and high efficiencies. 
The use of supercritical fluid as a mobile phase provides higher diffusivity 
and lower viscosity than liquid mobile phases, thereby providing higher 
throughput and chromatographic efficiencies as compared to liquid chro-
matography. The analysis of natural products has typically been challeng-
ing, not only because of the complex matrices but also the numerous com-
ponents with varying physical and chemical properties. To address these 
difficulties, multiple detectors are typically used during a single analysis 
whereas each detection technique is based on a different physical or chem-
ical property of the molecule. For example, mass detectors and PDA are 
commonly combined to obtain both mass and UV-spectral information. 
Evaporative light scattering, a more universal technique, addresses com-
pounds without ultraviolet absorbance (no chromophore) and poor ioniza-
tion by MS. The combination of these three detection techniques allows for 
analysis of a wide range of compounds. In this presentation, we will inves-
tigate the analysis of a number of natural products using triple detection in 
combination with CC. Identification and quantitation of compounds will 
also be illustrated. Guidance combining triple detection with CC will be 
provided based on the observations attained throughout the analysis. This 
approach when combined with sub-2 µm column chemistries will allow for 
the detection of compounds with a wide range of physical and chemical 
properties.
2063
DISSEMINATION OF ORIGINAL NMR DATA ENHANCES 
THE REPRODUCIBILITY OF NATURAL PRODUCT 
RESEARCH
Guido F. Pauli,1,2 J. Brent Friesen,1,2 Matthias Niemitz3, Jonathan Bisson,1 
David C. Lankin,1 Cristian Soldi,4,5 Jared T. Shaw,4 Dean J. Tantillo,4 Shao-
Nong Chen,1,2 James B. McAlpine1,2
1Dept. of Med. Chemistry & Pharmacognosy, 2Inst. for Tuberculosis 
Research, Coll. Pharmacy, UIC, 833 S. Wood St., Chicago (IL), USA; 
3PERCH Solutions Ltd., Puijonkatu 24 B 5, Kuopio, Finland; 4Dept. of 
Chemistry, University of CA-Davis, 1 Shields Avenue, Davis (CA) USA; 
5Univ. Fed. de Santa Catarina, Campus de Curitibanos, Rod. Ulysses 
Gaboardi, Km 3, Curitibanos - SC, 89520-000, Brazil
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The acquisition of 1D 1H NMR (HNMR) spectra is one of earliest steps 
in characterizing natural products and other organic molecules. For pu-
blication, HNMR information usually is “converted” into a table format, 
and sometimes spectral plots are provided. However, this transformation 
is lossy and frequently insufficient for unambiguous dereplication. This 
ambiguity can even lead to structural revision, such as in the recent case 
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of aquatolide (1), a sesquiterpene lactone from Asteriscus aquaticus. Our 
study demonstrates that public dissemination of original (digital) HNMR 
data (FIDs) can be a powerful means of enhancing the reproducibility of 
structural assignments and, thus, any downstream biological studies. Using 
the archived 800 MHz HNMR spectrum, and employing a semi-automated 
quantum mechanics-driven spectral analysis (HiFSA), we were able to rule 
out the initial assignment (1a), confirm the revision (1b), and achieve the 
full interpretation of the HNMR fingerprints. Using additional examples 
of constitutional and diastereomeric isomers which exhibit complex and 
near-identical HNMR spectra, we show that the public sharing of original 
HNMR data (FIDs) is not only essential for robust structural assignments, 
but can enhance the reproducibility of research with bioactive natural pro-
ducts and other organic molecules simply and productively.
Acknowledgement: We appreciate the diligent help of Michael J. Di Maso, 
UofCA Davis, with NMR data management.
2064
SJN1 A-D, NEW GLYCOLIPIDS FROM THE ANT-
ASSOCIATED BACTERIUM, DEINOCOCCUS GOBIENSIS 
SP.
Bora Shin1, Jongheon Shin1, and Dong-Chan Oh1
1Natural Products Research Institute, College of Pharmacy, Seoul National 
University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea
Bacteria in insect symbiotic systems are considered as an uprising source 
of novel bioactive small molecules because of the huge biological and che-
mical diversity of insects and their symbiotic microbes. Our recent studies 
have focused on the ecosystem of the carpenter ant Camponotus japoni-
cus. We isolated bacterial strains from queen specimen of C. japonicus and 
chemically analyzed their secondary metabolites by LC/MS. As a result, 
four new glycolipids, SJN1 A-D (1-4), were discovered by a Gram-negative 
bacterial strain belonging to Deinococcus gobiensis. The structures of SJN1 
A-D were determined mainly through NMR and mass spectroscopic data. 
The relative configuration of amino sugar was elucidated by 1H-1H coupling 
constants and ROESY NMR spectral analysis. The biological evaluation is 
still under progress.
2065
THE SECONDARY METABOLITES FROM HALOPHILIC 
ACTINOMYCETES FROM A SOLAR SALTERN IN KOREA
Seong-Hwan Kim1, Yoonho Shin1, So-Hyoung Lee2, Won Keun Oh3, Ki-Bong 
Oh2, Sang Kook Lee1, Jongheon Shin1, and Dong-Chan Oh1,*
1Natural Products Research Institute, College of Pharmacy, Seoul National 
University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea, 
2Department of Agricultural Biotechnology, College of Agriculture and 
Life Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 
151-921, Republic of Korea, 3Research Institute of Pharmaceutical Sciences, 
College of Pharmacy, Seoul National University, Sillim-dong, Gwanak-gu, 
Seoul 151-742, Republic of Korea
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Halophilic actinomycetes from saline environments are distinct from their 
terrestrial counterparts in terms of their physiology and secondary meta-
bolites. Since the discovery of a novel anticancer drug candidate, salino-
sporamide A, from an obligate marine actinomycete, studies of halophilic 
actinomycete-derived secondary metabolites have demonstrated the che-
mical potential of actinomycetes from saline environments. Salterns may 
be an extreme representative of saline environments, which possibly harbor 
halophilic actinomycetes with chemical potential. We selectively isolated 
actinomycete strains from salterns and investigated their bioactive com-
pounds. During our chemical studies, salternamides A−D (1−4), the first 
secondary metabolites from saltern-derived actinomycetes, were discove-
red from a halophilic Streptomyces strain (#HK10) isolated from a saltern 
on Shinui Island in the Republic of Korea. Salternamide A (1), which is 
the first chlorinated compound in the manumycin family, exhibited potent 
cytotoxicity against a human colon cancer cell line (HCT116) and a ga-
stric cancer cell line (SNU638) with submicromolar IC50 values. Moreo-
ver, xiamycins C-E (5-7), new indolosequiterpenoids, were identified from 
another Streptomyces sp. strain (#HK18) isolated from a topsoil sample of 
the saltern. Xiamycins C-E showed potent effects against porcine epidemic 
diarrhea virus infection via inhibiting viral replication.
2066
DISCOVERY OF NEW BIOACTIVE SECONDARY 
METABOLITES FROM BACTERIA IN EXTREME 
HABITATS
Kyuho Moon1, Beomkoo Chung2, Yoonho Shin1, Sang Kook Lee1, Ki-Bong 
Oh2, Jongheon Shin1, and Dong-Chan Oh1
1Natural Products Research Institute, College of Pharmacy, Seoul National 
University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, 2Department of 
Agricultural Biotechnology, College of Agriculture and Life Science, Seoul 
National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-921, Republic of 
Korea 
As part of our efforts to explore structurally and biologically novel second-
ary metabolites from unique environments for drug discovery, we have 
investigated secondary metabolites of actinomycete strains inhabiting in 
the Arctic Ocean, tidal mudflats, and Alaskan permafrost. First, arctico-
side and C-1027 chromophore-V, were isolated from a culture of an Arctic 
marine Streptomyces strain. These new compounds, bearing a benzoxazine 
ring, inhibited Candida albicans isocitrate lyase. Second, buanmycin and 
buanquinone, were discovered from the culture of a marine Streptomyces 
strain, from a tidal mudflat. The structure of buanmycin was determined 
by X-ray crystallographic analysis and NMR experiments including 13C-13C 
COSY. Lastly, we isolated bacterial strains from Alaskan permafrost sam-
ples. Buanmycin strongly inhibited the pathogenic Gram-negative bacteri-
um Salmonella enterica (MIC = 0.7 μM). In particular, buanmycin demon-
strated inhibition of sortase A, which is a promising target for antibiotic 
discovery.
2067
A NOVEL TRICYCLIC DILACTONE ISOLATED FROM 
AN ACTINOMYCETE DERIVED FROM GINESENG-
CULTIVATED SOIL
Yun Kwon1, Byung-Yong Kim2, Jongheon Shin1, and Dong-Chan Oh1
1Natural Product Research Institute, College of Pharmacy, Seoul National 
University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea, 
2ChunLab, Inc. 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Republic of Korea
An actinomycete strain BYK1336, identified as Streptomyces cinerochromo-
genes, was isolated from 4-year-old ginseng farm. While culturing the strain 
and analyzing its chemical profile by liquid chromatography coupled with 
electrospray ionization mass spectrometer (LC-ESI-MS), a previously-un-
reported secondary metabolite BYK1336.360 was detected along with the 
known compounds belonging to the classes of ansatrienin and naphtho-
mycins. The structure of BYK1336.360 was elucidated by comprehensive 
analysis of 1D and 2D NMR, mass spectrometric and infrared spectroscop-
ic data. BYK1336.360 is structurally novel by bearing a cyclodecatriene 
flanked by six-membered and seven-membered lactone ring.
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2068
STUDY OF THE CHINESE HERBAL PRESCRIPTION 
OF TONGFENGKANG IN PROTECTING VASCULAR 
ENDOTHELIAL FUNCTION IN RATS WITH 
HYPERURICEMIA
Chun Wang, Jianjun Zhang, Jingxia Wang, Yuan Zheng, Linyuan Wang
Beijing University of Chinese Medicine, 11 Bei San Huan Dong Lu, Beijing, 
100029, China
Tongfengkang (TFK) is the Chinese herbal prescription composed of lysi-
machia and phellodendron bark, etc, for treatment of hyperuricemia due to 
heat-dampness and blood stasis. The present study was designed to evaluate 
the anti-hyperuricemia effects of TFK and the possible active mechanisms. 
SD male rats were randomly divided into six groups which recorded as 
normal group, model group, Benzbromarone group, TFK groups (6.94g/
kg, 3.47g/kg, 1.47g/kg). The rats in the model group were prepared by feed-
ing yeact and high-purine for three weeks. The results showed that TFK 
can decrease the level of UA and ET-1 and increase the level of NO in se-
rum. It demonstrated that TFK could protect the vascular endothelial func-
tions. Furthermore, TFK can decrease the level of TXB2, IL-1β, TNF-α and 
TGF-β1 and increase the level of 6-keto-PGF1a in serum. It suggested that 
suppressing various inflammatory cytokines so as to protect the vascular 
endothelial is the important mechanism underlying the anti-hyperurice-
mia effects of TFK. 
2069
SIX SELAGINELLIN DERIVATIVES WITH PROTEIN 
TYROSINE PHOSPHATASE 1B INHIBITORY ACTIVITY 
FROM SELAGINELLA TAMARISCINA
Bing Tian Zhao1, Duc Hung Nguyen1, Jae-Sue Choi2, and Mi Hee Woo1
1College of Pharmacy, Catholic University of Daegu, Gyeongsan 712-702, 
Republic of Korea, 2Department of Food Science & Nutrition, Pukyong 
National University, Busan 608-737, Republic of Korea
As part of an ongoing search for new PTP1B inhibitors from medicinal 
plants, the methanol extract of the aerial parts of Selaginella tamariscina 
was found to inhibit 70% PTP1B enzyme activity at a concentration of 30 
µg/mL. Thus, bioassay-guided isolation of this active extract yielded six se-
laginellin derivatives (1‒6), comprising four new compounds (selariscinas 
A~D; 2~6). These compounds were found to possess inhibitory effect on 
PTP1B enzyme activity with IC50 values ranging from 5.5 ± 0.1 to 21.6 ± 1.5 
μM. Furthermore, compound 2 which served as mixed-competitive inhibi-
tor showed the greatest potency, with IC50 value of 5.5 ± 0.1 μM, when com-
pared with the positive control (ursolic acid, IC50 = 3.4 ± 0.1). This result 
indicated the potential of these selaginellin derivatives as lead molecules for 
the development of antidiabetic agents and the beneficial use of S. tamaris-
cina against hyperglycemia.
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2070
INVESTIGATION OF ANTIBACTERIAL AND BIOFILM 
INHIBITION ACTIVITY OF MICHELIA FIGO LEAF 
EXTRACTS AGAINST DENTAL BACTERIUM
Xun Song1, 2, Zhendan He2, Hongjie Zhang1
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, 
P. R. China. 2Department of Pharmacy, School of Medicine, Shenzhen 
University, Shenzhen, P. R. China. 
Dental plaque, a complex microbial biofilm, is a pathogenic factor in dental 
diseases such as dental caries and periodontal disease. The dental diseases 
usually begin with the formation of dental plaques. S. mutans, S. sobrinus 
and S. sanguinis are the primary bacterium for the biofilm formation. Some 
antibiotics and chemical agents could treat oral infections but often accom-
panied with side effects and drug resistance. To discover agents that can 
prevent biofilm formation or destroy biofilm is thus considered as a good 
strategy to avoid drug resistance. Plant natural products are our primary 
source for discovery of such potential agents. In our study, we have evalu-
ated more than 1,000 plant extracts for their antibacterial and anti-biofilm 
activity. One plant, Michelia figo (Lour.) Spreng., was found to effective-
ly prevent biofilm formation of dental bacteria. We thus re-collected the 
plant materials (leaves and stems) for further phytochemical investigation. 
Bioassay-guided separation was carried out to get the active constitu-
ents from this plant, which may lead to the potential use of the plant to 
prevent dental biofilm formation. [The work described in this paper was 
supported by HKBU Interdisciplinary Research Matching Scheme (RC-
IRMS/12-13/03)].
2071
CYTOTOXIC EFFECTS OF ANTHRAQUINONES FROM 
THE RHIZOME OF RHEUM TATARICUM ON HELA AND 
MDA-MB-435 CELLS
Wentao Dai1,2, Andrew J. Robles2, Cristina Rohena2, Jiangnan Peng2, Susan 
L. Mooberry2, Xingli Yan1, and Zengping Gao1*
1School of Chinese Materia Medica, Beijing University of Chinese Medicine, 
Beijing 100102, China, 2Department of Pharmacology, University of Texas 
Health Science Center at San Antonio, San Antonio 78229, USA
The effects of anthraquinones, aloe-emodin (TH-4), 1,3,8-trihydroxyan-
thraquinone (TH-6) and physcion-1-O-β-(6’-O-acetyl)glucopyranoside 
(TH-10) isolated from the rhizome of Rheum tataricum L., on the growth 
of HeLa and MDA-MB-435 cells were evaluated. Results show that TH-4, 
TH-6 and TH-10 inhibited the proliferation of HeLa cells but have no effect 
on MDA-MB-435 cells up to 100 µM. TH-4 and TH-6 caused HeLa cells to 
accumulate in G1 with a concurrent depletion of cells in the S and G2/M 
phases of the cell cycle. After treatment with TH-6, phosphorylation of 
proteins in the mTORC1 signaling pathway increased. Additionally, phos-
phorylation of p38 MAPK at T180/Y182 decreased in a time-dependent 
manner between 2 and 4 hours after treatment with TH-6. What’s more, 
both TH-4 and TH-6 induce cell death at least partially through apoptosis. 
These findings provide a possible mechanistic explanation for the prolifer-
ation inhibitory effect of TH-4 and TH-6 on HeLa cells.
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2072
DEVELOPMENT OF A VALIDATED HPTLC 
METHOD AND QUANTITATIVE ANALYSIS OF 
SOLANOPUBAMINE IN SIX SPECIES OF SOLANUM
Hattan A. Alharbi, Perwez Alam, Adnan J. Al-Rehaily, Mohammad S. 
Ahmad and Nasir A. Siddiqui
Department of Pharmacognosy, College of Pharmacy, King Saud University, 
Riyadh, Saudi Arabia
Quantification of biologically active marker compounds in crude drugs fa-
cilitates the production of therapeutically effective herbal formulations. The 
present study is designed to produce maiden work on quantification of a 
rare alkaloid solanopubamine in leaves and fruits of six different species of 
genus Solanum (S. schimperianum, S. villosum, S. coagulans, S. glabratum, S. 
incanum and S. nigrum extracted by two different methods) by a validated 
high performance thin layer chromatography method. Chromatography 
was performed on glass-backed silica gel 60 F254 precoated HPTLC plates 
with solvents CHCl3: CH3OH: NH4OH (30:20:1.5 v/v) as the mobile pha-
se. After development, the HPTLC plate was derivatized with dragendorff 
reagent, scanned, and quantified at 500 nm. The system was found to give 
compact spot for solanopubamine at Rf = 0.39 ± 0.01. The linear regression 
analyses data for the calibration plot showed good linear relationship with 
r2 = 0.998 with respect to area in the concentration range of 100- 900 ng. 
The regression equation for standard solanopubamine was found to be Y= 
-239.618 + 4.442x. The steroidal alkaloid solanopubamine was found to be 
present only in leaves extracts of S. schimperianum while it was absent in 
fruit extract of S. schimperianum and leaves as well as fruit extracts of S. vil-
losum, S. coagulans, S. glabratum, S. incanum and S. nigrum. The LOD and 
LOQ were found to be 35 ng and 110 ng band-1, respectively. The quantity 
of solanopubamine in leaves extract of S. schimperianum extracted by etha-
nol only and mixture of ethanol and ammonium hydroxide (6:4) was found 
to be 1.03 % w/w and 2.09 % w/w, respectively. Stress studies of solano-
pubamine exhibited the maximum (100%) degradation in base and H2O2 
treated samples and 61.4% in acid treated samples. The UV exposure and 
photo-oxidation to sample almost caused no damage but 12.91%, 13.83% 
and 14.08% destruction has been observed while exposed to room tempe-
rature, 40 °C and 50 °C, respectively. 
2073
DISCOVERY OF NOVEL BIOACTIVE NATURAL 
PRODUCT-LIKE COMPOUNDS BASED ON DIVERSITY-
ENHANCED REACTIONS
Yifu Guan1,2, Juan Wang1, Hongjie Zhang1*
1School of Chinese Medicine, Hong Kong Baptist University, Hong Kong 
SAR, P. R. China. 2HKBU Shenzhen Research Center, Shenzhen, P. R. China. 
Diversity-enhanced reaction (DER), a non-selectivity and non-specificity 
reaction, is proposed to increase the diversified chemical structures of nat-
ural products for drug discovery (Fig. 1). We have applied this method to 
quickly synthesize a number of BB1608-like derivatives (Scheme 1). 2 un-
derwent DER to afford a mixture. Separation and derivatization provided 
3-12, Compounds 3-12 were evaluated for their anticancer and antiviral 
activities. The development of more complex DER is in progress. [The work 
described in this paper was supported by HKBU Interdisciplinary Research 
Matching Scheme (RC-IRMS/12-13/03) and Natural Science Foundation 
of China (No. 21402166)].
 
 
 
2074
INVESTIGATION OF THE ANTIPROLIFERATIVE 
ACTIVITY OF LINOCIERA RAMIFLORA AND ITS 
ISOLATES
P. Annécie Benatrehina1, Li Pan1, C. Benjamin Naman1, Hee-Byung 
Chai1, Tran Ngoc Ninh2, Djaja Djendoel Soejarto3,4, L. Harinantenaina 
Rakotondraibe1, and A. Douglas Kinghorn1.
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210, USA; 2Institute of Ecology 
and Biological Resources, Vietnam Academy of Science and Technology, 
Hanoi, Vietnam; 3College of Pharmacy, University of Illinois at Chicago, 
Chicago, IL 60612, USA; 4Science and Technology, Field Museum, 1400 S. 
Lakeshore Dr., Chicago, IL 60605, USA.
Following the primary screening of Vietnamese plant extracts against the 
HT-29 human colon cancer cell line assay, the branch sample of Linociera 
cf. ramiflora (Roxb.) Wall. (Oleaceae) (sample A06576; voucher specimen 
DDS 14374) was selected as a candidate for further study. The methanol 
extract of this plant sample was subjected to a bioactivity-guided fraction-
ation aiming at the isolation of potential anticancer agents. Liquid-liquid 
partitions of this extract led to an active chloroform fraction (IC50 = 7.7 μg/
mL). Further separation of this fraction through successive column chro-
matography afforded numerous active sub-fractions, from which several 
new and known lignans and arylglycerol-substituted lignan derivatives to-
gether with some aromatic compounds were isolated. The structure deter-
mination as well as the antiproliferative and quinone reductase inducting 
activities of these compounds will be described.
2075
PREVALENCE OF ANTIMICROBIAL FUNGAL 
METABOLITES IN HYDRASTIS CANADENSIS CRUDE 
EXTRACTS
Joseph M. Egan1, Amninder Kaur1, Huzefa A. Raja1, Adam R. Brown1, 
Nicholas H. Oberlies1, Nadja B. Cech1
1Department of Chemistry and Biochemistry, University of North Carolina 
at Greensboro, Greensboro, NC, 27403, USA
Goldenseal (Hydrastis Canadensis L. Ranunculaceae) is a plant used in Na-
tive American traditional medicine to treat infection. This plant has been 
shown by our laboratory to harbor endophytic fungi that produce anti-
microbial secondary metabolites. The aim of this study was to determine 
whether antimicrobial fungal metabolites could be detected in the crude 
extracts of H. canadensis. A series of extracts were prepared in methanol 
and subjected to liquid-liquid partitioning to remove fats and sugars. A se-
cond extraction technique, using aqueous ethanol, was also employed to 
improve relevance of this study to the botanical dietary supplements indu-
stry. Investigations to identify fungal metabolites from these extracts using 
ultra-performance liquid chromatography coupled to high resolution mass 
spectrometry are ongoing. 
2076
DIVERSE OLIGOPEPTIDES ISOLATED FROM AQUATIC 
MICROBIAL CONSORTIA
Li Pan1, Heebyung Chai1, A. Douglas Kinghorn1, and Guy T. Carter2
1Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
The Ohio State University, Columbus, OH 43210, USA, 2 Biosortia 
Pharmaceuticals, 565 Metro Place South, Suite 300 Dublin, Ohio 43017, and 
National Oceanic and Atmospheric Administration (NOAA), Charleston, 
South Carolina 29412, USA.
Bioassay-guided purification has conducted on fractions prepared from 
uniquely harvested biomass of aquatic microalgae using HT-29 human 
colon cancer cell line, and has led to the isolation of a number of oligo-
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peptides, with the most representative sub-types being anabaenopepetins, 
oscillapeptins and aeruginosins. The structures of the isolated compounds 
were identified on the basis of spectroscopic data interpretation. A LC-MS 
dereplication procedure was employed to facilitate the minor cytotoxic 
agents isolation.
2077
EXTRACTION OF ISOFLAVONOIDS FROM IRESINE 
HERBSTII
Mohammed Hawwal
1
, Kyung Ah Koo2, John R. Porter
1, 2
1Department of Chemistry and Biochemistry, and 2Department of Biological 
Sciences, University of the Sciences in Philadelphia, 600 S. 43rd Street, 
Philadelphia, PA 19104, United State.
Biliary atresia outbreaks were reported four times in newborn Australian 
livestock between 1964 and 2013. Epidemiologic data implied that these 
outbreaks were caused by environmental exposure to an unusual forage 
plant. We isolated and identified the active toxic compound. Two similar 
isoflavonoids from Iresine herbstii have been reported. We have extrac-
ted I. herbstii, and are isolating the compounds by column chromatogra-
phy, flash chromatography and HPLC. We confirmed the presence of the 
compounds, 2´,2,5-trimethoxy-6,7-methylenedioxyisoflavanone (1) and 
2´,5-dimethoxy-6,7-methylenedioxyisoflavone (2). Future work will focus 
on ring opening reactions and testing the toxicities of all compounds in a 
zebrafish bioassay of biliary function. This is part of our ongoing efforts to 
determine SAR characteristics of the toxic compound. 
2078
TRADITIONAL PREPARATIONS AND METHANOLIC 
EXTRACTS OF PLANTS FROM PAPUA NEW GUINEA 
EXHIBIT SIMILAR CYTOCHROME P450 INHIBITION
Erica C. Larson1, Chris D. Pond1, Prem P. Rai2, Teatulohi K. Matainaho1,2,3, 
Pius Piskaut3, Louis R. Barrows1,2,3, Michael R. Franklin1
1Department of Pharmacology and Toxicology, University of Utah, 30 S. 
2000 E., Salt Lake City, Utah 84112, USA. 2School of Medicine and Health 
Sciences, University of Papua New Guinea, PO Box 5623, Boroko, NCD, 
Papua New Guinea. 3School of Natural and Physical Sciences, University of 
Papua New Guinea, PO Box 5623, Boroko, NCD, Papua New Guinea.
Human immunodeficiency virus (HIV) and tuberculosis (TB) infections 
constitute a large portion of the disease burden in Papua New Guinea 
(PNG). Treatment of HIV and TB require long-term administration of an-
tiretroviral and anti-TB drugs, respectively. In addition to Western med-
icine, traditional medicine (TM) is widely practiced in PNG. There is in-
creasing concern that traditional medicines may antagonize antiretroviral 
and anti-tuberculin drug efficacy. Plant-drug, or drug-drug, interactions 
can occur at the level of metabolism through two major mechanisms: en-
zyme induction or enzyme inhibition. Our previous study of common-
ly-used medicinal plants from PNG extracted in methanol found almost 
one third of TM extracts induced cytochrome P450 (CYP) subtype expres-
sion of CYP1A2 or CYP3A4, or both. In addition, almost two thirds in-
hibited CYP1A2, CYP3A4, or CYP2D6, or combinations thereof. In PNG, 
the most common route by which traditional medicines are consumed is 
ingestion of expressed juice, succus. We investigated CYP inhibition of 
independently recollected medicinal plants (n=17) and compared CYP 
inhibition by succus to the previous methanolic study through pair-wise 
comparisons of like genus and species. Results for the recollected succus 
samples were not significantly different from results obtained with metha-
nolic extracts (p<0.05). Therefore, data obtained previously with methano-
lic extracts likely represents biological activities found in more traditional 
medicinal preparations. In addition, these results confirm previous in vitro 
data that indicate use of traditional medicines concomitantly with ART or 
anti-TB drugs could dramatically alter their efficacy.
2079
ANTINOCICEPTIVE ACTIVITY OF THE ESSENTIAL OIL 
FROM Artemisia ludoviciana.
Gerardo D. Anaya-Eugenio1, Isabel Rivero-Cruz1, Robert Bye2, Edelmira 
Linares2, Rachel Mata1
1Departamento de Farmacia, Facultad de Química, Universidad Nacional 
Autónoma de México, D.F., 04510, México. 2Jardín Botánico, Instituto de 
Biología, Universidad Nacional Autónoma de México, México, D.F., 04510, 
México.
Artemisia ludoviciana Nutt. is widely used in Mexico for treating gastro-
intestinal disorders and painful complaints. The antinociceptive action of 
the essential oil (EO) and its volatile composition were investigated. EO 
decreased both the first and second phases of formalin-induced nocicep-
tion. The calculated median-effective dose (ED50) was 269 mg/kg. The ef-
fectiveness of EO (ED50 = 25.9 mg/kg) for attenuating neurogenic pain was 
corroborated using the hot plate test. The antinociceptive action of EO was 
partially blocked by naloxone suggesting that its mode of action involved 
an opioid mechanism. On the other hand, volatile constituents extracted 
by hydrodistillation and those obtained by HS-SPME were established by 
GC-MS; the oil showed high amounts of (±)-camphor, γ-terpineol and 
borneol, and the major light volatile compounds identified by HS-SPME 
were 1,8-cineole and (±)-camphor. Altogether, these results support the 
long-term use of A. ludoviciana for treating painful complaints.
2080
HIGH-THROUGHPUT CYTOCHROME P450 INHIBITION 
COCKTAIL ASSAY FOR EVALUATING POSSIBLE 
DRUG-BOTANICAL INTERACTIONS: APPLICATION TO 
LICORICE
Guannan Li, Dejan Nikolic, Richard B. van Breemen
Department of Medicinal Chemistry and Pharmacognosy, University 
of Illinois College of Pharmacy, UIC/NIH Center for Botanical Dietary 
Supplements Research, Chicago, IL 60612
Early detection of drug-drug interactions is essential during drug disco-
very and development, and the investigation of possible drug-botanical 
interactions is important for the safe use of botanical dietary supplements. 
Since inhibition of cytochrome P450 (CYP) enzymes is the most common 
cause underlying drug-drug or drug-botanical interactions, assays that fa-
cilitate the in vitro assessment of CYP inhibition are important preliminary 
tests that need to be carried out as justification for possible clinical trials 
of safety. Here, an efficient and cost-effective mass spectrometry-based 
high-throughput CYP cocktail inhibition assay was developed that uses 
10 substrates simultaneously against 9 CYP isoforms (1A2, 2A6, 2B6, 2C8, 
2C9, 2C19, 2D6, 2E1 and 3A4). The method was validated using known 
inhibitors of each CYP enzyme and then applied to the analysis of potential 
drug-botanical interactions involving the licorice species Glycyrrhiza gla-
bra L., Glycyrrhiza uralensis Fisch. Ex D.C., and Glycyrrhiza inflata Batalin. 
Supported by grant P50 AT000155 from the NIH ODS and NCCIH
2081
QUANTIFICATION OF POLYPHENOLS IN FREEZE-DRIED 
TABLE GRAPE POWDER
Daniel G. Nosal, Tristesse Burton, Brain Wright, Yongchao Li, and Richard 
B. van Breemen
Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois at Chicago College of Pharmacy, 833 S. Wood Street, Chicago, IL 
60612, USA.
Bioactive polyphenolic compounds such as phenolic acids, cinnamic acids, 
stilbenes, flavonoids, flavans, flavonols and anthocyanins are associated 
with the prevention of degenerative diseases such as cardiovascular disea-
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se and certain types of cancers. These polyphenols - specifically catechin, 
epicatechin, peonidin, cyanidin, malvidin, quercetin, kaempferol, isor-
hamnetin, and resveratrol - are found in various plants such as grapes. In 
this study, polyphenols in freeze-dried table grape powder prepared from 
red, green and black grapes (California Table Grape Commission) were ex-
tracted using various methods. Polyphenols in the extracts were characte-
rized and quantified using ultra high performance liquid chromatography 
tandem mass spectrometry (UHPLC-MS/MS). The chemically standardi-
zed grape powder is suitable for studies of the health benefits of grapes in 
animal and clinical studies.
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2082
RECOVERY OF METABOLITES FROM NATURAL DEEP 
EUTECTIC SOLVENT MATRICES BY COUNTERCURRENT 
SEPARATION
Yang Liu,1,* Jahir Garzon,1,* J. Brent Friesen,1,2 David C. Lankin,1 James B. 
McAlpine,1 Shao-Nong Chen,1 and Guido F. Pauli1
1UIC/NIH Center for Botanical Dietary Supplements Research, Department 
of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, 
University of Illinois at Chicago, Chicago, Illinois 60612, USA; 2 Physical 
Sciences Department, Rosary College of Arts and Sciences, Dominican 
University, River Forest, Illinois 60305, USA *represents equal contribution 
to this work
NAtural Deep Eutectic Solvents (NADES) were discovered in 2011 as being 
mixtures of polar “primary metabolites” that exhibit unexpected solubiliz-
ing and stabilizing abilities for hydrophobic and/or bioactive ingredients. 
However, due to the inherent low vapor pressure of NADES, it is chal-
lenging to recover analytes such as “secondary” metabolites from a NA-
DES-analyte(s) matrix by conventional liquid chromatography. The present 
study shows that countercurrent separation (CCS) can perform this task 
successfully. The resolution capability of CCS depends on the differential 
distribution coefficients (K values) of the analytes. Compared to most bio-
active constituents, the NADES components have extreme K values (close 
to 0 or ∞, in RP or NP, resp.) because of their high polarity. Glucose-cho-
line chloride-water (2:5:5, mole/mole) with rutin, quercetin, kaempferol, 
or daidzein were chosen as the test matrices. The CCS fraction analysis by 
UV-UHPLC and qHNMR showed that CCS can recover the target analyte 
completely from the NADES-analyte matrix, and at the same time yield 
the NADES quantitatively, allowing further study of “primary” NADES vs. 
bioactive “secondary” metabolites in botanical extracts.
2083
HIV INHIBITORY ACTIVITY FROM PAPUA NEW 
GUINEAN MEDICINAL PLANTS
Chris D. Ponda, Prem P. Raib, Louis R. Barrowsa, Teatulohi K. Matainahob
aDeparment of Pharmacology and Toxicology, Universtiy of Utah, 30 S 
200E., Salt Lake City, Utah 84112. bSchool of Medicine and Health Sciences, 
Universtiy of Papua New Guinea, P.O.Box 5623, Boroko, NCD, Papua New 
Guinea. 
Papua New Guinea has enormous biological diversity as a result of its topo-
graphy and tropical latitude. It also has a long and continued use of medicinal 
plants. In our lab we use bioassay guided discovery and dereplication based 
on a whole cell HIV assays, p24 flow cytometry, various chromatographic 
methods, and accurate mass LC/MS/MS. We have explored several collec-
tions of medicinal plants gathered by Pharmacy Students under the guidance 
of UPNG botanists and found several plants with potent anti-HIV activity. 
Here we report our recent findings on several active plants, including Maca-
ranga Tanarius, Causarina oligodon and Crassocephalum crepidiodes. 
2084
CHEMICAL COMPOSITION AND BIOLOGICAL ACTIVITY 
OF ESSENTIAL OILS FROM PIPER SPECIES OF 
PANAMA.
Ana I. Santana1, Roser Vila2, Salvador Cañigueral2, Mahabir P. Gupta1
1Centro de Investigaciones Farmacognósticas de la Flora Panameña, 
(CIFLORPAN), Universidad de Panamá, Panamá, Panamá. 2 Unitat 
de Farmacologia i Farmacognòsia, Facultat de Farmàcia. Universitat de 
Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain.
The chemical composition of the leaf essential oils obtained by hydrodis-
tillation of 6 Piper sp.(Piperaceae) from Panama were analyzed by a com-
bination of GC-FID and GC-MS using two capillary columns of different 
stationary phases (Supelcowax™10 and methylsilicone SE-30). Identifica-
tion of constituents was achieved by means of their GC retention indices 
in the two stationary phases and by comparison of their mass spectral 
fragmentation patterns with those stored in our own library, in the GC-MS 
database and with literature data. The main components identified in each 
species were as follows: cembratrienol (25,4%) and derivatives (8,9%), cem-
brene (15,3%), β-elemene (14,0%) in P. augustum Rudge; β-pinene (26,6%), 
6-E-nerolidol (12,8%), p-cymene (8,6%), and limonene (8,2%) in P. corru-
gatum Kuntze; α-pinene (19,4%), β-caryophyllene (13,9%), and limonene 
(8,1%) in P. curtispicum C.DC.; p-cymene (43,9%), β-pinene (14,5%) and 
γ-terpinene (8,0%) in P. grande Vahl; linalool (14,5%), α-phellandrene 
(13,8%), limonene (12,2%), β-pinene (10,1%) and α-pinene (9,6%) in 
P. jacquemontianum Kunth; 6-E-nerolidol (8,7%), α-pinene (6,6%), and 
α-copaene (5,3%) in P. multiplinervium C. DC. The ethnobotanical uses 
and biological activities of the species studies will be presented. Acknowl-
edgement: SENACYT, Panamá.
2085
CHARACTERIZATION OF ENVIRONMENTAL SAMPLES 
IN THEIR NATURAL STATE USING COMPREHENSIVE 
MULTIPHASE NMR 
Martine Monette1, Andre Simpson2, Hussain Masoom2, Yalda Liaghati 
Mobarhan2, Denis Courtier-Murias2, Blythe Fortier-McGill2, Ronald Soong2 
and Kimberly L. Colson1
1Bruker BioSpin, Billerica, MA 01821, USA; 2University of Toronto 
Scarborough, Toronto, ON, Canada 
Comprehensive Multi-Phase (CMP) NMR challenges traditional NMR me-
thods by adapting the NMR technology to match natural samples, rather 
than changing the sample to match a specific NMR technique. Comprehen-
sive Multiphase (CMP) combines all aspects of solution, gel and solid-state 
NMR into a single approach which allows the study and differentiation of 
all molecular constituents in-situ and in their natural state. Spectral editing 
approach permit the differentiation of liquid, gel and solid components in-
situ and when combined with molecular interaction studies, binding mecha-
nisms, kinetic transport across phases, bioaccumulation, biotransformation, 
and binding receptors can be assessed. 
This research evaluates the versatility and applicability of CMP-NMR to va-
rious disciplines. Both studies of molecular structure and interactions will be 
presented with respect to soils, algae, contaminant sequestration, and early 
plant growth. Combined the technique and permits a unique and unprece-
dented molecular window into intact samples including living organisms and 
hold great promise to understand biological stress, growth and disease across 
a wide range of field from environmental chemistry to medicine. 
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2086
ASTRAGALIN REDUCES OVARIAN FAILURE IN AN 
AGED RAT MODEL OF MENOPAUSE BY INHIBITING 
GRANULOSA CELL APOPTOSIS 
Min Wei1, Ye Lu1, Gail B. Mahady2, Daniel Liu3, Zhi S. Zheng1
1 Jiangsu Institute of Botany, Chinese Academy of Science, Nanjing, China; 
2 Department of Pharmacy Practice, College of Pharmacy, University of 
Illinois at Chicago, Chicago, IL 60612, USA; 3 Beijing Clinical Service Center, 
Beijing, China 100123
A traditional Chinese medical (TCM) formula, containing five medicinal 
herbs including Morus alba L. (mulberry; Moraceae), has been shown to 
be effective in clinical trials for the management of menopausal symptoms. 
Mulberry has been used in TCM for thousands of years for the treatment 
of a wide range of women’s reproductive disorders including breast cancer, 
dysmenorrhea, and menopause. Astragalin (AST), known chemically as 
kaemperferol-3-O-glucoside is a flavonoid glycoside isolated from mulber-
ry fruits. The in vitro and in vivo activities of AST on ovarian granulosa cell 
(GC) apoptosis were investigated. The effects of AST on cadmium chloride-
induced apoptosis in cultured rat ovary GCs were investigated using the 
MTT proliferation assay, the proliferation-related index and the Annexin 
V apoptosis assay. The in vivo effects of AST on 14-month old female rats 
were examined by measuring serum estrogen and progesterone levels, as 
well as the apoptosis rate of ovarian GCs by flow cytometry. 
The in vitro results showed that AST stimulated GC proliferation, increased 
17β-estradiol (E2) and progesterone (P4) secretion, and reduced cadmi-
um chloride-induced apoptosis. In vivo, AST treatment of aged female rats 
resulted in significant increases of serum E2 and P4 levels, altered levels 
of serum FSH and LH levels, and reduced apoptosis in ovarian GC cells. 
Treatment with AST increased anti-apopotic protein Bax and reduced the 
pro-apoptotic protein Bcl-2 in cultured rat ovarian GCs.
2087
SELECTIVITY AND MECHANISTIC INQUIRIES INTO THE 
REACTIVITY OF PERICOSINE A, AN ELECTROPHILIC 
CHLORINATED SHIKIMATE ANALOGUE
Tyler Olsen, Lin Du, Kenneth Nicholas, Robert Cichewicz
Natural Products Discovery Group, Institute for Natural Products 
Applications and Research Technologies, University of Oklahoma, 
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman OK 73019
Microorganisms are constantly competing for limited resources in their 
environment as characterized by secondary metabolite production and 
enzymatic inactivation of toxins. Pericosine A, a shikimate analogue pro-
duced by a Tolypocladium sp., has been shown to directly differentiate and 
inactivate nucleophilic toxins in complex chemical environments. Herein 
we detail the selectivity of pericosine A towards a diverse set of nucleophi-
les, as well as the computational and structural studies of the mechanistic 
pathways under which it operates. We also show reactivity of pericosine A 
adducts with monosaccharides to produce novel heterobicyclic scaffolds.
2088
RUFOMYCINS - ACTINOMYCETE PEPTIDES WITH 
POTENT ANTI-TB ACTIVITY
Yang Yu1, Shao-Nong Chen1,2, Sang-Hyun Cho2, Joo-Won Nam1, Edyta 
Grzelak2, James B. McAlpine1,2, Birgit U. Jaki1,2, Mary Choules2, Jin-Yong 
Kim3, Jinhua Cheng3,4, Seung Hwan Yang4, Hanki Lee4, Joo-Won Suh3,4, Scott 
G. Franzblau2, and Guido F. Pauli1,2
1Department of Medicinal Chemistry and Pharmacognosy, 2Institute for 
Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 
833 South Wood Street, Chicago, IL 60612, USA, 3Division of Bioscience and 
Bioinformatics, College of Natural Science, Myongji University, Cheoin-gu, 
Yongin, Gyeonggi-Do 449-728, South Korea, 4Center for Nutraceutical & 
Pharm. Materials, Myongji University, Cheoin-gu, Yongin, Gyeonggi-Do 
449-728, South Korea
The treatment of Tuberculosis (TB), one of most deadly infectious diseases 
caused by Mycobacterium tuberculosis, has become increasingly challenging 
due to the emerge of multiple and extensively drug-resistant (MDR/XDR) 
strains. The development of new anti-TB drugs is therefore in urgent de-
mand. In a continuing drug discovery program, based on a high-through-
put1,2 screening of 65,000+ actinomycete extracts, four anti-TB active cyclic 
heptapeptides, were isolated from a Streptomyces sp. MJM3507 extract: 
three new members of the rufomycin family (1-3), and one analogue (4) 
with the same constitution and relative stereochemistry of the previous-
ly reported rufomycin B2. The structures of 1-4 were determined through 
extensive analysis of 1D and 2D NMR-as well as mass spectrometric data. 
Compounds 1 and 2 showed MICs of 0.58 and 1.00 µg/mL, respectively, in 
the Microplate Alamar Blue Assay (MABA), whereas the mixture of 3 and 
4 (ratio ca 1:9 based on 1H NMR data) displayed a remarkable low MIC of 
0.074 µg/mL (MIC rifampicin = 0.05-0.10 µg/mL) and a selectivity index 
(IC50/MIC) as high as 675 (IC50 rifampicin > 100).
[1] Gao, W., et al. Org. Lett. 2014, 16(23), 6044-7. [2] Cai, G. P., et al. J. Nat. 
Prod. 2013, 76(11), 2009-2018.
2089
NEW POLYKETIDES FROM A FUNGICOLOUS ISOLATE 
OF PESTALOTIOPSIS DISSEMINATA
In Hyun Hwang1, Dale C. Swenson1, James B. Gloer1, and Donald T. 
Wicklow2
1Department of Chemistry, University of Iowa, Iowa City, IA 52242, USA, 
2Bacterial Foodborne Pathogens & Mycology Research Unit, Agricultural 
Research Service, National Center for Agricultural Utilization Research, 
USDA, Peoria, IL 61604
In the course of our studies of mycoparasitic and fungicolous fungi, an iso-
late (MYC-710 = NRRL 62562) was obtained from the surface of a basidio-
ma of Stereum complicatum in Georgia. The culture was identified by mi-
cromorphology and partial sequence analysis as Pestalotiopsis disseminata. 
Pestalotiopsis spp. are known to be prolific sources of structurally diverse 
secondary metabolites. An ethyl acetate extract of rice fermentation cultu-
res showed antifungal activity and was subjected to chemical investigation. 
Although the original activity was not recovered, these studies afforded se-
ven new polyketides (disseminins A – E and spiciferones D and E) and a 
related compound previously known only as a synthetic product. The struc-
tures of these compounds were determined mainly by analysis of HRMS 
and NMR data. Unusual bis-tetrahydrofuran and dioxabicyclo[3.2.1]octa-
ne ring systems were identified for disseminins A and B, respectively. X-ray 
crystallographic analysis of the p-bromobenzoate derivative of disseminin 
A confirmed the structure and enabled assignment of its absolute configu-
ration.
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THE ABC-AHP-NCNPR BOTANICAL ADULTERANTS 
PROGRAM’S LABORATORY GUIDANCE ON 
ANALYTICAL METHODS TO DETECT ADULTERANTS IN 
BOTANICAL MATERIALS
Stefan Gafner1, Mark Blumenthal1, Steven Foster 2, John Cardellina 3, Ikhlas 
Khan4, and Roy Upton5. 
1American Botanical Council, Austin, TX 78714, USA, 2Steven Foster 
Group, Eureka Springs, AR 72632, USA, 3ReevesGroup, Walkersville, MD 
21793, USA, 4NCNPR, University of Mississippi, University, MS 38677, 
USA, 5American Herbal Pharmacopoeia, Scotts Valley, CA 95067, USA
As the market for herbal medicines and dietary supplements increases, so 
do confirmed reports of undisclosed ingredients being added to botanical 
raw materials, extracts, essential oils, and finished botanical-based consu-
mer products. These problems not only present a significant challenge to 
the global botanical medicine and herbal supplement industries but, more 
importantly, put the health and safety of the consumer at risk. Identifying 
suitable test methods is crucial for in-house quality control units and third-
party analytical testing laboratories. However, the review and assessment 
of the available analytical methods is an expensive and time-consuming 
process. The ABC-AHP-NCNPR Botanical Adulterants Program Labo-
ratory Guidance Documents (LGDs) identify the most suitable methods 
for the authentication of specific botanical materials and the detection of 
adulterants. The first in the series, a review of methods to authenticate and 
detect adulteration of skullcap (Scutellaria lateriflora), has been published 
in 2015. Next are the LGDs on bilberry (Vaccinium myrtillus) extract, and 
black cohosh (Actaea racemosa). The presentation will give an overview of 
the Program with a focus on the purpose and content of the LGDs.
2091
PHYTOCHEMICAL AND INSECTICIDAL STUDIES ON T. 
ARJUNA
Alfonso Garcia1, Ilana Heckler1, John Hoffmann1, Renato Lúcio de 
Carvalho1, Preeti Dhar1*, Aaron Haselton2*
1Department of Chemistry, 2Department of Biology, 1 Hawk drive, SUNY 
New Paltz, NY 12561
Plants have co-evolved with insects, developing sophisticated mechanisms 
to defend themselves. Plants synthesize a wide range of compounds called 
secondary metabolites that are not directly related to plant metabolism but 
help the plants defend themselves against pests. Terminalia arjuna (TA) is 
a tree that belongs to the family Combretaceae and is found in abundance 
throughout India, Burma, Sri Lanka and Mauritius. The bark and fruits 
from this tree have been used in Ayurveda (the ancient Indian medicine 
system) for various ailments. Previous studies from our lab have shown the 
crude ethanolic extract of TA (bark) to show growth inhibition and pupa-
tion delay in third instar of Drosophila melanogaster. In the current investi-
gation, we have extracted the TA bark sequentially with hexane, ether, ethyl 
acetate and ethanol and have looked at the sequentially obtained ethanolic 
extract and its effects on the growth inhibition in larvae of D. melanogaster. 
Phytochemical analysis on the ethanolic extract of TA shows the presence 
of saponins, flavonoids, and carbohydrates. Results of the bioassays as well 
as phytochemical analysis will be presented.
2092
ALKALOIDS, FLAVANONES AND OTHER COMPOUNDS 
NEW TO GOLDENSEAL (Hydrastis canadensis)
Martha Leyte-Lugo, Daniel H. Foil, Daniel A. Todd, Emily R. Britton, and 
Nadja B Cech
Department of Chemistry and Biochemistry, The University of North 
Carolina Greensboro, P.O. Box 26170, Greensboro, North Carolina 27402, 
United States.
Hydrastis canadensis L. (Ranunculaceae), commonly known as goldenseal, 
is used in traditional and modern herbal medicine to treat a variety of con-
ditions including digestive problems and infections. Previous studies from 
our laboratory have indicated that leaf extracts from this botanical possess 
antimicrobial effects against the pathogenic bacterium Staphylococcus aure-
us. The goal of these studies was to identify chemical components of these 
extracts. Goldenseal leaves were homogenized and percolated in MeOH 
overnight, and the MeOH extract was concentrated in vacuo. The aqueous 
methanol layer was partitioned with hexane followed by ethyl acetate. 
Normal-phase flash chromatography yielded eight major primary fractions 
(FI-FVIII). Fraction II, III and IV was subjected to an additional stage of 
preparative HPLC, and these fractions yielded several known compounds 
previously not reported as constituents of goldenseal, two flavanones (1-2), 
one isoquinolone alkaloid (3), an isoindolobenzazepine alkaloid (4), and a 
spiro compound (5). Additionally, fraction FII afforded a new chromenone 
(6) and fraction IV a new methoxycarbonylbenzoic acid (7). The structu-
res of the isolates were established by spectrometric and spectroscopic me-
thods. Compound 1 demonstrated efflux pump inhibitory activity against 
Staphylococcus aureus.
2093
TEMPERATURE-DEPENDENT METABOLITE 
PRODUCTION BY ARCTIC ACTINOMYCETES
Brad Haltli 1,2,3, Alyssa Grunwald1, Noelle Duncan3, Hebelin Correa3, Martin 
Lanteigne2, Patricia Boland2, Russell G. Kerr1,2,3
1Department of Biomedical Sciences and 2Department of Chemistry, 
University of Prince Edward Island, Charlottetown, PE, CA, 3Nautilus 
Biosciences Canada Inc., Charlottetown, PE, CA.
Actinomycetes are a well-established source of natural products with ther-
apeutic potential, particularly for the treatment of infectious diseases. The 
exploration of microbes from underexplored habitats and the application 
of novel cultivation conditions are proven strategies for the discovery of 
novel bioactive metabolites. We set out to explore the metabolic diversity 
of cold-adapted actinomycetes isolated from marine sediments collected 
from Canada’s Arctic. To screen for metabolites differentially regulated by 
temperature, 45 strains were fermented at 15 °C and 30 °C and the resulting 
chemical extracts were tested for antimicrobial activity. Seventy-six percent 
of the strains exhibited antimicrobial activity against one or more patho-
gens. Strikingly, extracts prepared from fermentations incubated at 15 °C 
generated double the number of hits than fermentations conducted at 30 
°C. Overall, the majority (44 %) of strains exhibited a greater frequency of 
antimicrobial activity when fermented at 15°C. Metabolomic analysis (LC-
HRMS) was utilized to assess the differential production of metabolites in 
response to temperature. The results of these experiments will be presented.
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DISCOVERY, SYNTHESIS, AND BIOLOGICAL 
EVALUATION OF APRATYRAMIDE, A MARINE-DERIVED 
TRANSCRIPTIONAL STIMULATOR OF VEGF-A
Weijing Cai1,2, Lilibeth A. Salvador-Reyes1, Wei Zhang1, Susan Matthew1, 
Ranjala Ratnayake1,2, Valerie J. Paul3, Long H. Dang2,4, Hendrik Luesch1,2
1Department of Medicinal Chemistry, University of Florida, Gainesville, 
Florida 32610, USA, 2Center for Natural Products, Drug Discovery and 
Development (CNPD3), University of Florida, Gainesville, Florida 32610, 
USA, 3Smithsonian Marine Station, Fort Pierce, Florida 34949, USA, 
4Department of Medicine, University of Florida 32610, USA 
A collection of the marine cyanobacterium Moorea bouillonii from Apra 
Harbor in Guam afforded apratyramide, a linear depsipeptide consisting 
of four amino acid residues and one hydroxy acid moiety. The structure 
was elucidated by a combination 1D/2D NMR spectroscopic and mass 
spectrometric analysis. The absolute configuration of the stereocenters was 
determined by LC-MS analysis of the acid hydrolyzate. Apratyramide was 
then synthesized and tested for bioactivity. Apratyramide induced the tran-
scription and secretion of vascular endothelial growth factor A (VEGF-A) 
in multiple cell types. This activity is being explored for various applications 
where VEGF-A upregulation would be beneficial. 
2095
FINGERPRINT ANALYSIS COMBINED WITH MULTI-
RESPONSES EXTRACTION OPTIMIZATION OF 
COMASTOMA PEDUNCULATUM 
Tong Liu1, Yeling Wang1, Li Tang1*, Yue Liu1, Chunlin Long1 and Xiaoming Xu2
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2College of Physicians and Surgeons, Department of 
Medicine, Columbia University, New York, 10032, USA
A quality evaluating method using high-performance liquid chromatogra-
phy-diode array detector-electrospray ionization-tandem mass spectrome-
try (HPLC-DAD-ESI-MS/MS) was proposed for Comastoma peduncula-
tum (Rogle ex D. Dou) Holub, a traditional Tibetan herbal medicine. The 
optimum extraction conditions for herbal samples were firstly optimized 
using multi-responses optimization based on response surface methodolo-
gy (RSM), and achieved by Derringer’s desirability function and experimen-
tal validation. In the fingerprint analysis, 17 common peaks was developed 
among 10 batches of C. pedunculatum samples. 14 common peaks were 
identified using HPLC-DAD-ESI- MS/MS method based on their spectral 
characteristics or comparison with the authentic standards. Chemometrics 
techniques including similarity analysis, and hierarchical clustering analy-
sis were implemented to discriminate the 10 batches of samples collected 
from different origins. The results indicated that the 10 batches of samples 
shared two principle chromatographic patterns as well as differences. These 
results provided an effective and comprehensive quality analysis method 
for C. pedunculatum. Acknowledgements: Thank the supporting grant for 
NSFC-81274158, 81373765, NCET-12-0578, 13-0624, SEAC-12ZYZ019, 
111 Project B08044 and YLDX01013.
2096
POSSIBLE INVOLVEMENT OF NO/CGMP PATHWAY IN 
THE ANTIDEPRESSANT ACTIVITY OF PAEONIFLORIN
Jingxia Wang, Wei Li. Jianjun Zhang*
Beijing University of Chinese Medicine, Beijing 100029, China
Paeoniflorin is a water-soluble monoterpene glycoside isolated from the 
root of Paeonia lactiflora Pall.. Paeoniflorin (7-14 mg/kg, i.p.) produced 
a reduction in immobility period in tail-suspension test. The antidepres-
sant-like effect of Paeoniflorin (10 mg/kg, i.p.) in tail-suspension test was 
prevented by pretreatment with L-arginine (750 mg/kg, i.p.) [substrate for 
NOS]. Pretreatment of mice with 7-nitroindazole (25 mg/kg, i.p.) [a specific 
nNOS inhibitor] produced potentiation of the action of subeffective dose of 
Paeoniflorin (4 mg/kg, i.p.). In addition, treatment of mice with methylene 
blue (5 mg/kg, i.p.) [direct inhibitor of both NOS and sGC] potentiated the 
effect of Paeoniflorin (4 mg/kg, i.p.) in the tail-suspension test. Further-
more, the reduction in the immobility period elicited by Paeoniflorin (10 
mg/kg, i.p.) was also inhibited by pretreatment with sildenafil (5 mg/kg, 
i.p.) [phosphodiesterase 5 inhibitor]. Our findings demonstrated that the 
antidepressant-like effect of Paeoniflorin in the tail-suspension test invol-
ved an interaction with the NO-cGMP pathway.
2097
NEW ANTIINSECTAN DIOXOMORPHOLINES FROM 
ASPERGILLUS ALABAMENSIS NRRL 29810
Nicole M. Krausert,1 Patrick F. Dowd,2 Stephen W. Peterson,2 Donald T. 
Wicklow,2 and James B. Gloer.1
1Department of Chemistry, University of Iowa, Iowa City, Iowa, 52242, 
and 2USDA National Center for Agricultural Utilization Research, Peoria, 
Illinois, 61604
In the course of our studies of mycoparasitic and fungicolous fungi, an iso-
late (MYC-1193 = NRRL 29810) was obtained from the surface of a basidio-
mycete growing on a dead hardwood branch in a sabal palm swamp near 
the Econfina River in northern Florida. This fungal isolate was identified 
as Aspergillus alabamensis, a relatively new member of Aspergillus section 
Terrei, based on morphology and sequence analysis. The crude extract of 
a rice fermentation showed potent antiinsectan activity and was therefore 
selected for chemical investigation. Two new dioxomorpholines, along with 
the known compounds terrein and asteltoxin, were isolated using silica gel 
column chromatography and reversed phase HPLC. The structures of these 
metabolites were established by analysis of HRESIMS and 2D NMR data. 
Relative configurations were assigned using NOESY data, and the struc-
ture assignments were supported by NMR comparison with similar com-
pounds. The absolute configuration was determined on the basis of the op-
tical rotation of the hydroxyacid obtained upon acid hydrolysis. The major 
dioxomorpholine metabolite showed moderate activity in an antiinsectan 
assay against Spodoptera frugiperda.
2098
ISOLATION OF ANNONACOUS ACETOGENINS 
FROM ANNONA MURICATA FRUIT AND THEIR 
ANTIPROLIFERATIVE ACTIVITY ON HUMAN PROSTATE 
CANCER CELL PC-3 
Shi Suna, Jingchun Liua, Ninghui Zhoua, Wenjun Zhua, Q. Ping Doub, 
Kequan Zhoua
aDepartment of Nutrition and Food Science, Wayne State University, 5045 
Cass Ave, Detroit, MI, 48202. bBarbara Ann Karmanos Cancer Institute 
and Departments of Oncology, Pharmacology and Pathology, Wayne State 
University School of Medicine, Detroit, MI 48201
The fruit of Annona muricata is an edible and medicinal tropical fruit and 
commonly available in local markets. The previous work was continued, 
bioassay-guided fractionation of the fruit powder of A. muricata yielded 
three more novel bioactive compounds: C-35 annonaceous acetogenins, 
muricins M and N, and C-37 annonaceous acetogenins, muricenin. They 
all contain a mono-tetrahydrofuran ring and four hydroxyl groups. The 
structures were elucidated by spectral methods and chemical modificati-
on after isolation via open column chromatographic separation and HPLC 
purification. Especially, murices M and N demonstrated more potent anti-
proliferative activities against human prostate cancer PC-3 cells.
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DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION 
OF NEW BULKY ACYLOXY TACCALONOLIDES AS 
POTENT MICROTUBULE STABILIZERS
Antonius R. B. Ola,1 April L. Risinger,1,2 Jiangnan Peng,1 Cynthia L 
Zamiello,1 and Susan L. Mooberry1,2
1Department of Pharmacology, 2Cancer Therapy & Research Center, 
University of Texas Health Science Center at San Antonio, Texas 78229, 
USA 
The taccalonolides are a new class of microtubule stabilizers isolated from 
plants of the genus Tacca. As part of our structure-activity relationship study 
(SAR) to identify taccalonolides with optimal microtubule stabilizing and 
antitumor actions, we conducted semi-synthetic reactions to modify C-15 
of taccalonolide B (1). In this study, five novel bulky acyloxy taccalonolides 
were synthesized via DMAP catalyzed esterification and DMDO epoxida-
tion. The new bulky acyloxy taccalonolide mono esters were further tested 
for their antiproliferative potency against HeLa cells. Remarkably, all bulky 
acyloxy taccalonolide esters demonstrated better potency than taccalono-
lide AF (12), including two with subnanomolar potencies (IC50 of 0.6 nM 
for 11 and 0.8 nM for 9). In vivo antitumor activities were also evaluated in 
a murine xenograft model.
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TWO NEW POTENT ANTIMALARIAL ALKALOIDS, 
CRIPOWELLINS C AND D, FROM THE SWAMP LILY 
CRINUM ERUBESCENS. 
Christopher C. Presley1, Priscilla Krai2, Seema Dala2, Maria Cassera2, 
Michael Goetz3, and David G. I. Kingston1
1Department of Chemistry and Virginia Tech Center for Drug Discovery, 
Virginia Tech, Blacksburg, VA 24061 USA, 2Department of Biochemistry, 
Virginia Tech, Blacksburg, VA 24061 USA, 3Natural Products Discovery 
Institute, 3805 Old Easton Road, Doylestown, PA, 18902, USA
Malaria is a neglected tropical disease that has a disproportionate effect in 
poor and underdeveloped countries. As part of our ongoing search for new 
antimalarial compounds, an extract of the Swamp Lily Crinum erubescens 
was selected due to its potent antimalarial activity. Bioassay guided fractio-
nation yielded four potent antimalarial compounds. Compounds 1 and 2 
were identified as the known compounds cripowellins A and B, while com-
pounds 3 and 4 were determined to be the new compounds cripowellins C 
and D. Structures were elucidated using various 1 and 2-dimensional NMR 
techniques. The isolation and structure elucidation of the cripowellins and 
their biological data will be presented. 
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2101
BIOACTIVITY OF POLYPHENOLS FROM JABOTICABA 
WOOD 
Shi-Biao Wu1, Vanya Petrova1, Grace G.L. Yue2, Adam Negrin1, Jeanine M. 
D’Armiento3, Clara B.S. Lau2, Edward J. Kennelly1
1Department of Biological Sciences, Lehman College, and The Graduate 
Center, The City University of New York, Bronx, NY 10468; 2Institute of 
Chinese Medicine and State Key Laboratory of Phytochemistry and Plant 
Resources in West China, The Chinese University of Hong Kong, Shatin, New 
Territories, Hong Kong; 3Department of Medicine, College of Physicians and 
Surgeons, Columbia University, New York, NY 10032
Myrciaria cauliflora (Jaboticaba), native to Brazil, has been traditionally 
used for the treatment of respiratory problems such as asthma and chronic 
inflammation of the tonsils. This study was to identify and evaluate major 
polyphenols from the wood of jaboticaba tree for the first time for their 
therapeutic relevance to chronic obstructive pulmonary disease (COPD). 
Antioxidant and anti-inflammatory activity-guided fractionation led to the 
identification and isolation of 3,3’-dimethyellagic acid-4-O-sulphate. The 
ellagic acid derivative was compared to other potent compounds from the 
wood and fruits of jaboticaba such as ellagic acid, depside jaboticabin and 
anthocyanins delphinidin-3-O-glucose and cyaniding-3-O-glucose. The 
results indicate that 3,3’-dimethyellagic acid-4-O-sulphatate exhibited an-
tiradical activity and significantly inhibited chemokine interleukin-8 pro-
duction after cigarette smoke treatment of human small airway epithelial 
cells. Its activity was comparable to that of ellagic acid, but it may be more 
bioavailable because it is more water-soluble. Bioavailability of jaboticabin, 
a depside from jaboticaba, was further examined in vitro using the human 
intestinal Caco-2 cell monolayers and in vivo with an animal model. 
2102
UPLC-qTOF-MS CHEMOMETRIC STRATEGY TO 
IDENTIFY BIOACTIVE CONSTITUENTS FROM GARCINIA 
OBLONGIFOLIA 
Ping Li1, Harini Anandhi Senthilkumar2, Shi-Biao Wu2, Bo Liu1, Jimmie 
Fata3, Edward J. Kennelly2 and Chunlin Long1,4
1College of Life and Environmental Sciences, Minzu University of China, 
Haidian District, Beijing 100081, China, 2Department of Biological Sciences, 
Lehman College, and The Graduate Center, The City University of New York, 
Bronx, NY, 10468, 3Department of Biological Sciences, College of Staten 
Island, Staten Island, NY 10314, 4Kunming Institute of Botany, Chinese 
Academy of Sciences, Kunming 650201, China.
Garcinia oblongifolia is a well-known medicinal plant from southern China, 
with edible fruits. However, the phytochemistry and bioactivity of the dif-
ferent parts of G. oblongifolia are still not well studied. We developed a stra-
tegy to identify potential bioactive compounds from the leaves, branches, 
and fruits of G. oblongifolia by combining bioactivity analysis with UPLC-
qTOF-MS based chemometrics. Preliminary screening with human breast 
cancer estrogen receptor positive MCF-7 cells showed that G. oblongifolia 
branch extracts influenced cell growth in a dose-dependent fashion by cau-
sing a unique pattern of vacuolization, which was not observed with the leaf 
or fruit extracts. Cytotoxicity and cell proliferation studies are ongoing in 
order to further understand the difference in activity of the three extracts. 
The branch extract also showed strong antioxidant activity in DPPH and 
ABTS assays. UPLC-qTOF-MS combined with untargeted PCA and OPLS-
DA analysis was conducted to analyze and compare the three extracts, and 
12 compounds including 2 bioactive xanthones and 4 potential biomarkers 
were identified as the marker compounds for branches. Imaging and an-
tioxidant results indicate that the branch extract exhibits greater activity 
than the leaf and fruit extracts. These findings provide a useful strategy to 
analyze extracts to find potential biomarkers from different parts of medi-
cinal plants.
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ACHIEVEMENT OF SUSTAINABLE AGRICULTURAL 
SOLUTIONS THROUGH MODERN DEREPLICATION 
TOOLS 
Emily L. Whitson,1 Taylor Royalty,1 Arnaldo R. Rivera,1 Tamara 
Meragelman1
1Natural Products Chemistry, Bayer Crop Science Biologics, West 
Sacramento, CA 95605.
There is an increasing demand to provide safe and sustainably sourced food 
to the marketplace. With the goal of meeting this need we sought to define 
a dereplication solution that would allow us to prioritize leads and mini-
mize developing biological crop protection products that did not meet this 
objective. A dereplication database was constructed composed of natural 
products from microbial origins, in addition to currently approved hu-
man and veterinary antibiotics in both the United States and the European 
Union. Each entry contains publically available toxicological information, 
as well as molecular weight, molecular formula, and source organism (if 
available). In addition, the entries have an assigned score based on over 800 
different keywords describing a biological effect. At present our database 
is composed of over 600 compounds, primarily from the Order Bacillales, 
that contain compounds with keywords indicating either a potential haz-
ard (score = 2) or need further risk assessment (score = 1). We have also 
identified additional solutions to aid in the identification of prospective 
compounds based on predicted logP values and corresponding retention 
time windows, as well as observed MS/MS fragmentation patterns. Lastly, 
we have developed an algorithm that provides a probability of identification 
based on the aforementioned criteria to further aid in the selection pro-
cess. The dereplication database provides a unique solution for identifying 
known and potentially hazardous compounds in microbial samples where 
authentic standards are not readily available.
2104
PHARMACOLOGICALLY ACTIVE EXTRACTS FROM 
FLORIDA KEYS SPONGES INHIBIT OVARIAN CANCER 
CELL PROLIFERATION. 
Meera Patel, Gia McKnight, Tomasz Jurga, Melany P. Puglisi, PhD, Michael 
J Bradaric, PhD
Dept. of Pharmaceutical Sciences, College of Pharmacy; Chicago State 
University, Chicago, IL 
Ovarian cancer is a lethal gynecologic malignancy. Novel chemotherapeu-
tics are urgently needed as the five year survival rate has not dramatically 
improved in 20 years. Sponges and their associated microorganisms are po-
tential sources of pharmacologically active metabolites.
The purpose of this study is to screen extracts from sponges collected in the 
near shore habitats in the Florida Keys for growth inhibition of several ova-
rian cancer cell lines (HeyA8, ES2, and EG, SKPOV3ip1) to identify targets 
for bioassay-guided fractionation. For our preliminary studies, the com-
mon sponges from the seagrass beds in Long Key were extracted in ethyl 
acetate:methanol. The lipophilic extract was partitioned between ethyl 
acetate and deionized water, followed by chloroform and 70% methanol. 
Results from extracts from the fifteen sponges in the first-pass screening 
demonstrated that the 70% methanol, ethyl acetate, and chloroform par-
titions reduce cancer cell proliferation via MTT assays at 0.016 - 1 mg/mL 
in complete media. The collections, extractions and preliminary screening 
was conducted by PharmD candidates as part of a college wide research 
training program. Fractions exhibiting excellent IC50 values have been iden-
tified for the next phase of this study. Active metabolites will be isolated 
using bio-assay guided fractionation in a high throughput assay system. Re-
ductions in cell proliferation will then be confirmed by examining protein 
markers specific to the activated apoptotic pathway to elucidate the mecha-
nism of action. Ongoing studies will determine if any of these extracts also 
inhibit invasion or migration; another cancer cell hallmark. 
2105
IDENTIFICATION OF NOVEL INHIBITORS OF 
BOTULINUM NEUROTOXIN A
Chinni Yalamanchili1,2, Vamshi K. Manda1, Amar G. Chittiboyina1, William 
A. Harrell Jr3, Robert P. Webb3, and Ikhlas A. Khan1,2,4*
1National Center for Natural Products Research, 2Divison of Pharmacognosy, 
Department of BioMolecular Sciences, The University of Mississippi, 
University, MS, 38677, USA, 3US Army Medical Research Institute of 
Infectious Diseases, Fort Detrick, MD 21702-5011, USA
The current post-exposure treatment of botulism using antitoxins is inef-
fective to treat the already neuron-internalized botulinum neurotoxin. Our 
aim is to find novel small-molecule ‘phytochemical’ inhibitors of Botuli-
num neurotoxin serotype A (BoNT A). Fifteen plants were selected from 
‘traditional medicine’ based on symptoms similar to botulism. Around 850 
phytochemicals from these fifteen plants were virtually screened in silico 
in five BoNT A-inhibitor crystal structures. From the in silico output, top 
50 compounds were selected based on their docking scores, visual inspec-
tion and structural diversity. These compounds were screened in vitro by 
HPLC-BoNT A LC protease bioassay. Based on the in vitro results, seven 
compounds were further screened using the mouse phrenic nerve-hemi-
diaphragm ex vivo assay. At 20 µM, NPC-ACA-3 showed marginal protec-
tion against BoNT A. The details of the workflow along with the in vitro and 
ex vivo data will be presented.
2106
DETECTION OF ADULTERATION IN DIETARY 
SUPPLEMENTS: MACA (LEPIDIUM MEYENII) CASE 
STUDY BY NMR APPROACH
Jianping Zhao1, Mei Wang1, Ikhlas A. Khan1,2,3
1National Center for Natural Products Research, 2Department of 
Pharmacognosy, School of Pharmacy, University of Mississippi, University, 
MS 38677, USA; 3Department of Pharmacognosy, College of Pharmacy, 
King Saud University, Riyadh, Saudi Arabia
Adulteration of dietary supplements has been a potential safety concern 
for consumers and regulatory agencies. Maca, Lepidium meyenii Walpers 
(Brassicaceae), is a perennial herbaceous plant grown on the high Andean 
plateaus. Its small turnip-like root has been used as aphrodisiac, energizer, 
and fertility enhancer, and is so-called a natural Viaga or Peruvian ginseng. 
In recent years, Maca products have gained increasing popularity throug-
hout the world, and the demand and price have increased dramatically. The 
global supply shortage of maca plant material has made it prone to be a 
seriously adulterated dietary supplement. In the present study, a nuclear 
magnetic resonance (NMR) spectroscopic method was developed to assess 
the quality of maca products sold on the market. The method can be used 
as a rapid preliminary tool for detection of maca adulteration. 
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CHEMICAL INVESTIGATIONS INTO TERMITE-
ASSOCIATED ACTINOBACTERIA
Emily Mevers1, Jon C. Clardy1
Biological Chemistry and Molecular Pharmacology, Harvard Medical 
School, Boston, MA 02115
Investigations into numerous strains of termite-associated actinobacteria 
reveal that they are prolific producers of biologically active small molecules, 
including over 13 antimicrobial metabolites, such as fungichromin, bernin-
amycin, bafilomycins, and mycotrienin. These metabolites exhibit a range 
of potencies against gram-positive bacteria, gram-negative bacteria, and/or 
environmentally relevant fungal pathogens (i.e. Trichoderma harzianum). 
Interestingly, several analogs of the bafilomycin family of metabolites exhi-
bit inhibitory activity against most of the fungal pathogens except T. har-
zianum, where it only slows the growth rate. Furthermore, the bafilomycins 
visibly induce the production of a bright yellow pigment in the fungal cul-
ture. Three analogs of bafilomycin (C1, D, and E) were isolated and eva-
luated for potency. Bafilomycin C1 shows the greatest ability to elicit the 
production of this pigment, while bafilomycin E and D exhibit moderate 
and no activity, respectively. Identification of the major yellow pigments 
was made possible by growing the T. harzianum on solid media that was 
conditioned with spent liquid media from the bafilomycin-producing 
Streptomyces strain. Three major metabolites were identified, all of which 
loosely resemble the azaphilone family of metabolites. These metabolites 
exhibit moderate activity against most of the termite-associated actinobac-
teria and have no toxicity against the fungal pathogens. This project shows 
that termite-associated actinobacteria are prolific producers of antimicro-
bial agents, and that the pathogenic fungus, T. harzianum, has the ability to 
respond to a chemical threat with its own small molecules, inhibiting the 
growth and sporulation of the actinobacteria. 
2108
DISCOVERY OF EPOXYKETONE PROTEASOME 
INHIBITORS USING METAGENOME MINING
Jeremy G. Owen1, 2, Zachary Charlop-Powers1, Alexandra G. Smith1, 
Melinda A. Ternei1 , Paula Y. Calle1 , Boojala Vijay B. Reddy1, 2, Daniel 
Montiel1 , and Sean F. Brady1, 2
1Laboratory of Genetically Encoded Small Molecules and 2Howard Hughes 
Medical Institute, The Rockefeller University, New York, NY 10065.
This poster describes how short natural product sequence tags derived from 
conserved biosynthetic motifs can be used profile biosynthetic diversity in 
the environment and then guide the recovery of gene-clusters from meta-
genomic libraries. The results of a computational search for epoxyketone 
proteasome inhibitors within 185 globally distributed soil metagenomes are 
presented. This screen led to the identification of 99 unique epoxyketone 
sequence tags that were used to guide the recovery of nine epoxyketone 
encoding biosynthetic gene-clusters. Seven potent epoxyketone proteaso-
me inhibitors, clarepoxcins A–E (1-5) and landepoxcins A and B (6 and 7), 
were produced by heterologous expression of two of these pathways. 
 
 
2109
NEW BENZOPHENONE DERIVATIVES FROM 
THE COPROPHILOUS FUNGUS DELITSCHIA 
CONFERTASPORA
Dinith R. Jayanetti,1 Gerald F. Bills2, and James B. Gloer1
1Department of Chemistry, University of Iowa, Iowa City, IA 52242, 2Texas 
Therapeutics Institute, The Brown Foundation Institute of Molecular 
Medicine, University of Texas Health Science Center at Houston, 1881 East 
Road, Houston, TX, 77054.
During our ongoing studies of coprophilous (dung-colonizing) fungi as 
sources of new bioactive secondary metabolites, a culture of the copro-
philous fungus Delitschia confertaspora (ATCC 74209) originally obtained 
from a sample of rock hyrax dung collected in Namibia was targeted for in-
vestigation. Previous studies of this culture by scientists at Merck Research 
Laboratories yielded the unusual 2,6-diketopiperazine derivative flutimide, 
which inhibits the cap-dependent endonuclease of influenza virus. This 
fungus has recently been genome-sequenced as part of the 1000 fungal ge-
nome project. The interesting chemistry observed in this earlier work, the 
limited prior studies of other members of the genus, and the lack of reports 
about other chemistry produced by this species prompted us to undertake 
further studies of this organism. Chemical investigation of a D. confertaspo-
ra fermentation extract resulted in isolation of two new benzophenone 
derivatives. Both compounds have a somewhat unusual skeleton that in-
corporates three aromatic rings linked via two ketone carbonyl groups. The 
structures of these new metabolites were elucidated by analysis of 2D NMR 
and HRESITOFMS data.
2110
SILYMARIN SUPPRESSES CELLULAR INFLAMMATION 
BY INDUCING REPARATIVE STRESS SIGNALING
Erica Lovelace1, Jessica Wagoner1, James MacDonald2, Theo Bammler2, 
Young-Mo Kim3, Bobbie-Jo Robertson3, Thomas Metz3, Federico Farin2, 
Nicholas Oberlies4, and Stephen Polyak1
Departments of Laboratory Medicine1 and Environmental and Occupational 
Health Sciences2, University of Washington, Seattle, WA, 98104, 3Biological 
Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 
99354, 4Department of Chemistry and Biochemistry, University of North 
Carolina at Greensboro, NC, 27412.
Silymarin, an extract of the seeds of milk thistle (Silybum marianum), sup-
presses cellular inflammation. To define how this occurs, transcriptional 
profiling, metabolomics, and signaling studies were performed in human 
liver and T cell lines. Silymarin altered metabolic pathways; the extract ac-
tivated adenosine monophosphate protein kinase (AMPK) and inhibited 
of mammalian target of rapamycin (mTOR) within 4 h of exposure. Meta-
bolomics analyses showed silymarin suppression of glycolytic and amino 
acid metabolism. Anti-inflammatory effects arose with prolonged (i.e. 24 
h) silymarin exposure, with suppression of multiple pro-inflammatory si-
gnaling pathways including nuclear factor kappa B (NF-κB). Studies with 
murine knock out cells revealed that silymarin inhibition of both mTOR 
and NF-κB was partially AMPK dependent. Other natural products indu-
ced similar stress responses, which correlated with their ability to suppress 
inflammation. Thus, natural products activate stress and repair responses 
that culminate in an anti-inflammatory cellular phenotype. Natural pro-
ducts like silymarin may be useful as tools to define how metabolic, stress, 
and repair pathways regulate cellular inflammation. 
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(HP)TLC-BIOAUTOGRAPHY-MS/NMR – A NEW TOOL 
FOR THE SEARCH OF ANTI-TUBERCULOSIS LEAD 
COMPOUNDS
Edyta M. Grzelak1, Mary Choules1,2, Chang-Hwa Hwang1, Joo-Won Nam1,2, 
Yang Yu2, Geping Cai1, Wei Gao1, David C. Lankin2, James B. McAlpine1,2, 
Surafel G Mulugeta1, Jose G Napolitano2, Joo-Won Suh3,4, Seung Hwan 
Yang3, Jinhua Cheng3, Hanki Lee3, Jin-Yong Kim4, Sang-Hyun Cho1, Guido F. 
Pauli1,2, Scott G. Franzblau1, and Birgit U. Jaki1,2
1Inst. for TB Research, 2Dept. Med. Chem. & Pharmacognosy, COP, UIC, 
Chicago, IL, 60612, 3Center for Neutraceutical & Pharmaceutical Materials, 
4Div. of Biosciences & Bioinformatics, Col. Nat. Sci., Myongji University, 
Gyeonggi-Do 449-728, Republic of Korea
(HP)TLC-Bioautography-MS/NMR is a new method developed to respond 
to the quest for new anti-tuberculosis lead compounds and to overcome the 
limitations of the classical bioactivity-guided isolation concept. By combi-
ning modern microbiology, chromatographic, and spectrometric methods 
in a multidimensional setting, it is possible to obtain structural informati-
on about the compound of interest in an early purification step, and also 
overcome the challenges associated with (i) long isolation procedures, (ii) 
the frequent oversight of minor but highly-active compounds, (iii) the mo-
nitoring of anti-TB activity during fractionation, and (iv) the loss of bioac-
tivity due to “synergistic” effects. Exemplary applications involving actino-
mycete and Aspergillus extracts with anti-TB activity demonstrate that the 
new, integrated methodology enables the identification and/or isolation of 
new and known anti-TB compounds. Thus, TLC-Bioautography-MS/NMR 
methodology is fit for the purpose of TB drug discovery from natural sour-
ces. [Funding: NIH grant 5 R21 AI093919-02]
2112
MINIMIZING THE PROBLEMS WITH “PIMPS”
James B. McAlpine1,2, Jonathan Bisson1, Guido F. Pauli1,2
1Department of Medicinal Chemistry and Pharmacognosy, 2Institute for 
Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 
Chicago, IL, 60612, USA
A recent article by Baelli on the problems experienced by medicinal che-
mists with pan-assay interference compounds (PAINS) and Shoichet’s wor-
kii on the impact of aggregation occurring in high throughput screening 
libraries, prompts a consideration of how these and other similar problems 
are experienced by pharmacognosists with promiscuous invalid metaboli-
tes as panaceas (PIMPs). Contrary to the classical definition of secondary 
metabolites as being species specific (or near specific), several natural pro-
ducts, particularly in the more extensively investigated plant kingdom, are 
common across species, genera, and even families (e.g. β-sitosterol). In the 
course of bioactivity-guided fractionation, PIMPs have shown up as major 
components in active fractions of a wide variety of pharmacological assays, 
i.e., they have been designated as panaceas. As in the case of PAINS, the-
se assay results are almost invariably invalid and lead enthusiastic young 
scientists down a garden path. Why does this happen and how can it be 
avoided? Interestingly, the advances in modern methods of structure deter-
mination have exacerbated this problem, because it is possible to determine 
the structure of a compound when it is quite impure, and residual comple-
xity is characteristic of chromatographic fractionation. That these residuals 
are often the source of the bioactivity is also frequently overlooked. Classic 
examples where this has occurred and ways to avoid it will be outlined.
iBaell, J B, ACS Med. Chem. Lett. 2015, 6, 229. iiSeidler, J, McGovern, S L, 
Doman, T N, Shoichet, BK. J. Med. Chem. 2003, 46, 4477.
2113
ACCESSING CYANOBACTERIAL NATURAL 
PRODUCTS: A WORKFLOW FOR SEQUENCING, AND 
HETEROLOGOUS EXPRESSION.
Patrick J. Videau1, Benjamin Philmus1
1College of Pharmacy, Oregon State University, Corvallis, OR 97331
Cyanobacteria are a great source of structurally diverse bioactive com-
pounds with activities ranging from anti-tumor to anti-malarial to anti-
bacterial. The biggest obstacles to studying cyanobacteria are their low 
compound yields, slow growth rate, and genetic intractability. We have 
been working towards a workflow that couples next generation genome se-
quencing with heterologous expression of cyanobacterial natural products. 
We have chosen to use the model cyanobacterium Anabaena sp. 7120 as a 
heterologous host for cyanobacterial natural product gene clusters. Using 
lyngbyatoxin A as an example we show that Anabaena sp. 7120 is capable of 
recognizing marine cyanobacterial promoters and is capable of producing 
cyanobacterial natural products. We also show that the culture conditions 
can alter lyngbyatoxin A yield significantly. Using promoter fusions we 
show that Anabaena sp. 7120 has the capacity to recognize a wide variety of 
promoters from both free living and symbiotic cyanobacteria. Currently we 
are moving towards identifying and validating the gene clusters for a variety 
of intriguing cyanobacterial natural products.
2114
ANTIMICROBIAL ACTIVITY OF CONSTITUENTS 
ISOLATED FROM SEEDS OF PICRALIMA NITIDA (STAPF) 
TH. & H. (APOCYNACEAE)
Odoh Uchenna E.1, Tchimene Michel 1, Okoye Festus B. C.2, Ezugwu 
Christopher O.1, Osadaebe, Patience O3. and Ezejiofor Madu1
1Department of Pharmacognosy and Environmental Medicine, Faculty of 
Pharmaceutical Sciences, University of Nigeria, Nsukka, 2Department of 
Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Nnamdi 
Azikiwe University, Awka, Nigeria, 3Department of Pharmaceutical and 
and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of 
Nigeria, Nsukka.
Antimicrobial activity of two compounds isolated from seeds of Picralima 
nitida, namely, Alpha-amyrin acetate and β-sitoseterol were tested against 
two human Gram-positive bacteria (Staphylococcus aureus, Micrococcus 
luteus) and four Gram-negative ones (Escherichia coli, Pseudomonas aeru-
ginosa, Enterobacter cloacae, Klebsiella Pneumoniae). The compounds isola-
ted, were tested against the fungal strain Aspergilus niger and Candida albi-
cans. The structures of the compounds have been confirmed by HR-EIMS, 
1H-13C-NMR, COSY, HETCOR spectroscopic methods. The antimicrobi-
al activities were performed by agar well diffusion method. MIC and MBC 
were carried out by agar dilution method and viable cell count method, 
respectively. Alpha-amyrin acetate showed maximum antimicrobial activi-
ties while β-sitoseterol also showed superior antimicrobial activities when 
compared to standard antimicrobial drugs.
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POTENTIAL PANCREATIC LIPASE INHIBITORY 
ACTIVITY OF 2-ARYLBENZOFURAN DERIVATIVES 
FROM MORUS ALBA 
Byung Sun Min1, Ha Manh Tuan1, Tran Manh Hung1, and Jeong Ah Kim 2
1 College of Pharmacy, Drug Research and Development Center, Catholic 
University of Daegu, Gyeongbuk 712-702, Korea,2 College of Pharmacy, 
Kyungpook National University, Daegu 702-701, Korea.
Bioassay-guided isolation of the methanolic extract of Morus alba using 
pancreatic lipase inhibitory activity led to isolation of five new 2-arylbenzo-
furan derivatives (4–8), three new flavonoids (1, 2, 9), one new prenylated 
stilbene (3) and twelve known compounds including moracin B (10), mora-
cin E (11), isobavachalcone (12), morusin (13), sanggenol L (14), kuwanon 
T (15), kuwanon U (16), 5,6-dimethoxy-2-(3-hydroxy-5-methoxyphenyl)
benzofuran (17), mulberrofuran D (18), sanggenofuran A (19), mulberro-
furan D2 (20), and mulberrofuran A (21). Their structures were elucidated 
on the basis of comprehensive analysis of spectroscopic data. Compounds 
5, 7, 18 and 19 showed potent inhibition against pancreatic lipase with IC50 
values of 0.564, 0.388, 0.089 and 0.912 µM, respectively. 
 
 
 
2116
ALKALOIDS CONSTITUENTS FROM THE FRUITS OF PIPER 
NIGRUM L. AND THEIR ANTI-INFLAMMATION ACTIVITY
Bo Mi Lee1, Quynh Mai N.T1, Jeong Ah Kim2 and Byung Sun Min1
1College of Pharmacy, Drug Research and Development Center, Catholic 
University of Daegu, Gyeongbuk 712-702, Korea, 2College of Pharmacy, 
Kyungpook National University, Daegu 702-701, Korea.
Eight alkaloids, piperine, pellitorine, isopiperolein B, Pyroperine, dehydro-
pipernonaline, 1-Cinnamoyl piperidine, dihydopiperine, retrofractamide 
A, along with 3,4 methylenedioxy cinnamaldehyde, were isolated from the 
fruits of Piper nigrum L.. Their structures were elucidated by spectroscopic 
methods. In vitro activity assay showed that pellitorine, isopiperolein B, re-
trofractamide A and dehydropipernonaline presented remarkable activity 
on lipopolysaccharide (LPS)-induce NO release.
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2117
PROTEIN TYROSINE PHOSPHATASE 1B AND ALPHA-
GLUCOSIDASE INHIBITORY COMPOUNDS FROM THE 
LEAVES OF SMILAX CHINA L.
Bing Tian Zhao1, Duc Hung Nguyen1, Md Yousof Ali2, Jae-Sue Choi2, and Mi 
Hee Woo1
1College of Pharmacy, Catholic University of Daegu, Gyeongsan 712-702, 
Republic of Korea, 2Department of Food Science & Nutrition, Pukyong 
National University, Busan 608-737, Republic of Korea
Two new flavonoids, bismilachinone (11) and smilachinin (14), were isolat-
ed from the leaves of Smilax china L. together with 14 known compounds. 
The PTP1B and α-glucosidase inhibitory activities for compounds 1–16 
were evaluated on the molecular level. In the in vitro anti-diabetic assay, 
compounds 3, 4, 6, 11, 12, and 16 showed strong PTP1B inhibitory activity 
with IC50 values of 7.62, 10.80, 0.92, 2.68, 9.77, and 24.17 μM, respectively. 
Furthermore, compounds 2–7, 11, 12, 15, and 16 showed potent α-gluco-
sidase inhibitory activity with IC50 values of 8.70, 81.66, 35.11, 35.92, 7.99, 
26.28, 11.28, 62.68, 44.32, and 70.12 μM, respectively. In the kinetic study 
for the enzyme of PTP1B, compounds 6, 11, and 12 revealed competitive 
inhibition, and compounds 3, 4, and 16 showed non-competitive inhibi-
tion. These results demonstrate that the leaves of S. china are useful as po-
tential functional food ingredients for the prevention and treatment of type 
2 diabetes.
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2118
EXTRACTION OF LAVENDER ESSENTIAL OIL AND ITS 
ANTIOXIDANT ACTIIVITY
Qing Zhao1, Sha-Sha Jin1
1Department of Applied Chemistry, College of Science, Xi′an University of 
Technology, Xi′an 710054, China
The flowers and leaves of Lavender (Lavandula angustifolia Mill) have been 
used as a herbal medicine for the treatment of heal burns and insect bites. 
Previous studies have shown that its exacts exhibited wide range of bioac-
tivities such as analgesic, wound healing, antibacterial, antifungal, sedative 
and antidepressant effects. Lavender essential oil has attracted a great deal 
of interest for its potential uses in food, perfume and pharmaceutical indus-
tries. It has a soothing and calming effect on the nerves, relieving tension, 
depression, panic and nervous exhaustion in general and is effective to re-
duce anxiety in both clinical and preclinical studies. In this study, the details 
of the optimum extraction condition for lavender essential oil, its chemical 
constituents and antioxidant properties have been studied. It was found 
that the most abundant constituents of the lavender essential oil collect-
ed in Urumqi (Xiangjiang province, China) are linalool (2.1%) and linalyl 
acetate (3.0%), both of them have been proposed as topical palliatives of 
pain in animal models. The antioxidant activity indicated that the lavender 
essential oil can scavenge hydroxyl radicals.
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2119
DIFFERENTIAL INDUCTION OF SECONDARY 
METABOLITE PROFILES IN ENDOPHYTE FUNGI BY THE 
ADDITION OF EPIGENETIC MODIFIERS
Victor González-Menéndez, Rachel Serrano, Francisca Muñoz, Fernando 
Reyes, Olga Genilloud and Jose R. Tormo
Fundación MEDINA, Avda. Conocimiento 34, 18016, PTS, Granada, Spain
Fungal endophytes are known to produce a wide variety of secondary me-
tabolites (SMs) involved in their adaptation and survival within higher 
plants. The plant-microbe interaction may influence the expression of some 
biosynthetic pathways, otherwise cryptic in these fungi when grown out-
side its natural environment. Adding epigenetic small-molecule modifiers 
of Histone Deacetylase (HDAC) and DNA methyltransferase (DNMT) 
activities in fungal endophyte fermentations, may induce, among others, 
the expression of these biosynthetic pathways that occur naturally in plant-
microbe interactions.
The addition of these small-molecule epigenetic elicitors since the inocula 
of several fungi in our study, determined a more consistent activation of 
fungal endophytes silent biosynthetic pathways, compared to its only addi-
tion during their production fermentation. uHPLC analyses showed these 
differential types of responses, including profiles with few changes in their 
metabolite production, higher amounts of some or all SMs, or few changes 
but with new SMs present, proving that the use of these epigenetic modi-
fiers can ensure an extensive generation of new SMs, previously unknown 
to be produced by this group of endophyte fungi, in laboratory conditions.
2120
DELPHATISINE D AND CHRYSOTRICHUMINE A, 
TWO RARE NEW DITERPENE ALKALOIDS FROM 
DELPHINIUM CHRYSOTRICHUM
Yang-Qing He1 and Lyndon M. West2
1Department of Applied Chemistry, Xi’an University of Technology, Xi’an, 
Shaanxi 710054, P. R. China, 2Department of Chemistry and Biochemistry, 
Florida Atlantic University, Boca Raton, Florida 33431, USA
Chemical investigations of the Tibetan folk medicine Delphinium chrys-
otrichum resulted in the isolation of two new diterpenoid alkaloids, delpha-
tisine D (1) and chrysotrichumine A (2), together with eleven known com-
pounds including one sesquiterpenoid, 3β,6α-dlphydroxysclareollda (3) 
and ten diterpenoid alkaloids. Compund 1 is a rare isoatisine-type alkaloid 
from genus Delphinium and is the C-15 epimer of spiramine C which bear-
ing an internal carbinolamine ether linkage (N−C−O−C) between C-7 and 
C-20. Compound 2 is a rare natural C19-diterpenoid alkaloid possessing a 
nitrone group between C-17 and C-19. Their structures were elucidated on 
the basis of extensive spectroscopic analysis. Compound 3 is a sesquiter-
penoid first isolated from this genus. 
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2121
INVESTIGATION INTO THE BIOACTIVE METABOLITES 
OF DEEP SEA FUNGI
Candice L. Bromley1, Ryan M. Young1,2, Stephen Jackson3, Thomas Sutton3, 
Alan Dobson3, 4, Bill J. Baker1,2
1School of Chemistry, National University of Ireland, Galway, Ireland, 
2Department of Chemistry and Center for Drug Discovery and Innovation, 
University of South Florida, Tampa, FL 33620, 3Marine Biotechnology 
Center, Environmental Research Institute, National University of Ireland, 
Cork, Ireland,4 School of Microbiology, University College Cork, National 
University of Ireland, Cork, Ireland.
Eleven fungal strains were cultured from deep sea samples collected from 
Irish waters. The crude organic extracts of the fungi were initially tested for 
bioactivity against gram negative bacteria such as Escherichia coli and Pseu-
domonas aeruginosa, as well as gram positive bacteria such as Staphylococ-
cus aureus and Bacillus subtilis. In an attempt to increase the production of 
bioactive secondary metabolites epigenetic modifiers, capable of activating 
silenced or attenuated gene clusters in the fungi, were employed. Each of 
the fungal strains were exposed to two such epigenetic modifiers, namely 
sodium butyrate and 5-azacytidine, inhibiting histone deacetylase (HDAC) 
and DNA methyltransferase (DNMT) respectively. The effects of these 
epigenetic modifications on the bioactivity of the resulting fungal extracts 
were determined through a range of biological assays. Comparative investi-
gations of the metabolomic profiles produced by fungal strains were con-
ducted using LC-MS as well as NMR spectroscopy to establish any resultant 
changes in the bioactive secondary metabolites brought about through the 
epigenetic modification. 
2122
CHEMOMETRIC-DIRECTED BIOEXPLORATION OF 
NATURAL PRODUCTS
Joshua Kellogg1, Daniel A. Todd1, Joseph M. Egan1, Huzefa A. Raja1, 
Nicholas H. Oberlies1, Olav M. Kvalheim2, and Nadja B. Cech1
1Department of Chemistry & Biochemistry, The University of North 
Carolina Greensboro, Greensboro, NC 27402, USA, 2Department of 
Chemistry, University of Bergen, Bergen, Norway
A workflow for the chemometric analysis of a chromatographic fractiona-
tion series was developed, integrating partial least-square (PLS) statistical 
modeling with high-resolution mass spectrometry to yield an associative 
model that correlated chemical composition and bioactivity. Goldenseal 
(Hydrastis canadensis) fungal endophytes were evaluated to determine their 
secondary metabolite profile and their influence on growth of Staphylococ-
cus aureus strain SA1199. Pyrenocheata sp. extract and fractions inhibited 
the growth of SA1199 as much as 95.8 ± 1.7%, and the resulting PLS model 
predicted a single active ion (m/z 343) as the purported bioactive compo-
nent. Follow-up analysis tentatively identified the m/z 343 ion as the known 
antimicrobial macrosphelide A.
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ISOLATION, CHEMICAL PROFILING, AND 
STANDARDIZATION OF BETAINE, CHOLINE, 
ACETYLCHOLINE, AND 20-HYDROXYECDYSONE FROM 
ATRIPLEX SPECIES 
Mallika Kumarihamy1, Yan-Hong Wang1, Francisco Leon2, Mei Wang1, 
Andrew Smesler1, Stephen J. Cutler2, Ikhlas A. Khan1, 2, Ilias Muhammad1
1National Center for Natural Products Research and 2Department 
of BioMolecular Sciences School of Pharmacy, Research Institute of 
Pharmaceutical Sciences, University of Mississippi, University, MS 38677, 
USA
Atriplex canescens (Pursh) Nutt., is an evergreen, scurfy shrub endemic to 
the central and western regions of the North America. Native Americans 
have been used it in folkloric medicine for controlling pain, ant bites and 
other ailments. From the EtOH extract of A. canescens leaves three key di-
etary ingredients, namely betaine (1), choline (2), and 20-hydroxyecdyso-
ne (3) were isolated and identified as major chemical markers, along with 
oleanolic acid 3-O-β-D-glucopyranosyl-28-O-β-D-glucopyranoside (4), 
isovanillic acid (5), and β-sitosterol-D-glucoside (6). Chemical profiling 
of three major constituents 1-3 and acetylcholine (9), using RP-HPLC, in 
different plant parts of A. canescens, as well as among other species, namely 
A. fruiticulosa, A. fasciculate, A. semibaccata and A. lentiformis, revealed 
all four compounds are present in the extracts of different parts of A. ca-
nescents, but 20-hydroxyecdysone is not detected in other species of Atri-
plex. The presence of these dietary and nutritional constituents, particularly 
in A. canescens, explains the implications of this native US plant. 
Acknowledgement: Supported by the National Institute of General Medi-
cal Sciences (NIGMS), NIH Grant Number P20GM104932, and COBRE, 
CORE-NPN, Research Core C. 
2124
SORDARICINS AND PODOSPORINS FROM SORDARIA 
ARANEOSA
Jason A. Clement1, Jan M. Sigmund1, Michael A. Goetz1
1Natural Products Discovery Institute, Baruch S. Blumberg Institute, 
Doylestown PA, 18902, USA. 
During the course of exploring the antifungal constituents produced by the 
coprophilous fungus Sordaria araneosa, two new congeners (1 and 2) of 
podosporin A were isolated, along with podosporin A (3), sordarin, and 
hypoxysordarin. Compounds 1 and 2 showed weak activity against Staphy-
lococcus aureus, while 3 was not active. While sordarin and hypoxysordarin 
were active against Candida albicans, 1-3 were not active. The compounds 
were characterized by 1D and 2D NMR analysis and high resolution MS 
analysis. 
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2125
SCALE UP ISOLATION OF AAPTAMINE FOR IN VIVO 
EVALUATION SUGGESTS IN NEUROBIOLOGICAL 
ACTIVITY IS LINKED TO THE DELTA OPIOID RECEPTOR
Tyler A. Johnson1,2, Nicole L. McIntosh1, Eptisam Lambo1, Nicholas Lorig-
Roach2, Laura Milan-Lobo3, Li He3, Philip Crews2 and Jennifer L. Whistler3 
1 Department of Natural Sciences & Mathematics, Dominican University 
of California, 2 Department of Chemistry & Biochemistry, University of 
California, Santa Cruz, 3 Department of Neurology, University of California, 
San Francisco
Opioid receptors belong to the large superfamily of seven transmembrane-
spanning (7TM) G protein-coupled receptors (GPCRs). As a class, GPCRs 
are of fundamental physiological importance mediating the actions of 
the majority of known neurotransmitters and hormones. The Mu, Delta 
and Kappa (MOP, DOP, KOP) opioid receptors are particularly intriguing 
members of this receptor family as they are the targets involved in many 
neurobiological diseases such as addiction, pain, stress, anxiety, and de-
pression. Recently we discovered that the aaptamine class of marine sponge 
derived natural products exhibit selective agonist activity in vitro for the 
DOP versus MOP receptor. Our findings may explain reports by others 
that aaptamine (1) demonstrates in vivo anti-depressant effects in mouse 
models using the Porsolt Forced Swim Test. This project involved the ex-
traction of the sponge Aaptos aaptos (a source of 1), establishing a scale 
up purification procedure to provide sufficient amounts of 1 (30 mg) for a 
follow up in vivo evaluation and ultimately confirmation of the structure of 
1 using LC-MS and 1H NMR. The results our purification scheme, chemical 
analysis and in vivo evaluation of 1 using DOP receptor knock out mice in 
the Forced swim test, Locomotor test and Marble burying test are reported 
here in and suggest that the in vivo anti-depressant effects of 1 are linked 
directly to its agonist effects on the DOP receptor. 
2126
SECONDARY METABOLITES ISOLATED FROM SALVIA 
BOGOTENSIS 
Amer Tarawneh,1 Francisco Leon,1 Augusto Rivera,2 Stephen J. Cutler.1,*
1Department of BioMolecular Sciences, Division of Medicinal Chemistry, 
School of Pharmacy, The University of Mississippi, University, MS 38677, 
USA, 2 Departamento de Química, Universidad Nacional de Colombia, 
Ciudad Universitaria, Carrera 30 # 45-03, Bogotá, Colombia
Salvia is the most diverse genus in the Lamiaceae family, with close to 
1000 species distributed around the world. In the Americas the genus is 
represented by approximately 600 species. Several species of Salvia are cul-
tivated for their aromatic characteristics and are used as flavorings, food 
condiments, cosmetics, perfume additives and as folk medicines. As a part 
of our continuing search for novel, plant-derived biological agents, Salvia 
bogotensis was studied. Several separations using column chromatography 
(silica gel, Sephadex LH-20) and preparative TLC were performed to afford 
two new coumarin derivatives 1-2, a new glucoside monoterpenoid 3 and 
eleven previously known compounds. The structures of compounds were 
determined on the basis of HRMS, and 1D and 2D NMR studies, as well as 
by comparison with data from the literature. The new compounds do not 
show affinity to opioid and cannabinoid receptors, and showed moderate 
activity in antibacterial, antifungal, antimalarial and antileishmania assays.
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3001
DETERMINATION OF ADULTERATION IN ECHINACEA 
SPP. BY PRINCIPAL COMPONENT ANALYSIS OF UV 
SPECTRA
Mohammed Khan, Frank D’Amelio Sr., Youssef Mirhom*, and Rocky 
Graziose
Bio-Botanica Inc, 75 Commerce Drive, Hauppauge, NY 11788
Ultraviolet (UV) spectroscopy was used to determine adulteration in Echi-
nacea spp. Authenticated samples of Echinacea angustifolia and Echinacea 
purpurea roots were used to generate a predictive model using a Principal 
Component Analysis (PCA) algorithm. Adulterated and unadulterated test 
samples were used to show the effects of applying the model. Our results 
show that PCA is effective for distinguishing species of Echinacea, as well 
as determination of adulteration levels in Echinacea samples up to at least 
25% admixture.
Figure 1: PCA of UV spectra of authen-
ticated samples of E. angustifolia and 
E. purpurea showing 95% confidence 
intervals.
3002
A BRAZILIAN SAMPLE OF THE RED ALGA LAURENCIA 
NSP., YIELDS SPHINGOSINES NEW TO THE MARINE 
ENVIRONMENT
Erika M. Stein,1 Pio Colepicolo,1 Kehau Hagiwara,2 and Anthony D. Wright2
1Department of Clinical and Toxicological Analyses, Faculty of 
Pharmaceutical Sciences, University of São Paulo, 05508-900 São Paulo, 
Brazil; 2DKI-College of Pharmacy, University of Hawaii at Hilo, 34 Rainbow 
Drive, Hilo, Hawaii 96720
Marine algae belonging to the genus Laurencia are the most prolific produ-
cers of secondary metabolites compared to any other marine genus. The se-
condary metabolites produced by these plants are typically halogenated and 
have a wide variety of biological properties. The most common structural 
classes encountered being sesquiterpenes, diterpenes, triterpenes, sterols, 
C15 acetogenins and long-chain hydrocarbons. Sphingosines are among the 
lesser reported compounds isolated from this genus, with only one, (+)-N-
(2S, 3R)-2-acetamido-3-acetoxyoctadecan-l-ol, being reported to date. In 
this poster presentation we report the isolation of additional sphingosines, 
including 1 and 2, from the genus Laurencia, this time from a new species 
collected in Brazil.
 
3003
CYTOTOXIC POTENTIAL OF ESSENTIAL OILS OF 
Eucalyptus benthamii AND ITS RELATED TERPENES ON 
TUMOR CELL LINES
Paulo V. Farago1, Patrícia M. Döll-Boscardin1, Carla C. Kanunfre2, and Jane 
M. Budel1
1Department of Pharmaceutical Sciences, 2Departament of General Biology, 
State University of Ponta Grossa, Paraná, Brazil
Eucalyptus L. is traditionally used for many medicinal purposes. In partic-
ular, some Eucalyptus species have currently shown cytotoxic properties. 
Local Brazilian communities have used leaves of E. benthamii as an herb-
al remedy for various diseases, including cancer. Considering the lack of 
available data for supporting this cytotoxic effect, the goal of this paper was 
to study the in vitro cytotoxic potential of the essential oils from young and 
adult leaves of E. benthamii and some related terpenes (α-pinene, terpin-
en-4-ol and γ-terpinene) on Jurkat, J774A.1 and HeLa cells lines. Regard-
ing the cytotoxic activity based on MTT assay, the essential oils showed 
improved results than α-pinene and γ-terpinene, particularly for Jurkat and 
HeLa cell lines. Terpinen-4-ol revealed a cytotoxic effect against Jurkat cells 
similar to that observed for volatile oils. The results of LDH activity indicat-
ed that cytotoxic activity of samples against Jurkat cells probably involved 
cell death by apoptosis. The decrease of cell DNA content was demonstrat-
ed due to inhibition of Jurkat cells proliferation by samples as a result of 
cytotoxicity. In general, the essential oils from young and adult leaves of E. 
benthamii presented cytotoxicity against the investigated tumor cell lines 
which confirms their antitumor potential. This study was supported by 
Fundação Araucária (Brazil).
3004
ESSENTIAL OIL FROM LEAVES OF Eucalyptus benthamii: 
SECRETORY STRUCTURES, VOLATILE COMPOSITION 
AND BIOLOGICAL ACTIVITIES
Jane M. Budel1, Patrícia M. Döll-Boscardin1, and Paulo V. Farago1
1Department of Pharmaceutical Sciences, State University of Ponta Grossa, 
Paraná, Brazil
Eucalyptus benthamii Maiden et Cambage is a medicinal plant that is also 
widely used for reforestation in Southern Brazil. However, restricted data 
about its essential oil are available. The anatomical analysis was performed 
by the usual light and scanning microtechniques. The identification of vola-
tile constituents was achieved by GC-MS and GC-FID. The antioxidant po-
tential was evaluated by the phosphomolybdenum and 2,2-diphenyl-1-pic-
rylhydrazyl radical (DPPH•) methods. In vitro antimicrobial activity was 
investigated by the agar disk diffusion technique. Fumigant and repellent 
activities were carried out against head lice. Secretory ducts containing vol-
atile compounds were observed in mesophyll and petiole. The major vol-
atile components were α-pinene (22.6%), γ-terpinene (16.6%), p-cymene 
(10.6%), aromadendrene (9.9%), and terpinen-4-ol (5.9%). For phospho-
molybdenum method, the volatile oil of E. benthamii showed a total anti-
oxidant activity (43.15 ± 1.08%) higher than that achieved for rutin (20.70 
± 1.69%). However, a low antioxidant potential was observed by DPPH 
method (IC50 = 3209.66 ± 218.86 µg.mL–1). The essential oil of E. benthamii 
had an antimicrobial effect against Candida albicans, Escherichia coli, Pseu-
domonas aeruginosa, Staphylococcus aureus, and Streptococcus pyogenes 
strains. In the insecticidal activity against head lice, the investigated volatile 
oil demonstrated promising fumigant (Knockdown time50 = 36.67 ± 2.89 
min) and repellent (Repellent index = 35.03 ± 13.13%) effects. This study 
was supported by Fundação Araucária (Brazil).
3005
ANTITRYPANOSOMAL AND OPIOID RECEPTOR 
ACTIVITY OF MUSSAENDA LUTEOLA’S SECONDARY 
METABOLITES
Shaymaa M. M. Mohamed1,3, Enaam Y. Backheet 3, Soad A. L. Bayoumi 3, 
Stephen J.Cutler1,2 and Samir A. Ross1,2*
1 National Center for Natural Products Research and 2Department of 
BioMolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS 38677, USA, 3 Department of Pharmacognosy, Faculty of 
Pharmacy, Assiut University, Assiut, Egypt. 
Eight new secondary metabolites; five triterpene saponins; heinsi-
agenin A 3-O-β-D-glucopyranosyl(1→2)-O-α-L-rhamnopyranosyl 
(1→4)-O-β-D-glucopyranoside (1), heinsiagenin A 3-O-[α-L-rhamn-
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opyranosyl (1→2)-O-β-D-glucopyranosyl (1→2)]-O-β-D-glucopyra-
nosyl (1→4)-O-β-D-glucopyranoside (2), 2α-hydroxyheinsiagenin A 
3-O-α-L-rhamnopyranosyl(1→2)-O-β-D-glucopyranosyl (1→4)-O-β-D-glu-
copyranoside (3), 2α-hydroxyheinsiagenin A 3-O-β-D-glucopyranosyl 
(1→2)-O-β-D-glucopyranosyl (1→4)-O-β-D-glucopyranoside (4) and 
N-(2S, 3R, 4R-3-methyl-4-pentanolid-2-yl)-18-hydroxylanosta-8(9), 22E, 
24E-trien-27-amide-3-O-[α-L-rhamnopyranosyl(1→2)-O-β-D-gluco-
pyranosyl (1→2)]-O-β-D-glucopyranosyl (1→4)-O-β-D-glucopyranoside 
(5) , one iridoid glucoside; (5α, 9α)-8-epiloganin (7), and two alkaloids; 
10-methoxystrictosidine (9) and 10-methoxy pumiloside (11) were isolat-
ed from the aerial part of Mussaenda luteola (Rubiaceae) along with four 
known compounds: (7α)-morroniside (6), (7β) 7-O-methyl morroniside 
(8), 5α-carboxystrictosidine (10) and apigenin 7-O-neohesperidoside (12). 
Structural elucidation was based on the analyses of spectroscopic data and 
HR-ESI-MS. Compounds 1, 2 and 10 showed antitrypanosomal activity 
while only compounds 1 and 2 showed opioid receptor binding activity.
3006
ANTI-INFLAMMATORY AND ANTITUMOR 
PHENYLPROPANOID SUCROSIDES FROM THE SEEDS 
OF RAPHANUS SATIVUS
Hee Rae Kang1, Seulah Lee1, Hee Jeong Eom1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
A bioassay-guided fractionation and chemical investigation of the MeOH 
extract of Raphanus sativus seeds resulted in the isolation and identification 
of eight phenylpropanoid sucrosides (1-8) including two new compounds, 
named raphasativuside A and B (1-2) from the most active CHCl3-soluble 
fraction. The structures of these new compounds were elucidated through 
spectral analysis, including extensive 2D-NMR data, and chemical reaction 
experiments. We evaluated the anti-inflammatory effects of 1-8 in lipo-
polysaccharide (LPS)-stimulated murine microglia BV2 cells. Compounds 
2 and 5 exhibited significant inhibitory effect on nitric oxide production in 
LPS-activated BV-2 cells with IC50 values of 21.63 and 26.96 μM, respective-
ly. All isolates were also evaluated for their antiproliferative activities against 
four human tumor cell lines (A549, SK-OV-3, SK-MEL-2, and HCT-15). 
Compounds 1–7 showed consistent cytotoxicity against A549, SK-OV-3, 
SK-MEL-2, and HCT-15 cell lines with IC50 values of 6.71–27.92 μM. Ad-
ditionally, the free-radical scavenging activity of 1-8 was assessed using the 
DPPH (2,2-diphenyl-1-picrylhydrazyl) assay where compounds 1, 3, and 4 
scavenged DPPH radical strongly with IC50 values of 23.05, 27.10, and 29.63 
μg/mL, respectively.
3007
TILIABISFLAVAN A, A NEW FLAVAN-3-OL DIMER 
FROM TILIA AMURENSIS WITH CYTOTOXIC AND ANTI-
INFLAMMATORY EFFECTS
Hee Rae Kang1, Hee Jeong Eom1, Seulah Lee1, Jae Sik Yu1, and Seoung Rak 
Lee1
1Natural Product Research Laboratory, School of Pharmacy, Sungkyunkwan 
University, Suwon 440-746, Korea
Tilia amurensis Rupr. (Tiliaceae) is commonly known as bee tree and it has 
been used to treat various diseases as a Korean traditional medicine since 
ancient times. On the search for biologically active compounds from T. 
amurensis, a bioassay-guided fractionation and chemical investigation of 
its MeOH extract resulted in the isolation and identification of four flavan-
3-ols, including a new flavan-3-ol dimer, tiliabisflavan A (1). The isolat-
ed compounds were evaluated for their antiproliferative activities against 
A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines and their inhibitory 
effects on NO production in a lipopolysaccharide (LPS)-activated BV2 
cell line. Compound 1 exhibited the strongest cytotoxicity against A549, 
SK-OV-3, SK-MEL-2, and HCT-15 cell lines (IC50 (1): 13.37, 14.61, 5.68, 
and 11.03 μM, respectively). In addition, compound 1 significantly inhib-
ited NO levels with an IC50 value of 4.96 μM, which is more effective than 
NG-monomethyl-L-arginine (NMMA), a well-known NO synthase inhib-
itor.
3008
PRENYLATED ANTHRANOLS FROM THE LEAVES OF 
HARUNGANA MADAGASCARIENSIS
Johnson O. Oluwatosin,1,2 Ming Zhao,1 Wei-Lun Chen,1 Bernard D. 
Santarsiero,1 Steven M. Swanson,1,3 Joanna E. Burdette,1 Gloria A. Ayoola,2 
H. A. B Coker,2 and Chun-Tao Che.1
1Department of Medicinal Chemistry and Pharmacognosy, and WHO 
Collaborating Center for Traditional Medicine, College of Pharmacy, 
University of Illinois at Chicago, Chicago, IL 60612, USA, 2Department of 
Pharmaceutical Chemistry, University of Lagos, CMUL Campus, Lagos, 
Nigeria, 3School of Pharmacy, University of Wisconsin-Madison, Madison, 
WI 53705, USA
Four new prenylated anthranols 
(1-4), along with two known struc-
tures kenganthranol (5) and ha-
runganin (6), were identified from 
the leaves of the African medicinal 
plant Harungana magdagascarien-
sis. All anthranols were evaluated 
for cytotoxic activity against MDA-MB-435, MDA-MB-231, and OVCAR3 
cell lines. 6 showed activities with IC50 values of 6.3-8.7 μM.
3009
METHOD OPTIMIZATION OF AMYLOGLUCOSIDASE 
ACTIVITY ASSAY AND ITS APPLICATION IN ANALYSIS 
OF SECRETOME YIELD BY ASPERGILLUS NIGER 
Hongyan Ma, Si Wu
Institute for Natural Products Applications and Research Technologies, 
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman, OK 73019.
Identifying the active proteoforms of bioconversion enzymes from micro-
bial sources is important for novel compound delivery in pharmaceutical 
companies. Many of these enzymes are heavily post-translational modified 
and the modifications are known to regulate the enzymatic activities. Our 
preliminary glycol-proteomics results suggest that Amylogucosidase in A. 
niger secretome is heavily glycosylated with both N-linked and O-linked 
glycans. Here, using Amyloglucisidase as the model system, we develop an 
integrated proteomics approach to correlate the enzymatic activity with its 
differently post-translational modified proteoforms. Various LC separation 
formats (e.g., ion exchange, size exclusive column) are selected to fractiona-
te the total Amyloglucisidase extract. After evaluating the enzyme activities 
using glucose assay kits, the fractions containing the active proteoforms are 
further analyzed using the integrated top-down and bottom-up approach 
employed on an LTQ Orbitrap Velos mass spectrometry. The optimized 
method will be then applied to analyze the Amyloglucisidase in A. niger 
growing under different conditions (e.g., various pHs and temperatures). 
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3010
A NEW BIPHENYL DERIVATIVE FROM THE TWIGS OF 
CHAENOMELES LAGENARIA
Won Se Suh, Kyoung Jin Park, Joon Min Cha, Oh Kil Kwon, and Kang Ro 
Lee.
Natural Products Laboratory, School of Pharmacy, SungKyunKwan 
University, Suwon 440-749, Republic of Korea
Chaenomeles lagenaria (LOISEL) KOIDZ. is deciduous shrub with distri-
bution in Korea and China. This plant has been used as Korean traditional 
medicine to treat diarrhea, edema, and rheumatism. Previous phytochemi-
cal investigation on C. lagenaria reported triterpenes, phenolic compounds, 
and flavonoids. In our continuing search for bioactive constituents of Ko-
rean medicinal sources, we investigated an 80% MeOH extract of the twigs 
of C. lagenaria. Column chromatographic purification of the CHCl3 frac-
tion resulted in isolation of a new biphenyl derivative (1), along with three 
known biphenyl compounds (2-4). The chemical structure of the new com-
pound was determined on the basic of spectroscopic analyses including 1D 
and 2D NMR data. The cytotoxic activities of isolates (1-4) were evaluated 
by determining their cytotoxic effects on the human tumor cell lines (A549, 
SK-OV-3, SK-MEL-2, and HCT-15) using a SRB assay.
3011
ABSOLUTE CONFIGURATION OF THE 1,2-DIOL OF 
DIGOXIN DETERMINED BY ELECTRONIC CIRCULAR 
DICHROISM INDUCED WITH [MO2(OAC)4] 
Yulin Ren1, Hennrique Taborda Ribas1, Ellen Sass2, Hee-Byung Chai1, David 
M. Lucas1,2, and A. Douglas Kinghorn1
1Division of Medicinal Chemistry and Pharmacognosy, College of 
Pharmacy, The Ohio State University, Columbus, OH 43210, United States, 
2Department of Internal Medicine, College of Medicine, The Ohio State 
University, Columbus, OH 43210, United States
Digoxin, a cardiac glycoside derived from Digitalis lanata, has been long 
used to treat congestive heart failure. When a number of agents were tested 
in an early drug repurposing study, digoxin emerged as a potential anti-
cancer agent. The structure of digoxin was determined by analysis of its 
spectroscopic data and confirmed by the single-crystal X-ray diffraction in 
previous work. In the present investigation, the conformation of the cen-
tral ring system of digoxin was characterized based on its published crystal 
structure, and the absolute configuration was ascertained by analysis of the 
electronic circular dichroism (ECD) induced with [Mo2(OAc)4] and NO-
ESY 2D NMR spectra. When evaluated for its cytotoxicity toward a panel 
of human cancer cell lines, including HT-29 human colon cancer cells and 
the human MV4:11, THP-1, and Kasumi-1 myeloid leukemia cell lines, di-
goxin showed potent activity, exhibiting IC50 values of 10 nM at 72 hour 
incubation, and 100, 59, and 89 nM at 48 hour incubation, respectively.
3012
MICROBIAL TRANSFORMATON OF BAVACHIN BY 
ABSIDIA COERULEA 
Fubo Han and Ik-Soo Lee
College of Pharmacy and Research Institute of Drug Development, 
Chonnam National University, Gwangju 500-757, Republic of Korea.
Bavachin is one of the major bioactive flavonoid constituents in Fructus 
Psoraleae (Buguzhi in Chinese), and it displays a broad range of biological 
activities such as antibacterial, antifungal, anti-inflammatory, antioxidant, 
antitumor, phytoestrogenic, α-glucosidase inhibitory, and osteoblastic pro-
liferation stimulating activities. In order to improve its bioavailability, we 
investigated the application of microorganisms as biocatalysts for the trans-
formation of bavachin. Screening studies using twenty two microbes indi-
cated that bavachin could be transformed by several fungal strains includ-
ing Absidia coerulea, Mucor hiemalis, and Cunninghamella elegans. And 
our subsequent scale-up fermentation studies of bavachin using A. coerulea 
resulted in the identification of two novel microbial metabolites together 
with a recently reported compound bavachinone A. Chemical structures of 
the three compounds were elucidated on the basis of spectroscopic analysis. 
This is the first report on the biotransformation of bavachin by microbes, 
which suggested a potential process to prepare novel derivatives from plant 
secondary metabolites through microbial enzymes. 
3013
STRUCTURAL CHARACTERIZATION OF MONACOLIN 
COMPOUNDS FROM RED YEAST RICE BY LIQUID 
CHROMATOGRAPHY AND TANDEM MASS 
Yan-Hong Wang1, Bharathi Avula1, Zhihao Zhang1, Mei Wang1, 
Satyanarayanaraju Sagi1, Zulfiqar Ali1, and Ikhlas A Khan1,2,3
1National Center for Natural Products Research, Research Institute of 
Pharmaceutical Sciences, The University of Mississippi, University, MS 
38677, USA, 2Department of BioMolecular Sciences, School of Pharmacy, 
The University of Mississippi, University, MS 38677, USA, 3Department of 
Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi 
Arabia
Monacolin compounds including its acid form such as monacolin K and 
monacolin K acid are markers of red yeast rice (RYR). With the aim of 
quality assurance and adulterant assessment, the fragmentation pathways 
of nine monacolins were investigated using tandem mass spectrometric 
technique (QToF MS/MS). Nine compounds were classified into three sub-
groups according to the substitution at C-8 and whether in acid form at 
C-1’ or forming lactone by cyclization between C-1’ and C-5’. The key frag-
ments of three sub-groups were summarized and applied to the identifica-
tion of monacolin compounds from red yeast rice by UHPLC-QToF MS.
3014
THE GENERALLY USEFUL ESTIMATE OF SOLVENT 
SYSTEMS METHOD ENABLES THE RAPID SEPARATION 
OF CURCUMINOIDS BY COUNTERCURRENT 
SEPARATION
Yang Liu,1 J. Brent Friesen,1,2 James B. McAlpine,1,3 Shao-Nong Chen,1,3 and 
Guido F. Pauli1,3
1 Department of Medicinal Chemistry and Pharmacognosy, College of 
Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, USA, 
2 Physical Sciences Department, Rosary College of Arts and Sciences, 
Dominican University, River Forest, Illinois 60305, USA, 3 Institute for 
Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 
Chicago, Illinois 60612, USA
The Generally Useful Estimate of Solvent Systems (GUESS) method was 
originally developed for the selection of countercurrent separation (CCS) 
solvent systems. It was shown if an analyte can be eluted at Rf value ≈ 
0.5 by the organic phase or an equivalent organic-only solvent system on 
NP-TLC, the analyte will be delivered into the distribution coefficient (K 
value) sweet spot range by the matching solvent system in CCS. However, 
although >100 research papers have cited the original GUESS publication 
since 2005, few of them have actually applied the predictive TLC part of 
the method. The current study demonstrates the rapid prediction power 
of the GUESS method for CCS solvent systems. It tested three curcumi-
noids in n-hexane-EtOAc-MeOH-Water, CHCl3-MeOH-Water and n-hex-
ane-CHCl3-MeOH-Water solvent system families. When developing with 
the organic phase of n-hexane-CHCl3-MeOH-Water (3:7:7:3, v/v), the TLC 
Rf values of curcumin, demethoxycurcumin, and bisdemethoxycurcumin 
were 0.50, 0.46, and 0.38, while their measured K values were 0.57, 0.97, 
and 1.91 in normal phase CCS. The present study indicates that the GUESS 
method can facilitate natural product separation by CCS.
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3015
BOSWELLIA SERRATA AND OCIMUM SANCTUM 
EXTRACTS REDUCE INFLAMMATION IN AN OVA-
INDUCED ASTHMA MODEL OF BALB/C MICE 
Kapil K. Soni1,2, Temitope Lawal1,3, Sheila Wicks1, Udeshi Patel4, and Gail. B. 
Mahady1,
1Clinical Pharmacognosy Lab., Dept. of Pharmacy Practice, College of 
Pharmacy, University of Illinois at Chicago IL 60612; 2Dept. of Bioscience 
Barkatullah University, Bhopal MP India; 3Department of Pharmaceutical 
Microbiology, University of Ibadan, Ibadan, Nigeria; 4Honors College, 
University of Illinois at Chicago, Chicago, IL, 60605, USA.
This study investigated the in vivo anti-inflammatory effects of Boswellia 
serrata and Ocimum sanctum extracts in HL-60 cells and in OVA-indu-
ced inflammatory lung disease in BALB/C mice. The plant materials were 
collected in Vidisha (M.P.), India, identified and air-dried. The dried plant 
materials were pulverized to a powder, extracted in 95% ethanol to ex-
haustion, dried and fractionated. The extract and fractions were tested for 
their effects on leukotriene C4 synthase, leukotriene A4 hydrolase and cy-
clooxygenase-2 in HL-60 cells. The active dried ethanol extracts were then 
tested in vivo in an OVA-induced asthma mouse model, and inflammation 
was assessed using 2-D in vivo imaging. Both extracts and some fractions 
inhibited leukotriene-C4-synthase, leukotriene-A4-hydrolase and/or cyc-
looxygenase-2 (COX-2) activities in cultured HL-60 cells, IC50 1-10 µg/ml. 
Intragastric administration of the extracts to OVA-challenged BALB/c mice 
at a dose of 100 mg/kg body weight led to a significant reduction of OVA-
induced lung inflammation as determined by 2-D in vivo imaging using a 
Xenogen IVIS imaging system. The results showed significant inhibition in 
vivo and in vitro inflammation suggesting a plausible mechanism of action 
for the management of asthma.
3016
ADAPTABILITY OF SUBTROPICAL ALGAE TO LOCAL 
MICROBIAL POPULATIONS
Albert Nelson1, Thy Nguyen1, Kaitlin Ferguson1, Julia Sears1, Urszula 
Tanouye2, Skylar Carlson2, Theodore Weyna3, Jason Kwan3, Brian T. 
Murphy2, Melany P. Puglisi1
1Chicago State University College of Pharmacy, Departments of 
Pharmaceutical Science, Douglas Hall 206, 9501 South King Drive, 
Chicago, IL 60628, 2University of Illinois at Chicago, College of Pharmacy, 
Department of Medicinal Chemistry and Pharmacognosy, 900 South 
Ashland Avenue, Chicago, IL 60607, 3University of Wisconsin-Madison, 777 
Highland Avenue, Madison, WI 53705
Marine algae found in the seagrass beds of the Florida Keys appear to be 
less susceptible to disease and die-offs reported for Thalassia testudinum. 
In the present study, we explore the hypothesis that algal antimicrobial che-
mical defenses are adapted to the microbial flora in their immediate micro-
habitat. To explore whether algal chemical defenses have co-evolved within 
their distinct microenvironments, we evaluated the inhibitory activities 
of algal extracts from twenty-four common algae in Florida seagrass beds 
against a panel of diverse marine bacteria. The panel of bacteria included 
strains isolated from the surface of the algae and from other aquatic and 
marine locales, including North Atlantic Ocean, Red Sea, and South Pacific 
Ocean, Iceland and the Great Lakes. Algal samples were placed in sterile 
seawater and sonicated for 5 minutes. Pieces of algae and seawater were 
plated separately on nutrient rich A1 or M1 plates. Sediment samples were 
diluted using sterile DI water, heat shocked at 37° C for 7 minutes, and 
added directly to nutrient-rich and -limited agar plates and allowed to in-
cubate for 3-5 weeks. Individual colonies were isolated using nutrient rich 
freshwaterbased-A1 media. We analyzed the pattern of growth inhibition 
or promotion of algal extracts against co-isolated strains and those from 
other environments, and found that activity was not patterned on target 
strain phylogeny, but rather to isolation origin. Non-Floridian strains ten-
ded to either strong growth inhibition or promotion in response to many 
algal extracts, whereas co-isolated strains exhibited more nuanced patterns 
of activity, suggesting specific bacterial-algal interactions. 
3017
TLC-BIOAUTOGRAPHY LINKED WITH GUESS: A 
TRUELY TARGETED ACTIVE COMPOUND ISOLATION 
PROCESS
Edyta M. Grzelak1*, Yang Liu2*, Joo-Won Nam2, J. Brent Friesen1,2, Shao-
Nong Chen1,2, David C. Lankin2, James B. McAlpine1,2, Joo-Won Suh3,4, 
Seung Hwan Yang3, Jinhua Cheng3, Hanki Lee3, Jin-Yong Kim4, Sang-Hyun 
Cho1, Guido F. Pauli1,2, Scott G. Franzblau1, and Birgit U. Jaki1,2
1Inst. for TB Research, 2Dept. Med. Chem. & Pharmacognosy, COP, UIC, 
Chicago, IL, 60612, 3Center for Neutraceutical & Pharmaceutical Materials, 
4Div. of Biosciences & Bioinformatics, Col. Nat. Sci., Myongji University, 
Gyeonggi-Do 449-728, Republic of Korea *Equal contributors
In order to optimize the isolation procedure of anti-TB lead compounds, 
a truly targeted isolation approach was developed, which aligns (HP)TLC-
bioautography with GUESS1 based countercurrent separation (CCS). (HP)
TLC-bioautography was specifically developed for Mycobacterium tubercu-
losis, using the mc2 7000 lux ABCDE strain, while the GUESS method is 
used to rapidly determine the optimal CCS solvent system. Optimal CCS 
conditions target the separation of the inhibition zones within a range of 
optimal CCS partition coefficients referred to as the “CCS sweet spot”, with 
a corresponding TLC Rf-value ~0.5. Hereby, the CCS solvent system is cho-
sen on the basis of the Rf-value of the bioactive component(s) rather than 
the fraction as a whole. This approach accelerates the isolation process and 
prevents the isolation of non-active metabolites and byproducts. The new 
TLC-bioautography-GUESS-CCS workflow is demonstrated with the frac-
tionation of an extract from an anti-TB active actinomycete strain. [Fun-
ding: NIH R21 AI093919-02]
1Friesen & Pauli, G.U.E.S.S. - A Generally Useful Estimate of Solvent Sy-
stems for CCC. Journal of Liquid Chromatography & Related Technologies. 
2005, Volume 28, Issue17, 2777-2806
3018
LIGNANS FROM SAMBUCUS WILLIASMII HANCE 
AGAINST OSTEOPOROSIS: A PHARMACODYNAMIC 
AND PHARMACOKINETIC STUDY
Hui-Hui Xiao1,2, Chi-On Chan1,2, Ka-Chun Wong1,2, Daniel Mok Kam-
wah1,2, Shun-Wan Chan1,2, Raymond Cooper1, Xin-Sheng Yao3, Man-Sau 
Wong1,2,*
1Department of Applied Biology and Chemical Technology, The Hong Kong 
Polytechnic University, Hung Hom, Kowloon, Hong Kong, PRC 2State Key 
Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), 
Shenzhen 518057, PRC 3Institute of Traditional Chinese Medicine & Natural 
Products, College of Pharmacy, Jinan University, Guangzhou 510632, PRC 
There are approximately 20 families in the Sambucus genus, distributed 
widely in temperate and subtropical areas in the world. As part of Traditio-
nal Chinese Medicine, Sambucus williamsii Hance (SWH) has been used 
for the treatment of bone and joint diseases for thousands of years. Use 
of the plant was first recorded in Tang Materia Medica, completed during 
the Tang Dynasty (618 -907 A. D.) and also described in the New Materia 
Medica, a book for herbal clinical use, whereby SWH was distributed to 
joints, and used to reunite fractured tendons and bones. Although SWH 
has a long history of clinical use, its chemical components were not fully 
characterized until recently. 
We have shown the major phytochemicals in SWH are lignans, including 
several new compounds. This lignan-rich fraction obtained from SWH, 
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exerts protective effects against bone loss induced by ovariectomy in aged 
rats. Eighty five compounds to date have been isolated and several bioactive 
lignans have been identified exhibiting in vitro and exert oestrogen-like ef-
fects on osteoblasts. In our continuing study on SWH we undertook an oral 
PK study of SWH which exhibited a profile with very rapid absorption and 
fast elimination in blood. These PD and PK studies, the identification of its 
components and possible mechanism will be presented. 
3019
THE DEPIGMENTING EFFECT AND MECHANISM S OF 
KUWANON O AND SANGGENON T FROM THE ROOTS 
OF MORUS AUSTRALIS
Mingfu Wang, Shuting Hu
School of Biological Sciences, The University of Hong Kong, Hong Kong, P.R. 
China
Kuwanon O and sanggenon T, two resorcinol-type polyphenols from the 
root extract of Morus australis, were found to reveal significant depigmen-
ting effects in both murine b16f10 and melan-a cell lines. But their de-
pigmenting mechanisms are slightly different in two cell systems. In b16 
cells, kuwanon O and sanggenon T, together with other two phenolics, 
induced post-transcriptional degradations of MITF without suppressing 
its mRNA expression, leading to significant decreases of TRP-1 and TRP-2 
production. While in melan-a cells, the levels of tyrosinase families were 
suppressed via MITF downregulation at both transcription and translation 
level by them, with kuwanon O inducing the greatest suppression. Further 
evaluations in artificial skin model demonstrated the outstanding depig-
menting effects of kuwanon O and sanggenon T. Meanwhile, according to 
the structure-activity relationship study of theses compounds, to screen 
or synthesize resorcinol flavonone derivatives with isoprenyl group in the 
Diels-Alder substituent might be a new direction for the search of potent 
hypopigmenting agents
3020
ISOLATION OF BIOACTIVE CHEMICAL CONSTITUENTS 
FROM JUSTICIA PROCUMBENS
Dongying Wang, Kanglun Liu, Yifu Guan, Chuenfai Ku and Hongjie 
Zhang*
School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, 
China.
Justicia procumbens L. (Acanthaceae) is a traditional herb used in Chinese 
medicine (Juechuang) for the treatment of fever, pain, diarrhea and hepa-
titis. The methanol extract of the plant displayed potent anti-HIV activity 
in our study. In order to identify the bioactive compounds of the plant, we 
re-collected the plant materials from Fujian province, China. Phytochemi-
cal investigation of the methanol extract led to the isolation of a number of 
aryl naphthalide lignans containing sugar units. Further LC-MS analysis 
revealed that abundant number of aryl naphthalide lignans were present 
in the extract and the sub-fractions of the plant. Aryl naphthalide lignans 
have been reported to have plenty of biological activities including anti-
viral and anticancer activities. We thus look 
forward to isolating many different lignans of 
this type and conducting their biological eva-
luation against different disease targets inclu-
ding cancers and other viral diseases. [The stu-
dy was supported by grants from the RGC of 
the Hong Kong SAR, China (HKBU 262912), 
HKBU Interdisciplinary Research Matching 
Scheme (RC-IRMS/12-13/03), and Mr. Kwok 
Yat Wai and Madam Kwok Chung Bo Fun 
Graduate School Development Fund]. 
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3021
TURNING A NEGATIVE INTO A POSITIVE: USING 
BACTERIAL SELF-RESISTANCE TO IDENTIFY NEW 
NATURAL PRODUCTS.
Brent Kronmiller1, Benjamin Philmus2
1Center for Genome Resources and Biocomputing, Oregon State University, 
Corvallis, OR 97331, 2College of Pharmacy, Oregon State University, 
Corvallis, OR 97331
Antibiotic resistance in microbial pathogens is poised to become a problem 
throughout the world. This necessitates the discovery of new compounds 
and drug leads. Genome sequencing has revealed that microbial genomes 
harbor biosynthetic capacity greatly in excess of known compounds for a 
particular strain. Due to the enormous amount of sequencing data available 
new ways of identifying gene clusters and compounds of interest are re-
quired. Microorganisms that produce biologically active compounds must 
be resistant to their action or else gain no selective advantage in producing 
them. These resistance genes co-localize with genes responsible for biosyn-
thesis in biosynthetic gene clusters (BGCs). We have developed a computer 
program that seeks to identify interesting compounds by their biological 
mechanism of action called ISMAS (In silico Mechanism of Action Scree-
ning). ISMAS essentially turns a computer into a high-throughput assay 
searching for compounds with a particular mode of action and has the ad-
vantage of being able to identify natural products from cryptic gene clusters 
as well as compounds for which an in vitro bioassay is not available. Here 
we present the potential of coupling ISMAS with heterologous expression 
for the discovery of new natural products.
3022
A DESIGNER LICORICE EXTRACT: SELECTIVE 
DEPLETION OF GLABRIDIN AND CONGENERIC 
METABOLITES BY COUNTERCURRENT SEPARATION
Laura L Gauthier1, Charlotte Simmler1, Richard B. van Breemen1, Shao-
Nong Chen1, Guido F Pauli1, J Brent Friesen2 
1Department of Medicinal Chemistry and Pharmacognosy UIC/NIH Center 
for Botanical Dietary Supplements Research, College of Pharmacy, 
University of Illinois at Chicago, Chicago, IL 60612; 2Department of Natural 
Science, Rosary College of Arts and Sciences, Dominican University, River 
Forest, IL 60305
The present study explores Countercurrent Separation (CCS) as a powerful 
method to Deplete and Enrich Select Ingredients to Generate Normalized 
Extract Resources. A DESIGNER extract of European licorice (Glycyrrhiza 
glabra L.) depleted of glabridin (1) and four congeneric metabolites (2-5) 
was prepared for biological testing. Solvent system (SS) selection was based 
on partition coefficient (K value) determination measured by UV follo-
wing two-phase distribution. The SS composed of Hexanes/Ethyl Acetate/
Methanol/Water 7:5:6:4, v/v, was used with the lower phase mobile on a 
High Speed Countercurrent Chromatography (HSCCC) apparatus for the 
fractionation of G. glabra crude extract. An orthogonal CCS step was de-
veloped for the continued purification of each compound. The purity and 
identity of each compound was 
determined by qHNMR. All 
other extract resources were 
recombined to build up the 
DESIGNER extract. The results obtained highlight that CS enables the si-
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multaneous and targeted enrichment and depletion of structurally related 
metabolites.
This research was supported by NIH Grants P50 AT000155 and T32 
5T32AT007533 
3023
TWO NEW CYTOTOXIC MEROTERPENOIDS 
PRODUCED BY THE MARINE SEDIMENT-DERIVED 
STREPTOMYCES SP. CP26-58
Stephanie R. Gee,1 Hana Martucci,1 Trevor Gokey,1 Anton B. Guliaev,1 
Walter M. Bray,2 R. Scott Lokey,2 Taro Amagata1
1Department of Chemistry and Biochemistry, San Francisco State 
University, San Francisco, California 94132, 2Department of Chemistry and 
Biochemistry, University of California, Santa Cruz, Santa Cruz, California 
95064 
A chemical library containing 474 organic extracts has been applied to an 
image-based anticancer screening using HeLa cells. This screening iden-
tified 41 strains that showed potent cytotoxic effects against HeLa cells. 
Based on the bioassay-guided fractionation, two new meroterpenoids (1 
and 2) were isolated from one of the active strains, Streptomyces sp. CP26-
58, together with the known tetronasin (3). The structures of the two new 
compounds possessing an unprecedented six-fused ring system were firmly 
assembled by comprehensive 1D and 2D NMR analysis. In addition, their 
absolute configurations were deduced based on ab intio electronic circular 
dichroism (ECD) spectral calculations. 
3024
EVALUATION OF THE ANTI-DIABETIC AND 
ANTIHYPERLIPIDEMIC EFFECT OF METHANOL 
EXTRACT OF STROPHANTHUS HISPIDUS ROOTS D.C. 
(APOCYNACEAE)
Odoh Uchenna E.1, Ezugwu Christopher O. 1 Ugwuoke, Christopher. E. C., 
Ezea Sampson C. and Onu Samuel
1Department of Pharmacognosy and Environmental Medicine, Faculty of 
Pharmaceutical Sciences, University of Nigeria, Nsukka.
The study is to establish the anti-diabetic effect of the methanol root ex-
tract of Strophanthus hispidus and to examine the effect of these extracts 
on the lipid profile of alloxan-induced diabetic rats. The acute toxicity test 
was carried out using standard methods. Diabetic mellitus was induced 
in 25 rats by single intraperitoneal injection of alloxan (150 mg/kg body 
weight). Two days after induction, the hyperglycaemic (>200 mg/dl) rats 
were treated orally with different doses (200, 400 and 800 mg/kg) of the 
extract for 14days, glibenclamide (5 mg/kg) was used as the standard drug. 
The lipid profile was evaluated in diabetic treated groups compared with 
control. Similar study as above was carried out on normal rats. The extracts 
were found to be relatively safe. The extract at a dose of 800 mg/kg showed 
the most significant (P < 0.05) reduction (69.43 %) in fasting blood glucose 
level in the diabetic rats; for normal rats,, it was 41.92 %. The extract at 
doses of 200 and 400 mg/kg also showed reduction (64.77 and67.75 %) re-
spectively in diabetic rats; (27.5 and 34.2 %) respectively in normal rats. The 
extract showed a dose- independent decrease in the lipid profile examined 
at the end of the 14 day period. Phytochemical screening revealed the pre-
sence of carbohydrates, alkaloids, flavonoids, reducing sugars, terpenoids, 
Saponins, proteins, resins, steroids, glycosides and tannins. It can be con-
cluded that the methanol root extract of S. hispidus possesses anti-diabetic 
and hypolipidemic properties on alloxan-induced diabetic rats. 
3025
INHIBITORY EFFECT ON NO PRODUCTION OF 
COMPOUNDS FROM STYRAX OBASSIA
Byung Sun Min1, Thao Quyen Cao1, Tran Manh Hung1, and Jeong Ah Kim 2
1College of Pharmacy, Drug Research and Development Center, Catholic 
University of Daegu, Gyeongbuk 712-702, Republic of Korea, 2 College of 
Pharmacy, Kyungpook National University, Daegu 702-701, Korea.
Two new benzofurans, 2-(3,4-dimethoxyphenyl)-5-(1,3-dihydroxypropyl)-
7-methoxybenzofuran (1), and 2-(3,4-methylenedioxyphenyl)-5-(3-hy-
droxymethyletoxy-1-hydroxypropyl)-7-methoxybenzofuran (2) along 
with eleven known compounds as syringaresinol (3), lariciresinol (4), 
pinoresinol (5), epi-pinoresinol (6), 2-(3,4-methylenedioxyphenyl)-5-(1,3-
dihydroxypropyl)-7-methoxybenzofuran (7), egonol (8), homoegonol (9), 
salicifoliol (10), machicendonal (11), homoegonol glucoside (12), and 
3β-acetoxyolean-12-en-28-aldehyde (13) were isolated from stem bark 
of Styrax obassia. Their chemical structures have been identified mainly 
by means of spectroscopic analysis. Their anti-inflammatory activity was 
evaluated against LPS-induced NO production in macrophage RAW264.7 
cells.
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3026
STUDY ON THE ANTI-INFLAMMATORY ACTIVITY 
FROM ZIZYPHUS JUJUBA MILL
Bo Mi Lee1, Joo-Sang Lee1, Jeong Ah Kim2 and Byung Sun Min1
1College of Pharmacy, Drug Research and Development Center, Catholic 
University of Daegu, Gyeongbuk 712-702, Republic of Korea, 2College of 
Phamacy, Kyungpook National Universiy, Daegu, 702-701, Republic of 
Korea
In search for anti-inflammatory agents from natural sources, we found that 
n-hexane and CHCl3 soluble fraction of the methanol extract of the fruits 
of Zizyphus jujuba showed potent inhibitory activity against LPS-induced 
nitric oxide in RAW264.7 cells. In the experiment, n-hexane and CHCl3-
soluble fractions were approximately 2.5-fold more potent than EtOAc, 
BuOH and aqueous soluble fractions at the test concentrations (0~30 µg/
mL). Therefore, the two solvent fractions were selected for the further iso-
lation of the active constituents. All the isolated compounds and their inhi-
bitory activities against LPS-induced NO production in the murine macro-
phage cells will be presented.
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3027
ECHINOCHLORINS A~C FROM THE GRAINS OF 
ECHINOCHLOA UTILIS (BARNYARD MILLET) AND THEIR 
ANTI-INFLAMMATORY ACTIVITY
Mi Hee Woo1, Duc Hung Nguyen1, Bing Tian Zhao1, U Min Seo1, Thi Trang 
Nguyen1, Do Youn Jun2, and Young Ho Kim2
1College of Pharmacy, Catholic University of Daegu, Gyeongsan 712-702, 
Republic of Korea, 2Laboratory of Immunobiology, School of Life Science and 
Biotechnology, College of Natural Sciences, Kyungpook National University, 
Daegu 702-701, Republic of Korea
Three new compounds (echinochlorins A-C; 1, 8, and 9) together with 
eight known compounds, isolated form the methylene chloride and ethyl 
acetate fractions of grains of Echinochloa utilis, were examined with regard 
to their effect on nitric oxide (NO) production in lipopolysaccharide (LPS)-
activated murine macrophage RAW 264.7 cells. The results indicated that 
compounds 3, 5, and 9 possessed potent NO inhibitory activity against li-
popolysaccharide (LPS)-induced NO release with IC50 values of 36.04, 4.80, 
and 20.78 µM, respectively. In summary, the isolates compounds showed 
novel biological activity of inhibition in NO production, suggesting that E. 
utilis may be applied as supplemental functional foods having a beneficial 
effect against inflammation. 
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3028
EXTRACTION AND ISOLATION OF 6-GINGEROL FROM 
GINGER
Qing Zhao1, Wen-Na Yan1
1Department of Applied Chemistry, College of Science, Xi´an University of 
Technology, Xi´an 710054, China
Ginger (Zingiber officinale) is one of the most commonly used as spice 
food and dietary supplement and has become an important ingredient in 
Ayurvedic and Chinese herbal medicines for the treatment of various dis-
eases and disorders such as colds, nervous system disorders, asthma, gingi-
val infections, toothache, paralysis, constipation, diabetes and rheumatism. 
Previous chemical investigations have revealed that the major chemical 
constituents of this plant are 6-gingerol and its derivatives which are re-
sponsible for antioxidant and anti-inflammatory activities. In this paper, 
the optimum isolation conditions for 6-gingerol were obtained with the 
3.61% yields by 80% ethanol for 120 min at 50 oC and the materal-to-liquid 
ratio of 1:20. The 6-gingerol was analyzed by gas chromatographic, as well 
as by comparison the retention times of the standard samples.
3029
ISOLATION, STRUCTURE ELUCIDATION AND 
BIOLOGICAL EVALUATION OF NOVEL CATHEPSIN 
INHIBITORS FROM MARINE CYANOBACTERIA 
Fatma H. Al-Awadhi†, Valerie Paul§ and Hendrik Luesch†,‡
†Department of Medicinal Chemistry, ‡Center for Natural Products, Drug 
Discovery and Development (CNPD3), University of Florida, Gainesville. 
§Smithsonian Marine Station, Fort Pierce, Florida, USA.
In our continuous search for novel bioactive compounds from marine cya-
nobacteria, we isolated three novel modified peptides named grassytatins 
D-F. Their structures were elucidated using a combination of both NMR 
spectroscopy and mass spectrometry (MS). The hallmark structural feature 
in those peptides is the presence of statin unit, which led us to suspect that 
these compounds are aspartic protease inhibitors. The protease inhibitory 
activity was assessed in vitro using cathepsin D and E enzymes. Grassysta-
tins D-F showed a potent cathepsin E inhibitory activity with IC50 values 
of 38, 5, 0.5 nM respectively. Those peptides also inhibited cathepsin D but 
were less potent compared to their inhibitory activity against cathepsin E. 
Grassystatins D-F inhibited cathepsin D with IC50 values of 1.9, 0.9 µM 
(Grassystatin D and E), and 50 nM (Grassystatin F). 
3030
CYCLIC DIARYLHEPTANOIDS FROM THE AUSTRALIAN 
ENDEMIC PLANT ALLOCASUARINA LUEHMANNII
Bao N. Nguyen1, Ngoc B. Pham1, Peter Healy2, Hoan T. Vu1, and Ronald J. 
Quinn1
 
1Eskitis Institute, Griffith University, Brisbane, QLD 4111, Australia, 2School 
of Natural Sciences, Griffith University, Brisbane, QLD 4111, Australia
We report the isolation of new cylic diarylheptanoids that bind to Plas-
modium falciparum ubiquitin conjugating enzyme PF10_0330. Pf ubiqui-
tin conjugating enzyme PF10_0330 is a potential target for anti-malarial 
chemotherapy. The X-ray of one of these compounds allowed the absolute 
configuration to be established. Binding to the Pf ubiquitin conjugating en-
zyme PF10_0330 was demonstrated using bio-affinity mass spectrometry.
3031
DISCOVERY PLATFORM FOR POTENT ADC PAYLOADS 
FROM MARINE SOURCES
Venkat Macherla, Egle Pociute, Guillermo Cardenas, Paige Stout, Tamara 
Mayer, Jacob Beverage, Eduardo Esquenazi
Sirenas Marine Discovery, 3550 General Atomics Ct, San Diego, CA 92121
Marine organisms have emerged as an important source of biologically 
active small molecules, particularly for highly potent cytotoxins. Because 
of this potent bioactivity, the traditional small molecule, single agent drug 
discovery approach is severely hampered by a dose-limiting therapeutic 
window. However, the recent success of Antibody Drug Conjugates (ADC), 
which offers the targeted delivery of cytotoxins to tumor cells via antibody-
binding, provides a renewed path for promising, potent, anti-cancer com-
pounds. ADC’s and similar targeting approaches are truly an enabling tech-
nology for natural products. In our ongoing drug discovery program, we 
have developed a unique ADC payload discovery platform which allows a 
rapid identification of marine-derived cytotoxic payloads. Using this tech-
nology, we have discovered potent ADC payloads. The discovery platform 
and initial results will be discussed. 
3032
DESCRIPTION OF BACTERIAL COMMUNITIES IN TWO 
CARIBBEAN OCTOCORALS AND ASSESSMENT OF 
THEIR ABILITY TO PRODUCE NATURAL PRODUCTS
Erin McCauley1, Brad Haltli1,2, and Russell Kerr1,2
1Department of Biomedical Sciences, 2Department of Chemistry, University 
of Prince Edward Island, 550 University Ave., Charlottetown, PE C1A 4P3 
The octocorals Antillogorgia elisabethae and Erythropodium caribaeorum 
are common members of reef communities in the Caribbean and have been 
shown to contain the bioactive terpenes pseudopterosins and eleutherobin, 
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respectively. The core microbiome of these octocorals has been identified 
through the use of culture dependent and culture independent bacterial 
libraries. The culture independent libraries revel that the genus Endozoico-
monas is a member of the core microbiome for both octocorals. In addition, 
their presence in the larvae on A. elisabethae suggests that Endozoicomonas 
spp. may be transmitted vertically from parent to offspring. The culture de-
pendent library revealed great taxonomic diversity and led to the identifica-
tion of a novel bacterium Pseudobacteriovorax antillogorgiicola, which was 
determined to be a member of the novel family Pseudobacteriovoracaceae. 
This bacterium, as well as the others present in culture dependent library 
were fermented and analyzed using a High Performance Liquid Chroma-
tograph-High Resolution Mass Spectrometer (HPLC-HRMS). The mass 
and retention time of ions detected by the HPLC-HRMS were coupled with 
principal component analysis to allow for identification of novel ions in the 
bacterial fermentations. 
3033
ETHNOMEDICINAL PLANTS INVESTIGATION IN 
HEZHEN NATIONALITY
Yue Liu1, 2, Yuanxia Jing1, Shuixian Zhang1, Hongbo Sun1, Li Tang1, Jinchao 
Feng1, Chunlin Long1, Luqi Huang2*
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2 National Resource Center for Chinese Materia 
Medica, China Academy of Traditional Chinese Medicine, Beijing 100700, 
China
The Hezhen is one of the smallest minorities in China. With a population of 
5,354 in 2010, the Hezhen people mainly live in five settlements including 
Aoqi in Jiamusi, Jiejinkou and Bacha in Tongjiang, Zhuaji in Fuyuan and Si-
pai in Raohe counties along the rivers of Songhua, Heilongjiang and Wusuli 
in the northeast of Heilongjiang Province in China. The Hezhen have fished 
and hunted for generations. Because the Hezhen had little genetic commu-
nication with other nationalities in history, Hezhen people have kept their 
own traditional knowledge for living healthy, especially for the fishing and 
hunting related illness, such as rheumatism, arthritis, etc. Fifty-four spe-
cies including medicinal uses, parts and purposes were catalogued based 
on the ethnobotanical investigation of medicinal plants in five settlements 
of Hezhen people. These species are belonging to thirty four families, fifty 
two genera and involved in seventeen different medicinal purposes. The 
medicinal uses of fourteen species are unique in Hezhen people compared 
with the Mongolia, Ewenki, and Oroqen nationality. This research explored 
and recorded the traditional medicinal knowledge of the Hezhen, and the 
result may be preparing the ground for the development of ethnopharma-
cology of the Hezhen. Acknowledgment: financial support by project of 
NSFC-81274158, 81373765, NCET-12-0578, 13-0624, “111”-B08044 and 
YLDX01013. 
3034
ARYLATION OF α,β-UNSATURATED KETONES VIA 
PHOTOCHEMICAL REACTION
Qian Yang1, Jie Han,2 Zun-Ting Zhang2, Yang-Qing He1
1Department of Applied Chemistry, Xi’an University of Technology, Xi’an, 
Shaanxi 710054, China, 2Key Laboratory of the Ministry of Education for 
Medicinal Resources and Natural Pharmaceutical Chemistry, and School of 
Chemistry and Chemical Engineering, Shaanxi Normal University, Xi’an, 
Shaanxi 710062, China
Development of efficient and reliable method to form a C-C bond between 
heteroaromatics and carbon α to carbonyl group has been a subject of in-
terest in organic chemistry. The use of photochemical reaction to approach 
the arylation of enones has proven to be a transformation of great unity 
in pharmaceutical and organic synthesis. In this study, the direct coupling 
of α-idio substituted unsaturated ketones with heteroaromatics has been 
achieved via photochemical reaction. A variety of α-heteroarylunsaturated 
ketones were obtained in moderate yields from the corresponding α-idio 
substituted unsaturated ketones with heteroaromatics such as pyrrole, fu-
ran, thiophene. The reaction worked smoothly in acetonitrile under a mer-
cury lampwithout any additives, which provides a catalyst and base-free 
approach for the arylation of α,β-unsaturated ketones.
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AN IMPURITY INVESTIGATION IN A NEW PROCESS 
FOR THE SYNTHESIS OF FESTINAVIR
Sloan Ayers1, Adrian Ortiz2, Zhongping Shi2, Tamas Benkovics2, and Greg 
Beutner2
1Analytical and Bioanalytical Development, Bristol-Myers Squibb Co., New 
Brunswick, NJ 08903, USA, 2Chemical Development, Bristol-Myers Squibb 
Co., New Brunswick, NJ 08903, USA.
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Festinavir is a synthetic analog of the natural nucleoside thymidine, and 
is currently under development at Bristol-Myers Squibb (BMS) for the 
treatment of HIV. A new process was developed at BMS for the synthe-
sis of festinavir, including innovative steps such as a pyranose to furanose 
ring-chain tautomerization, and an oxidation/thermal elimination step in-
volving an intermediate sulfilimine. Three impurities that formed in the 
thermal elimination step proved to be troublesome, as they were difficult 
to purge from the penultimate intermediate, and their resulting daughter 
impurities were difficult to purge from the final product. These impurities 
also decreased the yield of the desired products by a significant degree. Elu-
cidating the structures of these impurities was paramount to determining 
how to adjust the synthetic conditions to minimize their formation. The 
isolation and structural elucidation of these impurities will be presented, as 
well as the resulting process changes.
3036
HYPOGLYCEMIC AND ANTIHYPERGLYCEMIC 
ACTIVITIES OF AN AQUEOUS EXTRACT AND 
COMPOUNDS FROM Acourtia thurberi ROOTS.
Ana Laura Martínez1, Abraham Madariaga-Mazon1, Edelmira Linares,2 
Robert Bye2 and Rachel Mata1
1Facultad de Química, and 2Instituto de Biología, Universidad Nacional 
Autónoma de México, Mexico City, 04510, Mexico.
Acourtia thurberi (Asteraceae) is a medicinal plant commonly used for 
treating diabetes in Mexico. Therefore the present study was undertaken to 
assess the antidiabetic potential of an infusion (Ati) and compounds from 
the plant using well known animal and in vitro models. In addition, the 
potential acute toxicity of the infusion and perezone (1), the major com-
ponent of the plant, was analyzed using the Lorke method. The results in-
dicated that oral administration of Ati (31.6-316.2 mg/kg) or 1 (31.6 mg/
kg) decreased postprandial glucose levels in mice during an oral glucose 
tolerance test. On the other hand, Ati inhibited yeast α-glucosidase in a 
concentration-dependent manner with an IC50 value of 1804.8 ppm. Re-
garding the toxicity studies, Ati can be considered as non-toxic in the Lorke 
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model since the calculated LD50 was higher than 5000 mg/kg; on the oth-
er hand, the LD50 for 1 was 1264.9 mg/kg. Altogether, these preliminary 
results have a tendency to support the alleged antidiabetic properties of 
Acourtia thurberi in Mexican folk medicine.
3037
SUPERCRITICAL FLUID CHROMATOGRAPHIC METHOD 
FOR THE ANALYSIS OF CANNABINOIDS IN EXTRACTS 
OF CANNABIS SAMPLES 
Mei Wang1, Yan-Hong Wang1, Bharathi Avula1, John van Antwerp3, Jon F. 
Parcher1, Mahmoud A. ElSohly1,2 and Ikhlas A. Khan1,2
1National Center for Natural Products Research, and 2Division of 
Pharmacognosy, Department of BioMolecular Science, School of Pharamacy, 
University of Mississippi, University, MS 38677, USA, 3Waters Corporation, 
Milford, MA 01757, USA 
A rapid method is developed for the analysis of cannabinoids in extracts of 
cannabis samples using supercritical fluid chromatography (SFC) coupled 
to UV and electrospray ionization-mass spectroscopic (ESI-MS) detection. 
Eleven cannabinoids, viz. CBL, CBD, ∆8-THC, THCV, ∆9-THC, CBC, 
CBN, CBG, THCA-A, CBDA and CBGA, were well separated in an 8 min 
run. The developed SFC method was validated according to ICH guidelines 
and used to quantitate these cannabinoids in 29 different Cannabis sativa 
plant samples. The quantitation results were verified by comparison with a 
standard UPLC method. The described method offers an alternative means 
for identification and quantification of cannabinoids in Cannabis plants 
and products. In addition, conditions for decarboxylation of the acid forms 
of the major cannabinoids were examined at 80 °C, 95 °C, 110 °C, 130 
°C and 145 °C with different time intervals in order to select the most 
appropriate condition for complete decarboxylation. 
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3038
MODELING CELLULAR RESPONSES IN NON-SMALL 
CELL LUNG CANCER USING MARINE DERIVED 
NATURAL PRODUCTS
Oswald NW, McMillan EA, Posner BA, White MA, MacMillan JB
Department of Biochemistry, UT Southwestern Medical Center at Dallas
Using a group of well annotated non-small cell lung cancer (NSCLC) cell 
lines (mutation status, gene expression profiling, siRNA profiling) selective 
and non-selective cytotoxic natural products can be identified based upon 
data of the sensitive cell lines. We have focused our efforts on discovery of 
natural products from marine-derived bacteria through the screening of a 
collection of ~6500 natural product fractions. A screen of the 6500 natural 
product fractions against 27 non-small cell lung cancer cell lines has re-
vealed a number of promising fractions. 
Target identification predictions can be made based upon cell line data of 
sensitive and non-sensitive cell lines, thereby allowing for further prioriti-
zation of natural product fractions. LCMS and NMR data is combined with 
the bioinformatics and screening data to allow for better prioritization of 
natural product fraction leads. The lead fractions are further analyzed to 
identify known and novel compounds of interest. Biological activities are 
then followed up with further cytoxicity and mechanistic studies of the na-
tural product against NSCLC cell lines. Representative biomarkers of both 
resistant and sensitive NSCLC cell lines are also identified. This has led to 
a number of insights into the sensitivities of cancers based upon their mu-
tation status.
3039
PEROXISOME PROLIFERATOR ACTIVATOR RECEPTOR 
ALPHA (PPARΑ) ACTIVATION USING A FREE FATTY 
ACID LIBRARY; FATTY ACIDS COMPARED.
John F. Rebhun1, Rodney A. Velliquette1, Samantha J. Roloff1, Kelly M. 
Glynn1, Jat Rana1, Kevin W. Gellenbeck2 and Jeffrey D. Scholten1
1Analytical Science Department, Amway Corporation, 7575 Fulton St. 
East, Ada, MI 49355 USA, 2Nutrilite Division of Amway, Concentrate 
Development, 5600 Beach Blvd, Buena Park, CA 90622 USA
Peroxisome proliferator activated receptor alpha (PPARA) is a nuclear hor-
mone receptor, of particular interest for its impact on a number of health 
and wellness issues, including the circulatory system, wound healing, skin 
inflammatory issues and barrier function. To assess direct and limited 
indirect PPARA activation, a reporter assay was developed using a Gal4-
PPARA Ligand Binding Domain (LBD) fusion construct and the upstream 
activating sequence (UAS) controlling luciferase production. 
Here we describe the evaluation of a compound library containing 68 
different free fatty acids, many of them are of current interest in the food 
and nutrition industry. Their activation of PPARA was evaluated using the 
Gal4-UAS PPARA reporter assay above. Many of them activated PPARA 
with some limitations on the size and saturation status of the individual 
compounds. Oleic acid and linoleic acid were two activating molecules that 
were selected for further analysis and evaluated side by side. They activa-
ted PPARA and this activation was blocked by a known PPARA inhibitor, 
GW6471 at 10 uM. Activation of specific genes involved with keratinocy-
te differentiation, wound repair and barrier function were evaluated and 
discussed.
3040
MICROBIAL TRANSFORMATION OF GINGER ISOLATED 
COMPOUNDS
Roberta Marques Dias de Ávila, João Batista Fernandes, Maria Fátima das 
Graças Fernandes da Silva, Paulo Cezar Vieira
Departamento of Chemistry, Federal University of São Carlos, São Carlos, 
SP, CEP 13565-905, Brazil.
Ginger or ginger root, the rhizome of the plant Zingiber officinale, has been 
consumed as a delicacy, medicine, or spice for many years. A number of 
studies have been conducted on the medicinal properties of ginger against 
various disorders. Gingerols are among the bioactive compounds isolated 
from ginger. In order to check for the possibility of obtaining new gingerol 
derived compounds we have carried out microbial transformation of seve-
ral gingerols using the fungus Colletotrichum gloeosporioides. Cultivation of 
the fungus in different culture media and having zingerone (1) and [6]-gin-
gerol (2) as starting material for the biotransformation, dimer derivatives 
such as 3 and 4 originated from oxidative coupling were isolated. [6]-gin-
gerol was transformed into 5 a product that can be obtained from Baeyer-
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Villiger type reaction followed by hydrolysis. Isotope labelling proved that 
compound 3 is a product from [6]-gingerol biotransformation.
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3041
BIOLOGICAL ACTIVITIES OF TRITERPENES ISOLATED 
FROM THE MEDICINAL MUSHROOM GANODERMA 
LUCIDUM.
Daniel Sliva1,2,3, Jagadish Loganathan3, Marta Dudek4, Michal Glensk5 and 
Vitold B. Glinski5
1DSTest Laboratories, Purdue Research Park, 5225 Exploration Dr., 
Indianapolis, IN 46241, 2Indiana University School of Medicine, 
Indianapolis, IN 46202, USA, 3Indiana University Health, Indianapolis, IN 
46202, 4Medical University of Warsaw, Dept. of Physical Chemistry, Warsaw, 
Poland, 5Planta Analytica, 39 Rose St., Danbury, CT 06810.
Methanol extract of Ganoderma lucidum subjected to fractionation on sili-
ca gel medium pressure column afforded over 40 fractions. Further fractio-
nation was carried out using Centrifugal Partition Chromatography (FCPC 
Rousselet Robatel, France), in the hexane-EtOAc-MeOH-Water systems 
adjusted for the polarity of each fraction. Some isolates were further puri-
fied by preparative HPLC. Methyl esters of ganoderic and lucidenic acids 
were obtained by methylation of the acids. Twelve compounds, including 
ganoderic acid A (1), methyl ganoderate A (2), methyl lucidenate A (3), 
methyl lucidenate F (4), lucidenic acid D2 (5), lucidenic acid A (6), luci-
denic acid N (7), ganoderic acid DM (8), ganoderic acid F (9), ganoderic 
acid C (10), ganoderiol F (11) and ganodermonondiol (12) were evaluated 
for their biological activities. Antibacterial activity was determined against 
Gram -positive and -negative bacteria, anti-inflammatory effect against en-
dotoxin (lipolysaccharide, LPS) induced inflammatory response in human 
macrophages, and anti-proliferative effects in human breast and colon can-
cer cells. We identified ganoderic acid DM as the most potent triterpene 
with anti-bacterial, anti-inflammatory and anti-proliferative effects when 
compared to other Ganoderma isolates.
3042
ANTIHYPERALGESIC ACTIVITY OF AN EXTRACT AND 
COMPOUNDS FROM ANODA CRISTATA 
Krutzkaya Juárez-Reyes1, Myrna Déciga-Campos2 and Rachel Mata1. 
1Facultad de Química, Universidad Nacional Autónoma de México, Mexico 
City 04510, Mexico, 2Escuela Superior de Medicina del IPN, Mexico City, 
Mexico.
Anoda cristata (Malvaceae) is used as food and to treat stomach complaints, 
fever, cough, wounds and diabetes. In a previous work, the antidiabetic ac-
tion of a free mucilage aqueous extract (FM-AE) and major compounds 
[acacetin (1) and diosmetin (2)] from the plant was reported. This work 
was undertaken to establish the potential antihyperalgesic action of A. cri-
stata using the formalin test in hyperglycemic (NA/STZ: 50/ 130 mg/kg, 
i.p.) mice. In all cases the treatments were administered subcutaneously in 
the dorsal surface of the right hind paw. FMAE (10-100 µg/paw), 1 (1-7.5 
µg/paw) and 2 (0.1-6 µg/paw), induced significant decrease in licking time. 
In order to determine the mode of action of 1 and 2, the animals were pre-
treated with naloxone (3 µg/paw), flumazenil (6 µg/paw), ketanserin (3 µg/
paw), L-NAME (150 µg/paw), ODQ (75 µg/paw) or glibenclamide (3 µg/
paw). The effect of 1 was abolished with naloxone and flumazenil, revealing 
its opioid and GABA mechanisms of action. However, pretreatment with 
ketanserin was the only one that antagonized the effect of 2, consistent a 
serotonergic pathway mediating its pharmacological action. The antihyper-
algesic effect of FMAE, 1 and 2 could be of benefit in diabetic patients with 
neuropathic complications.
3043
TRP CHANNEL ANTAGONISTS FROM A NOVEL 
TUNICATE-ASSOCIATED FUNGUS 
Zhenjian Lin,1 Zhenyu Lu,2 May Hamdy Abdel Aziz,2 Chris A. Reilly,2 and 
Eric W. Schmidt1,3
1Department of Medicinal Chemistry, L.S. Skaggs Pharmacy Institute, 
University of Utah, Salt Lake City, Utah 84112 USA. 2Department of 
Pharmacology and Toxicology, L.S. Skaggs Pharmacy Institute, University of 
Utah, Salt Lake City, Utah 84112 USA. 3Department of Biology, University 
of Utah, Salt Lake City, Utah 84112 USA. 
We have aimed to examine cultivable associates of ascidians as sources of 
bioactive natural products. A novel filamentous fungus, Eurotiomycetales 
strain 110162, was identified from the ascidian Diplosoma sp. collected in 
Papua New Guinea (10.0370785 S 145.767741 E). Strain analysis by 18S 
rRNA, RNA poly-merase II (RPB2) and internal transcribed spacer (ITS) 
gene sequences indicated that strain 110162 represents a member of the 
Class Eurotiomycetes, and the strain may represent a novel order within this 
class. From this novel filamentous fungus, a series of prenylated polyketide 
metabolites were isolated and showed selective TRPM8 antagonist activity.
3044
ANTIFUNGAL AND ANTIPARASITIC ACTIVITIES OF 
LAURUS NOBILIS (BAY LEAVES) 
H. Ranjith W. Dharmaratne1, Surendra Jain1,2, Babu L. Tekwani1,2, Melissa 
R. Jacob1, N.P. Dhammika Nanayakkara1
1National Center for Natural Products Research and 2Department of 
BioMolecular Sciences, School of Pharmacy, University of Mississippi, 
University, MS 38677, USA.
In the course our search for safe antimicrobial agents from natural sources, 
an extract of leaves and twigs of Laurus nobilis (LN), commonly known as 
bay leaves, showed activity against Cryptococcus neoformans and Leishma-
nia donovani. Activity guided fractionation of the extract led to isolation of 
costunolide as the active compound. Costunolide showed moderate activi-
ties against C. neoformans (IC50 5.15 µg/mL) and L. donavani promastigo-
tes (IC50 4.04 µg/mL) and amastigotes (IC50 1.85 µg/mL). This compound 
also exhibited good activity against Trypanosoma brucei (IC50 1.64 µg/mL). 
Costunolide has previously been isolated from L. nobilis and several other 
species and a number of other biological activities have been reported for 
this compound. 
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3045
SINGLE SHOT DECONVOLUTION OF THE SYMBIOTIC 
BUGULA NERITINA METAGENOME
Ian J. Miller1, Theodore Weyna1, Stephen S. Fong2, Grace Lim-Fong3, Jason 
C. Kwan1
1Division of Pharmaceutical Sciences, University of Wisconsin-Madison, 
Madison, WI 53705, USA, 2Department of Chemical and Life Science 
Engineering, Virginia Commonwealth University, Richmond, VA 23284, 
USA, 3Department of Biology, Randolph-Macon College, Ashland, VA 
23005, USA.
With the increasing availability of deeply sequenced data sets, it has be-
come clear that the biosynthetic potential of uncultured microbes, which 
are believed to account for 99.9% of bacteria, remains largely untapped. 
Understanding the ecological roles and full biotechnological potential of 
these uncultivated microbes has historically been limited by our access to 
complete genomes. Even for systems where biosynthetic pathways have 
been described, such as with the bryostatin producing endosymbiont of 
Bugula neritina, Candidatus Endobugula sertula, a lack of genomic and 
ecological context for natural product biosynthesis limits our understand-
ing of secondary metabolite production and its role in the environment. 
Thus, culture-independent approaches are becoming increasingly import-
ant in the study of natural products. Our approach presented here offers a 
streamlined bioinformatic technique able to unlock the diversity in a single, 
unenriched environmental sampling and assemble multiple bacterial ge-
nomes from the metagenome of the marine invertebrate, Bugula neritina. 
Ultimately, this method represents a powerful tool to explore unculturable 
bacteria and their biosynthetic potential in complex microbial systems.
3046
EUDISTAMIDES A AND B, NOVEL CYCLIC 
DEPSIPEPTIDES FROM A MARINE-DERIVED 
STREPTOMYCES SP.
Fan Zhang1, Navid Adnani1, Emmanuel Vazquez-Rivera2, Doug R. Braun1, 
and Tim S. Bugni1
1Pharmaceutical Sciences Division, University of Wisconsin–Madison, 
Madison, WI 53705, USA, 2Molecular & Environmental Toxicology Center, 
University of Wisconsin–Madison, Madison, WI 53705, USA
Addressing antibiotic resistance represents a significant challenge. Methods 
for rapid structure determination of bacterially produced antibiotics would 
help streamline discovery pipelines. Therefore, we evaluated application 
of biomolecular NMR strategies for rapid structure elucidation of pep-
tide-based natural product antibiotics. Two novel peptides eudistamides A 
and B (1 and 2), were isolated from a marine Streptomyces sp. Both com-
pounds 1 and 2 contain a unique 3-(2-Methylphenyl)acrylic acid moiety, 
which was assigned by 1D and 2D NMR experiments. The sequences of 
the amino residues in 1 and 2 were elucidated on the basis of 3D NMR 
experiments, and further confirmed by HRESIMS and 1D and 2D NMR 
data. The absolute configurations were determined by advanced Marfey’s 
method after acid hydrolysis. Compound 2 displays antibacterial activities 
against strains of Methicillin-resistant Staphylococcus aureus (MRSA), E. 
coli and Bacillus subtilis.
3047
MARINE NATURAL PRODUCTS DRUG DISCOVERY 
FROM ACTINOMYCETES AT FUNDACION MEDINA
Jose R. Tormo, Daniel Oves, Rodney Lacret, Catalina Moreno, Mercedes 
DeLa Cruz, Caridad Díaz, Ignacio González, Jesús Martín, Ignacio Pérez-
Victoria, Francisca Vicente, Fernando Reyes and Olga Genilloud
Fundación MEDINA, Avda. Conocimiento 34, 18016, PTS, Granada, Spain
Among microbial environments, marine-derived actinomycetes represent 
a highly diverse source for finding new NPs that remains still largely un-
derexplored for Human Health Drug Discovery. Fundación MEDINA is 
devoting strong efforts in evaluating this genuine source for novel leads by 
collaborating with more than 20 international partners through granted 
projects, developing a library of NPs extracts and fractions for HTS drug 
discovery derived from the subset of marine actinomycetes included in our 
microbial collection of 116.000 strains.
Strategies followed in the generation of this Library of marine NP extracts 
included: geographical and taxonomic selection of strains, focused fermen-
tation methodologies, and tailored-made semi-automated SPE extraction 
and fractionation approaches to overcome the special characteristics of 
marine-like culture media. As a result, MEDINA’s Marine Natural Products 
Program is starting to generate new promising hits with high potential to be 
developed as Drug candidates. Global screening results, mainly focused on 
our anti-infective programs will be discussed including preliminary results 
on the identification of some of the new molecules derived from this Drug 
Discovery effort.
3048
TO DISCOVER BIOACTIVE COMPOUNDS FROM THE 
PLANTS IN LINGNAN REGION OF SOUTHERN ASIA
Hongjie Zhang
School of Chinese Medicine, Hong Kong Baptist University, 7 Baptist 
University Road, Kowloon Tong, Kowloon, Hong Kong SAR, China.
Lingnan is a geographic regi-
on referring to “Five Ranges”, 
which covers five Southern 
provinces of China and 
northern part of Vietnam. 
It is located in a tropical and 
sub-tropical climate zone 
with rich rainforests and 
diversified plant resources. 
For a decade, our research 
programs have investigated 
the chemical and biological 
properties of several thou-
sands of the terrestrial plant 
samples in Lingnan region. We have evaluated the plant samples against 
cancer, parasites, fungi, bacteria and viruses (Figure 1). Bioassay-guided 
fractionation of the selected plant extracts led to the isolation of more than 
300 compounds of varying degrees of structural complexity, novelty and/
or biological activity (anticancer, antiviral, anti-bacterial, anti-fungal and 
antimalarial activities). [The work described in this paper was collabora-
tive efforts within multi-disciplinary cooperative programs supported by 
grants from the Research Grants Council of the Hong Kong Special Admi-
nistrative Region, China (Project No. HKBU 262912 and HKBU12103014), 
HKBU Interdisciplinary Research Matching Scheme (RC-IRMS/12-13/03), 
Faculty Research Grants, Hong Kong Baptist University (FRG2/14-15/047 
and FRG1/13-14/029), and NIH Grants 3U01TW001015-10S1 and 
2U01TW001015-11A1 (administered by the Fogarty International Cen-
ter as part of an International Cooperative Biodiversity Groups program, 
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lead compounds from plant source 
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through funds from NIH, NSF, and Foreign Agricultural Service of the 
USDA)].
3049
ALPHA-GLUCOSIDASE INHIBITORS FROM Sporormiella 
minimoideS
Manuel Rangel-Grimaldo, Abraham Madariaga-Mazón, Isabel Rivero-Cruz, 
Mario Figueroa and Rachel Mata
Departamento de Farmacia, Facultad de Química, Universidad Nacional 
Autónoma de México, Mexico City, México 04510
Sporormiella minimoides is an endophytic fungus obtained from Hintonia 
latiflora (Rubiaceae) leaves, a medicinal plant widely used in Mexico to 
treat diabetes. Bioassay- guided fractionation of the organic extract of the 
fungus yielded the isolation of a novel metabolite characterized as 5,7’-di-
hydroxy-2,4’,7,9’-tetramethoxy-1’H, 4H, 6’H-spiro[naphthalen-1,2’-phe-
nalen]-4,6’-dione (1) obtained as a racemic mixture (1a and 1b). The re-
lated known compounds preussochromone C (2) and corymbiferone (3) 
were also isolated. Compounds 1-3 and acarbose (positive control) inhib-
ited yeast α-glucosidase (IC50 values of 2.91, 66.5, 155.5 and 876.9 µM, re-
spectively). Kinetic analysis revealed that 1-3 behaved as mixed-type inhib-
itors (Ki’s = 2.7, 52.0 and 163.8 µM, respectively). Finally, docking studies 
predicted that 1a could bind to the catalytic site of the enzyme (PDB code 
3A4A), whereas 1b, 2 and 3 to an allosteric site.
 
 
                                             1a                                    1b                                   2                                  3 
3050
DEVELOPMENT OF ANTIOXIDANT PEPTIDES THAT 
TARGET THE PULMONARY ARTERIES FOR THE 
TREATMENT OF PULMONARY HYPERTENSION
Leah R. Villegas1, Lara Kirkbride-Romeo2, Juan M. Martinez1, MyPhuong 
T. Le2
1Department of Pediatrics and Cardiovascular Pulmonary Research, 
2Division of Renal Diseases and Hypertension, University of Colorado, 
Anschutz Medical Campus, Aurora, CO 80045.
Pulmonary hypertension (PH) is a multifaceted disease that affects the lung 
blood vessels and eventually leads to right heart failure. Therapeutic strate-
gies using antioxidants have shown promising efficacy, but have major limi-
tations, in particular, the lack of site-specific distribution of the antioxidants 
to the lungs and pulmonary arteries. Targeted drug delivery can overcome 
this major issue. For this study, we will investigate the efficacy of targeting 
the delivery of antioxidants to the pulmonary arteries as a treatment for PH.
Botanicals and their extracts are widely used for both traditional medicine 
and pharmaceutical development. Bioactive peptides isolated from natu-
ral sources have been shown to have strong antioxidant activities. For this 
study, we focused on identifying peptides with superoxide dismutase and 
catalase activity, two important antioxidants that play a role in PH. Within 
our library of over 300 botanical species, we have identified several peptide 
extracts with potent antioxidant activity (EC50 = 0.14ug – 2.10ug), which 
will be further developed as a therapeutic targeting the pulmonary arteries.
3051
TOTAL SYNTHESIS AND BIOLOGICAL EVALUATION 
OF LYNGBYASTATIN 7 FOR THE TREATMENT OF 
PULMONARY DISEASES
Danmeng Luo1,2, Qi-Yin Chen1,2, and Hendrik Luesch1,2
1Department of Medicinal Chemistry, University of Florida, Gainesville, 
Florida 32610, United States, 2Center for Natural Products, Drug Discovery 
and Development, University of Florida, Gainesville, Florida 32610, United 
States
Lyngbyastatin 7 is marine-derived cyanobacterial cyclodepsipeptide that 
showed better potency towards inhibiting elastase than sivelestat, the only 
approved drug targeting this enzyme. The discovery of elastase inhibitors is 
of great importance since this enzyme plays a significant role in several pul-
monary diseases, such as chronic obstructive pulmonary disease, the third 
leading cause of death worldwide. We established the first total synthesis 
of lyngbyastatin 7 and validated the elastase-inhibitory activity in enzyme 
assays. Lyngbyastatin 7 also outperformed sivelestat in our cellular assays, 
where the compound protected human bronchial epithelial cells against 
elastase-induced antiproliferative effects as well as attenuated the transcrip-
tion of sICAM-1 and IL1β which are induced by elastase. The synthetic ac-
cessibility overcomes the supply issue and paves the way for the synthesis of 
diverse analogues with the goal of discovering effective therapeutics against 
elastase-mediated pathologies.
3052
BIOACTIVITY-GUIDED IDENTIFICATION OF BOTANICAL 
INHIBITORS OF KETOHEXOKINASE
MyPhuong T. Le1,*, Miguel A. Lanaspa1, Christina M. Cicerchi1, Jatinder 
Rana2, Jeffrey D. Scholten2, Brandi L. Hunter1, Christopher J. Rivard1, R. 
Keith Randolph2, and Richard J. Johnson.1
1Division of Renal Diseases and Hypertension, Department of Medicine, 
University of Colorado Anschutz Medical Campus, Aurora, Colorado 80045, 
USA, 2Amway Research and Development, 7575 Fulton, Ada, Michigan 
49355, USA.
The excessive consumption of added sugars is epidemiologically associated 
with rising prevalence of obesity, metabolic syndrome, and cardiovascular 
diseases in the United States. As a major constituent of added sugars, fruc-
tose has been shown to cause a variety of adverse metabolic effects, such 
as impaired insulin sensitivity, hypertriglyceridemia, and oxidative stress. 
Recent studies have shown that ketohexokinase isoform C (KHKC) is the 
key enzyme responsible in fructose metabolism that drive’s fructose’s ad-
verse effects. The primary objective of this study was to identify botani-
cals with inhibitory activity against KHKC. Extracts from 406 botanicals 
were screened initially at 50 µg/mL for their inhibitory activity using a cell 
free, recombinant human KHKC assay. Dose response evaluations were 
conducted on botanical extracts that inhibited KHKC by ≥ 30%. Angelica 
archangelica, Garcinia mangostana, Petroselinum crispum, and Scutellaria 
baicalensis were the top four botanical candidiates identified with inhibito-
ry activity against KHKC and prevented fructose-induced ATP depletion 
and elevation in triglyceride and uric acid production. 
3053
α-GLUCOSIDASE INHIBITORS FROM Vauquelinia 
corymbosa
Laura Flores-Bocanegra1, Araceli Pérez-Vásquez1, Robert Bye2, Edelmira 
Linares2, Rachel Mata1
1Facultad de Química, 2Instituto de Biología, Universidad Nacional 
Autónoma de México, Mexico City, 04510
An extract from Vauquelinia corymbosa Bonpl. (Rosaceae) showed not-
ed inhibitory effect (IC50 = 28.6 µg/mL) against yeast α-glucosidase when 
Poster Session - Monday, July 27th
113Abstracts | 2015 Annual Meeting of the ASP | July 25th–29th, 2015 | Copper Mountain, CO, USA
tested with a well-known spectrophotocolorimetric assay. Bioassay-guid-
ed fractionation the active extract led to the isolation of prunasin (1), 
(-)-epi-catechin (2), hyperoside (3), isoquercetin (4), quercitrin (5), querce-
tin-3-O-(6´´-benzoyl)-β-galactoside (6), picein (7) and methylarbutin (8). 
The most active compound was 6 with an IC50 of 30 µM; according to a ki-
netic analysis compound 6 behaved as mixed-type inhibitor (ki = 50 µM; α= 
0.97). The information generated in this study indicates that V. corymbosa 
is a source of new α-glucosidase inhibitors which might delay glucose ab-
sorption in vivo. The presence of compounds 1-6 in the plant might explain 
the reputed antidiabetic activity of V. corymbosa in Mexican folk medicine. 
Concerning the occurrence of prunasin (1) in this species, National Health 
Authorities should provide effective communication to consumers about 
the risk from its inappropriate usage.
3054
INVESTIGATION OF INTERSPECIES INTERACTIONS 
BETWEEN MARINE MICROMONOSPORACEAE FOR 
IDENTIFICATION OF NOVEL ANTIBIOTICS
Navid Adnani1, Emmanuel Vazquez-Rivera1, Srikar Adibhatla1, Gregory A. 
Ellis1, Doug Braun1, Tim S. Bugni1*
1Pharmaceutical Sciences Division, University of Wisconsin-Madison, 
Madison, WI 53705, USA
Despite the continued rise in antibiotic-resistant infections, discovery of 
novel antibiotic scaffolds have been on a steady decline. In part, the decline 
in new antibiotics can be attributed to the repeated use of relatively stan-
dardized methods for natural product isolation, leading to the figurative 
“low-hanging fruit” being picked. Genomic analyses of actinomycetes have 
highlighted many biosynthetic gene clusters from which natural products 
have not yet been isolated under standard laboratory growth conditions. 
Our study investigated whether interspecies interactions, via co-culture, 
can stimulate production of novel antibiotics. Marine invertebrate-associ-
ated Micromonopsoraceae were used based on the high biosynthetic po-
tential, yet relatively low number of reported chemistry. Microscale (500 
μL) cultivation followed by bioactivity screening and LCMS-based second-
ary metabolomics enabled rapid growth and comparative analyses of hun-
dreds of co-culture pairs and monoculture controls simultaneously. Using 
this approach, we identified a novel antibiotic produced via co-culture of a 
Micromonospora sp. with a Rhodococcus sp. In addition to progress towards 
elucidation of the structure, whole genome sequencing of both bacteria was 
performed to identify the biosynthetic origin and producing organism of 
the antibiotic. Furthermore, proteins differentially expressed between co- 
and monocultures were investigated using comparative proteomic analyses. 
Overall, our study aims to reinvigorate antibiotic discovery by investigating 
interspecies interactions.
3055
THE DEFENSIVE CHEMISTRY OF THE IRISH 
NUDIBRANCH ARCHIDORIS PSEUDOARGUS 
(GASTROPODA OPISTHOBRANCHIA).
Ryan M. Young and Bill J.
Baker. School of Chemistry, National University of Ireland Galway, Galway, 
Republic of Ireland; Department of Chemistry and Center for Drug 
Discovery and Innovation, University of South Florida, Tampa, FL, USA.
Historically, marine natural products from the Republic of Ireland have 
been greatly underrepresented in the literature despite having a coastline 
of over 4500 miles. Archidoris pseudoargus is a soft-bodied, slow moving 
Dorid nudibranch which inhabits the coastal waters of Ireland and the Uni-
ted Kingdom. Nudibranchs are a good source of new chemical diversity, 
employing these secondary metabolites to deter predation. In this study we 
have identified new chemistry as well as used a metabolomics approach to 
identify the origin of said chemistry.
In early Spring, mature adults come together to reproduce and shortly the-
reafter to oviposit on the subtidal rocky shoreline. These egg sacs can be 
brightly colored and exposed to predation, yet none of the many surroun-
ding predators appear to feed on these nutrient rich egg masses. We have 
investigated whether the defensive chemistry of the parents is responsible 
for protecting the egg masses. 
   
Left: A photo of a mature Right: The egg mass of A. psuedoargus 
Archidoris psuedoargus adhered to an algal substrate 
specimen.
3056
CO-CULTURE BETWEEN INSECT-ASSOCIATED 
MICROORGANISMS STIMULATES POLYKETIDE 
PRODUCTION
Camila R. Paludo1,4, Eduardo A. Silva-Junior1,4, Fábio S. Nascimento2, 
Cameron R. Currie3, Jon Clardy4, Mônica T. Pupo1
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de 
São Paulo, Ribeirão Preto, SP 14040-903, Brazil; 2Faculdade de Filosofia, 
Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão 
Preto, SP 14040-901, Brazil; 3University of Wisconsin, Madison, WI 53706, 
USA; 4Harvard Medical School, Boston, MA 02115, USA
Social insects have been associated with microorganisms that can produce 
antimicrobial compounds in order to protect their colonies against patho-
gens. Natural products biosynthesis can be stimulated using co-culture 
techniques, once in natural conditions microorganisms are competing for 
nutrients and space. Monascus ruber SdFCP01 and Candida sp. SdFCP02, 
both isolated from brood cells of the Brazilian stingless bee Scaptotrigona 
depilis, were co-cultured and the production of the polyketide monascuspi-
loin by M. ruber was elicited. The ecological roles that M. ruber and Candi-
da sp. play in S. depilis colony have been investigated.
 
 
 
 
                      
O
HO
O
O
O  
  M. ruber             Candida sp.                    Monascuspiloin 
 
3057
ELUCIDATION OF THE MANGICOL AND 
NEOMANGICOL BIOSYNTHETIC PATHWAY FROM THE 
MARINE FUNGUS FUSARIUM EQUISETI CNC-477
Stephen A. Bell and Jaclyn M. Winter
Department of Medicinal Chemistry, College of Pharmacy, University of 
Utah, Salt Lake City, UT 84112.
While actinomycetes are often regarded as good resources for the discovery 
of bioactive metabolites, the recent explosion in whole genome sequencing 
has brought filamentous fungi back into the spotlight as feasible resources 
for drug discovery programs. The marine-derived fungal strain Fusarium 
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equiseti CNC-477, characterized by the Fenical laboratory, was shown to be 
a prolific producer of rare sesterterpene (C25) polyols. Mangicols A–G con-
tain an unprecedented spirotricyclic core and possess remarkable anti-in-
flammatory activity, whereas neomangicols A–C contain a tetracyclic ske-
leton and exhibit antimicrobial activities. Both classes of molecules contain 
multiple hydroxylations on the uncyclized prenyl chain and neomangicols 
A and B contain an additional chlorine or bromine atom, respectively, that 
is crucial for bioactivity. De novo genome sequencing and assembly has re-
vealed candidate biosynthetic clusters responsible for the synthesis of these 
sesterterpene polyols. These biosynthetic clusters, a proposed biosynthetic 
route and the development of alternative platforms for the heterologous 
production of the mangicols and neomangicols will be presented.
 
3058
THE MANDELALIDES ARE PRODUCED BY A SYMBIONT 
IN THE PHYLUM VERRUCOMICROBIA IN THE 
TUNICATE LISSOCLINUM SP.
Theodore R. Weyna1, John J. Barkei1, Ian J. Miller1, Kerry L. McPhail2, and 
Jason C. Kwan1
1 Pharmaceutical Sciences Division, School of Pharmacy, University of 
Wisconsin, Madison, Wisconsin 53705, United States 2 Department of 
Pharmaceutical Sciences, College of Pharmacy, 203 Pharmacy Building, 
Oregon State University, Corvallis, Oregon 97331, United States
An increasing number of natural products from higher animals have been 
found to ultimately derive from a bacterial symbiont. Through connection 
of pathways with whole symbiont genomes, metagenomics has the poten-
tial to yield deeper insights into these symbiotic relationships. In order to 
investigate the biosynthetic source of mandelalides, a group of macrolides 
with nanomolar cytotoxicity, we carried out shotgun metagenomic sequen-
cing of DNA extracted from a new Lissoclinum species (a tunicate) residing 
in the waters off the coast of South Africa. As most of the bacterial contigs 
in the tunicate metagenome were classified as belonging to the phylum Ver-
rucomicrobia, we took all Verrucomicrobia classified contigs and subjected 
them to an iterative reassembly procedure. The resulting genome was found 
to contain a complete trans-AT PKS pathway. The pathway includes two 
monooxygenase domains, two trans-acting ATs, a glucosyl transferase, an 
O-methyltransferase and a β-methylation cassette. Bioinformatic analysis 
of this pathway predicted intermediates consistent with the mandelalides 
final structures. Although we found that one published Verrucomicrobia 
genome contains secondary metabolite pathways (Opitutus terrae PB90-
1), this is the first example of a specific natural product attributed to this 
phylum. 
3059
BIOLOGICALLY ACTIVE NATURAL PRODUCTS FROM 
CASSINE VIBURNIFOLIA
Tanja Grkovic1, Rhone Akee1, Jason Evans1,2, Jerry M. Collins3, and Barry 
O’Keefe3,4
1Natural Products Support Group, Leidos Biomedical Research Inc., 
Frederick National Laboratory for Cancer Research, Frederick, MD 21702, 
2Data Management Services, Inc. National Cancer Institute, Frederick, MD 
21702, 3Natural Products Branch, Developmental Therapeutics Program, 
Division of Cancer Treatment and Diagnosis, Frederick National Laboratory 
for Cancer Research, Frederick, Maryland 21702, 4Molecular Targets 
Laboratory, Center for Cancer Research, Frederick National Laboratory for 
Cancer Research, Frederick, Maryland 21702.
Plant-sourced natural products have been a generous source of novel anti-
cancer drugs and drug leads. Here, we present the results of a study done on 
the plant Cassine viburnifolia that showed potent NCI-60 cell line growth 
inhibition as well as activity in the subsequent hollow fiber and xenograft 
studies. Bioassay-guided isolation led to the identification of three quinone 
methide-containing natural products. Their structures, activity profiles and 
relationship to the activity of the crude extract will be presented.
3060
DEVELOPMENT OF A NATURAL PRODUCT-BASED 
FRACTION LIBRARY FOR IMPROVED PERFORMANCE 
IN HIGH-THROUGHPUT SCREENING SYSTEMS
Christopher C. Thornburg1, Tanja Grkovic1, John R. Britt1, Rhone K. Akee1, 
James A. Whitt1, Jason R. Evans2, Paul G. Grothaus3, Jerry M. Collins3 and 
Barry R. O’Keefe3,4
1Natural Products Support Group, Leidos Biomedical Research, Inc., 
Frederick National Laboratory for Cancer Research, Frederick, Maryland 
21702, 2Natural Products Support Group, Data Management Services, 
Inc., National Cancer Institute, Frederick, Maryland 21702, 3Natural 
Products Branch, Developmental Therapeutics Program, Division of Cancer 
Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland 
21702, 4Molecular Targets Laboratory, Center for Cancer Research, National 
Cancer Institute, Frederick, Maryland 21702.
The Natural Products Repository (NPR) within the Natural Products 
Branch at NCI contains over 230,000 unique extracts derived from more 
than 75,000 plant, marine and microbial organisms. Importantly, this na-
tional resource is available to the research community for screening and 
isolation of crude extracts. However, compatibility issues that make them 
challenging for liquid handling systems, coupled with a high rediscove-
ry and false-positive hit rate, reduce the enthusiasm for high-throughput 
screening of whole extract libraries in targeted assays systems. Further-
more, the chemical complexity inherent to whole extracts may mask ac-
tive components present as minor metabolites. In order to address these 
limitations and make the Natural Products Repository more valuable to 
the extramural research community, we have developed methodology for 
the pre-fractionation of these whole extracts prior to biological testing. No-
tably, several marine, microbial and plant extracts examined in the NCI60 
cancer cell line screen showed enhanced biological activity after fractio-
nation. Additionally, these methods have recently been adapted for auto-
mation and high-throughput processing in order to build a library of pre-
fractionated natural products from over 100,000 extracts from the Natural 
Products Repository.
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3061
DETECTION OF HALOGENATED TRYAMINE AND 
TYROSINE DERIVATIVES IN EXTRACTS OF ALGOA BAY 
ASCIDIANS
Candice L. Bromley1, Andrea Raab2, Denzil Beukes3, Jörg Feldman2, Marcel 
Jaspars2 and Michael T. Davies-Coleman3
1Rhodes University, Grahamstown, South Africa, 2Marine Biodiscovery 
Centre, Department of Chemistry, College of Physical Sciences, University 
of Aberdeen, Old Aberdeen, AB24 3UE, Scotland (UK), 3University of the 
Western Cape, Cape Town, South Africa.
The crude organic extracts of ascidian species collected from Algoa Bay, 
South Africa were analysed using liquid chromatography with parallel in-
ductively coupled plasma mass spectrometry/electrospray mass spectrom-
etry (LC-ICP-MS/ESI-MS). The data obtained was used to detect a number 
of brominated and iodinated tyramine and tyrosine derivatives with in the 
ascidian extracts establishing this method as a powerful tool for the derep-
lication of halogenated metabolites in complex mixtures.
3062
A NOVEL NATURAL PRODUCT BLEND EXHIBITS 
SYNERGESTIC ANTIOXIDANT ACTIVITY
Wei Gao1, Mohan R. Kaadige1, Zhe Zhang1, Clinton J. Dahlberg1, John G. 
Babish1, Xiaolan Kou1, Matthew L. Tripp1
1Nature’s Sunshine, Lehi, UT 84043, USA 
Oxidative stress plays an 
important role in the deve-
lopment of many chronic 
diseases, such as metabolic 
syndrome and cardiovascular 
diseases. Antioxidants from 
foods and dietary supple-
ments help mitigate oxidative 
stress. The in vitro antioxidant 
activities of apple fruit, ber-
gamot orange, turmeric root 
and rhizome, green tea leaf, grape seed, grape skin, olive leaf, blueberry, 
capsicum and mangosteen pericarp extracts were studied individually and 
in combinations against reactive oxygen and nitrogen species. F105, a uni-
que mixture of these extracts displayed potent antioxidant synergy in these 
assays (Figure 1). 
3063
PROMISING NATURAL PRODUCTS AGAINST 
GLUCOCORTICOID RESISTANT ACUTE 
LYMPHOBLASTIC LEUKEMIA 
Fatima Rivas1*, Gustavo Palacios2, Taotao Ling1, Kara Anderson1, Roberta 
Marino2, Cynthia Jeffrey1 
1Department of Chemical Biology and Therapeutics. 2Department of 
Pathology. St. Jude Children’s Research Hospital, 262 Danny Thomas Place, 
Memphis, TN  38105-2794. 
Acute lymphoblastic leukemia (ALL) is one of the most common pedia-
tric cancers in developed countries. Although, ALL has a high cure rate 
(>94%), up to a quarter of patients relapse and at that stage their progno-
sis is poor. Refractory ALL cases are commonly associated with drug resi-
stance, particularly to glucocorticoid (GC) treatment, an integral compo-
nent of the therapy. Our main objective is to identify new compound leads 
from terrestrial natural products to serve as tool compounds and potential 
therapeutic agents. To evaluate hundreds of natural product fractions, we 
developed dexamethasone (Dex) pre-B resistant ALL stable cell lines. These 
Figure 1. Synergistic antioxidant activity of F105
Dex resistant cells were characterized via microarray gene expression and 
protein analysis to interrogate the glucocorticoid pathway. Using CellTiter 
Glow proliferation assay, we screened our natural product fractions against 
Dex resistant cell lines and PBMCs. Promising compound leads have been 
identified and we are current validating them. Our preliminary mechanistic 
studies on mode of action have focused on the jatrophone sesquiterpenoids 
and tripterine derivatives. These compound leads will provide insights into 
GC resistant ALL. 
3064
DISCOVERY OF 20-HYDROXYECDYSONE FROM 
XEROPHYLLUM ASPHODELOIDES (TURKEY BEARD) 
Dan Tian1, John R. Porter1
1Program in Pharmacognosy, Department of Chemistry & Biochemistry, 
University of the Sciences, Philadelphia, PA 19104 USA
Ecdysterone (20-hydroxyecdysone) is one of the key hormones in insects 
and crustaceans. A number of higher plants contain ecdysteroids. Phytoec-
dysteroids play a role in the chemical defenses of plants. We report the dis-
covery of 20-hydroxyecdysone 1 from Xerophyllum asphodeloides L. (Nutt.) 
collected from the NJ pinelands with a brine shrimp assay-guided fractio-
nation approach. The isolated 20-hydroxyecdysone showed modest activity 
(LD50 12.5 μg/mL) in the brine shrimp assay. The spectroscopic data agree 
with the reported data. This is the first report of the discovery of 20-hydro-
xyecdystone in X. asphodeloides.
3065
AMERICAN INDIAN BOTANICALS: POSSIBLE 
ALTERNATIVES TO HORMONE THERAPY DURING 
MENOPAUSE
Tristesse Burton1, Tareisha Dunlap1, Huali Dong1, Guannan Li1, Judy 
Bolton1, Djaja Soejarto1, and Richard B. van Breemen1
1UIC/NIH Center for Botanical Dietary Supplements Research, Department 
of Medicinal Chemistry and Pharmacognosy, University of Illinois at 
Chicago, Chicago, IL 60612
Although pharmaceutical hormone therapy (HT) remains the standard cli-
nical treatment for managing menopausal symptoms, many women seek 
alternatives such as botanical dietary supplements since HT has been asso-
ciated with increased risk of breast cancer, coronary heart disease and stro-
ke. The leading botanicals that women take for menopause are black cohosh 
and red clover, which were also traditionally used by American Indians. 
Although these two botanicals have been investigated extensively, there are 
still numerous American Indian plants that lack scientific studies on their 
safety and efficacy. Amorpha canescens Pursh. (Fabaceae) - leadplant, Echi-
nocystis lobata (Michx.) Torr. & A. Gray (Cucurbitaceae) - wild cucumber, 
and Silphium perfoliatum L. (Asteraceae) - cup plant inflorescent tissue 
were examined for estrogenic, chemopreventive, and anti-inflammatory 
potential in initial screenings based on American Indian ethnobotany and 
published biological data. Leadplant MeOH extract was selected as the best 
candidate for bioassay-guided fractionation due to high anti-estrogenic ac-
tivity in the Ishikawa cell-based assay and anti-inflammatory activity in the 
Griess assay. Cup plant and Lespedeza capitata Mixch. (Fabaceae) – round-
head lespedeza (chosen from the other 12 species) are being pursued as 
alternatives due to significant anti-estrogenic and estrogenic activity, re-
spectively. This project will identify possible novel and effective drug leads 
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for menopausal symptoms, cancer, and inflammation and provide support 
for American Indian traditional knowledge.
3066
ISOLATION AND STRUCTURE ELUCIDATION OF 
A POSSIBLE ANT TRAIL PHEROMONE, FROM 
EPOTHILONE B PRODUCING FERMENTATIONS OF 
SORANGIUM CELLULOSUM
Daniel Benigni1, Douglas Weaver1, John Baumes1, Jonathan Karten2, Mark 
Kosmoski1, Linda Phillips3
1 Bristol-Myers Squibb, Global Manufacturing and Supply, Syracuse, New 
York, 2Bristol-Myers Squibb Research and Development, New Brunswick, 
New Jersey, 3Research and Development, Lawrenceville, New Jersey
Sorangium cellulosum is a myxobacteria producing epothilone B. During 
the development of the process to purify epothilone B from fermentation 
of Sorangium cellulosum we identified a possible ant trail pheromone. The 
initial detection, isolation and structure elucidation of S-3,4-dihydro-8-hy-
droxy-3,5,7-trimethylisocoumarin will be presented as well as literature 
regarding its biosignificance. 
3067
MAGNOLIA BARK EXTRACT IS A POTENT NRF2 
ACTIVATOR
Arun Rajgopal, Steven R Missler, Samantha J Roloff, Jeffery D Scholten
Analytical Sciences, Amway 7575 Fulton street East, Ada MI 49355
Oxidative and xenobiotic stress have been shown to be causative agents 
for many diseases including cancer, age-related macular degeneration, car-
diovascular diseases, and age-related memory loss. Cells have protection 
mechanisms against these stressors, in part, through the activation of the 
Nrf2 pathway. Research suggests that promoting health resilience could 
be achieved by transiently activating the Nrf2 pathway through an intake 
of dietary phytochemicals in the absence of oxidative stressors. Magnolia 
(Magnolia officinalis) bark has been widely used in traditional Chinese 
medicine they are rich in Magnolol and Honokiol. Here, we demonstrate 
that magnolia bark extract stimulates the Nrf2 pathway in mammalian liver 
cells both by reporter and gene expression assay. We also show that Mag-
nolia bark helps protect cells against oxidative stress toxicity. We further 
carried out bioassay directed fractionation of the extract and show that the 
NRF2 activation is due to, in part, by the phytochemicals, magnolol and 4 
methoxy honokiol, present in the magnolia bark extract.
3068
K-TARGETED ISOLATION OF C-GLYCOSYLFLAVONES 
FROM VITEX AGNUS-CASTUS BY COUNTERCURRENT 
METHODOLOGY
Daniel M. Kulakowski1, Jonathon Bisson1, Shao-Nong Chen1, J. Brent 
Friesen1,2, and Guido F. Pauli1.
1University of Illinois at Chicago, Department of Medicinal Chemistry 
and Pharmacognosy, UIC/NIH Center for Botanical Dietary Supplements 
Research, Chicago, IL 60612, USA, 2Physical Sciences Department, Rosary 
College of Arts and Sciences, Dominican University, River Forest, IL 60305, 
USA.
C-glycosylated flavones, including orientin, isoorientin, vitexin, and isovi-
texin, are minor but biologically significant constituents of fruit extracts 
of the chaste-tree (Vitex agnus-castus L.), a botanical supplement used to 
treat PMS and postmenopausal symptoms. The partition coefficient, or 
K-value, is the ratio of the concentration of a compound in each phase of 
a biphasic solvent mixture and is a physicochemical property of a partic-
ular compound in a particular solvent system. This value can be used to 
predict retention volume (Vret) in a countercurrent separation procedure. 
The K-values of C-glycosylflavones present in complex botanical fractions 
have been determined in a number of solvent system families (HEMWat, 
EBWat, HterAcWat, terAcWat) using the shake-flask technique combined 
with relative LC-MS quantification. This K-value database has been used to 
develop targeted centrifugal partition (CPC) and high-speed countercur-
rent chromatography (HSCCC) methods. In each separation procedure the 
actual K value and Vret was reasonably predicted by the shake-flask partition 
experiment, confirming the utility of this approach in choosing a solvent 
system and targeting the fraction that contains the desired compound. This 
K-value database allowed for the efficient isolation of C-glycosylflavones 
from V. agnus-castus using orthogonal CCC and CPC methods.
3069
ANTIOXIDANT PROFILE AND HS-SPME/GC-MS-TOF 
ANALYSIS OF VOLATILE COMPOUNDS OF ALNUS 
ACUMINATA SSP. ARGUTA BARK.
María Isabel Aguilar, José Fausto Rivero-Cruz, Georgina Duarte-Lisci and 
Cristian Alvarado-López
Facultad de Química, Universidad Nacional Autónoma de México, Cd. 
Universitaria, D.F. 04510, México.
Alnus acuminata ssp. arguta (Schlecht.) Furlow (Betulaceae) (aile) is a widely 
used wild plant in the Mexican traditional medicine to treat acute inflamma-
tion, as astringent, antimicrobial and for treatments of syphilis. In vivo stu-
dies have demonstrated an anti inflammatory action and diarylheptanoids 
as components of the methanol extract of the stem bark. This extract exhibi-
ted antioxidant activity using four in vitro model systems: DPPH˙, ABTS˙+, 
FRAP˙ radical scavenging activities and inhibition of lipoperoxidation in 
β-carotene bleaching assay. Total phenol content of the methanol extract was 
determined using standard spectrophotometric methods (Folin-Ciocalteu, 
22.5 ± 1 mg GAE/g of stem bark) and IC50 values of 0.04 mg/mL and 0.2 mg/
mL in DPPH and ABTS assays were four fold lower and five fold higher than 
reference compounds respectively. In FRAP test, the extract showed weak an-
tioxidant activity, and good response in the β-carotene bleaching test. 
The volatile composition of Alnus acuminata stem bark was determined by 
solid-phase microextraction/mass spectrometry analysis. Forty three com-
pounds, among others, alcohols, aromatic compounds, terpenoids and ke-
tones were identified using this technique. The presence of antioxidant phe-
nolic compounds in this plant may justify some of its medicinal properties.
Objetivos particulares
• Determinación de los compuestos marcadores mayoritarios presentes 
en la corteza por CCF.
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• Determinación de fenoles totales por el método de Folin-Ciocalteu y 
por fórmula farmacopéica.
• Demostrar la capacidad antioxidante del extracto metanólico 
mediante los ensayos in vitro DPPH, ABTS, FRAP y blanqueamiento 
de b-caroteno de la materia vegetal para así complementar estudios 
científicos monográficos tipo OMS.
• Determinación de compuestos volátiles por el método HS-SPME-
GC-MS-TOF.
3070
DEVELOPMENT AND VALIDATION OF AN RP-HPLC-
PDA METHOD FOR QUANTIFYING JUGLALIN IN 
HYDRANGEA SEEMANNII PHYTOPREPARATIONS
Isabel Rivero Cruz, Daniel Peña García, Araceli Pérez, and Rachel Mata
Facultad de Química, Universidad Nacional Autónoma de México, Mexico 
City, 04510, Mexico
Hydrangea seemannii L. Riley (Hydrangeaceae) is a medicinal Mexican plant 
highly valued for the treatment of type II diabetes mellitus (TII-DM). Recent-
ly, we reported the antidiabetic action of an infusion of this plant and isolated 
the main active components, which included isoquercitrin, hyperoside, tri-
folin, guaijaverin, astragalin, and juglalin (kaempferol 3-O-α-L-arabinopyra-
noside). Hence, a suitable reversed-phase high-pressure liquid chromatog-
raphy-photodiode array detection (RP-HPLC-PDA) method was developed 
for quantifying juglalin, the marker compound. The mobile phase consisted 
of a linear gradient of water (containing 0.1% formic acid) and acetonitrile 
(ACN) of 95:5 (0 min) to 100 of ACN (15 min) at a flow rate of 1.2 mL min−1 
and the detection was carried out at 254 and 327 nm. The method was suc-
cessfully validated in terms of linearity, accuracy, precision, and detection and 
quantitation limits. This procedure is appropriated for quality control and 
elaboration of standardized phytopreparations of H. seemannii.
3071
ANTIOXIDANT ACTIVITY OF MORINGA OLEIFERA 
ISOTHIOCYANATES 
Patricio Rojas-Silva1,2, Tugba B. Tumer1,3, Alexander Pulev1, and Ilya 
Raskin1, and Carrie Waterman1
1Plant Biology Department, Rutgers, The State University of New Jersey, New 
Brunswick, NJ-USA. 2Center for Translational Research, School of Medicine, 
Universidad De Las Américas UDLA, Quito, Ecuador. 3Department of 
Molecular Biology and Genetics, Çanakkale Onsekiz Mart University, 
Çanakkale, Turkey.
Moringa oleifera Lam. (Brassicales) is an edible tropical tree with medicinal 
properties. Here, we describe a fractionation process of moringa leaves by 
fast centrifugal partition chromatography (FCPC) to generate polyphenol 
and isothiocyanate (ITC) rich fractions (Fig.1). The polyphenol-rich fraction 
showed direct antioxidant activity assayed by oxygen radical absorbance ca-
pacity (ORAC), while the ITC-rich fraction demonstrated indirect antioxi-
dant properties assayed by NQO1 activity in Hepa1c1c7 cells. Also, purified 
4-[(α-l-rhamnosyloxy) benzyl] isothiocyanate (ITC-1), and 4-[(4’-O-acetyl-
α-l-rhamnosyloxy)benzyl] isothio-cyanate (ITC-4) were evaluated for their 
ORAC and NQO1 inducer potency in comparison with sulforaphane (SF) 
at 5 µM (Fig.2). Both ITCs were as potent as SF in inducing NQO1 activity. 
These findings suggest that edible M. oleifera leaves contain a potent mixture 
of antioxidants that could explain its health promoting effects.
 
 
 
 
 
 
Fig. 1  Fig. 2  
 
3072
BRAZILIAN CERRADO BIOME PLANT EXTRACT BANK 
SCREENING IN INFLAMMATORY DISEASE AND 
CANCER ENZYMES
Laila S. Espindola1,2, Brice Wilson2, John A. Beutler2, Kirk R. Gustafson2, 
Barry R. O’Keefe2
1Laboratório de Farmacognosia, Universidade de Brasília, Brasília, Brazil 
2Molecular Targets Laboratory, National Cancer Institute / NIH, Frederick, 
MD, USA
A total of 702 extracts from the Brazilian Cerrado Biome Plant Extract Bank 
of the University of Brasília, Brazil - produced from 95 species represen-
ting 40 families were tested for inhibitory activity against p38 kinase and 
MALT1 protease. These enzymatic targets are implicated in inflammatory 
disease and B-cell lymphoma, respectively. Data from both assays were 
compared directly in order to identify those extracts with specificity for 
p38. This resulted in the identification of 13 extracts from 6 plant families 
(Annonaceae, Flacourtiaceae, Hippocrateaceae, Sapindaceae, Sapotaceae 
and Malpighiaceae) that showed specific p38 inhibition. These extracts 
were then eluted through polyamide resin to remove polyphenolic com-
pounds. Two extracts (Pouteria gardneri and P. ramiflora) lost their activity, 
but an additional extract maintained enzymatic inhibition following poly-
amide and continues to be investigated. Here we report initial results on the 
identification of natural product inhibitors of p38.
3073
AZAPHILONE MOLECULES FROM FRESHWATER 
DERIVED FUNGI
Vanessa M. Nepomuceno, Eoghainin O’hAinmhire, Joanna E. Burdette*, 
Brian T. Murphy*
Department of Medicinal Chemistry and Pharmacognosy, University of 
Illinois at Chicago
Ovarian cancer is the most lethal gynecological malignancy and the fifth 
leading cause of cancer death among women. This high mortality rate is 
due to difficult detection, unclear symptoms, and an absence of known 
precursor lesions. In addition, tumors that are initially responsive to che-
motherapeutics often become resistant. Thus, discovery of novel drug leads 
for ovarian cancer treatment is of paramount importance. To address this 
need, our lab focuses on secondary metabolites produced by microorga-
nisms in the aquatic environment as a source for new therapeutic leads. In 
particular, freshwater-derived fungi remain largely uninvestigated for novel 
chemical scaffolds. Hence, there is untapped potential in this environment 
for structural uniqueness. In the current study, a fraction library of se-
condary metabolites produced by freshwater-derived fungi were screened 
for potential selective toxicity against chemo-resistant ovarian cancer cells. 
Two new molecules of the azaphilone class have been identified from fun-
gal strain FJ015 in Lake Huron. Herein, we report the structure elucidati-
on of these metabolites by analysis of one- and two-dimensional nuclear 
magnetic resonance spectroscopy and high-resolution mass spectrometry. 
Details of the biological activity of these molecules will also be discussed.
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3074
A NEW BROMINATED INDOLE FROM HAPLOSCLERIDA 
WITH SELECTIVE CYTOTOXICITY AGAINST THE PANC-1 
TUMOR CELL LINE
Nicholas Lorig-Roach1, Tyler A. Johnson2, Fred A. Valeriote3, and Phillip 
Crews1
1Department of Chemistry and Biochemistry, University of California, Santa 
Cruz, CA, 95064, 2Dominican University of California, San Rafael, CA, 
94901 3Josephine Ford Cancer Center, Henry Ford Health System, Detroit, 
Michigan, 48202
An extract of a species of Haplosclerida sponge obtained from the National 
Cancer Institute repository displayed selective cytotoxicity to a pancreatic 
cancer cell line (PANC-1) relative to the CEM cell line in a disk diffusion 
assay. Two brominated indoles, the known 6-bromo conicamin (1) and the 
new 2’-oxo derivative (2) were identified via bioactivity guided fraction-
ation followed by accurate mass and NMR experiments. Upon purification 
of these initially co-eluting compounds, the new indole (2) was determined 
to be responsible for the cytotoxic activity of the extract. Its potency and 
breadth of activity are currently being evaluated.
3075
DRUG INTERACTION POTENTIAL OF MITRAGYNA 
SPECIOSA AND ITS CONSTITUENTS THROUGH PXR 
MODULATION
Shabana I. Khan1,2, Vamshi K. Manda1, Olivia R. Dale1, Zulfiqar Ali1, Larry 
A. Walker1,2, and Ikhlas A. Khan.1,2
1National Center for Natural Products Research, 2Department of 
Biomolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS 38677
The leaves of Mitragyna speciosa (kratum), which are rich in alkaloids, are 
traditionally consumed for the stimulant and euphoric effects and as a substi-
tute for opium. This study was conducted to predict the drug interaction po-
tential of kratum with concomitantly used conventional drugs by determin-
ing the effects of its methanolic extract, an alkaloid enriched fraction and the 
isolated constituents (indole and oxindole alkaloids) on pregnane X receptor 
(PXR)-mediated expression of drug metabolizing enzymes (CYPs) and trans-
porters (P-gp). A significant activation of PXR was observed with the extract 
and the alkaloid fraction with EC50 of 18 and 8 µg/mL, respectively. Several of 
the isolated constituents increased PXR activity with EC50 values in the range 
of 2-6 µM. A significant increase in the expression of mRNA for CYP1A2 and 
P-gp was observed by the total extract, alkaloid enriched fraction and eight 
of the isolated constituents while CYP3A4 mRNA was increased only by four 
constituents. These results indicate that chronic use or high consumption of 
Mitragyna speciosa may affect the pharmacokinetics and pharmacodynamics 
of co-administered drugs which are substrates of CYPs and P-gp by altering 
their metabolism and transport. Further in vivo studies are warranted.
3076
PHENOLIC COMPOUNDS FROM GLYCYRRHIZA 
URALENSIS (CHINESE LIQUORICE )
Zulfiqar Ali1, Ikhlas A. Khan1,2
1National Center for Natural Products Research, 2Division of 
Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, 
University of Mississippi, MS 38677
Glycyrrhiza uralensis has been used in Chinese traditional system of me-
dicine for many ailments. Over 20 phenolic compounds such as flavono-
ids, isoflavonoids, flavanoids, isoflavanoids, and coumarins conjugated 
with prenyl unit(s) were isolated from the methanol extract of G. uralensis 
and characterized by means of NMR and mass spectroscopic techniques. 
Herein, isolation and structure determination of purified compounds are 
described.
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3077
A NOVEL PIMARANE DITERPENE AND CYTOTOXIC 
ANGUCYCLINES FROM A MARINE-DERIVED 
ACTINOMYCETE IN VIETNAM.
Michael W. Mullowney,1 Eoghainín Ó hAinmhire,1,2 Urszula Tanouye,1 
Baojie Wan,3 Sanghyun Cho,3 Scott G. Franzblau,1,3 Joanna E. Burdette,1,2 
Pham Van Cuong,4 Brian T. Murphy1,2
1Dept of Med Chem & Pharmacognosy, COP, UIC, Chicago, IL, USA, 
2Center for Pharmaceutical Biotechnology, COP, UIC, Chicago, IL Illinois, 
USA, 3Institute for Tuberculosis Research, COP, UIC, Chicago, IL, USA, 
4Institute of Marine Biochemistry, Vietnam Academy of Science and 
Technology, Hanoi, Vietnam
A screening of our actinomycete fraction library against a cisplatin-resi-
stant ovarian cancer cell line (OVCAR5) led to the isolation of catbapima-
renone (1), lagumycin B (2), dehydrorabelomycin (3), phananthroviridone 
(4), and WS-5995 A (5). These compounds were produced by a Micromo-
nospora sp. isolated from sediment in the East Sea of Vietnam. Compounds 
2-4 were cytotoxic with LC50 values ranging from 0.34 µg/mL to 9.12 µg/
mL, while 5 exhibited selective cytotoxicity toward the Kuramochi cell 
line and 1 was inactive. Compound 1 is a novel Δ8,9-pimarane diterpene, 
representing one of approximately twenty actinomycete-produced diter-
penes reported to date while 2 has yet to receive formal characterization 
in the peer-reviewed literature. The 
structure elucidation of 1 and 2 was 
performed by combined NMR, MS, 
and CD spectroscopic analysis. The 
isolation and cytotoxicity of 1-5, as 
well as the structure elucidation of 1 
will be presented.
3078
ANTIMICROBIAL PROPERTIES AND CHEMICAL 
PROFILING OF THE ACESSORY NIDAMENTAL GLAND 
IN THE SQUID EUPRYMNA SCOLOPES
Samantha M. Gromek1, Anne A. Sung1, Allison Kerwin2, Andrea Suria2, 
Spencer V. Nyholm2, and Marcy J. Balunas1,*
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, 69 North Eagleville Road, Storrs, CT 06269, 
USA, 2Department of Molecular and Cell Biology, University of Connecticut, 
Storrs, CT 06269, USA
The Hawaiian bobtail squid, Euprymna scolopes, has served as a model for 
studying host-microbe interactions such as the light organ symbiosis with 
the bioluminescent bacterium Vibrio fischeri. We have previously charac-
terized the composition of the bacterial consortium found in the accessory 
nidamental gland (ANG), part of the reproductive system of the female 
host. Our continued research supports the hypothesis that bacteria from 
the ANG are deposited into the egg jelly coat (JC) where they produce 
antimicrobial secondary metabolites that protect eggs from harmful mi-
croorganisms and degradation throughout their embryonic period, during 
which time they are physically unprotected. Given that the ANG symbiosis 
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has naturally evolved to select for bacteria with antimicrobial properties, 
this provides a source of secondary metabolites that are more likely to have 
potent antibiotic activity. Bacterial isolates from the ANG and JC have 
been cultured and extracted, and have shown potent antibacterial activi-
ty against a suite of marine and human pathogens. Chemical networking, 
activity-guided isolation, compound identification, and biological activity 
of isolates will be discussed. Future studies will involve investigations of the 
mechanism(s) of antimicrobial activity and medicinal chemistry to probe 
structure-activity relationships. 
3079
FUNGAL METABOLITES AS NOVEL ANTHELMINTICS 
AGAINST SOIL-TRANSMITTED HELMINTHES.
Cedric Pearce1, Blaise Darveaux1, Huzefa Raja2 and Nicolas H. Oberlies2
1Mycosynthetix, Inc. Hillsborough, NC, United States; 2University of North 
Carolina Greensboro, Greensboro, NC, United States
It is estimated that over 2 billion people worldwide are suffering from com-
plications due to infections with soil transmitted helminthes (STHs), but 
very little research is being conducted by human health pharmaceutical 
companies. In the USA, it is estimated that in distressed areas of poverty, 
just under 4 million people harbor undiagnosed STH infections.Anthel-
mintic resistance to broad spectrum compounds has become a worldwide 
issue. Our initial goal was to screen a unique collection of filamentous fun-
gi and pure isolated fungus metabolites against Brugia malayi microfilaria, 
Haemonchus contortus L1 and Strongyloides stercoralis L3. We confirmed 
a number of active fungi against all three targets. Many of these active ex-
tracts were produced by cultures not previously shown to produce anthel-
mintic metabolites. De-replication procedures demonstrated metabolite 
novelty. Of the 90 pure compounds tested, we identified active metabolites 
against all three target species. One of the active pure compounds identified 
was enniatin D which belongs to a structure class known to have anthel-
mintic activity, thereby validating the approach.
3080
ASSESSMENT OF DRUG INTERACTION POTENTIAL OF 
ESCHSCHOLZIA CALIFORNICA (CALIFORNIA POPPY) 
THROUGH MODULATION OF CYPs, P-gp AND PXR 
Vamshi K. Manda1, Mohamed A. Ibrahim1, Olivia R. Dale1, Mallika 
Kumarihamy1, Stephen J. Cutler2, Ikhlas A. Khan1, 2, Larry A. Walker1,2, Ilias 
Muhammad1 and Shabana I. Khan.1, 2
1National Center for Natural Products Research, 2Department of 
BioMolecular Sciences, School of Pharmacy, University of Mississippi, 
University, MS 38677. 
Eschscholzia californica, a North American plant, is traditionally used for 
depression, neurasthenia, and various psychiatric conditions. With the ra-
pid rise in the use of herbal supplements in combination with conventional 
drugs, the risk for potential herb-drug interactions is also increasing. Most 
of the clinically relevant pharmacokinetic drug interactions occur due to 
modulation of Cytochrome P450 enzymes (CYPs), P-glycoprotein (P-gp), 
and Pregnane X receptor (PXR). This study aimed to determine the effects 
of an EtOH extract, BuOH and CHCl3 fractions and alkaloids of California 
poppy on the activity of CYPs, P-gp and PXR. The extract and fractions 
showed strong inhibition of CYP3A4, 2D6, and 2C19 and a weak inhibition 
of 2C9 and 1A2. Among the alkaloids, escholtzine inhibited 3A4, 2D6 and 
2C19 (IC50 3.0, 2.0 and 0.4 µM) and protopine inhibited 2D6 and 2C19 
(IC50 0.04 and 1.3 µM). No inhibition of P-gp was observed with the extract, 
fractions or its constituents. A significant activation (>2 fold) of PXR was 
observed with the extract and fractions (30 µg/mL) while the alkaloids were 
not as potent (>1.5 fold at 60 µM). Further studies are in progress to find 
out if the PXR activation would lead to an increased expression of drug me-
tabolizing enzymes and transporters (CYPs and P-gp). Acknowledgement: 
Supported by the National Institute of General Medical Sciences, NIH 
Grant Number P20GM104932.
3081
ANTIBIOTIC-PRODUCING BACTERIA ASSOCIATED 
WITH THE NESTS OF THE LEAF-CUTTING ANT Atta 
sexdens rubropilosa 
Eduardo A. Silva-Junior1,4; Camila R. Paludo1,4; Fábio S. Nascimento2; 
Cameron R. Currie3; Jon Clardy4; Mônica T. Pupo1
1Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de 
São Paulo, Ribeirão Preto, SP 14040-903, Brazil, 2Faculdade de Filosofia, 
Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão 
Preto, SP 14040-901, Brazil, 3University of Wisconsin, Madison, WI 53706, 
USA, 4Harvard Medical School, Boston, MA 02115, USA. 
The leaf-cutting ants are associated with bacteria that produce antibiotics 
to protect their colonies against invading microorganisms. Natural prod-
ucts produced by these bacteria were selected by ants during thousands 
of years of evolution and may be useful for drug discovery. We have been 
studying the antibiotic-producing bacteria associated with the nests of the 
leaf-cutting ants Atta sexdens rubropilosa. These bacterial strains isolated 
from the ants and the fungal garden inhibited the growth of the fungal gar-
den parasite Escovopsis sp. and the human pathogens Staphylococcus aureus 
ATCC 3538, Proteus mirabilis ATCC 29906 and Candida albicans ATCC 
10231. The antibiotics produced by these bacteria will be presented.
3082
IDENTIFICATION OF CELLULAR PROTEIN TARGETS OF 
SILYMARIN-DERIVED FLAVONOLIGNANS
Erica S. Lovelace1, Toni Kline2, Kathleen Olivas2, Jessica Wagoner1, Nicholas 
H. Oberlies3, Christophe Combet4, Lindsey N. Anderson5, Richard D. Smith5, 
Aaron T. Wright5, and Stephen J. Polyak1,2,6.
Departments of Laboratory Medicine1, Microbiology2, and Global Health6, 
University of Washington, Seattle, WA, 98104, 3Department of Chemistry, 
University of North Carolina, Greensboro, NC, 27412, 4INSERM, Lyon, 
France, 5Pacific Northwest National Laboratory, Richland, WA, 99354.
Silymarin, an extract of the seeds of milk thistle [Silybum marianum (L.) 
Gaertn. (Asteraceae)] protects liver cells from virus infection, oxidative 
stress, and inflammation. It was hypothesized that silymarin provides hepa-
toprotection by binding to cellular proteins. The hypothesis was addressed 
by establishing an affinity-based system for capturing, identifying, and vali-
dating the cellular proteins bound by the flavonolignan mixture silibinin, a 
major bioactive component of silymarin. Diazirine or diphenylketone pho-
toreactive groups and alkyne or azide moieties were chemically engineered 
onto eleven derivatives of silybin A or silibinin. Toxicity and anti-hepatitis 
C virus (HCV) activity testing of probes on human hepatoma cells indica-
ted that all probes had antiviral activity that was separable from compound-
induced toxicity. Probes were then used to capture cellular proteins from 
hepatoma cells. Mass spectrometry and statistical filtering revealed 26 pu-
tative cellular protein targets, which specifically bound to a photoaffinity 
probe. Binding of the probe to protein targets was dose-dependently inhi-
bited by silybin A. Descriptions of the putative targets, along with chemical 
validation of the interaction of silibinin with the targets, will be presented. 
The approach should permit further unraveling of the complex biology ari-
sing when cells encounter natural products.
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3083
A QUARTZ CRYSTAL MICROBALANCE STUDY OF 
GREEN TEA BINDING TO BOVINE SERUM ALBUMIN
Elsadig E. Ali1, Brian J. Doyle2, and Shannon J. Timpe1
1 Department of Mechanical Engineering, Bradley University, Peoria, IL, 2 
Departments of Biology and Biochemistry, Alma College, Alma, MI
The development of new label-free assays is important for furthering our 
understanding of biologically active chemicals in complex mixtures such 
as botanical extracts. A quartz crystal microbalance (QCM) can be used 
to measure the change in mass that occurs due to the binding of a ligand 
to a drug target protein when the protein is immobilized to the surface of a 
quartz crystal. In this study differences in binding to bovine serum albumin 
(BSA) between epigallocatechin gallate (EGCG), a natural polyphenol and 
the most abundant catechin in tea, and a crude green tea extract has been 
investigated using a QCM. The adsorption of EGCG and green tea onto a 
surface functionalized with BSA was measured at various concentrations. 
Langmuir and Freundlich isotherms were used to model the adsorption 
data. The Langmuir isotherm better described the adsorption behavior 
with correlations of 0.67 and 0.92 for EGCG and green tea, respectively. 
The better fit to the Langmuir model indicates that adsorption occurs ho-
mogeneously and that aggregation is negligible. Saturation was reached at 
0.24 ng/cm2 for EGCG and at 0.68 ng/cm2 for green tea. The increased ad-
sorption of the crude extract compared to pure EGCG indicates that EGCG 
is not the only chemical constituent interacting with BSA and that these 
constituents likely bind to additional sites since competitive binding is a 
non-dominant effect. However, the lower rate of adsorption observed for 
the crude extract indicates that there is some competition for binding to the 
EGCG binding sites. 
3084
IMMUNOMODULATORY DRUG DISCOVERY FROM 
TUNICATE-ASSOCIATED MARINE BACTERIA
Ashley M. West1, Ziyan Zhao2, Adam Zweifach2, Marcy J. Balunas1,*
1Division of Medicinal Chemistry, Department of Pharmaceutical Sciences, 
University of Connecticut, Storrs, CT 06269, USA, 2Department of 
Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, 
USA
There is a critical need for new immunomodulatory compounds, inclu-
ding immunosuppressants for use with organ transplantation or to treat 
autoimmune diseases, as well as immune adjuvants to enhance anticancer 
or antiviral immunity. We have employed a new phenotypic assay using 
cytotoxic T cells to identify two kinds of immunologically-relevant small 
molecules: immunosuppressive compounds that do not work via known 
cellular signaling pathways, and compounds that enhance the responses of 
cells stimulated through their T cell receptors, but do not affect cells in the 
absence of stimulation. Our library of tunicate-associated marine bacteri-
al extracts has been screened using this assay resulting in several extracts 
prioritized for further investigation. Bioassay-guided fractionation of one 
of the lead extracts has led to the isolation of a potent immune-enhancing 
compound (EC50 = 0.6 ng/mL). Compound identification and further bio-
logical analyses will be discussed. Future studies will include identification 
of molecular target(s) as well as optimization of compounds for potential 
preclinical development.
3085
ANTICANCER POTENTIAL OF WITHANOLIDES AND ITS 
DERIVATIVES FROM PHYSALIS PERUVIANA (POHA)
Mayuramas Sang-ngern1, Ui Joung Youn1, Eun-Jung Park1, Tamara P. 
Kondratyuk1, Gabriella Miklossy4, Marisa M. Walla2, Charles J. Simmons3, 
James Turkson4, John M. Pezzuto1, and Leng Chee Chang1
1Department of Pharmaceutical Sciences, Daniel K. Inouye College of 
Pharmacy, University of Hawaii at Hilo, Hilo, HI, USA, 2U.S. Department of 
Agriculture, Agricultural Research Service, U.S. Pacific Basin Agricultural 
Research Center, Hilo, Hawaii, USA, 3Department of Chemistry, University 
of Hawaii at Hilo, Hilo, HI 96720, USA, 4University of Hawaii Cancer 
Center, Honolulu, HI 96813, USA
Aberrantly active nuclear factor-κB 
(NF-κB) and signal transducer and ac-
tivator of transcription (STAT3) protein 
are critical factors that regulate tumor 
processes. Convincing evidence shows 
the association between NF-κB and 
STAT3 plays integrated role in promo-
ting cancer development. Consequently, 
inhibitors of NF-κB and STAT3 isolated 
from natural sources might be useful as 
novel anticancer therapeutics. Bioassay-
guided fractionation of the organic ex-
tracts from both the aerial parts and 
fruits of Physalis peruviana (Pp) led to the isolation of a series of witha-
nolides (WS) including a chlorinated withanolide. Among them, ten com-
pounds inhibited TNF-α-induced NF-κB activity with IC50 values in the 
range of 0.04– 31.2 μM. Seven isolated compounds inhibited nitric oxide 
(NO) production in lipopolysaccharide-activated murine macrophage 
RAW 264.7 cells with IC50 values in the range of 0.2 – 44.6 μM. The iso-
late, 4β-Hydroxywithanolide E, differentially inhibited the viability of all 
three cell lines, with 6-fold preferential effect against human tumor lines 
(U251MG and MDA-MB-231), with IC50 values of 0.3 and 0.1, respectively, 
compared to effects on normal NIH-3T3, with IC50 value of 0.6 μM. 
3086
SYNTHESIS OF FIRE ANT VENOM ALKALOIDS, 
DEHYDROSOLENOPSINS B & C 
H. M. T. Bandara Hereath, N. P. DhammikaNanayakkara
National Center for Natural Products Research, School of Pharmacy, 
University of Mississippi, University, MS 38677, USA.
Piperidine alkaloids are the major constituents of the venom of the impor-
ted fire ant, Solenopsis invicta. Even though the alkaloid fraction is mainly 
comprised of (2R,6R)-trans-2-methyl-6-alky- and 6– alkenylpiperidines 
small amounts of (2R,6S)-cis-analogs are also present. Several procedures 
have been reported for the stereospecific synthesis of (2R,6S)-cis- and 
(2R,6R)-trans-2-methyl-6-alkylpiperidine constituents. However, no pro-
cedure has so far been reported for the stereospecific synthesis of (2R,6R)-
trans-2-methyl-6-alkenylpiperidine constituents. We have developed a pro-
cedure for the stereospecific synthesis of the major (2R,6R)-trans-2-methyl-
6-alkenylpiperidine fire ant venom alkaloids, (2R,6R)-dehydrosolenopsin 
B and C. 
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3087
PHARMACOKINETIC, IN VITRO AND IN SILICO 
ASSESSMENT OF ANTI-INFLAMMATORY ALKALOIDS 
FROM ISATIS TINCTORIA L.
Matthias Hamburger1, Evelyn Jähne1, Veronika Butterweck2,3, Mouhssin 
Oufir1, Daniela Eigenmann1, Maxime Culot4, Roméo Cecchelli4, Fruzsina 
Walter5, Mária Deli5, and Martin Smiesko1
1Department of Pharmaceutical Sciences, University of Basel, Switzerland, 
2Department of Pharmaceutics, University of Florida, Gainesville, USA, 
3Pharma Technology, School of Life Sciences, Muttenz, Switzerland, 
4Université Lille Nord, Lens, France, 5 Biophysics, Hungarian Academy of 
Sciences, Szeged, Hungary.
We previously identified the alkaloids tryptanthrin (1), indirubin (2) and 
indolinone (3) as pharmacologically active compounds in woad (Isatis tinc-
toria L.). They inhibit COX-2, 5-LOX catalyzed leukotriene synthesis, and 
mast cell degranulation at low µM to nM concentrations, and they possess 
drug-like physico-chemical properties. A pilot pharmacokinetic study in 
rats (2 mg/kg i.v. b.w.) showed that 1 and 2 have half-lives of 30-40 min, 
whereas 3 was rapidly eliminated. In silico predictions for 1-3 indicated 
high oral absorption and favourable blood-brain transport. In animal and 
human in vitro blood-brain-barrier (BBB) models 1 and 3 displayed high 
BBB permeation. In the Caco-2 intestinal absorption model, 1 showed high 
permeation, while the recovery of 3 was low. 
 
 
    1  2   3 
3088
IN VITRO OPIOID RECEPTOR DISPLACEMENT AFFINITY 
AND IN VITRO BEHAVIORAL STUDIES BY TETRAD 
ASSAY OF NELUMBO NUCIFERA FLOWER
Mallika Kumarihamy1, Francisco Leon2, Sara Pettaway2, Janet Lambert2, 
Christopher Hill1, Mei Wang1, Lisa Wilson2, Christopher R. McCurdy2, 
Mahmoud ElSohly3, Stephen J. Cutler1,2, Ilias Muhammad1
1National Center for Natural Products Research, Departments of 
2BioMolecular Sciences and 3Pharmaceutics and Drug Delivery, School of 
Pharmacy, Research Institute of Pharmaceutical Sciences, University of 
Mississippi, University, MS 38677, USA
Nelumbo nucifera Geartn. (lotus), is a perennial aquatic plant native to 
South-East Asia. Both white and pink flowers are reported to have a calming 
effect when smoked or made into a tea. Bioassay-guided isolation and iden-
tification of from EtOH extracts revealed eight benzyltetrahydroisoquino-
line alkaloids, nuciferine (1), N-nor-nuciferine (2), asimilobine (3), arme-
pavine (4), O-methylcoclaurine (5), N-methylcoclaurine (6), coclaurine 
(7), and neferine (8), and as well as linoleic and palmitic acids. Compounds 
5-8 showed high percent of radioligand displacement in opioid receptors 
displayed various degrees of displacement activities. Based on the GTPγS 
functional agonist assay, neferine was determined to be a weak δ-agonist. 
The acidic and basic partitions, 1, 7 and mixture of 5-7 were subjected to 
mouse tetrad assay, of which the acidic partition displayed decreased loco-
motion, and increased catalepsy, hypothermia, and antinociceptive activi-
ty at doses of 75-100 mg/kg/ip. This work, along with traditional use and 
the reported bioactivities of the alkaloids, suggested further studies on N. 
nucifera are needed to understand the roles that the extracts or individual 
compounds might contribute to the behavioral effects. Acknowledgement: 
Supported by the National Institute of General Medical Sciences (NIGMS), 
NIH Grant Number P20GM104932, and COBRE, CORE-NPN, Research 
Core C. 
3089
LC-MS METABOLOMICS AND CHEMOTAXONOMY OF 
ILEX SPECIES
Adam Negrin1, Timothy J. Motley2, and Edward J. Kennelly1
1Department of Biological Sciences, Lehman College and The Graduate 
Center of the City University of New York, Bronx, NY, 10468, 2Department 
of Biological Sciences, Old Dominion University, Norfolk, Virginia, 23529
Ilex is a cosmopolitan monotypic genus in the Aquifoliaceae with centers of 
diversity in Asia and South America. Several species have been used tradi-
tionally in the preparation of medicinal teas for treating and preventing va-
rious ailments, while others are consumed primarily for their caffeine con-
tent. In order to assess the evolution of metabolites in caffeine-containing 
Ilex species, leaf samples of 41 Ilex species and hybrids were collected, pro-
cessed, and extracted for analyses by UPLC-TQD and UPLC-qToF mass 
spectrometry. Multiple reaction monitoring of compounds and their major 
mass fragments were developed to detect methylxanthines in leaf extracts 
at lower limits of detection between 1-10 ng/mL. Three methylxanthines 
(caffeine, theobromine, and theophylline) and the methyluric acid, theac-
rine, were quantified in I. guayusa, I. paraguariensis, and I. vomitoria. Ilex 
guayusa showed the highest content of caffeine, followed by I. paraguarien-
sis and I. vomitoria. Though there have been reports of caffeine content in I. 
cassine, we were not able to detect caffeine nor other methylxanthines using 
both UPLC-TQD-MS and UPLC-qToF-MS. Chlorogenic acid and three of 
its isomers were quantified to compare total chlorogenic acid content across 
all species in this study. The results showed that all caffeine-containing Ilex 
species also had high concentrations of chlorogenic acids. Ilex guayusa, 
I. paraguariensis, and I. vomitoria were compared with Ilex cassine using 
UPLC-qToF-MS and the data analyzed using PCA, OPLS-DA, and heat-
maps to visualize and identify differences in metabolite profiles among 
these species. The results revealed triterpenoid saponins as chemotaxono-
mically informative marker compounds in caffeine-containing Ilex species. 
3090
A MICROBIAL DRONE SYSTEM FOR TARGETING AND 
DESTROYING PSEUDOMONAS BIOFILMS
Josh Erickson, Garrett Heimann, Yudi Rusman and Christine E. Salomon
Center for Drug Design, University of Minnesota, Minneapolis, MN 55455 
Antibiotics are the primary methods of treatment for biofilm related infec-
tions. However, most antibiotics have significantly less potency against pa-
thogens in their biofilm growth state, which can be up to 1000 times more 
resistant to antimicrobial agents than their planktonic counterparts. There 
is clearly a need for new, biofilm-specific therapeutic approaches, and here 
we present the development of an engineered Lactococcus microbial drone 
that binds to and disrupts Pseudomonas aeruginosa biofilms. This probiotic 
can be combined with traditional natural products screening approaches to 
identify synergistic combinations of therapeutics. We will also present an 
improved flexible bioreactor for growing and testing reproducible, robust 
biofilms on a variety of clinically and industrially relevant surfaces. 
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3091
GREAT LAKES-DERIVED FUNGAL EXTRACTS YIELD 
COMPOUNDS TARGETING PEDIATRIC CANCER.
Corena V Shaffer1, Lin Du3,4, Wentao Dai3,4, April Risinger1,2, Pooja Sarkar1, 
Robert Cichewicz3,4, Susan Mooberry1,2
1Department of Pharmacology and 2Cancer Therapy & Research Center, The 
University of Texas Health Science Center at San Antonio, San Antonio, TX 
78229. 3Natural Products Discovery Group and 4Department of Chemistry 
and Biochemistry, University of Oklahoma, Norman, OK 73019.
There is an unmet medical need to identify more effective and less tox-
ic treatments for rare, but fatal childhood solid tumors including medul-
loblastoma, rhabdomyosarcoma, Ewing’s sarcomas and neuroblastoma. 
Fundamental to the success of improving therapies for pediatric cancers 
is the use of screening tools focused on the selectivity/specificity of dis-
ease-relevant targets. Tied to this is the need for source material that has 
chemical diversity and the ability to impact diverse biological pathways. To 
address this, we have initiated a project aimed at identifying fungal-derived 
compounds specifically targeting these childhood cancers. We screened 
fungal extracts acquired from diverse sediment layers of the Great Lakes 
which have until now, been an untapped resource for new fungal species. A 
screen, based on the SRB assay, was used to identify extracts with selectivity 
against a single type of pediatric cancer. Bioassay-guided fractionation was 
then used to isolate compounds with activity against these cancer types. 
Mechanistic studies are identifying the modes by which the compounds 
specifically inhibit childhood cancers.
3092
STRUCTURAL AND EVOLUTIONARY RELATIONSHIPS 
OF KETOSYNTHASE DOMAINS FROM MODULAR 
POLYKETIDE SYNTHASES
Jeremy R. Lohman1, Andrzej Joachimiak2, George N. Phillips, Jr.3, and Ben 
Shen4
1Department of Biochemistry, Purdue University, 175 S University St., 
West Lafayette, IN 47907, 2Midwest Center for Structural Genomics 
and Structural Biology Center, Biosciences Division, Argonne National 
Laboratory, 9700 South Cass Avenue, Building 202, Argonne, Illinois 60439, 
3Department of Biochemistry and Cell Biology, Rice University, Houston, 
Texas 77251, 4Departments of Chemistry, The Scripps Research Institute, 
Jupiter, Florida 33458.
To understand how the structures of ketosynthase domains (KS) from hy-
brid non-ribosomal peptide synthase-polyketide synthase (NRPS-PKS) 
and acyltransferase-less PKS (AT-less PKS) differ from the paradigm 
deoxyerythronolide B synthase (DEBS) we used sequence similarity ana-
lysis and high-throughput structural biology. DEBS-like PKS KS form a 
single similarity cluster and hybrid NRPS-PKS and AT-less PKS KS form 
distinct similarity clusters. Furthermore, AT-less PKS KS display multip-
le clusters that correlate with incoming substrates. Structures reveal that 
functional KS domains have identical catalytic residues. Three loops sur-
rounding the active site display unique orientations that correlate with the 
sequence clustering. Furthermore, residues in the substrate binging pocket 
correlate with incoming substrate. Together this information reveals how 
substrate specificity is determined by both large structural changes and 
subtle sequence variations. This information will be used to reprogram the 
biosynthetic pathways to enable combinatorial biosynthesis. We also reveal 
the structural evolution of a NRPS-PKS KS into an AT-less PKS KS.
3093
LCMS-BASED HIERARCHAL CLUSTERING AS A 
METHOD TO ASSESS BIOSYNTHETIC RELATIONSHIPS 
AMONG BACTERIA
Chris S. Thomas1, Gregory A. Ellis1, Doug Braun1, Adam Book2, Cameron 
Currie2, Tim S. Bugni*1
1Pharmaceutical Sciences Division, University of Wisconsin-Madison, 777 
Highland Ave., Madison, WI USA 2Department of Bacteriology, University 
of Wisconsin-Madison, Madison, WI USA
With the recent outpouring in whole genome sequencing technologies, 
natural product chemists now have greater access than ever before to the 
genomic information surrounding biosynthetic potential. The continued 
decrease in cost for whole genome sequencing holds great promise as a 
tool for prioritizing bacterial strains for drug discovery. Nonetheless, rapid 
methods to prioritize strains for discovery programs are still needed. We 
sought to investigate hierarchal clustering analysis (HCA) based on LCMS 
profiles as a method to evaluate metabolomic relationships among strains 
and examine how these relationships were reflected in genomes using who-
le genome analysis. To test this method, we analyzed a group of marine 
Streptomyces spp. using LCMS, and developed open-source workflows in R 
with XCMS to generate hierarchal clusters. We ensured clusters produced 
using R were comparable to clusters made using proprietary software. Trees 
from LCMS data were directly compared to 16S rDNA phylogenetic trees, 
and relationships between these clusters were investigated further using 
principal component analysis (PCA). A second group of Streptomyces spp. 
with whole genomes assembled were also analyzed by LCMS-HCA. The 
relationships identified based on metabolites were assessed in tandem with 
whole genome analysis. Overall, our LCMS-based HCA methods aim to 
assist the strain selection process for natural product drug discovery plat-
forms, and in addition can offer an alternative “pre-selection” tool to guide 
future genomic analyses.
3094
BIOCOMPATIBLE POLYMER DELIVERY OF BIOFILM 
DISRUPTORS OF VIBRIO CHOLERAE
F.P. Jake Haeckl2, Julia Blöhbaum1, Brian León2, Christopher J. Jones3, 
Andrew T. Cheng3, Walter M. Bray4, Fitnat H.Yildiz3, Roger G. Linington2
1Institute of Textile Chemistry and Macromolecular Chemistry RWTH 
Aachen University, Aachen, Germany, 52056, 2Department of Chemistry and 
Biochemistry, 3Department of Microbiology and Environmental Toxicology, 
4Chemical Screening Center, University of California, Santa Cruz, 1156 High 
Street, Santa Cruz, CA 95064.
Biofilms are large aggregates of bacterial cells that adhere to surfaces as a 
survival strategy against antibiotics and harsh environmental conditions. 
These aggregates contribute to up to 80% of microbial infections, parti-
cularly in cases where medical devices are required. In our lab, we have 
screened a large natural products library for the inhibition of biofilm for-
mation in Vibrio cholerae. From lead compounds we synthesized a library 
of analogs, the most promising of which is compound 1. Recently, we have 
developed a system whereby can deliver compound 1 via a polymer coating 
to delay colonization of V. cholerae on non-native substrates in both static 
and flow conditions. The biological data of this compound and its polymer 
delivery application will be presented.
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3095
THE ANTIDEPRESSANT-LIKE EFFECTS OF 
PAEONIFLORIN IN RATS MODEL EXPOSED TO 
CHRONIC RESTRAINT STRESS
Wei Li, Jingxia Wang, Yingli Zhu, Jianjun Zhang *
Beijing University of Chinese Medicine, 11 Beisanhuandonglu, Beijing, 
100029, China
The purpose of this sduty was to evaluate the antidepressant-like effects of 
paeoniflorin (PF) in a rat model of chronic restraint stress (CRS) and the 
possible active mechanisms. SD male rats were randomly divided into six 
groups which recorded as normal group, model group, fluoxetine group, 
paeoniflorin groups (10m/kg, 20mg/kg, 40mg/kg). The rats in the mod-
el group were prepared by CRS combined with radiation respectively for 
21 days and were fed separately. The results showed that CRS-exposed rats 
emerged depressive-like behaviour with reduced weight in open field test 
and step down test, low motor activity as well as reduced consumption of 
sucrose, with increased concentrations of CORT, ACTH in plasma and 
CRH in hypothalamus. Furthermore, the contents of NO and cGMP were 
reduced after PF treated by Griess and RIA methods seperately, and chang-
es with the mRNA expression of sGCα2
`
 sGCβ1
`
 PDE2A
`
 PDE5A
`
 PDE9A. 
These results suggest that the modulation of the HPA axis and cGMP syn-
thetase and hydrolases are important mechanisms underlying the antide-
pressant-like effects of paeoniflorin in CRS-treated rats.
3096
FLUORESCENT AZAPHILONOIDAL PIGMENTS FROM 
THE ENDOPHYTIC FUNGUS Biscogniauxia sp.
Mario Figueroa, Carlos A. Fajardo-Hernández, Osmaly Villedas, Luis R. 
Gómez-Lagunas, and Manuel A. Aparicio-Cuevas
Departamento de Farmacia, Facultad de Química, Universidad Nacional 
Autónoma de México, Mexico City 04510, Mexico
As part of our continuing search for novel cytotoxic fungal compounds, 
the entophytic fungus Biscogniauxia sp. (Xylariaceae) was isolated from a 
Bromelia species collected in the Ecological Reserve on the campus of the 
National Autonomous University of Mexico. Fungal identification was as-
sessed by nuclear ribosomal internal transcribed spacer (ITS) barcoding. 
The organic (CHCl3-MeOH) extract from the axenic solid (moisture rice) 
culture showed promising growth inhibition activity when tested at 20 μg/
mL against HCT-15 (colorectal) and HeLa (cervix) cell lines (96.5 and 96.3 
% of inhibition, respectively). Dereplication results of the organic extract by 
UPLC-PDA-HRESI-MS/MS against a database containing more than 200 
fungal secondary metabolites revealed the presence of the dimeric tetrahy-
droxanthone secalonic acid G. From this extract, a series of known and new 
fluorescent azaphilonoidal pigments were isolated. Their structures were 
elucidated using a set of spectroscopic and spectrometric techniques. In 
addition, these compounds were tested for antiproliferative activity against 
a panel of cancer cell lines.
3097
DEVELOPMENT OF SAFE AND EFFECTIVE BOTANICAL 
DIETARY SUPPLEMENTS
Richard B. van Breemen
UIC/NIH Center for Botanical Dietary Supplements Research, University of 
Illinois College of Pharmacy. 833 S. Wood Street, Chicago, IL 60612
Regulated differently than drugs or foods, the market for botanical dietary 
supplements continues to grow worldwide. The recently implemented US 
FDA regulation that all botanical dietary supplements must be produced 
using Good Manufacturing Practice is an important step toward enhanc-
ing the safety of these products, but additional safeguards could be imple-
mented, and unlike drugs, there are currently no efficacy requirements. To 
ensure a safe and effective product, botanical dietary supplements could 
be developed rigorously in a manner analogous to pharmaceuticals that 
involves identification of mechanisms of action and active constituents, 
chemical standardization based on the active compounds, biological stan-
dardization based on pharmacological activity, preclinical evaluation of 
toxicity and potential for drug-botanical interactions, metabolism of active 
compounds, and finally, clinical studies of safety and efficacy. Although not 
required, completing as many of these steps as possible would contribute 
to the translation of botanicals from the field to safe human use as dietary 
supplements.
3098
SCREENING FOR ANTIDIABETIC COMPOUNDS FROM 
GOJI BERRIES: IDENTIFICATION OF NOVEL SMALL 
MOLECULE PPARγ ACTIVATORS 
Chinni Yalamanchili1,2, Amar G. Chittiboyina1, Yelkaira Vasquez1,2, Shabana 
Khan1 and Ikhlas A. Khan1,2,3
1National Center for Natural Products Research, 2Divison of Pharmacognosy, 
Department of BioMolecular Sciences, The University of Mississippi, 
University, MS 38677, USA, 3Department of Pharmacognosy, College of 
Pharmacy, King Saud University, Riyadh, Saudi Arabia
The identification of novel antidiabetic PPARγ agents with lesser toxicity 
profile is of interest since the current PPARγ agonists, glitazones display se-
rious side effects including heart failure and edema. Goji berries are used in 
the traditional Chinese medicine for the treatment of diabetes mellitus and 
hypertension and sold in health food products in the western countries. 
The aim of our study is to identify new PPARγ agonists from Goji berries 
by in silico screening from Goji berries, a followed by in vitro testing. Cry-
stal structures of PPARγ with both partial and full agonist were used for in 
silico screening for higher predictivity. The in silico screening approach led 
to the identification of several small molecule amides having the favorable 
conformation in both partial and full agonist PDB structures. Subsequently, 
24 small molecule amides were synthesized and tested using in vitro lu-
ciferase reporter gene assay. Compounds CA-G-001, CA-G-008 and CA-
010 showed selectivity to PPARγ vs. PPARα and good fold activation when 
compared the positive control, Rosiglitazone. The details of in silico, in vitro 
results and other data will be presented. 
3099
EPIGENETIC MODIFICATION OF TAMPA BAY FUNGAL 
STRAIN PRODUCES NEW AND KNOWN COMPOUNDS 
ACTIVE AGAINST MRSA
Matthew A. Knestrick1,3, Danielle H. Demers1,3, Renee Fleeman2, Lindsey N. 
Shaw2, Bill J. Baker1,3
Departments of 1Chemistry, 2Cell Biology, Microbiology, and Molecular 
Biology, and 3Center For Drug Discovery and Innovation, University of 
South Florida, 4202 E. Fowler Ave., Tampa, FL 33620
In the face of increasingly resistant bacteria like the ESKAPE pathogens, 
there is a dire need for new and novel drug candidates. Marine fungal en-
dophytes live in harsh environments, producing secondary metabolites as 
a survival strategy. In the laboratory, production of secondary metabolites 
is often down-regulated. Epigenetic modifiers can be used to activate down 
regulated biosynthetic pathways to access a greater chemical repertoire. 
Following a high-throughput, epigenetic-based screen of mangrove endo-
phytic fungi, one fungal strain from the Tampa Bay area was identified for 
its activity against ESKAPE pathogen Staphylococcus aureus. It was grown 
in large scale and in epigenetically modified conditions. Its secondary me-
tabolites were extracted, and the fractionation and purification of extracts 
was guided by NMR. Epigenetic modification of the fungi caused the pro-
duction of new and known compounds with one new compound exhibi-
ting activity against S. aureus.
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3100
A BIOMIMETIC DIVERSITY-ORIENTED APPROACH TO 
THE PSEUROTINS
Arianne C. Hunter, Sean P. Abbott, Mallory J. Boucher and Indrajeet 
Sharma
Department of Chemistry and Biochemistry, University of Oklahoma, 
Norman, OK-73019
Pseurotins are a small family of secondary microbial metabolites isolated 
from the fermentation broth of Pseudeurotium ovalis. Pseurotin natural 
products possess a wide range of biological activities including inhibition of 
chitin synthase, inhibition of monoamine oxidase, antifungal, anti-angio-
genic, and dopamine antagonistic activity. Structurally, the pseurotin fami-
ly contains a highly substituted 1-oxa-7-azaspiro[4,4]non-2-ene-4,6-dione 
core (highlighted in red) that has been implicated in the biological activities 
of these natural products. Access to these natural products is limited due to 
poor fermentation yields or lengthy syntheses. To exploit therapeutic po-
tential of the pseurotins, we are developing a biomimetic approach to the 
pseurotin core structure starting from readily available amino acids. The 
biomimetic approach consists of three main features: i) Condensation of 
a β-ketoester 4 and an amino acid 5 to form an epoxide 3; ii) α-Acylation 
to form a diketone 2; iii) Nucleophilic ring opening of epoxide to form the 
spiro-core 1. 
3101
DEVELOPMENT OF A SENSITIVE AND RAPID HPLC 
METHOD FOR QUANTITATIVE MEASUREMENT OF 
GINKGOLIC ACID IN DIETARY SUPPLEMENTARYS 
Jing Li, Rahul Pawar, Alexander J. Krynitsky, Gregory O. Noonan. 
The Center for Food Safety and Applied Nutrition/U.S. Food and Drug 
Administration
Dietary supplements containing extracts of Ginkgo biloba are one of the 
most widely used supplements. These products are used for their purported 
benefit to improve cognitive functions, blood circulation and in manage-
ment of neurodegenerative conditions. The beneficial effects of extracts are 
primarily attributed to flavonoids and triterpene lactones. Ginkgolic acids, 
a group of structurally-related alkyl phenols, have been shown to have some 
negative health effects. The European Union currently limits the amount of 
ginkgolic acid in supplements to a level of 5 parts-per-million (ppm) or less. 
Recently, the National Toxicology Program reported that G. biloba extracts 
caused cancers of thyroid and liver in rats and mice models. In the light of 
this report, we intend to measure ginkgolic acids content of Ginkgo dietary 
supplements in US market. 
An HPLC-UV method using a biphenyl column was developed for the 
separation of three forms of ginkgolic acids (13:0, 15:1, 17:1). The samples 
were extracted by the QuEChERS method, in which the ginkgolic acids 
were partitioned in the acetonitrile layer, followed by HPLC-UV analysis. 
The developed method was validated for linearity, repeatability, accuracy, 
limits of detection, limits of quantitation and spiked recovery. The method 
successfully quantified total ginkgolic acid amounts below 5 ppm levels. 
Quantitative data on the ginkgolic acid content in the dietary supplements 
will be presented.
3102
CHEMOACTIVATION OF A BACTERIAL PROTEASE: 
EXPANDING THE MOLECULAR ARSENAL AND 
EXPLORING THERAPEUTIC POTENTIAL 
Gopal Peddabuddi, Jesse A. Coker, Cici Zhou, Nathan P. Lavey, Adam S. 
Duerfeldt
Department of Chemistry and Biochemistry, Institute for Natural Products 
Applications and Research Technologies (INPART), 101 Stephenson 
Parkway, University of Oklahoma, Norman, OK 73019
Bacterial caseinolytic protease P (ClpP) is a tetradecameric serine protease 
highly conserved across species. In a healthy bacterial cell, ClpP is respon-
sible for maintaining homeostasis through the highly regulated degradati-
on of misfolded, mistranslated, denatured, and obsolete proteins. In a strain 
dependent fashion, microbes rely upon properly functioning ClpP for se-
cretion, virulence, reproduction, pathogenicity, and/or survival. Therefore, 
it is not surprising that aberrant activation of this protease, which results in 
uncontrolled proteolysis, leads to detrimental bactericidal or bacteriostatic 
activity. This observation has catapulted ClpP into the spotlight as a promi-
sing new antibacterial target.
Although potent ClpP activators have been disclosed, the structural di-
versity is constrained to one natural product class, the acyldepsipeptides 
(ADEPs), and a limited collection of small molecules identified in high-
throughput screens of commercial libraries. Unfortunately, known ClpP ac-
tivators suffer from poor bioavailability, limited solubility, effluxation, and/
or metabolic weaknesses, which limit applicability and impede clinical uti-
lity. To allow for the continued exploration of ClpP as a potential therapeu-
tic target, and provide new chemical probes to investigate the role of ClpP 
in a variety of bacterial strains, our lab has integrated a multidimensional 
and collaborative approach to diversify the arsenal of ClpP activators. Pro-
gress towards this endeavor will be presented. 
3103
A VALIDATED METHOD FOR DETERMINATION OF 
CANNABINOID CONTENT IN DIETARY SUPPLEMENTS 
BY UPLC-MS
Jameson R. Lindberg and Holly E. Johnson
Department of Analytical Chemistry, Alkemist Labs, 1260 Logan Ave, Costa 
Mesa, CA 92626
Natural products containing cannabinoids derived from Cannabis sati-
va (L.), a medicinal plant with a long history of ethnobotanical uses, are 
now emerging as popular dietary supplements in the consumer market-
place. In spite of the ambiguous interpretation of the federal legal status, 
cannabinoid products are now readily available from online outlets and 
are increasingly being marketed by mainstream retailers. Many states have 
enacted legislation conferring various levels of legal status to Cannabis, 
and in recent months thirteen states have passed so called “low-THC” or 
“CBD-only” laws to allow widespread access to certain natural products 
that are less contentious in terms of the current Schedule I classification by 
the federal Controlled Substances Act. Although techniques exist for quan-
tification of cannabinoids in crude plant materials as well as in blood and 
urine, dietary supplements present analytical challenges due to complex 
matrices and the inherent variability of bioactive forms with oral delivery. 
Reported here is a validated method for rapid determination of cannabidiol 
(CBD), cannabidiolic acid (CBD-A), Δ9-tetrahydrocannabinol (THC), Δ9-
tetrahydrocannabinolic acid (THC-A) and cannabigerol using UPLC with 
detection by photo-diode array and single quadrupole mass spectrometry.
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3104
STUDY OF ANTIOXIDANT ACTIVITY OF AÇAÍ 
EXTRACTS (EUTERPE OLERACEA)
Greg Raner
Department of Chemistry and Biochemistry, University of North Carolina at 
Greensboro
Investigation of the potential health benefits of açaí to deliver effective 
strategies to treat or mitigate a variety of human ailments will require the 
identification of bioactive chemical constituents, identification of biologi-
cal targets and associated molecular mechanisms. Reductions in oxidative 
stress (OS) resulting from increased production of reactive oxygen species 
(ROS) can be achieved in living cells via two discrete mechanisms. One 
mechanism, critical to restoration of cellular homeostasis is the induction 
of cytoprotective anti-oxidant enzymes such as heme oxygenase-01 and 
NADPH quinine oxidoreductase to eliminate ROS. Induction of such cy-
toprotective enzymes is dependent on the Nrf2/ARE signaling pathway. 
Inhibition of toxicologically important cytochrome P450 enzymes such 
as CYP2A6, CYP2B6, CYP1A1 and CYP2E1 involved in ROS generation 
presents yet another potential strategy to reduce OS. The current study uti-
lizes a novel bioassay-guided fractionation on açaí berry to study the (a) 
induction of anti-oxidant enzymes via the Nrf2/ARE signaling pathway in 
cultured HepG2 cells and (b) inhibition of CYP2A6, CYP2B6, CYP1A1 
and CYP2E1 using individually expressed human liver P450s in vitro. Our 
results indicated the presence of bioactive constituents in açaí with a poten-
tial to modulate Nrf2/ARE signaling pathway and subsequent induction of 
cytoprotective phase II enzymes. Açaí has also been found to have inhibi-
tory constituents towards CYP2B6 and CYP1A1, along with a host of other 
human P450 isoforms. Interestingly, some of the fractions were found to be 
active in both the experimental models indicating possible potentiating or 
synergistic effect. This study promises the identification of cytoprotective 
constituents of açaí and associated mechanisms of action.
3105
META- APPROACHES TO HARVEST NATURAL 
PRODUCTS FROM HARMFUL ALGAE BLOOMS.
Charlotte Gény1, Guy Carter2 and Mark T. Hamann1
1Department of BioMolecular Sciences, School of Pharmacy, University of 
Mississippi, University, MS 38677, USA, 2Biosortia Pharmaceuticals, 565 
Metro Place South, Suite 300, Dublin, OH 43017, USA.
In 2009, Ross Youngs established the 
company Biosortia Pharmaceuticals 
based on a new harvesting technique 
utilizing microalgae natural products 
chemistry to overcome the lack of 
efficiency of drug discovery. This ap-
proach has focused on the micro-algal 
consortia using a meta-metabolomics 
and a mega-scale approach. 
Global warming and rising CO2 con-
centrations in the atmosphere play a 
principal role in intensifying phytoplankton blooms in eutrophic and hyper-
trophic lakes. Harmful algae blooms have pivotal ecological and economical 
impacts because of the toxic secondary metabolites produced by algae-rela-
ted microorganisms . However, these metabolites ironically can also serve as a 
source of new drug leads or in the construction of new drug leads.a 
Biosortia has developed a unique harvesting technology capable of acquiring 
a large quantities of biomass containing a wide diversity of microorganisms 
grown under stress conditions originating from the environmental compe-
tition during a bloom where gene mutations and evolution in the related 
microorganisms are promoted.b These approaches may provide access to 
new complex biology and chemistry. A preliminary screening has already 
revealed several promising hits for treatment of various diseases including 
cancer, neurological diseases, metabolic diseases, infectious diseases, and 
antiparasitic. This uncommon protocol of discovering new natural products 
may offer new drug-like molecules for many disease targets.
aPenn, K. et al. ISME J 2014, 8 (9), 1866-1878. bUchiyama, J. et al., Photosynth 
Res 2015, 1-12.
3106
ANALYSIS OF COUMARIN AND OTHER COMPOUNDS 
IN COMMERCIALLY AVAILABLE CINNAMON AND 
CINNAMON SUPPLEMENTS UTILIZING QUANTITATIVE 
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
K. Brian Killday1, Michelle A. Markus1, Christian Fischer2 and Kimberly L. 
Colson1
1Bruker BioSpin, Billerica, MA, USA, 2Bruker BioSpin GmbH Rheinstetten, 
Germany
Cinnamon is an important flavoring agent utilized worldwide. The dried 
inner bark of Cinnamomum verum (Ceylon cinnamon) is referred to as 
“true” cinnamon whereas the barks of C. cassia (Chinese cassia), C. bur-
mannii (Indonesian cassia), and C. loureiroi (Saigon cassia) (collectively 
known as cassia cinnamon) are also marketed as cinnamon. Because of its 
lower cost, Cassia cinnamon and, in particular, Indonesian cassia has re-
placed Ceylon cinnamon as the species most widely used in the food and 
beverage industry in the United States, Canada, and Europe.1 Cassia cin-
namon has been shown to contain high levels of the naturally occurring 
compound coumarin, which can be hepatotoxic to individuals sensitive 
to it. Because of this, the European Union has set regulatory limits on the 
amount of coumarin allowed in cinnamon containing foods. A number 
of clinical trials have shown cassia cinnamon to have modest antidiabe-
tic activity. As a result, there are currently many dietary supplements on 
the market containing both true and cassia cinnamon. Supplement labels 
contain suggested usage levels from 1 gram up to 4 grams of cinnamon per 
day. The amounts of coumarin and other marker compounds in cinnamon 
bark, powder, foods, and supplements have previously been analyzed with 
a validated UPLC-UV/MS method.1 We are in the process of developing 
an automated high throughput NMR method to quantitate coumarin and 
other key components in cinnamon containing products. Results with va-
rious commercial cinnamon samples and supplements will be presented.
1Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IA. J. Agric. Food. 
Chem. 2013; 61, 4470-4476.
3107
NOVEL QUASSINOID FROM JAMAICAN CASTELA 
MACROPHYLLA BLOCKS INDUCTION OF CYTOCHROME 
P450 1 ENZYMES AND LUCIFERASE GENES
Rupika Delgoda1, Suneel K Kandagatla 2, Greg Ranor2, Eileen Brantley3, 
Simone Badal1, Sheena Francis1, Helen Jacobs4
1Natural Products Institute, University of the West Indies, Mona, Jamaica 
West Indies, 2 Department of Chemistry and Biochemistry, University of 
North Carolina at Greensboro, Greensboro, NC 27402, USA 3Department 
of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, 
California, 92350, USA, 4Department of Chemistry, University of the West 
Indies, Mona, Jamaica West Indies
In this study we investigated the potential for a novel quassinoid, 
glaucarubulone-15-O-β-D-glucopyranoside (Gg) isolated from the endemic 
Jamaican Castela macrophylla plant to inhibit cytochromes P450 (CYPs), in 
particular CYP1A1 and CYP1B1 enzymes, known to convert polyaromatic 
hydrocarbons (PAHs) into carcinogenic metabolites. Gg attenuated by nearly 
70-fold, the ability of PAH, benzo-a-pyrene(B[a]P) to induce CYP1A gene 
expression in MCF-7 breast cancer cells as determined by real-time RT-PCR. 
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Gg was also shown to directly inhibit the enzyme activity of human CYP1A1 
and CYP1B1 enzymes (IC50, 6.93 ± 0.31µM and 9.17 ± 0.91µM respectively) 
according to non-competitive kinetics. Given the ability of Gg to block the in-
duction of phase I gene expression, we investigated its effects on antioxidant 
response element (ARE)-dependent induction by crude acai berry fractions. 
Where acai_92H at 50µg/mL caused an approximate five- to seven-fold in-
duction of luciferase gene expression, the inclusion of Gg reduced the induc-
tion to below two-fold over the entire range of concentrations, and at 250 
nM Gg, complete loss of induction was observed. Taken together, these data 
suggest that the plant isolate Gg may be an interesting candidate to provide 
insights into mechanisms of cellular transcription. 
3108
PENICILLIUM CHRYSOGENUM, AN ENDOPHYTE 
FROM PADINA GYMNOSPORA, AS A SOURCE OF 
DIKETOPIPERAZINES, PEPTIDES AND GRISEOFULVIN
T de JASAndrade1,2, A Somensi2, AR Araújo2, M Jaspars3, DHS Silva2
1IFPI, Pr. Liberdade 1597, Teresina PI, Brazil 2Institute of Chemistry, 
UNESP, 14800 – 060, Araraquara, SP, Brazil 3Marine Biodiscovery Centre, 
University of Aberdeen, Scotland, UK
Endophytic fungi tend to live within the host organism over its entire life. 
Once associated, the fungi alter nutrient content and enhance or begin 
production of secondary metabolites which may play important roles in 
adaptation, defense against predators and represent an important source 
for bioprospection. Fungi from marine organisms have been shown to pro-
duce a variety of bioactive compounds and some are currently under de-
velopment as antitumoral, anti-inflammatory agents among others. Padina 
gymnospora is a brown alga collected in the Brazilian southeast coast which 
afforded a fungal strain identified as Penicillium chrysogenum. Its crude 
extract afforded nucleotides, diketopiperazine derivatives in addition to 
griseofulvin and 7-dechorogriseofulvin. The secondary metabolites iden-
tification was carried out mainly by ESIMS, NMR analyses and search in 
Antimarin2011®, MarinLit® and ChemSpider® databanks. In addition, their 
antiinflammatory activities were investigated and the results evidenced the 
dose-dependent inhibition of NO overproduction by hirsutatin A, a cyclo-
hexadepsipeptide obtained from P. chrysogenum extract and previously iso-
lated from the insect pathogenic fungus Hirsutella nivea.
3109
ABSOLUTE CONFIGURATION ASSIGNMENT OF 
REMOTELY SEPARATED ALCOHOLS BY THE CSSF-
TOCSY-INEPT EXPERIMENT
Lu Yang, R. Thomas Williamson
Merck Research Laboratories, Process & Analytical Chemistry, NMR 
Structure Elucidation, Rahway, NJ 07065, USA.
Natural products containing remotely separated secondary alcohols widely 
exist in marine and terrestrial organisms. Absolute stereochemistry assign-
ment of these alcohols by NMR spectroscopic methods remains challeng-
ing. This is mostly because the severely overlapping resonances flanking 
the stereocenters invalidate the conventional Mosher analysis. Herein, our 
recently developed 1D selective NMR experiment, CSSF-TOCSY-INEPT, 
has provided a convenient solution to the stereochemistry of these alcohols. 
It is achieved via chemical shift selective (CSS) excitation of the oxygenated 
methine signals, followed by TOCSY and INEPT transfer to generate the 
13C NMR subspectra of all carbon segments subtended at each stereogen-
ic center. 13C subspectra consolidation and the extract of anisotropic shift 
(Δδ) from (R) and (S)-Mosher esters allow the simultaneous configuration 
assignment of all alcohols. The new approach is unrestricted by the distance 
between the remote alcohols and also effective for polyhydroxylated com-
pounds, which make it an attractive and unique tool for structure elucida-
tion of macrolide, acyclic lipids, etc.
3110
ISOLATION OF ACACETIN FROM CALEA URTICIFOLIA 
AS A POTENT INHIBITOR OF HUMAN MONOAMINE 
OXIDASE-A AND B
Narayan D Chaurasiya1, Vedanjali Gogineni2, Francisco Leon2, Marvin J 
Nuñez3, Stephen J. Cutler2, Larry A Walker1,2 and Babu L Tekwani1,2
1National Center for Natural Products Research and 2Department of 
BioMolecular Sciences, School of Pharmacy, The University of Mississippi, 
University, MS 38677, USA. 3Laboratorio de Investigacion en productos 
Naturales, Facultad de Quimica y Farmacia, Av. Heroes y martires del 30 de 
Julio, San Salvador, El Salvador.
Calea urticifolia (Asteraceae: Asteroideae) has long been used as a traditio-
nal medicine in El Salvador to treat arthritis, fever among other illnesses. 
Phytochemical investigations revealed the presence of sesquiterpene lac-
tones, predominantly germacranolides. The chloroform extract of aerial-
parts of C. urticifolia showed potent inhibition of recombinant human 
MAO-A and -B. Further bio-assay guided fractionation led to the isolation 
of a flavonoid, acacetin, as the most prominent MAO inhbitory constituent. 
Acacetin is a promising neuromodulator with significant affinity towards 
serotonin receptors. Follow-up studies showed reversible binding of acace-
tin with human MAO-A and -B resulting in competitive inhibition. Acace-
tin was about 4 fold more selective towards MAO-B compared to MAO-A. 
The results indicate potential for development of acacetin for treatment of 
psychiatric disorders.
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3111
HEAVY METALS IN BACOPA INGREDIENTS COLLECTED 
FROM THE MARKET IN EUROPE, INDIA AND THE 
UNITES STATES
Maged H. M. Sharaf1, Andrew Blank2, and Brandon Podhola2
1American Herbal Products Association, Silver Spring, MD 20910, 2Nature’s 
Way Brands, Green Bay, WI 54311, USA
Bacopa monnieri (L.) Pennell (Scrophulariaceae) is a creeping, prostrate, so-
mewhat succulent perennial that grows in moist environments. Bacopa is an 
important plant in the traditional Indian systems of medicine (Ayurveda, 
Siddha, and Unani). Traditionally, the entire plant is used as a brain tonic to 
enhance memory, development, learning ability, and concentration. Bacopa 
is gaining popularity worldwide and is classified as dietary ingredient under 
the U.S. Dietary Supplement Health and Education Act of 1994 (DSHEA). 
Bacopa has also been recommended as an agent for phytoremediation be-
cause of its ability to accumulate heavy metals from contaminated soils. Con-
cerns were raised following a 2013 article published in Planta Medica that 
claimed elevated levels of Cd, Pb, Cu, and Zn in all tested bacopa plant samp-
les collected from peri-urban areas in India.
We analyzed 75 samples of bacopa plant material and extracts acquired from 
14 companies in Europe, India, and the United States. This presentation will 
summarize the results of this market study, which refute the results of the 
2013 article. 
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3112
NOVEL BOTANICAL EXTRACTS AND SMALL 
MOLECULE INHIBITORS FOR AFRICAN SLEEPING 
SICKNESS, CHAGAS DISEASE, AND VISCERAL 
LEISHMANIASIS
Jeannie M Stubblefield1,3, Alexis M Gross1,3, Anuradha L Pathiranage1,2, 
Matthew Wright1,2, Norma Dunlap1,2, Scott Handy1,2, Anthony L Newsome1,3
1Department of Biology, Middle Tennessee State University, Murfreesboro, 
TN 37132, USA, 2Department of Chemistry, Middle Tennessee State 
University, Murfreesboro, TN 37132, USA, 3Tennessee Center for Botanical 
Medicine Research, Middle Tennessee State University, Murfreesboro, TN 
37132, USA.
Three of most devastating neglected tropical diseases - African Sleeping 
Sickness, Chagas Disease and the Leishmaniases - are caused by vector-
borne, flagellated protozoa. An estimated 30,000 people are infected and up 
to 70 million are at risk of developing African Sleeping Sickness. Chagas Di-
sease affects an estimated 7-8 million people primarily in Latin and South 
America, and is also classified as an emerging infectious disease threat in 
the United States. The Leishmaniases affect 10-12 million people in almost 
100 countries. These diseases can be extremely debilitating and even fatal 
if untreated. However, current drug therapies have significant issues with 
toxicity and there are growing concerns about developing resistance. In this 
study, botanical extracts from plants that are used in traditional Chinese 
medicine were screened for inhibitory activity against the bloodstream 
form of T. brucei. Selected extracts were fractionated based on bioactivity 
to identify active pure compounds. In addition, a library of small molecules 
was synthesized to probe the structure of a botanically-derived compound 
with known anti-microbial properties. Selected extracts and compounds 
with low toxicity were further screened against the intracellular forms of T. 
cruzi and L. donovani. These screens identified several novel compounds 
with IC50 values in the low micromolar range and low cytotoxicity that have 
potential to be developed into new drug therapies for these diseases.
3113
STRUCTURE ELUCIDATION OF A PROTON-DEFICIENT 
NATURAL PRODUCT USING LR-HSQMBC SUPPORTED 
BY DFT CALCULATIONS
Josep Saurí1, Susanna T.S. Chan2, Alexei V. Buevich1, Kirk R. Gustafson2, R. 
Thomas Williamson1 and Gary E. Martin1
1NMR Structure Elucidation, Process & Analytical Chemistry, Merck and 
Co., Inc., Rahway, NJ 07065, 2Molecular Targets Laboratory, Center for 
Cancer Research, National Cancer Institute, Frederick, MD 21701.
A severely proton-deficient marine alkaloid (C28H21N7O2) was intractable 
to structural characterization using only conventional 1D and 2D NMR 
techniques including HMBC data, which generally provides primarily 
two- and three-bond correlations. A sensitive, complementary approach 
to obtain very long-range (≥ 4JCH) heteronuclear correlations is afforded by 
the recently reported LR-HSQMBC experiment. An INEPT pulse sequence 
element inserted after t1 evolution, converts anti-phase long-range hetero-
nuclear coupling information back into in-phase magnetization thereby 
alleviating cancelation of responses emanating from small (<2 Hz) scalar 
couplings. The role of the LR-HSQMBC experiment in the determination 
of this natural product structure will be illustrated.
LR-HSQMBC data were employed to gain access to numerous 4JCH and se-
veral 5JCH heteronuclear coupling pathways that were pivotal in linking tog-
ether segments of the alkaloid structure, which could not be accomplished 
solely relying on HMBC data. The observed 4JCH and 5JCH heteronuclear 
couplings were reasonable and consistent with DFT calculation of the cou-
pling constants and chemical shifts performed on the proposed structure 
of the alkaloid. The structure was also consistent with the results generated 
using the ACD Structure Elucidator CASE program.
3114
EXTENDING THE STRUCTURAL DIVERSITY OF A 
MARINE DERIVED FUNGUS SPICARIA ELEGANS KLA03
Dehai Li, Rui Liu, Zhenjian Lin, Hongjuan Wei, Fazuo wang, Yepeng Luan, 
Tianjiao Zhu, Qianqun Gu
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School 
of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, 
People’s Republic of China.
Marine derived fungi are a powerful resource to produce unique bioactive 
structures. Although thousands of compounds with various chemical struc-
tures have been disclosed, most of the gene clusters encoding secondary 
metabolites are silent under a single culture condition. To maximize the 
chemical diversity of fungal metabolites, the so called “OSMAC” approach 
has been used on the marine sediments derived fungus Spicaria elegans 
KLA03. Including the original isolated cytochalasins Z9-Z15 (glucose based 
medium under static conditions), fourteen new polyketides of this family 
were further isolated including spicochalasin A and aspochalasins M-Q (st-
arch and soybean based medium upon shaking for 8 days), 7-deoxy-cyto-
chalasins Z7 and Z9 (adding a cytochrome P-450 inhibitor to glucose based 
medium under static conditions), aspochalasins R-T (starch and soybean 
based medium, shaking for 14 days), and cytochalasins Z21-Z23 (adding D- 
and L-tryptophan to glucose based medium, static conditions), as well as 
eleganketal A possessing a rare substituted 3H-spiro[isobenzofuran-1,3’-
isochroman]-4’(1’H)-one skeleton. In addition, spicarins A-D were also 
discovered from the acetylated extract of this strain. 
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3115
DE NOVO SYNTHESIS OF A VERTEBRATE SUNSCREEN 
COMPOUND
Andrew R. Osborn,1 Khaled H. Almabruk,1 Garrett Holzwarth,2 Shumpei 
Asamizu,1 Jane LaDu,3 Kelsey M. Kean,4 P. Andrew Karplus,4 Robert L. 
Tanguay,3 Alan T. Bakalinsky,2 and Taifo Mahmud1
1Department of Pharmaceutical Sciences, 2Department of Food Science 
and Technology, 3Department of Environmental and Molecular Toxicology, 
and 4Department of Biochemistry and Biophysics, Oregon State University, 
Corvallis, OR 97331, USA.
Current paradigms suggest that gadusol, a sunscreen and antioxidant found 
in fish, is derived from 4-deoxygadusol, a precursor of mycosporine-like 
amino acids produced by cyanobacteria, fungi, algae, and marine inverte-
brates. The accumulation of these compounds in marine animals has been 
proposed to be of dietary or symbiont origin. Here, we report that gadusol 
is synthesized de novo in zebrafish (Danio rerio) from a pentose phosphate 
pathway intermediate, sedoheptulose 7-phosphate, by a novel two-enzyme 
system, a 2-epi-5-epi-valiolone synthase (EEVS) and a methyltransferase-
oxidoreductase (MT-Ox). Heterologous expression of the fish genes in en-
gineered yeast resulted in the production of gadusol in yeast. The product 
suppresses the UVB-sensitivity of a rad1∆ mutant of Saccharomyces cerevi-
siae, confirming the UVB-protective activity of gadusol. 
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3116
REBIOGRAM ENHANCES THE SEARCH OF BIOACTIVE 
NATURAL PRODUCTS
Shao-Nong Chen,1,2,3 J. Brent Friesen,1,3,4 James B. McAlpine,1,3 Cassia R. 
Overk,1,2 Judy L. Bolton,1,2 Guido F. Pauli1,2,
1Department of Medicinal Chemistry and Pharmacognosy, 2UIC/
NIH Center for Botanical Dietary Supplements Research, 3Institute for 
Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, 
Chicago, IL 60612, 4Physical Sciences Department, Rosary College of Arts 
and Sciences, Dominican University, River Forest, IL 60305
Finding active component(s) from natural sources using traditional chro-
matographic methods is a time consuming and tedious task. Especially with 
solid support material, potential loss due to irreversible absorption cannot 
be avoided during the separation procedure. In contrast, countercurrent 
separation (CCS), a liquid-liquid chromatography, can achieve loss free se-
paration as it does not apply solid support material. This special characte-
ristic deserves more attention when searching for bioactives from complex 
natural sources via bioassay guided fractionation (BGF) procedures. Con-
sidering recent progresses in CCS methodology, a considerable amount of 
sample can be loaded into a centrifugal partition chromatography (CPC) 
instrument with a single injection. ReBioGram is a new approach that en-
hances BGF for the search of bioactive natural products. It takes full ad-
vantage of CCS ability to swap the mobile phase in two separated runs to 
generate a pair of fractions that are exact normal- and reserved-phase mir-
ror images of each other in K-plot. Almost a symmetric ReBioGram could 
be delineated based on bioactivities of these fractions, which could be used 
further to validate and prioritize active fraction. 
Pueraria montana var. lobata (Willd.) (PL) has an isoflavone profile similar 
to that of Trifolium pratense (L.) (TP). However, the content of active com-
ponents in PL is much lower than in TP. Guided by the alkaline phospha-
tase in Ishikawa cell assay, and using CPC fractionation and HPLC purifica-
tion, we demonstrate the efficiency of ReBioGram method in the isolation 
of active component (ca 0.2 mg) from a DCM extract of PL aerial parts in 
just two separation steps.
3117
NEW AND KNOWN MANDELALIDES FOR BIOLOGICAL 
MECHANISM AND STRUCTURE-ACTIVITY 
RELATIONSHIP STUDIES 
Mohamad Nazari1, Kevin Snyder2, H.C. Paul Cheong2, Justyna Sikorska1, 
Jeffrey D. Serrill1, Jane E. Ishmael1 and Kerry L. McPhail1
1Department of Pharmaceutical Sciences, College of Pharmacy, 2Department 
of Chemistry, College of Science, Oregon State University, Corvallis, OR 
97331, U.S.A.
Mandelalides A-D are polyketide macrolides reported from a new Lisso-
clinum species of South African ascidian in 2012. The conformational fle-
xibility of the macrolactone skeleton and the presence of two discrete and 
independent stereochemical regions confounded the absolute assignments 
of mandelalides A-D by spectroscopic methods. The absolute structure of 
mandelalide A was subsequently corrected, through total synthesis, to a 
configuration where all five stereocenters in the northern hemisphere were 
inverted. The revision of mandelalide A makes it likely that mandelalides 
B-D were also misassigned. Further evaluation of the potent biological acti-
vity is also needed given that the glycosylated mandelalides A and B showed 
potent cytotoxicity to human NCI-H460 lung cancer cells (IC50, 12 and 44 
nM, respectively) and mouse Neuro-2A neuroblastoma cells (IC50, 29 and 
84 nM, respectively), while insufficient amounts of non-glycosylated man-
delalides C and D prevented their biological testing as pure compounds. 
Herein, computational methods have been used to predict 13C and 1H NMR 
chemical shifts for comparison to the experimental data for mandelalide 
A and investigate the absolute configurations of mandelalides B-D, which 
contain an additional furanone compared to mandelalide A. In addition, 
new members of the mandelalide family have been isolated and characteri-
zed from a re-collection of the source tunicate, and provide further insight 
into the structure-activity relationships of this compound series.
3118
PHENYLPROPANOIDS AND FLAVONES FROM DESMOS 
PEDUNCULOSUS (ANNONACEAE) FROM VIETNAM
Jason A. Clement1, John G. Ondeyka1, Michael A. Goetz1
1Natural Products Discovery Institute, Baruch S. Blumberg Institute, 
Doylestown PA, 18902, USA. 
The genus Desmos consists of several species of trees and shrubs, mainly 
found in southeastern Asia. Many of these species have had few or no re-
ports of their chemistry. Phytochemical investigation of the tree Desmos 
pedonculosus (A. DC.) Bân (Annonaceae) from Vietnam led to the isolation 
and characterization of two flavones and several benzoate esters derived 
from cinnamyl alcohol. Three of the isolated benzoate esters have not been 
reported previously from nature. A comparison of the chemistry of diffe-
rent plant parts will be presented, as well as a consideration of the identified 
components relative to other members of genus Desmos. This work illustra-
tes the potential for the discovery of new natural products from the NPDI 
plant extract collection, in particular the pre-fractionated plant extract set 
currently being developing. 
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3119
FIVE NOVEL O-METHYLATED BIOPTERIN GLYCOSIDES 
FROM TWO MICROCYSTIS BLOOMS MATERIALS
Marina Lifshits, Dimitry Kovalerchick and Shmuel Carmeli
Raymond and Beverly Sackler School of Chemistry and Faculty of Exact 
Sciences, Tel-Aviv University, Ramat Aviv, Tel-Aviv 69978, Israel
Five uniqe biopterins, 2’,3’,4’-tri-O-methyl-�-mannobiopterin (1), 
3’-O-methyl-�-glucobiopterin (2), 3’-O-methyl-�-rhamnobiopterin 
(3), 3’-O-methyl-�-mannoheptobiopterin (4), and 6’-O-methyl-�-
glucoobiopterin (5), were isolated from the extracts of two bloom materials 
of Microcystis spp. collected from a fishpond (IL-337) and Lake Kinneret 
(IL-347), Israel. The structure of the pterins was established interpretation 
of their UV, CD, 1D and 2D NMR spectra and HR mass measurements. 
Their antimicrobial and cytotoxic properties were evaluated but all were 
found not active in both assays. The structure elucidation of the coum-
pounds will be described.
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3120
COMBINATORIAL BIOSYNTHESIS BY THE SPONGE 
TEDANIA BRASILIENSIS OPTIMIZES THE ANTI-
PARASITIC ACTIVITY OF BROMOPYRROLE ALKALOIDS
Roberto G. S. Berlinck1, Lizbeth L. L. Parra1, Eduardo Hajdu2, Antonio G. 
Ferreira3, Andre G. Tempone4
1Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, 
SP, Brazil; 2Museu Nacional, Universidade Federal do Rio de Janeiro, RJ, 
Brazil; 3Departamento de Química, Universidade Federal de São Carlos, 
São Carlos, SP, Brazil; 4Instituto Adolfo Lutz, São Paulo, SP, Brazil; 5Museu 
Nacional, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil; 
6Departamento de Química, Universidade Federal de São Carlos, São 
Carlos, SP, Brazil
Tedania brasiliensis is a rare species of marine sponge endemic to Brazil, 
which gave an anti-viral, antileishmanial and antitrypanosomal extract. 
Bioassay-guided isolation yielded a series of 16 new pseudoceratidine (1) 
derivatives with variable number of bromines and length of the triamine 
chain, as well as tedamides, unique alkaloids within this series bearing a 
completely modified pyrrole moiety. The potency against Leishmania in-
fantum and Trypanosoma cruzi parasites of the isolated alkaloids showed 
influence by the bromination level, results which will be presented and 
discussed.
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3121
MOLECULAR MECHANISMS THAT UNDERLIE THE 
SEXUAL STIMULANT ACTIONS OF (SALVIA LANIGERA) 
AND (OSTEOSPERMUM VAILLANTII).
Tawfeq AlHowiriny ª*, Kamal ElTahir†, and Areej Altaweel* 
*Department of Pharmacognosy, College of Pharmacy, King Saud University, 
P.O. Box 2457, Riyadh 11451, Saudi Arabia †Department of Pharmacology, 
P.O. Box 2925, King Khalid University Hospital, King Saud University, 
Riyadh 11461, Saudi Arabia ªMedicinal, Aromatic and Poisonous Plants 
Research Center (MAPPRC), College of Pharmacy, King Saud University, 
P.O. Box 2457, Riyadh 11451, Saudi Arabia
The effects of extracts and subfractions of Salvia lanigera rhizomes, Osteo-
spermum vaillantii and sildenafil on the sexual behavior of male rats and 
their effects on the intracavernosal pressure (ICV), intracavernosal cyclic 
cyclic guanosine monophosphate (GMP) and dihydrotestosterone plasma 
level were examined. The sexual behavior was followed for four hours using 
infra-red video cameras to quantify the effects on various male sexual be-
haviors. The results revealed that the active subfraction in case of S. lanigera 
was the hexane fraction of the chloroformic extracts (C/H) whereas that of 
O. vaillantii was the acetonitrile fraction of the alcoholic extracts (A/Ac). 
(C/H), (A/Ac) and sildenafil significantly increased the total sexual stimu-
lation index from 53.8 ± 2.7 (control) to 116 ± 3.8, 253 ± 2.7 and 401 ± 30.1, 
respectively. They significantly increased the index of successful mounting 
and ejaculation from 2.6 ± 0.5 (control) to 19 ± 0.5, 13 ± 0.6 and 18 ± 1.7, 
respectively. They significantly increased the cyclic GMP level from 0.94 ± 
0.07 (control) to 2.81 ± 0.19, 2.65 ± 0.14 and 3.66 ± 0.19 ng/mg wet weight 
tissue, respectively. Furthermore, (C/H) increased plasma dihydrotestoste-
rone level. Other treatments did not affect this parameter. (C/H), (A/Ac) 
and sildenafil increased the (I.CV) pressure. Both extracts and sildenafil 
acted via an increase in cyclic GMP with an additional increase in dihydro-
testosterone release in case of (C/H). 
3122
SCREENING OF PLANT EXTRACTS FOR ANTI-
INFLAMMATORY ACTIVITY 
Yulia Radko1, Steen B. Pedersen2, Lars P. Christensen1
1Department of Chemical Engineering, Biotechnology and Environmental 
Technology, Faculty of Engineering, University of Southern Denmark, 
Campusvej 55, 5230 Odense M, Denmark. 2Department of Clinical 
Medicine, Aarhus University, Tage-Hansens Gade 2, 8000 Aarhus C, 
Denmark.
In our search for natural products with anti-inflammatory activity, which 
are comparable to that of the polyphenol resveratrol, we investigated a lar-
ge number of medicinal plant extracts for their anti-inflammatory activity. 
Among the tested extracts were the n-hexane, dichloromethane, ethyl ace-
tate and methanol extracts produced by sequential extraction of aerial parts 
and roots of the medicinal plants, Rhodiola rosea, Achillea millefolium, Va-
leriana officinalis, Platycodon grandifloras. Many of these extracts showed 
strong effect on interleukin-6 (IL-6) production in LPS-stimulated THP-1 
macrophages. We found that all four extracts of roots of V. officinalis and 
P. grandiflorus as well as the n-hexane, ethyl acetate, and methanol extracts 
of aerial parts of A. millefolium were able to inhibit production of IL-6 in 
LPS-stimulated THP-1 cells comparable to the anti-inflammatory control 
resveratrol (50 µM). Interestingly some extracts, among them methanol ex-
tracts of roots of R. rosea, showed an inflammatory effect.
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ISOLATION OF CHROMOPHORIC AND NON-
CHROMOPHORIC COMPOUNDS IN NATURAL 
PRODUCTS USING INTEGRATED FLASH AND 
PREPARATIVE CHROMATOGRAPHY
Melissa Wilcox, Yogesh Choudhari, PhD, Ajit Patil, MS Pharm
Grace Discovery Sciences, 2051 Waukegan Road, Deerfield, IL 60015
Isolation and purification of active components from natural origin is 
a challenging process, traditionally requiring multiple steps and large 
amounts of organic solvent. Natural product extracts have been shown to 
contain both chromophoric and non-chromophoric components. Iden-
tifying non-chromophoric compounds in complex mixtures can be diffi-
cult because traditional ultraviolet (UV) detection fails to detect targets and 
impurities that are present at low levels or lack chromophores. Evaporative 
light scattering detection (ELSD) provides advantages over spectroscopic 
detectors for detecting compounds that are deficient in a UV-absorbing 
chromophore. Here we demonstrate the isolation and purification of cap-
saicins in chili powder to greater than 95% purity using a new “dual mode” 
flash chromatography and preparative chromatography system capable of 
detecting both chromophoric and non-chromophoric compounds. Addi-
tionally, non-chromophoric Stevioside & Rebaudioside A can be purified to 
98.65% & 98.5% purity respectively from other non-chromophoric impuri-
ties using the same system. Isolation of these and other active compounds 
will be reviewed in detail demonstrating simple and effective purification 
on a single integrated system.
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PHYTOCHEMICAL CONSTITUENTS AND CYTOTOXIC 
ACTIVITIES OF THE TRADITIONAL HERBAL MEDICINE 
MARSDENIA TENACISSIMA
Li Tang1* , Mingbo Zhao2, Yirun Wang1, Yeling Wang1, Yue Liu1, Chunlin 
Long1
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing, 10081,China. 2State Key Laboratory of Natural and Biomimetic 
Drugs, School of Pharmaceutical Sciences, Peking University Health Science 
Center, Beijing 100191, China
Marsdenia tenacissima (Roxb.) Wight et Arn is a traditional herbal medicine, 
which has been used for centuries in southwest China in the treatment of 
cancer, neoplasia, and other diseases. The drug made from M. Tenacissima, 
named as antitumor injection, had been proved high clinical effective for 
hepatocellular carcinoma, lung cancer, and gastric cancer. Previous studies 
indicated that the main effective components in M. Tenacissima were C21 
steroidals. The aim of the present work is the elaboration of constituents 
and the cytotoxic activities of C21 steroidals in the title herb. Twenty-four 
compounds were isolated and structurally determined from the ethanol 
extract under the bioassay-guided procedure, including sixteen C21 steroid-
als, three azulenes, four disaccharide derivatives, and a bisepoxyligan. There 
are twelve novel compounds among them. The cytotoxic activities of C21 
steroidals were evaluated using MTT assays on three human non small cell 
lung cancer cells, NCI-H292, NCI-H460, and NCI-H1975 cell lines. Two 
C21 steroidals, Tenacissoside I and Tenacigenin A, exhibited good potency 
against the three cell lines with IC50 values of 0.32 and 0.97, 0.74 and 2.69, 
1.59 and 7.70 μM, respectively.The results support the ethnomedicinal 
usage of M. Tenacissima. Acknowledgements: Thank the supporting grant 
for NCET-12-0578, 13-0624, 111Project B08044 and YLDX01013.
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PHYTOCHEMICAL ANALYSIS OF THE 
HEPATOPROTECTIVE FRACTION OF COMASTOMA 
PEDUNCULATUM USING HPLC-DAD-ESI-MS/MS 
Yeling Wang1, Li Tang1*, Yanyu Cai1, Yue Liu1, Chunlin Long1 and Xiaoming 
Xu2
1College of Life and Environmental Sciences, Minzu University of China, 
Beijing 100081, China, 2College of Physicians and Surgeons, Department of 
Medicine, Columbia University, New York, 10032, USA
Comastoma pedunculatum (Rogle ex D. Dou) Holub is a traditional Tibetan 
herbal medicine used under the name “zangyinchen” for the treatment of 
liver and gallbladder disease. In the present work, we describe a phytoche-
mical analysis to profile the hepatoprotective fraction (ethyl acetate extract) 
of the title herb using a high performance liquid chromatography-diode 
array detector electrospray ionization-tandem mass spectrometry (HPLC-
DAD-ESI-MS/MS) analytical method. Seventeen compounds, comprising 
6 xanthones, 6 flavonoids, and 5 saponins, were separate and determinate 
in the hepatoprotective fraction, based on the comparison of their UV and 
MS data with those of authentic compounds and published data. Carbon 
tetrachloride-induced acute liver injury model was used for evaluation of 
antihepatotoxic activity of the ethyl acetate extract of C. pedunculatum. 
The biochemical marker enzymes in serum and liver homogenate of rat 
were assayed, including aspartate aminotransferase (AST), alanine ami-
notransferase (ALT), and total bilirubin(TB), along with the microscopic 
pathological examinations for liver tissue.These results may help to gain 
a better understanding of the therapeutic basis of C. pedunculatum and 
establish a better quality control method for this Tibetan herbal medici-
ne. Acknowledgements: Thank the supporting grant for NSFC-81274158, 
81373765, NCET-12-0578, 13-0624, SEAC-12ZYZ019, 111Project B08044 
and YLDX01013.
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